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Abstract 
The research in this thesis is focused on new intermolecular additions of diverse 
nucleophiles to allenic and bisallenic motifs catalysed by transition metals. In the first project 
we developed a new Au-catalysed azidation of allenes for the synthesis of functionalised 
allylic azides, which are important precursors to many functional groups. A cationic Au(I)-
catalyst was found as a suitable activator for the allenic π-system favouring the attack of 
challenging azides as nucleophiles and giving access to the desired allylic azides. Deuterium-
labelling experiments revealed that the reaction goes via a vinyl gold intermediate, which 
allowed an orthogonal functionalisation of the allenes, using as electrophile iodine to break 
the Au-C giving valuable iodo-alkenyl azides. Besides, preliminary mechanistic studies by 
NMR disclosed a possible inner-sphere mechanism with the formation of Au-N3 complexes 
with a continuous exchange of counterions involved in the reaction.  
The second part of the present thesis was aimed to develop a novel platinum-catalysed 
carbo- and heterocyclization of 1,5-bisallenes to obtain 6- or 7-membered rings with and extra 
oxygen functional group incorporated in the skeleton of the molecule. These cyclic compounds 
are interesting building blocks encountered into the core of several natural products, especially 
in terpene and sesquiterpene family. Cationic Pt(II)-catalysts with electron-withdrawing 
ligands were found appropriate to lead the ring closing of these 1,5-bisallenes. The reaction 
seems to be triggered by the attack of oxygen nucleophiles to the activated terminal π-system 
of the bisallene showing different coordination modes, which give access to isomeric 6- or 7-
membered rings. Deuterium labelling and preliminary mechanistic experiments revealed, that 
the formation of the products goes via a vinyl platinum intermediate in the different cyclization 
modes. Besides, the reaction has been monitored by 1H NMR in order to study the 
decomposition level of the bisallenes under catalytic conditions and the possible 
interconversion between the isomeric cyclic products.  
 
 
 
 
 
 
 
7 
 
Table of Contents 
Declaration                                                                                                                                2 
Dedication                                                                                                                                 3 
Acknowledgements                                                                                                                   4 
Abstract                                                                                                                                     6 
Abbreviations                                                                                                                          11 
Chapter 1. General Introduction on allenes: history, structure and synthesis               15 
 1.1. History                                                                                                                 16 
1.2. Structure and characterization                                                                             17 
  1.2.1. Symmetry of allenes                                                                            17 
  1.2.2. Bond lengths and angles                                                                      18 
  1.2.3. Infrared (IR) and ultraviolet-visible (UV) spectroscopy                     18 
  1.2.4. Nuclear magnetic resonance spectroscopy (NMR)                             18 
  1.2.5. Axial chirality in allenes                                                                     19 
 1.3. Synthesis of allenes                                                                                             20 
 1.4. Synthesis of allenes from alkynes                                                                       20 
  1.4.1. Homologation reaction of acetylene derivatives                                 20 
  1.4.2. Synthesis of allenes by isomerization of alkynes                                24 
  1.4.3. Synthesis of allenes by metal-mediated SN2’ substitution                  24 
  1.4.4. Synthesis of allenes via copper(I)-catalysed coupling of  
           N-tosylhydrazone and alkynes                                                             33 
Chapter 2. Gold-catalysed hydroazidation of allenes                                                        36 
 2.1. Introduction                                                                                                         37 
 2.2. Relativistic effects                                                                                               38 
 2.3. Chemistry of gold-allene complexes                                                                   39 
 2.4. Gold-catalysed reactions of allenes with nucleophiles                                       41 
8 
 
 2.5. Gold-catalysed intermolecular reactions of allenes and nucleophiles                41 
  2.5.1. Gold-catalysed intermolecular reactions of allenes with 
  oxygen  nucleophiles                                                                            42 
  2.5.2. Gold-catalysed intermolecular hydroamination of allenes                  44 
  2.5.3. Gold-catalysed intermolecular hydrothiolation of allenes                  48 
  2.5.4. Gold-catalysed intermolecular hydroarylation of allenes                   49 
 2.6. Allyl azides                                                                                                          50 
 2.7. Aims and objetives                                                                                              52 
2.8. Results and discussion                                                                                         52 
 2.8.1. Screening of conditions                                                                       53 
 2.8.2. Synthesis of allenes                                                                             65 
 2.8.3. Gold-catalysed intermolecular addition of azides to allenes               68 
 2.8.4. Isomerisation of allyl azides 124 and 125                                           70 
 2.8.5. Deuterium-labelling experiments                                                        72  
 2.8.6. Formation of side products: Proposed mechanism                             74 
 2.8.7. Preliminary mechanistic studies of the catalytic cycle                       77  
 2.8.8. Applicability and versatility of this transformation                            86 
              2.8.9. Attemps to develop a gold-catalysed oxidative cross-coupling  
                        reactions of allenes                                                                             87           
2.9. Conclusions                                                                                                         88 
 2.10. Experimental section                                                                                         89 
Chapter 3. Platinum-catalysed carbo- and heterocyclisation of 1,5-bisallenes             122 
3.1. Introduction                                                                                                      123 
 3.2. Platinum-catalysed intermolecular reactions of allenes with nucleophiles      124 
 3.3. Introduction to the chemistry of bisallenes                                                      127 
 3.4. Reactivity of 1,5-bisallenes                                                                               128 
9 
 
  3.4.1. Thermal carbocyclisation of 1,5-bisallenes                                        129 
  3.4.2. Transition metal-catalysed reactions of 1,5-bisallenes                       130 
         3.4.3. Transition metal-catalysed reactions of 1,5-bisallenes adding an  
  additional partner                                                                              133 
  3.4.4. Radical cyclisation of 1,5-bisallenes                                                 139 
 3.5. Aims and objetives                                                                                            140 
  3.6. Results and discussion                                                                                      141 
  3.6.1. Synthesis of starting materiales                                                         141 
  3.6.2. Catalysts screening                                                                            147 
  3.6.3. Solvent Screening                                                                              153 
              3.6.4. Scope of platinum-catalysed alkoxycyclisation reaction of  
1,5-bisallenes                                                                                     155 
  3.6.5. Internal references to quantify NMR yields                                      158  
  3.6.6. Experiments to study the level of decomposition of the starting material 
            under reaction conditions                                                                    158 
  3.6.7. New screening of platinum catalysts                                                 162   
  3.6.8. Scope with different oxygen-nucleophiles                                        163 
  3.6.9. Optimisation conditions using H2O as nucleophile                           164  
  3.6.10. Screening of platinum-catalysts with the new conditions using H2O  
                                      as nucleophile                                                                                       165 
  3.6.11. Scope of platinum-catalysed hydroxycyclisation reaction of  
               1,5-bisallenes                                                                                   166 
  3.6.12. New optimization studies                                                                169 
  3.6.13. Mechanistic insights and deuterium-labelling experiments            173 
 3.7. Conclusions                                                                                                       181  
 3.8. Experimental section                                                                                         183 
10 
 
References                                                                                                                            256 
Appendix                                                                                                                              267 
Appendix A                                                                                                              268 
Appendix B                                                                                                              271 
  
11 
 
Abbreviations 
Å   angstrom 
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AcO   acetoxy group 
app   apparent 
Bn   benzyl  
(BOC)2O    tert-butyoxycarbonyl anhydride 
bs   broad singlet 
bt   broad triplet 
n-Bu   n-butyl lithium (in hexanes, 2.5M) 
t-Bu   tertiary butyl 
calc.   calculated 
oC   degrees Celsius 
cm-1     inverse centimetre (unit for wavenumber) 
d   doublet 
dd   doublet doublet 
ddd   doublet doublet doublet 
dt   doublet triplet 
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DFT   Density Functional Theory 
DMF   N,N-dimethylformamide 
DMSO   dimethylsulfoxide 
DMAP   4-dimethylaminopyridine 
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EDG   electron donating groups 
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General introduction on allenes: 
history, structure and synthesis 
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1.1. History 
The chemistry of allenes has flourished exponentially during the last few years, due 
to the extraordinary versatility inherent to their structure. The origin of allene chemistry arose 
when in 1875, the first chemist awarded with the Nobel prize, Jacobus Henricus Van't Hoff 
published in “La Chimie dans l’space”[1] his theory about these optically active compounds, 
and using homemade cardboard structures he predicted the existence of two stereogenic axes 
in the allene moiety (Figure 1). There have been many attempts to synthesise these cumulenic 
structures,[2] and it was in 1887 that Burton and Pechmann,[3] obtained “glutinic acid” 1 (Figure 
2) when trying to justify the non-existence of these “unstable structures”. However, due to the 
lack of analytical instrumentation in that age, the confirmation of the glutinic acid structure 
was not reported until 1954 by Jones and coworkers.[4]  
 
 
 
 
 
 
Figure 1. Predicted structure of an allene using tetrahedral models by Van’t Hoff.[1] Figure reproduced from: 
https://webspace.yale.edu/chem125/125/history99/6Stereochemistry/vanthoff/tetrahedra.html 
In 1935, Kohler, Walker and Tisher published the resolution of this racemic allenic 
carboxylic acid,[5] and a year later Maitland and Mills verifying experimentally Van’t Hoff’s 
prediction, synthesised the first enantiomerically pure axial chiral allene 2 (Figure 2).[6] 
  
Figure 2. Glutinic acid 1, (S)-(+)1,3-di(α-napthyl)1,3-diphenylallene 2 
In 1924 Staudinger and Ruzicka published a work based on the discovery of the 
structure of the first naturally occurring allene, Pyrotholone, obtained from Chrysanthemum 
cinerariaefolium.[7] However, advances in spectroscopy later confirmed that instead of an 
allenic skeleton this molecule showed a conjugated diene moiety.[8] A few years later, the 
genuine first naturally occurring allene was discovered: Mycomycin 3 (Figure 3),[9] a fungal 
metabolite with a high antibiotic activity.[10] 
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Figure 3. Mycomycin 3, first discovered naturally occurred allene 
1.2. Structure and characterisation of allenes 
The structure of allenes consists of a linear 3-carbon skeleton formed by two π-bonds, 
which are orthogonal to each other connected by a sp-carbon. If the two terminal sp2-
hybridised carbons bear different substituents, these species are provided with axial chirality.  
1.2.1. Symmetry of allenes   
The two perpendicular angles of the allene give rise to a tetrahedral conformation 
(D2d): there is a C2 axis lying through the 3 aligned carbons and two perpendicular C2 axes 
passing through the sp-hybridised carbon of the allene. Moreover, the main C2 axis contains 2 
symmetry planes, which divide the allene in two sections each containing two substituents. 
The arrangement of these two planes of symmetry is known as Sd symmetry and it is 
characteristic of allenes (Figure 4).[11]  
 
Figure 4. Axes and planes of symmetry of allenes. Figure made with tools provided in: 
http://symmetry.otterbein.edu/gallery/index.html 
The tetrahedral D2d conformation of allenes is adopted only by members in the 
cumulene family with an odd number of carbons. Analogues with an even number of carbons 
show planar conformation (D2h symmetry) when the molecule is not substituted.[12] Recently 
Tykwinski and coworkers published a wide range of properties, syntheses and varieties of 
cumulenes with an even number of cumulenic carbons.[13] 
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1.2.2. Bond lengths and angles 
The study of the structural features of allenes is essential to understand the nature, 
reactivity, selectivity and chirality of this functional group. Theoretical analysis on bond 
lengths and bond angles were published and confirmed quantitative and qualitatively by 
different methods.[14] It was observed that the length of C=C of the allene molecule (C3H4) is 
0.03 Å shorter than C=C of an ethene[15] and 0.06 Å longer than acetylene.[16] 
Depending on the technique used for the measurement (IR, Raman, Mw) the length of 
C=C belonging to the simplest allene is ≈ 1.308 ± 0.008 Å, with slight modifications depending 
on the nature of the functional groups in substituted allenes.[17] This C=C=C group provides 
rigidity to the molecules, explaining their interesting peculiarities.[11a] 
1.2.3. Infrared (IR) and Ultraviolet-Visible (UV) spectroscopy 
As the two π-systems of the allene are perpendicular to each other, the conjugation 
between them is roughly non-existent. Thus, allenes do not exhibit any absorption of light 
above 200 nm, so that UV-visible spectroscopy is rarely used for the detection and 
identification of allenes.[18] 
One of the most common empirical methodologies to characterise allenes is infrared 
spectroscopy (IR). The linear C=C=C shows two easily recognisable bands in the IR spectra. 
One corresponds to the asymmetric stretching vibration of the C=C=C bonds between 1930 – 
1950 cm-1 and the second one is the symmetric stretching vibration of C=C=C at ≈ 1075 cm-1. 
In symmetrically substituted allenes the symmetric stretch mode of C=C=C is not active in IR 
because there is no change in the dipole moment, whereas it will be present in a Raman 
spectrum.[18-19]  
1.2.4. Nuclear magnetic resonance Spectroscopy (NMR) 
NMR techniques are essential in the determination and identification of organic 
molecules, and also a very useful methodology for the determination of allene structures. The 
chemical shift of the allenic protons appears slightly more deshielded than the ethylene 
protons. This can be explained by the central sp-carbon and the anisotropic contribution of the 
non-conjugated π-orbitals of the allene, which has an influence on the proton shielding.[18] 
Also, four-bond coupling constant (J4) in allenes is normally observed, for example the J4 
between two protons in the simplest allene, was reported with a value of ≈ 6.50 - 7.00 Hz. This 
long-range coupling constant suggests some σ→π interactions, which are supported by 
experimental and theoretical calculations.[18-20]  
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13C NMR is a valuable tool for the identification of allene moieties. The sp-hybridised 
carbon bears an intense paramagnetic effect, showing low field chemical shifts, up to 200 ppm. 
Also, as with 1H NMR, the nature of the allene structure has an important role in these high 
frequency values. Table 1 shows chemical shift values in 13C NMR for allenes and cumulenes. 
It can be observed that the sp-carbon of the cumulated alkenes with an odd number of carbons 
(non-planar molecules, C2 and C3 in entries 1, 3 and 5) display higher chemical shifts. In 
contrast, the sp-carbon of cumulenes with an even number of carbons (planar symmetry, C2 
entries 2 and 4) display lower chemical shifts.[18] 
Entry Compound 
13C NMR Chemical shifts (ppm, relative to TMS) 
C1 C2 C3 
1 H2C1=C2=C1H2 73.6 212.5 - 
2 H2C1=C2=C2=C1H2 118.0 171.1 - 
3 Ph2C1=C2=C1Ph2 112.5 208.3 - 
4 Ph2C1=C2=C2=C1Ph2 122.7 152.0  
5 Ph2C1=C2=C3=C2=C1Ph2 117.8 181.6 119.3 
Table 1. 13C NMR values for allenes and cumulenes [18] 
1.2.5. Axial chirality in allenes 
The unique structural nature of allenes reveals an uncommon axial chiral property, 
and two different substituents in each sp2-carbon make allenes optically active. This allene 
feature is due to its tetrahedral symmetry (D2d), the two non-conjugated π-systems and also the 
impossibility of free rotation due to the rigidity of the molecule in standard conditions. 
The absolute configuration of the enantiomeric species can be determined according 
to the configurational nomenclature of Cahn, Ingold and Prelog.[21]  
  
Figure 5. Representation of axial chirality of allenes 
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These rules propose that to enumerate the (S) or (R) stereoisomers, allenes are viewed 
through their C2 axis (see Figure 4), placing first the atom with higher atomic number directly 
attached to the sp2-carbon topmost of the vertical axis (see number 1 Figure 5). Then, in the 
horizontal axis (see 3 in Figure 5) the atom with higher atomic number will take precedence 
over the other substituent (see number 4 in Figure 5). The stereochemistry of these cumulenic 
alkenes will be determined via clockwise (R) or counter-clockwise (S) screw pattern of atomic 
number (Figure 5).[22]  
1.3. Synthesis of allenes  
There are a significant number of publications, reviews or books dedicated to the 
synthesis of allenes.[19, 21a, 22b, 23] Originally, these species were considered unstable and 
laborious to make. Moreover, the detection and determination of these species due to the lack 
of progress in analytical techniques delayed advances on their synthesis as starting materials 
and their versatility in synthetic chemistry. However, in the last 20 years, the chemistry of 
these cumulenic alkenes has blossomed exponentially due to the development of robust 
methods for the synthesis of mono, di, tri and tetrasubstituted allenes,[23d, 23f, 23g, 24] in racemic 
or enantiomeric form.[22b, 23f, 23g, 25] In this introduction we will emphasise the most important 
reactions to synthesise allenes related to the ones used on the experimental work of this thesis.  
1.4. Synthesis of allenes from alkynes 
1.4.1. Homologation reaction of acetylene derivatives 
 Since Pierre Crabbé and coworkers discovered the first one-step homologation of 
acetylenes into allenes using paraformaldehyde, an amine and a copper catalyst in 1979,[26] 
numerous modifications have been developed to enhance the scope of the reaction. The 
versatility and robustness of this reaction has been shown using different metals such as Cu, 
Zn or Cd, various amines or chiral amines, different temperatures, aldehydes, ketones, and 
there are two examples of this reaction assisted by microwave irradiation. For example, 
monosubstituted allenes 5 (Scheme 1) can be synthesised by modified Crabbé-homologations 
changing the amine, copper salts or starting materials.[26-27] 1,3-Disubstituted allenes 6 and 
1,1,3-trisubstituted allenes 9 have been synthesised from aldehydes or ketones instead of 
paraformaldehyde, using zinc[28] or cadmium[29] as catalysts. Also, with the right choice of 
amine, the group of Mukay obtained allene 6 under microwave irradiation.[30] Optically active 
1,3-disubstituted allenes such as (R)-7,[25a, 31] have been synthesised using copper(II) and 
zinc(II) catalysts and aldehydes, using chiral amine (S)-8 as an organocatalyst in moderate to 
good yields and high ee (%). 
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Scheme 1. Allene formation by acetylene homologation 
 The mechanism of the Crabbé homologation is proposed to proceed by addition of 
copper-acetylide ion 12, formed by complexation of the copper to terminal alkyne 4 and 
deprotonation by the amine, to an iminium ion 10 generated in situ from a Mannich-type 
reaction between the aldehyde 11 and the amine. Subsequently, an intramolecular 1,5-hydride 
shift occurs from the -proton of the amine group on the propargylamine intermediate to the 
copper-activated triple bond achieving the allene 5 (Scheme 2, top right). 
Scheme 2. Proposed mechanisms of the Crabbé homologation using CuBr, diisopropyl amine and 
paraformaldehyde 
The first attempt to study the mechanism of this acetylenic homologation was reported 
by Pierre Crabbé and coworkers in 1980. They reported the formation of a hydridocopper(I) 
complex 13 (Scheme 2, bottom right). In this case a hydride is transferred from the 
propargylamine intermediate giving the allene with the concomitant release of the iminium 
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product.[32] At the same time, Fillion and coworkers published the mechanistic study of this 
homologation, as part of their attempt to study the mechanism of the Mannich reaction.[33] 
They suggested that one of the hydrogen atoms from the diisopropylamine migrates via a 1,5-
hydride shift to the internal acetylene carbon activated by CuBr to obtain the desired allene 
(See Scheme 2). 
Recently, an interesting computational mechanistic study of this reaction has been 
published.[34] López and coworkers evaluated the role of the copper examining the reaction 
with and without the catalyst. They proposed that the copper is essential in the reaction to 
activate the alkyne (a2 Scheme 3). Subsequent hydride shift through the transition state (b2, 
Scheme 3) shows quite low activation energies in comparison with absence of catalyst. 
Besides, copper stabilizes the zwitterionic vinyl carbanion intermediate (c2 Scheme 3), 
triggering the formation of the allene. In previous proposals the role of copper was as a 
BrØnsted acid/base catalyst abstracting the proton from the diisopropylamine and managing 
the 1,5-hydride shift.[32] However, in their work López and coworkers invoked that the H-shift 
from the amine derivative to the triple bond occurs without any copper-H interaction, and their 
computational study suggests that the activation of the alkyne with copper occurs from the 
opposite face to the hydride transfer (Scheme 3).[34]  
 
Scheme 3. Computational mechanistic study of methyl allene formation via Crabbé homologation. Relative Gibbs 
free energies in Kcal/mol[34] 
A similar mechanism has been postulated by the group of Ma, employing as catalysts 
ZnI2 and CdI2 to achieve 1,3-di-6 and 1,1,3-trisubstituted 9 allenes (Scheme 4). In both 
proposals the metal coordinates with the triple bond forming, after deprotonation, the 
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intermediate 14, similar to the copper analogue 12 (Scheme 2). These species react with the 
iminium ion 15 preformed in situ with morpholine and aldehydes if ZnI2 is the catalyst, or 
pyrrolidine and ketones if the reaction is catalysed by CdI2, generating the propargylic amine 
16 (Scheme 4). The catalyst coordinates to the triple bond in 16, and after a 1,5-hydride shift 
and subsequent β-elimination generates the desired products 6 and 9.  
   
Scheme 4. Proposed mechanism for the synthesis of 1,3-disubstituted 6 and 1,1,3-trisubstituted 9 allenes, via 
acetylene homologation 
This homologation reaction has been employed in the synthesis of naturally occurring 
allenes with good yields and high enantioselectivities. Recently, Ma and coworkers reported 
the highly enantioselective synthesis of linear allenes extracted from seed oils such as 
laballenic acid 17, lamenallenic acid 18 or the hydroxy acid 19, used as antifungals, using 
CuBr2 as catalyst and (S)-8 (see Scheme 1) as an organocatalyst (Figure 6).[35] With the same 
reaction conditions Ma developed the synthesis of the insect pheromone 20,[25a] first isolated 
in 1970 by Horler from male “dried bean beetles” Acanthoscelides obtectus.[36] 
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Figure 6. Laballenic acid 17, lamenallenic acid 18, hydroxy acid 19 and insect pheromone 20 
1.4.2. Synthesis of allenes by isomerization of alkynes 
An isomerization reaction is a process where the constitution of the molecule is 
modified, maintaining the same molecular weight and the same empirical formula.[24b] The 
formation of the allenes by isomerization of the analoguous alkyne is one of the earliest ways 
of synthesis reported.[24b, 37] This reaction is carried out with terminal alkynes normally in the 
presence of strong bases (n-Buli, t-BuOK, KOH, NaNH2) and high temperatures (Scheme 
5).[38] 
   
Scheme 5. Synthesis of allenes by isomerization reaction 
Trisubstituted allenes can also be synthesised via an isomerization reaction from 
internal alkynes. In this particular case, metalation and subsequent protonolysis gave access to 
allene 21 (Scheme 6).[24b] 
  
Scheme 6. Synthesis of trisubstituted allene 21 by isomerization reaction 
1.4.3. Synthesis of allenes by metal-mediated SN2’ substitution 
One of the most effective and commonly used methodologies for the synthesis of 
allenes is the metal-mediated substitution reaction of propargyl derivatives (SN2’). These 
reactions can occur through a stereoselective addition of the organometallic compound from 
the same face (syn) or the opposite face (anti) of the leaving group depending on the nature of 
the substrate, the reductive agent, the leaving group or the temperature.[24c]  
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1.4.3.a. Organocopper-mediated synthesis of allenes  
Since the first report of an organocopper-mediated SN2’ substitution reaction by P. 
Rona and P. Crabbé in 1968,[39] this method has been widely used for the synthesis of allenes 
by C-C bond formation using carbon-based organocuprates, and for the synthesis of halo-, 
stannyl-, or silylallenes, even in the enantiomeric version, from the propargylic electrophiles 
and heterocuprates.[22b, 23f-h] Alongside this, P. Crabbé and coworkers also studied 
organocuprates combined with Grignard and organozinc reagents to expand the scope of this 
reaction upon different substrates.[23f, 24d]  
The mechanism for this reaction is proposed to be triggered by the interaction between 
a d-orbital of the copper and the π* orbitals of the electrophilic alkyne (Figure 7), with the  
formation of a Cu(III) intermediate 22, which, after reductive elimination gives rise to the 
allene 23 via a formal anti-SN2’.[24d] 
 
Figure 7. Interaction between an electrophilic alkyne and d-orbital of copper catalyst 
 
Scheme 7. Mechanism for the synthesis of allenes by SN2' anti-stereoselective via organocuprates 
Chirality transfer from the propargyl starting material to the allene using this 
methodology is possible. An example is shown in Scheme 8, where formal syn-SN2’ was 
proposed to explain the transfer of chirality from the propargyl ether 24 (Scheme 8). The 
reaction was carried out using copper(I), a Grignard reagent and P(OEt)3 as additives, used to 
avoid the anti-SN2’. The use of chloride to preform the Grignard reagent was a determinant in 
the selective β-elimination step. Due to its electronegativity and the small size, the chloride 
favours the transition state 25 by chelation with the strong Lewis acid MgCl2, favouring the 
syn-SN2’ to achieve allene 26.[24d, 40] 
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Scheme 8. Proposed mechanism for the synthesis of allenes via syn-SN2' with organocuprates 
Frequently, cuprates are used in combination with Grignard and organozinc precursors 
to modify the reactivity of those species. The use of phosphines as additives has shown to 
improve the regio- and anti-stereoselectivity leading the reaction toward the desired product 
(Scheme 9). For example, propargyl epoxide 27, in the presence of lithium organocuprate is 
thought to react according to the mechanism proposed previously, generating a σ-copper(III) 
intermediate similar to 22 (Scheme 7), achieving allene 29 in low ratio, accompanied by α-
allenol 28, which could come from the protodemetalation of the same intermediate (Scheme 
9). Interestingly, the addition of phosphines enhances the formation of the desired allene 29.[41] 
The use of CuCN, Gridnard reagents and phosphines with the same substrate showed high 
yields, excellent selectivities and high anti-diastereoselectivity of allenes 30 and 31. 
  
Scheme 9. Different outcomes in the SN2' substitution of propargyl epoxyde 27 with lithium cuprates, magnesium 
cuprates and zinc cuprates 
Organocuprates have been highly relevant in the total synthesis of many natural 
products and pharmacologically active target molecules.[35] As an example, the methylated 
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carbacyclin derivative (±) 33 (Scheme 10), which is a promising anti-thrombotic agent, or the 
allenic prostaglandin analogue of enprostil (±) 35,[42] the most relevant and marketed allenic 
prostaglandin, which is usually administered an as inhibitor of gastric acid secretion, or to 
reduce postprandial serum gastrin levels. Both were synthesised by an SN2’-reduction of the 
propargyl acetates (±) 32 and (±) 34 respectively with the concomitant release of the leaving 
group.[35] 
 
Scheme 10. Synthesis of racemic carbacyclin derivative 33 and racemic allenic prostaglandins analog 35 
 This organocopper-mediated substitution has been applied to the synthesis of 
enantiomerically enriched haloallenes 37a and 37b, important allene skeletons found in many 
natural products.[10, 23f] For example panacene 37a and 37b (Scheme 11) were the first isolated 
bromoallene found in nature in 1977, obtained from Aplysia brasiliana, a sea hare indigenous 
and it is used as a feeding deterrent to predatory fishes. The synthesis was developed via anti-
SN2’-substitution of propargyl derivative 36a and 36b using LiCuBr2.[43]  
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Scheme 11. Synthesis of panacenes 37a and 37b 
(±)-Laurallene 38 (Figure 8), (±)-kumausallene 39 or (±)-obtusallene 40 are a few 
more examples of these complex bromoallene natural products.[10, 23f, 44]  
 
Figure 8. (±)-Laurallene 38, (±)-kumausallene 39, (±)-obtusallene 40 
 The synthesis of these species can be performed selectively via syn or anti SN2’ 
depending on the halocuprate reagent of the type LiCuX2 (X = Cl, Br, I).[24d] For example, 
silylated bromoallenes 42 and 44 (Scheme 12) were synthesised stereoespecifically under mild 
conditions, via copper-mediated anti-SN2’ substitution from alkyne anti-41 or syn-43.[24d]   
  
Scheme 12. Synthesis of enantiomerically pure bromoallenes of serine-derivatives 
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 This methodology has also been used on the synthesis of advanced molecular 
materials.[45] Krause and coworkers in 1999 reported the first allenophane 45 (Scheme 13) 
synthesised via copper-mediated SN2’ substitution in moderate yields.[46]  
  
Scheme 13. Synthesis of the first allenophane 45 
Other complex chiral molecular materials have been synthesised employing axial 
chiral allenes as building blocks conferring structural stability and interesting chiroptical 
properties.[45, 47] Additionally, these macromolecules are being employed as chiral ligands for 
metal complexes, chiral sensors, hosts for small guest molecules or ligands for asymmetric 
catalysis.[23f, 45-46] 
1.4.3.b. Organozinc-mediated synthesis of allenes 
 The synthesis of allenes via organozinc compounds is an attractive pathway to 
synthesise allenes and bisallenes. Generally, this organometallic reagent is used with cuprates 
as mentioned before,[24c, 24d] or Pd catalysts.[23d, 24c, 48] For example, the reaction of lithium 
triorganozincates with propargyl mesylates was proposed to occur through an SN2’-type 
mechanism, achieving the allenylzinc intermediate 46, which after quenching with water 
affords allene 47, or by a Pd(0)-catalysed dimerization forms 1,2-bisallene 48 (Scheme 14). 
Scheme 14. Synthesis of allenes and bisallenes via lithium triorganozincates 
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1.4.3.c. Aluminium-mediated synthesis of allenes 
 Aluminium hydride reagents such as diisobutylaluminium hydride (DIBAL-H) or 
lithium aluminium hydride (LiAlH4) are also employed in substitution reactions via the SN2’ 
pathway to synthesise allenes from propargylic alcohols, epoxides or ethers. The mechanism 
of this substitution reaction is proposed to be triggered by intermediate 49 (Scheme 15), where 
the aluminium coordinates to the oxygen, followed by hydride attack to the triple bond leading 
to the subsequent SN2’-type process with the release of the oxygen as leaving group, generating 
1,1-disubstituted allenes 50. This methodology is commonly used as a powerful tool to 
synthesise α-allenol derivatives.[24c] The stereoselectivity of this process can be modulated to 
be either syn or anti, depending on the hydride source, the temperature of the reaction, leaving 
groups used or the propargylic substrates.[24c, 49] 
  
Scheme 15. Synthesis of allenes via SN2'-reaction using LiAlH4 
 The high efficiency of this methodology has been applied in the synthesis of natural 
products such as allenic steroid 51 (Scheme 16),[10, 50] or the “grasshopper ketone” 52, isolated 
in 1968 from secretion of flightless grasshopper Romalea microptera showing repellent effects 
on its predators.[51] This famous allenic carotenoid belongs to the most numerous allenic 
naturally occurring group. Structurally, these species exhibit the allene moiety as well as a 
cyclohexylidene ring in their skeleton.[10] Dinoxanthin, neoxanthin, peridinin or fucoxanthin 
are carotenoids in marine animals which skeleton is formed by at least one of these building 
blocks showing properties varied as immune enhancements, antioxidation and 
photoprotection.[10]  
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Scheme 16. Synthesis of allenic steroids 51 and "grasshopper ketone" 52 by reduction of propargylic alcohols using 
aluminium hydrides [35] 
1.4.3.d. Indium-mediated synthesis of allenes 
 Indium is a versatile metal-reagent, which in the presence of propargyl halides 
generates allenylindium intermediates. These species are effective cross-coupling partners in 
reactions with organo-palladium complexes[52] and afford α-allenyl alcohols in the reaction 
with carbonyl groups.[53] Besides, allenylindiums can be generated in aqueous media, 
accentuating the importance of these reagents in organic synthesis and making it possible for 
reactions of these precursors to occur with non-soluble compounds in organic solvents such as 
carbohydrates.[53a, 54] 
 Chan and coworkers reported the first indium-mediated coupling of aliphatic or aryl 
aldehydes with 2-propynyl bromide derivatives 53 to produce α-allenols 54 as well as β-
propargylic alcohols 55 (Scheme 17).[53b] In order to synthesise selectively α-allenol 
derivatives 54, the use of γ-substituted propargyl bromide 53 was essential.[53b] In a different 
approach, this selectivity issue was solved by the group of Alcaide and coworkers by using 
THF as a solvent and a saturated solution of ammonium chloride as an additive, in the reaction 
of β-lactam-containing propargyl derivatives as substrates.[55] 
 
Scheme 17. Indium-mediated coupling of aldehydes with 2-propynyl systems 
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 The proposed mechanism to explain the formation of the propargylic alcohol 55 and 
the α-allenol 54 goes via a Barbier-type reaction between an γ-alkyl halide 53 and a carbonyl 
group, catalysed by indium metal. In the example of Alcaide et al, the use of the ammonium 
salt was crucial to minimise the nucleophilic addition of the allenylindium intermediate to the 
carbonyl group, using water as the solvent (Scheme 18).[53a]  
 
Scheme 18. Proposed mechanism for the indium-mediated synthesis of α-allenols [54a] 
 Allenylindium intermediates can also be involved in metal-catalysed cross-coupling 
reactions. The group of Lee reported a versatile one-pot palladium-catalysed reaction of 
aromatic halides and allenylindium intermediates to obtain bisallene 56 and trisallene 57 
(Scheme 19) with high chemo- and regioselectivity.[52]  
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Scheme 19. Palladium-catalysed cross-coupling reactions of in situ generated allenylindium reagents with organic 
halides 
1.4.4. Synthesis of allenes via Cu(I)-catalysed coupling of N-tosylhydrazones and 
alkynes 
 Metal-catalysed coupling reactions are efficient ways to synthesise allenes, with 
palladium and copper catalysts being the most investigated.[23f, 56] N-Tosylhydrazone and diazo 
derivatives are important precursors in these metal-catalysed coupling reactions with terminal 
alkynes to generate C-C bonds in high yields.[56e, 57]  
 In 2011 Wang, inspired by the published work of Suarez and Flu,[57b] developed the 
first synthesis of functionalised di- and trisubstituted allenes 6 and 9 (Scheme 20) from 
terminal alkynes 4 and N-tosylhydrazones 58 via copper(I) catalysis under mild conditions 
(Scheme 20).[58]  
    
Scheme 20. Synthesis of di- and trisubstituted allenes 6 and 9 by coupling of N-hydrazones 58 and terminal alkynes 
4 catalysed by copper(I) 
Wang proposed a mechanism initiated by the formation of copper(I) acetylide species 
12 (Scheme 21) from the terminal alkyne 4 and the copper(I) salt in the presence of base. Then, 
the diazo intermediate 59 generated in situ by deprotonation of N-tosylhydrazone 60, reacts 
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with acetylide 12 generating copper-carbene complex 61. 1,2-Migratory insertion of the 
alkynyl group would form intermediate 62, which suffers a 1,3-copper migration to obtain 
intermediate 63. Allenes 6 and 9 were formed after protonolysis of intermediate 63 with the 
concomitant regeneration of the copper(I) catalyst.[56c, 58]  
   
Scheme 21. Proposed mechanism of the Cu(I)-mediated synthesis of trisubstituted allenes through coupling of N-
tosylhydrazones with terminal alkynes. 
 In 2013 the group of Wang published two articles reporting a few modifications on 
this reaction. In their first article, they reported the use of a cheaper copper(I) salt (CuI) to 
trigger the formation of the copper-carbene complex 61 (see Scheme 21) in the synthesis of 
the 1,3-disubstituted allene 6 from terminal alkyne 4 and N-tosylhydrazones 64, easily 
preformed from the corresponding aldehyde (Scheme 22).[59] 
 
 Scheme 22. Synthesis of 1,3-disubstituted allenes by coupling of N-tosylhydrazones and terminal alkynes 
 Wang and coworkers were also able to develop an efficient synthesis for trisubstituted 
allyl allenes 65 (Scheme 23) by modifying the final protonation step. Thus, instead of a 
protonolysis of the nucleophilic organocopper intermediate 63 (Scheme 21), a carbon-based 
electrophile was used to trap the organocopper species 62 (Scheme 23) leading towards the 
formation of allyl substituted allenes 65.[56d]   
35 
 
  
Scheme 23. Synthesis of allyl allenes by coupling of N-tosylhydrazones, terminal alkynes and allyl halides  
 Recently, Wang and coworkers have also published a novel synthesis of 1,1-
disubstituted allenes 67, promoted by a copper-carbene migratory insertion (Scheme 24). In 
this work, ethyne gas and N-tosylhydrazones 66 derived from aromatic ketones were used, 
obtaining allenes 67 in high yields.[56b]  
  
Scheme 24. Synthesis of 1,1-disubstituted allenes by coupling of N-tosylhydrazones and ethyne catalysed by CuI 
 Simultaneously, Ley and coworkers reported an excellent work based on Wang’s 
proposed mechanism (see Scheme 21), incorporating the concept of flow chemistry for the in 
situ formation of the unstable diazo compounds 68 (Scheme 25) at room temperature, carrying 
out the reaction under milder conditions to obtain 1,3-disubstituted allenes 69.[56c] 
  
Scheme 25. Synthesis of di-substituted allenes by coupling of diazo compounds with terminal alkynes catalysed 
by Cu 
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Chapter 2. 
Gold-catalysed hydroazidation of allenes 
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2.1. Introduction 
 “Golden times” or “a golden age” are colloquial expressions that are reminiscent of 
prospering situations or epochs with satisfactory economical wealth. This concept was 
acquired because in the past gold was employed as a valuable currency. 
 Among its properties, gold is corrosion and moisture resistant, a good thermal and 
electrical conductor (collectors for solar cells, components of circuits), and it is the most 
ductile and malleable metal. Gold is neither toxic, nor an allergen and it is not harmful to the 
environment. Therefore gold is commonly used in dental issues such as orthodontic 
appliances, crowns, bridges or fillings, and in drugs for medical disorders such as rheumatoid 
arthritis or tumours / cancer of stomach and intestines.[60]  
 In contrast, the growth of gold in chemistry was not as expected. Schmidbaur, in an 
interesting review about how gold chemistry has blossomed, said “an old rule of catalyst 
research appears to regard gold as black sheep among the noble metals, for it has so far found 
practically no catalytic application”,[61] in other words, gold was eclipsed by other 
catalytically active metals such as platinum, palladium, rhodium, osmium, or ruthenium and 
mercury, “platinum group metals (pgm)”, which were physically and chemically similar. 
 Besides, another reason for its exclusion of research could be supported on the lack of 
chemisorption on gold in heterogeneous catalysis, with the “pgm” group of metals being more 
catalytically effective.[62] 
 About 655 publications in gold chemistry were reported until 1977, highlighting 
remarkable work on gold catalysed heterogeneous hydrogenation of olefins reported by Bond 
and coworkers.[63] During this period several alternatives for selective oxidation of 
hydrocarbons,[64] in particular the oxidation of carbon monoxide were widely investigated. 
Haruta, in one of his communications mentioned, “The chemical industry would be 
transformed if selective oxidation of hydrocarbons could be achieved efficiently using cheap 
and clean oxygen from the air. Doing that with gold as a catalyst is a method gaining in 
allure”.[65] In 1987 Haruta and his colleagues published the awaited oxidation of carbon 
monoxide at low-temperatures by heterogeneous gold catalysis.[64, 66] Simultaneously, 
Hutchings and coworkers reported a hydrochlorination of ethyne under heterogeneous gold 
catalysis.[67] After these two works, the importance of gold as catalyst was established, and 
more or less at the same time Ito and coworkers developed the first homogeneous asymmetric 
gold catalysis,[68] followed by interesting works in this field by Fukuda and Utimoto[69] in 
addition to Teles and coworkers.[70] Several homogeneous gold-catalysed examples were 
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revealed previously, however, from 2000 until our days the number of publications in this field 
has grown exponentially.[71] 
2.2. Relativistic effects  
 The unique chemical features of gold are remarkably affected by relativistic effects in 
comparison with the “pgm” (Figure 9). These effects consider velocity as meaningful relative 
to the speed of light “c” due to the high speed of the electrons moving close to a heavy nucleus. 
As a consequence, radial contraction is given, where the s and p orbitals are contracted. In 
contrast, d and f orbitals are expanded, being more shielded from the nucleus and suffering a 
weaker attraction from the core with subsequent energetic destabilisation.[72] 
 
Figure 9. Relativistic contraction of the 6s orbital in different elements. This figure was reproduced directly from: 
D.J. Gorin, F.D. Toste, Nature, 2007, 446, 394-403.[72-73] 
 This contracted 6s orbital forms strong covalent bonds (Au-Ligand), confirming the 
greater first ionization potential (9.22 eV.) compared with silver (7.57 eV.). In contrast, the 
second ionization potential is 0.09 eV lower than silver, since the electrons that remain in the 
5d-level are higher in energy (Figure 10). Thus, gold has a remarkable electron affinity (2.31 
eV) if it is compared with silver (1.23 eV), therefore, it shows high electronegativity (2.4) 
manifesting the formation of auride (Au-I) compounds (CsAu or RbAu) with semiconductor 
properties.[74] Besides, AuI–AuI species display bond strength similar to strong hydrogen bonds 
and they can be used for their optical properties and medical applications.[75] 
The yellow colour of gold is another confirmation of relativistic effects. The small 
bandgap between the Fermi level and the 5d electrons (Figure 10) favours the absorption into 
visible light, reflecting red and yellow light.[72-73] 
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Figure 10. AuH and AgH bond energies. Relativistic (R) and non-relativistic (NR) orbitals. This figure was 
reproduced from: D.J. Gorin, F.D. Toste, Nature, 2007, 446, 394-403.[72-73]  
 The relativistic contraction of the s orbital also affects the catalytic properties of gold. 
The high electronegativity of Au(I) is linked with a strong Lewis acidity, whereas, cationic 
Au(I) species possess a “soft” Lewis acidity activating efficiently π-systems (alkynes, allenes 
and alkenes).[73] Oxidation of Au(I) to Au(III) is rarely given in catalysis. However the use of 
an external oxidant makes it possible for oxidation to Au(III) and the subsequent reduction in 
oxidative coupling reactions.[76] According to this, Au(I) is able to catalyse reactions without 
exclusion of air or in aqueous media.[73] 
2.3. Chemistry of gold-allene complexes 
 After the consolidation of gold as a powerful catalyst in organic chemistry, a large 
number of works in hetero- and homogeneous catalysis have been reported. Focusing our 
interest on homogeneous gold catalysis, electrophilic activation of unsaturated moieties has 
drawn much attention. However, in this introduction to the experimental work carried out, 
only the remarkable versatility of allenes as substrates for gold-catalysed functionalization will 
be described.[77] 
 The allene skeleton is associated with selectivity problems as well as higher reactivity 
than alkynes and alkenes (Figure 11). In addition to the regio- (to provide constitutional 
isomers), stereo- (cis- or trans-addition to obtain stereoisomers) and chemoselectivity (single 
or double addition) found in reactions with alkynes and alkenes, due to their two orthogonal 
π-systems allenes also have positional selectivity issues, the challenge being addition towards 
a specific double bond.[77-78]  
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Figure 11. Diverse selectivity modes in unsaturated compounds [77-78] 
 Coordination of gold to allenes also displays more complexity than the complexation 
with alkynes or simple alkenes. Gold can coordinate to allenes in a common η2-coordination 
mode with either one of the double bonds of the allene 70 (Figure 12). Similarly to the 
coordination of gold with simple alkenes, depending on the electronic properties of ligands 
employed and the substituents of the allene skeleton, the gold will be shifted towards the 
central carbon as in 71 or one of the terminal carbons of the allene as in 72 (Figure 12).[77, 79] 
However, there is yet another possibility for coordination. Structure 73 (Figure 12) shows a 
coordinative mode where gold is σ-bounded to the sp-hybridized carbon of the allene (η1-
coordination). This structure can be seen as the σ-allyl cation 73, a zwitterionic carbene 74 or 
η1-bent allene 75 (Figure 12). This η1-coordination mode has been proposed in transition 
states,[80] reactive intermediates for C-X bond formation, or in axis-to-center chirality transfer 
reactions with allenes.[77, 79]  
 
Figure 12. Modes of coordination of gold with allenes[77] 
 These modes of gold-allene coordination have been supported by computational (DFT 
calculations) and (VT) NMR studies,[81] revealing how these species can interconvert and that 
the η2-coordination favours preferentially to the less hindered π-system of the allene in the 
ground state. Mile and coworkers reported experimental data, where they detected a η1-gold-
allene radical using ESR spectroscopy at 77 K.[77, 82] In addition, an example of a gold-allene 
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with η1-coordination has been isolated (76, Scheme 26) using a strongly-electron donating 
tetraaminoallene as substrate.[77, 81, 83]  
 
Scheme 26.Example of η1-coordination mode of gold-complexes using high electron-donating groups 
2.4. Gold-catalysed reactions of allenes with nucleophiles 
 Gold-allene interactions are frequently electrophilic activations, with nucleophilic 
attack of carbon-based nucleophiles (arenes, carbon pronucleophiles) and heteroatoms 
(nitrogen, oxygen and sulfur) in inter- and intramolecular versions the most reported. Gold-
catalysed hydrofunctionalisation of allenes for the synthesis of heterocycles (intramolecular 
reaction) has been studied extensively during the past years.[77, 84] Gold-catalysed addition of 
external nucleophiles to allenes (intermolecular reactions) has received less attention (Scheme 
27). The present chapter of this thesis deals with the external addition of nucleophiles to allenes 
to give allyl derivatives, and this introduction will focus on this topic only. 
  
Scheme 27. General example of a gold-catalysed intermolecular reactions of allenes with nucleophiles to give allyl 
derivatives 
2.5. Gold-catalysed intermolecular reactions of allenes with nucleophiles  
 The formation of E-allylated compounds by complexation of nucleophiles to allenes 
is generally assisted by an electrophilic activation of gold to one of the π-systems of the allene 
leading to the formation of a vinyl-gold complex as an intermediate. However, the attack of 
the external nucleophile can be managed depending on the interactions with the metal and its 
nature. Thus, two mechanisms are proposed for this reaction: inner- and outer-sphere 
mechanisms (Scheme 28).  
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Scheme 28. Inner- and outer-sphere mechanism for the gold-catalysed intermolecular reaction of allenes with 
nucleophiles 
 In the inner-sphere mechanism (green in Scheme 28), it has been proposed that the 
external nucleophile coordinates with gold first (77, Scheme 28). Then, η2-coordination of the 
Au-Nu with one of the π-systems of the allene generates the tricoordinate complex 78, which 
after the intramolecular attack of the nucleophile, gives rise to Z-vinyl-gold complex 79. 
During the gold-elimination process, isomerization by rotation of a C-C bond has been 
proposed (80, 81), which gives the E-allyl product 84.[77] 
 In the outer-sphere mechanism (red in Scheme 28), the gold is proposed to behave as 
a π-acid, activating the allene (82, Scheme 28) for the subsequent nucleophilic attack on the 
activated sp2-carbon from the opposite face, to give the E-vinyl-gold intermediate 83, which 
after protodemetalation gives the allyl derivative 84. 
2.5.1. Gold-catalysed intermolecular reactions of allenes with oxygen nucleophiles 
 The addition of oxygen nucleophiles to allenes is widely employed to obtain versatile 
allyl ethers with high atom economy and in high yields. However it should be noted that the 
addition of oxygen nucleophiles in the enantioselective version has not been reported so far. 
In 1998 Shulz and Teles published the first gold-catalysed reaction of allenes and 
alcohols.[70] However, the groups of Zhang,[85] Yamamoto[86] and Widenhoefer[87] developed 
the bulk of the hydroalkoxylations of allenes catalysed by gold to obtain E-allyl ethers 
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(Scheme 29). Recently, an interesting review from Muñoz covers all these reported gold-
catalysed hydroalkoxylations.[88] 
Cationic N-heterocyclic carbenes (NHC-Au complexes) 86a[87b] or phosphine-Au 
complexes 86b and 86c[85a, 86a] have been used as the best catalytic systems for these reactions. 
Hydroalkoxylation reactions using NHC-Au complexes 86a (Scheme 29) led to the attack 
through an outer-sphere mechanism.[87] Whereas, the use of phosphine-Au complexes 86b and 
86c proposed the formation of tricoordinated gold-complex 78 (Scheme 28) following an 
inner-sphere mechanism to obtain allyl derivatives 87 (Scheme 29).[77, 86] Generally, the 
addition of the oxygen nucleophiles is favoured to the less hindered double bond of the allene 
87 (Scheme 29).[86-87] However, the regioselectivity towards the most hindered carbon of the 
allene can be enhanced when an excess of alcohol is used.[77, 89] If the allene is substituted with 
heteroatoms such as alkoxyallenes[85b] 88a or 4-vinylidene-2-oxazolidinones[89a] 88b (Scheme 
29), the nucleophilic attack occurs at the most substituted carbon 89 (Scheme 29).   
 
Scheme 29. Gold-catalysed intermolecular hydroalkoxylation of allenes 
 DFT calculations on the Au(I)-catalysed hydroalkoxylation of simple allenes showed 
that the addition of the nucleophile is the rate limiting step and occurs via an outer-sphere 
mechanism, with the attack to either terminal sp2-carbons of the allene moiety in 90 and 92 
(Scheme 30).[90] The study showed that although the product of the attack to the less substituted 
carbon is thermodynamically more stable 93, the nucleophilic addition to the more substituted 
carbon 91 is kinetically favoured. Energy values confirmed that the hydroalkoxylation reaction 
is irreversible so it was proposed that the kinetically favoured product 91 isomerised to the 
thermodynamically more stable and most experimentally observed product 93 in a process 
catalysed by gold via a cyclic transition state.[77, 90]  
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Scheme 30. DFT studies for Au(I)-catalysed hydroalkoxylation of allenes 
2.5.2. Gold-catalysed intermolecular hydroamination of allenes 
 The addition of nitrogen nucleophiles to allenes catalysed by gold is an attractive 
pathway to synthesise enamines, imines, hydrazones or allyl amines with high atom economy 
and good yields. It is important to mention that amines can coordinate easily with the metal 
centre, therefore the electrophilic activation of the allene can be conditioned by the nature of 
the catalyst or the Au-N interactions.[77, 91]  
 The first Au(III)-catalysed intermolecular hydroamination of chiral 94b and non-
chiral 94a allenes using aniline as a nucleophile was reported by Nishina and Yamamoto 
(Scheme 31).[92] In this work, high chirality transfer and selectivity problems (regio-, stereo-, 
chemo- and positional selectivity)[78] were solved, obtaining enantiomerically enriched E-
allylated products 95b. The suggested mechanism proposed the formation of a tricoordinate 
gold-complex 78 (Scheme 28).[77, 92]  
  
Scheme 31. Au(III)-catalysed intermolecular hydroamination of chiral and non-chiral allenes using aniline as 
nucleophile [77]  
 Aryl amines have also been used by Widenhoefer[93] with mono-, 1,1- and 1,3-
disubstitued allenes, and also by the group of Kimber[77, 94] with valuable allenamides as 
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substrates, obtaining high yields and good regioselectivities. In his work, Kimber achieved the 
Markovnikov E-allylamino carbamates 98a (Scheme 32) proposing an outer-sphere 
mechanism, where the Au(I)-π-allyl complex could be stabilised by conjugation with the 
nitrogen of the allenamide with the subsequent addition of the nucleophile to less hindered 
carbon of the allene.[94] On the other hand, Widenhoefer proposed the formation of E-
allylamines 98b (Scheme 32) via two alternative inner- or outer-sphere mechanisms, without 
enough experimental evidence to decide between them.[93] 
  
Scheme 32. Synthesis of E-allylamino carbamates and E-allylamines.  
It is interesting to emphasise the work of Widenhoefer and coworkers to obtain E-
allylamines 100a and 100b (Scheme 33) using N-unsubstituted carbamates as nucleophiles 
with mono-, 1,1-, 1,1,3- and tetrasubstituted allenes,[95] as well as its enantioselective 
version[96] with 1,3-disubstituted allenes catalysed by gold complexes. Generally, the addition 
of nucleophiles occurs at the terminal sp2-carbon of the allene moiety, whereas, in this 
hydroamination reaction catalysed by NHC-Au complexes the attack occurs at the most 
hindered carbon of the allene (100a, Scheme 33). The proposed interpretation of this unusual 
addition resides in an outer-sphere mechanism with the rapid and reversible interconversion 
of the Au(I)-π-allene, and the attack occurring to the most hindered carbon (Scheme 33).[95] In 
the enantioselective version, the authors used chiral bis(gold) phosphine complexes 101b. One 
of the two gold centers is proposed to catalyse the C-N bond formation process, and the other 
metal-centre increases the conversion to the desired product. Also,  the N-allyl carbamate 
product can coordinate with the second gold-centre, modifying the catalytically active species 
and promoting racemization of enantiomerically pure allenes 99b (Scheme 33).[77, 96]  
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Scheme 33. Synthesis of N-unsubstituted allyl carbamates catalysed by Au(I)  
Less reactive aliphatic secondary amines (such as morpholine) have also been used as 
nucleophiles by the groups of Bertrand[97] and Yamamoto.[86b, 98] Their intermolecular additions 
to allenes, catalysed by Au(I)-complexes gave rise to Markovnikov E-allyl products in good 
yields. Both reactions are proposed to take place through an inner-sphere mechanism. 
However it should be noted that the authors found evidences of gold-amine complexes in the 
reactions.  
Although the nucleophile generally attacks the sp2-carbons of the allene, it has been 
observed that selectivity problems arise when small nucleophiles are employed (ammonia and 
hydrazine). In this case, the addition occurs at the central, terminal or both carbons of the 
allene, depending on steric factors. The group of Bertrand used simple ammonia or the parent 
hydrazine as nucleophiles for the addition to allenes employing CAAC-Au-complexes to 
obtain imines or hydrazones derivatives in good yields from the unusual attack of the nitrogen 
nucleophile to the central carbon of the allene (Scheme 34).[99] DFT calculations on this 
reaction were recently published using hydrazine as N-nucleophile.[91b] In this study, an outer-
sphere mechanism is proposed. Thus, when 1,2-propadiene 102 (Scheme 34) is used as 
substrate, the addition of ammonia led to the attack at the sp2-carbon to form 103, whereas, 
the addition of hydrazine took place on both terminal and central carbon of the allene 
generating allyl hydrazine 104 and imine 105 respectively. Additionally, the attack of 
hydrazine and ammonia to the central carbon of the allene was also observed employing 
tetraphenyl-1,2-butadiene 106 as substrate (Scheme 34). In this case, the energy profile 
suggests a rapid but reversible nucleophilic addition to the terminal sp2-carbon of the allene, 
and slower but irreversible attack to the central carbon of the allene skeleton, obtaining 
products 107 and 108.[77, 91b, 99] 
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Scheme 34. Au(I)-catalysed hydroamination of allenes using ammonia and hydrazine as nucleophiles 
 The group of Toste[80] reported a full mechanistic study of the Au(I)-catalysed 
intermolecular addition of nitrogen nucleophiles to allenes. In this work, the authors used 
hydrazide as the nucleophile, the symmetrical 1,7-diphenylhepta-3,4-diene 109 as the 
substrate and Ph3PAuNTf2 as an effective catalyst source to obtain allyl derivatives 110 in high 
yields (Scheme 35). Kinetic analysis, NMR experiments, DFT calculations, chirality transfer 
and reversibility experiments as well as experiments to analyse the electronic properties in the 
ligand of the gold-complex led to the proposal of an outer-sphere mechanism where allene 
activation by Au(I) is the rate-limiting step, with a transition state invoking an η1-gold-bent 
allene coordination complex before the nucleophilic attack.[77, 79-80] 
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Scheme 35. Proposed mechanistic study for the Au(I)-catalysed addition of hydrazides to allenes 
 Another example of C-N bond formation employing allenes as substrates is the one 
reported by the group of Zhang, where sulfonamides are used as nucleophiles to obtain 
valuable Markovnikov N-allyl sulfonamides in high yields.[77, 100]  
2.5.3. Gold-catalysed intermolecular hydrothiolation of allenes 
 The affinity of gold for sulfur is known. Several gold complexes are employed using 
sulfur ligands to catalyse reactions or as precursors to insert new ligands due to the lability of 
sulfur. There is only one example of gold-catalysed intermolecular hydrothiolation of allenes 
reported so far.[101] This work published by the group of Yamamoto shows a double addition 
of sulfur nucleophiles to the central sp-carbon of the allene, obtaining dithioacetal products 
111 (Scheme 36). The reaction is catalysed by AuBr3 using exclusively mono-aryl allenes such 
as 94a as substrates and aryl sulfides as nucleophiles. In the mechanism, a double catalytic 
cycle was suggested. The formation of a gold-sulfide complex by in situ ligand exchange, and 
the vinyl sulfide 112 as an intermediate are essential steps in the proposed catalytic cycle 
(Scheme 36).[77, 101]   
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Scheme 36. Reaction and proposed mechanism of gold-catalysed hydrothiolation of allenes 
2.5.4. Gold-catalysed intermolecular hydroarylation of allenes 
 Electron-rich aromatic compounds can also be used as nucleophiles in reactions with 
allenes catalysed by gold-complexes. High selectivity has been observed in the examples 
reported so far to obtain E-allyl derivatives from the attack to the less hindered sp2-carbon of 
the allene. Outer-sphere mechanism is the most accepted mechanistic proposal for these 
reactions, where the gold activates the allene by an η2-coordination, and the aromatic 
compound is added to the allene in a Friedel-Crafts-type reaction.[77] 
 The first gold-catalysed hydroarylation was reported by Skouta and Li,[102] employing 
electron-rich aromatic compounds such as anisole, mesitylene 113 or tetramethylbenzene 
(Scheme 37) as nucleophiles to obtain the Markovnikov E-allylated product 114. However, no 
reaction was observed with indole or benzene. Although an inner-sphere mechanism invoking 
aryl-Au(III) species was initially proposed, the authors did not report supporting evidence for 
this proposal.[102] 
 
Scheme 37. Au(III)-catalysed intermolecular reaction of aryl compounds to allenes 
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 Similar results were obtained by Gagné and coworkers employing (4-
ClC6H4O)3PAuCl/AgBF4 as the catalytic system.[103] The E-allylated product was obtained in 
moderate to good yields when electron-rich methoxy-substituted arenes were used as 
nucleophiles and unhindered monosubstituted allenes and 1,1-dimethylallene were employed 
as substrates. However, heterocyclic systems (pyrrole, indole and furan) did not give rise to 
the desired products.[77, 103] 
 After the attempts of the groups of Li[102] and Gagné[104] to catalyse addition of 
heterocycles to allenes, Widenhoefer and coworkers[105] used NH- and N-Me-indoles 116 
(Scheme 38) as nucleophiles for the addition to NHC-Au-activated allenes, such as 115, to 
obtain E-allyl product 117. Outer-sphere attack to the Au(I)-π-allene complex from the C(3) 
position of the indole via an iminium ion was proposed.  
 
Scheme 38. Synthesis of allyl N-Me-indoles 117 catalysed by Au(I) using substituted allenes 
 The enantioselective version of the previous reaction[105] was developed by the group 
of Che.[106] In this work, the authors employed a binuclear Au(I)-phosphine complex using (S)-
(–)-MeO-BIPHEP (BIPHEP = biphenylphosphine) ligand. DFT calculations suggested AuI-
AuI interactions, where one of the metal centres binds to the indole and the other one to the 
allene simultaneously, both being essential to improve the enantioselectivity of the reaction.  
2.6. Allyl azides 
  Organic azides were discovered in 1894 by Peter Griess,[107] however, the versatility 
of these functional groups was widely expanded in the 1950s and 1960s with the uses of aryl, 
alkyl and acyl azides in industry,[108] or in pharmaceuticals, with special attention in the 
treatment of HIV.[109] A remarkable example for the use of azides in organic synthesis is the 
1,3-dipolar azide-alkyne (Scheme 39) cycloaddition developed by Huisgen[110] as a powerful 
tool in the synthesis of triazoles 118 with high stereoselectivity and in mild conditions or a 
copper-catalysed version of this reaction reported by Sharpless,[111] and also microwave 
assisted to reduce the time.[110b, 112]  
  
51 
 
 
Scheme 39. General synthesis of triazoles via 1,3-dipolar addition 
 In this thesis azides have been employed as nucleophiles to generate allylic azides in 
the reaction with the activated allenes. NaN3 or TMSN3 are the most common and easily 
manageable nucleophilic azide sources, in addition to organoaluminium[113] or trialkyl tin 
azides[114] generally preformed in situ. Formation of extremely toxic and explosive HN3 from 
NaN3 and TMSN3 is commonly observed due to small traces of protic components, a process 
difficult to avoid in the reaction media. Although the true nucleophile in our reaction, this 
hazardous acid is considered explosive due to its violent decomposition forming nitrogen and 
hydrogen, in addition it produces stable complexes with haemoglobin, blocking the oxygen 
transport (same effects with CN groups) or lowered blood pressure,[115] so special precautions 
that were undertaken for the generation and use of this reagent will be described in the results 
and discussion section.  
 Allylic azides, the desired products in our reactions, are common building blocks for 
the synthesis of natural products or nitrogen containing heterocycles or also to introduce 
complex functional groups into simple molecules. These allylic skeletons can undergo 
dimerizations via 1,3-dipolar additions[116] or  give [3,3]-sigmatropic rearrangements.[117] 
Besides, they are useful precursors to many functional groups[109b, 109c] such as amines[118] and 
nitriles.[119] Allylic azides 119 (Scheme 40) can be obtained by substitution reactions of allylic 
alcohols,[120] allylic esters,[118a, 121] allylic halides[116, 122] and allyl silanes[123] using as catalysts 
Ag, Mo(IV), Pd(0, II and IV) and triphosgene.  
 
Scheme 40. Classic approach for the synthesis of allyl azides 
 The first reported example of synthesis of these allylic structures using allenes as 
substrates was the monoaddition of iodine azide to allene 120.[117] 121 was obtained as major 
product, as well as 122 and the tetrazole 123, which results from the attack of MeCN to the 
iodonium ion intermediate with the subsequent azide attack to the nitrilium species (Scheme 
41). 
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Scheme 41. Iodine azide addition to allenes 
 Recently, a copper(I)-catalysed trifluoromethyl-azidation of allenes (Scheme 42) has 
been developed by Liu and coworkers.[124] This method shows good regio- (terminal sp2-
carbon) and stereoselectivity (E-isomer), with moderate to good yields, using TMSN3 as azide 
source. 
 
Scheme 42. Copper(I)-catalysed trifluoromethyl-azidation of allenes 
 Cheng and coworkers[125] have reported an intermolecular carboazidation of allenes 
catalysed by palladium complexes with aryl iodides using TMSN3 as azide source. The 
reaction works efficiently, however regio- and stereoselectivity was low, because of the rapid 
1,3-shift of the azido group which was observed.   
2.7. Aims and objectives 
 The aim of this work was to develop a new method for the synthesis of allyl azides. 
This was explored by employing allenes as substrates, catalysing the reaction by using gold 
complexes and using the more challenging azides as nucleophiles. Once the new methodology 
was developed, we aimed to add to the synthesis the possibility of an orthogonal 
functionalisation of the allenes, via vinyl gold intermediate, whose Au-C bond is cleaved by 
using iodine as an electrophile. In a further step, this allyliodide will be functionalised using 
cross-coupling reactions, as well as 1,3-dipolar additions. 
2.8. Results and discussion  
 In the following chapter I will describe a novel gold-catalysed intermolecular addition 
of azides to substituted allenes, developed in our group that adds to the pool of available 
reactions for the synthesis of these interesting allylic azides, with some extra benefits (Scheme 
43).[126]  
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Scheme 43. General Scheme to the Au(I)-catalysed intermolecular addition of azides to allenes 
 This project started as a collaboration with Prof. Hashmi (University of Heidelberg) 
and one of his Master student (Stephanie Hoene), who carried out the preliminary screening 
of different parameters to get the best reaction conditions. In the next few pages, a summary 
of her work will be presented, showing the high sensitivity of this methodology to reaction 
conditions such as solvents, counterions, catalysts and additives. 
2.8.1. Screening of conditions  
 Preliminary results showed that TMSN3 was the best azide source,[127] due to the low 
solubility of NaN3 in organic solvents. The combination of Ph3PAuCl/AgOTf to generate the 
cationic Au(I)-complex was chosen. Commercially available cyclohexylallene 96b was 
employed as the standard substrate for the screening at different temperatures (Scheme 44). 
Solvents tested with the previous conditions, included THF, MeCN, toluene and DCM. The 
reaction worked in THF, toluene and DCM, however the affinity of gold catalysts for 
chlorinated solvents was confirmed with the best results achieved with DCM. In addition, the 
reaction was also tested at different temperatures, with no further improvement.  
 
Scheme 44. Best conditions and yields achieved after the screening of silver salts, solvents, azide sources and also 
different temperatures. Conversion was obtained by integration of a characteristic signal of each compound in the 
1H NMR spectra of the crude of reaction in relation to the starting material observed at the end of the reaction 
 The “soft” Lewis acidity of cationic Au(I)-complexes is widely employed in 
electrophilic activations of unsaturated moieties such as alkynes, alkenes and allenes. Thus, 
the need of halide abstractors and the concomitant formation of counterions in many cases is 
important for the catalytic activity of the Au(I)-complexes with unsaturated moieties. There 
are many reports focused on this topic, which highlight the importance of gold-counterion 
interactions in the catalytic process.[128] Depending on the size and electronic properties, 
counterions can be placed on the metal coordination sphere providing stronger or weaker 
interactions to the metal centre modulating the catalytic activity. Different silver and sodium 
salts were tested in the reaction as halide abstractors to preform the gold cationic complex 
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[Ph3PAu]+X ̶, in order to enhance the catalytic activity of the Au(I)-complex (see Scheme 45 
and Table 2). NaBArF and AgNTf2 (Entries 1 and 2) in presence of the standard Au(I)-catalyst 
showed no conversion to the desired products. In contrast, moderate activity was observed 
when SbF6– or OTf – were used as counterions were used (Entries 3 and 4), giving slight 
conversion to the desired E-allyl azide 124a as well as the anti-Markovnikov allyl azide 125a 
(Table 2). The best results were obtained using AgOTf as the halide abstractor (Entry 4), which 
is reported to have strong interactions with the metal centre due to its small size.  
 
Scheme 45. Screening of different silver and sodium salts to preform cationic Au(I)-complexes 
[a] Conversion was obtained by integration of a characteristic signal of each compound in the 1H NMR 
spectra of the crude of reaction in relation to the starting material observed at the end of the reaction. 
Table 2. Screening of different halide abstractors as source of the counterions 
 Phosphine-Au(I) complexes and NHC-Au(I) complexes generally show similar 
reactivities. In some cases complexes with these two ligands show different catalytic activity. 
NHC-ligands are strong σ-donors, but also π-donation to the metal centre L ̶ M (π → d) is 
given, as well as M ̶ L (d → π*) backdonation. Phosphine ligands are also σ-donors with the 
contribution of 2 electrons to the metal centre, however, this ability can be modulated 
depending on the nature of their substituents. They can also accept electron-density from the 
metal, but, due to the lack of π* orbitals in the ligand, the M  ̶L backdonation is from d M→ σ* 
L.[83f, 129] In addition to the standard (Ph3P)AuCl, several ligands were also tested in our 
azidation reaction to tune the activity of the catalyst. N-heterocyclic carbenes (NHC), nitrogen 
acyclic carbenes (NAC) and triphenylphosphite ligands (Figure 13) were employed. The 
results revealed that the strong σ-donation of the NHC-Au(I)-complexes is not favourable, 
giving scarce conversions to the desired allyl azides. In contrast, phosphine and phosphite 
ligands displayed generally good reactivities and selectivities towards the desired allyl azides 
under the reaction conditions. Phosphite ligands display a weak σ-coordination with the metal 
Entry Salts Solvent T (oC) T (h) Conversion % (Ratio, 124a:125a)[a] 
1 NaBArF toluene 80 18 0 
2 AgNTf2 toluene 80 18 0 
3 AgSbF6 DCM 30 20 20 (1.2:1) 
4 AgOTf DCM 45 17 33 (1:2.3) 
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centre and higher π-acceptor character, and in our reaction they gave higher selectivities and 
better yields towards the allyl azides.[130] 
 
Figure 13. Au(I)-complexes screened in the intermolecular addition of azides to allenes. NHC1-, NHC2-, NHC3- 
and NAC-Au(I) chloride were synthesised by Hashmi’s group and sent by them 
 In general, strong electrophiles, such as proton sources or electrophilic halogens, are 
required to break the Au-C bond of the vinyl gold intermediate proposed in the final step of 
the mechanism of these reactions.[131] However, in this work and in contrast to the previous 
intermolecular additions of alcohols or amines as nucleophiles to allenes (see introduction of 
the present chapter), TMSN3 does not have any proton source. Therefore an additional proton 
is essential for the protonolysis step, to close the catalytic cycle with the concomitant 
regeneration of the Au(I)-complex.[132] The formation in situ[114a, 133] of the HN3 with TMSN3 
and TFA gave the best conversions in the reaction with the phosphine-Au(I) complex (other 
acids did not work well, see Table 3), obtaining the allyl azides 124a and 125a and also the 
product from the addition of CF3COO ̶  to the activated terminal allene moiety (126, Scheme 
46) and the unexpected acetamide 127, which will be further mentioned later in this chapter 
(Scheme 46).[131c, 134]   
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Scheme 46. Acid screening to generate in situ the hydrazoic acid and its subsequent addition to the allene moiety 
Entry Acid (Eq.) T (oC) t (h) 
Conversion %,  
(Ratio, 124a:125a:126:127:128)[a] 
1 - 45 17 33, (1:2.3:0:0:0) 
2 AcOH (1.5) 30 19 7, 124a 
3 H2O (3.0) 30 25 23, (1.9:0:0:0:1) 
4 H2SO4 (3.0) 30 18 - 
5[b] H2SO4 (3.0) / H2O (5.0) 30 18 38, (1.7:1:0:1.2) 
6 CF3COOH (3.0) 30 18 100, (5:1:4:4:0) 
7 CF3SO3H (3.0) 30 18 decomposition 
[a] Conversion was obtained by integration of a characteristic signal of each compound in the 1H NMR 
spectra of the crude of reaction in relation to the starting material observed at the end of the reaction. 
[b] Reaction carried out with (PhO)3PAuCl as catalysts. 
Table 3. Screening of acids to generate in situ the HN3 and its subsequent addition as nucleophile to activated 
allenes 
 HN3 is classified as a very dangerous compound due to its high toxicity and its 
explosive character at higher concentrations.[115, 135] In order to minimise the risk to handle this 
compound, a few modifications on the reaction were performed, such as temperatures lower 
than 35 oC and diluted solutions of this strong acid (< 20 % weight).[136] 
 With the new conditions in hand, a new catalyst screening was performed, using again 
the complexes shown in Figure 13. However, no significant changes were observed with NHC-
Au complexes that gave low conversion and selectivity towards the trifluoroacetate adduct 
126. Full conversion was obtained with (Ph3P)AuCl and (PhO)3PAuCl, achieving higher 
isolated yields using (Ph3P)AuCl/AgOTf (Table 4) as a catalytic source 
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Scheme 47. Catalyst screening with the new conditions 
Entry LAuCl t (h) Conversion (%) 
Isolated yield %,  
(Ratio, 124a:125a) 
1[a] L = (Ph3P) 2.5 100 33, (1:1)  
2[a] L = (PhO)3P 22 100 50, (1:1) 
[a] Isolated yields were obtained by column chromatography in silica gel 
Table 4. Screening of catalysts under the best reaction conditions 
 These final conditions were employed by my colleague with several mono- and 
disubstituted allenes achieving low to moderate yields as well as good selectivities of E-allyl 
azide 124a and 125a.  
 My contribution to the project started by expanding the scope of the reaction with 
different substituted substrates using the best reaction conditions achieved by my colleague. 
However, we encountered some reproducibility issues, with different conversions, isolated 
yields and selectivities. In order to address these issues and get a more robust and reproducible 
procedure for this reaction, I started a new screening of reaction conditions, taking into account 
the order in which the different components were added to the reactions, as well as different 
purification techniques.  
 In the previous screening, (PhO)3PAuCl, AgOTf and the allenic substrate were 
sequentially added and dissolved in dry DCM in a Schlenk tube under inert atmosphere to 
preform the Au(I)-π-allene intermediate. To generate the hydrazoic acid in situ, TMSN3 and 
TFA were dissolved in dry DCM at 0oC in a second Schlenk tube under inert atmosphere. 
Then, the catalyst solution was taken out with a syringe under argon and added at 0oC to the 
hydrazoic acid solution. Then, the reaction was heated at 30oC until complete conversion.  
 Hydrazoic acid is a highly volatile acid and should be handled at lower temperatures. 
In order to minimise the loss of product during the addition process of the Au(I)-π-allene 
solution to the second Schlenk, a new experimental procedure was devised. In this case, in a 
dried and flushed with N2 Schlenk tube, cationic Au(I)-complex was preformed in dry DCM 
at 0oC and this temperature was kept during the addition of the rest of the components to avoid 
loss of the volatile acid. The allene, TMSN3 and TFA were added sequentially under N2 at 0oC 
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and stirred for 2 minutes. The mixture was then warmed up to room temperature or heated at 
30oC until complete conversion.  
 This new procedure prevents the loss of product during the addition to the second 
Schlenk flask and ensures the accuracy of the final concentration, which also proved to be an 
important factor in the reaction. To test this, three reactions at different concentrations of 
substrate were performed (see Table 5). The best results were achieved using 0.41 M as the 
new concentration of allene in dry DCM with improved selectivity to the allyl azide 124a and 
125a, minimising the formation of product 126 but with the formation of the amide 127 (Table 
5, Entry 3). 
 
 Scheme 48. Best reaction conditions employing different concentrations 
Entry Concentration (M) Ratio (124a:125a)[a] Ratio 126[a] Ratio 127[a] 
1[b] 0.11 3.3:1 0.9 - 
2[b] 0.27 2.1:1 0.6 1.04 
3[c] 0.41 3.9:1 0.6 2.4 
[a] Ratios were obtained by integration of a characteristic signal of each compound in the 1H NMR 
spectra of the crude of reaction in relation to the starting material observed at the end of the reaction. 
[b] After 22 h, conversion ≈ 25%. [c] Full conversion after 18 h. 
Table 5. Screening of the best reaction conditions using different concentrations 
 AgOTf is one of the best gold partners to generate cationic Au(I)-complexes by acting 
as a halide abstractor and counterion or just by itself as an effective catalyst.[128a, 137] It is known 
that silver salts are highly hygroscopic and it is recommended to handle them under anhydrous 
conditions.[138] Up to this point, all the reactions had been carried out with the same AgOTf 
batch, weighed in the open air and were slightly moist from being stored in a desiccator for a 
long time. Thus, a brand new batch was purchased. Surprisingly, the first reaction carried out 
with this new and anhydrous AgOTf batch with the conditions shown in Entry 1 (Table 6) did 
not reach complete conversion (≈ 50%) after 48 h, so this result suggested that the traces of 
H2O present in the old AgOTf batch could have an essential role in the reaction. Results in 
Table 3, show that a proton source is needed to carry out the protonolysis of the vinyl gold 
intermediate. However, it is important to note that the reaction shown in Entry 1 (Table 3), 
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without a proton source, only with TMSN3 at 45 oC, gave 33% conversion. This result implies 
that traces of water were present in the reaction media, probably from the moist AgOTf batch.  
 It is known, that the hydrazoic acid can be generated with different proton sources 
such as MeOH[139] and  acids.[115, 140] Also reported is the synthesis of hydrazoic acid in situ 
with water as proton source or in a mixture with AcOH.[114a, 133, 136] However, observing our 
previous results, water does not seem to be a strong enough acid to give the full protonolysis 
of the key intermediate in our reaction.[115, 141] A few experiments were performed in order to 
understand the role of water in the reaction (Table 6). Entries 1 and 2 show the differences 
between the moist AgOTf batch and the new one, observing that approximately 50% of the 
allene did not react even after longer times. Water was confirmed as a suitable proton source 
in combination with TFA, achieving full conversion with the phosphite-Au(I) catalysts after 
22 h (Entry 6 to 8 and 11). By increasing the amount of water used in the reaction, the 
selectivity towards the desired allyl azides improved, but also resulted in significant amounts 
of allyl alcohol 128 being observed (Entries 8 and 11). We also tested other proton sources as 
additives (see entries 10, 12, 13 and 14). Entries 11 to 14 (Table 6) show that the majority of 
the proton sources worked efficiently. AcOH, NH4OH(ac) 5.0 N and MeOH (Entries 12, 13 and 
14) gave lower selectivity to the allyl azide 124a and 125a than with H2O (Entry 11). 
Therefore, we chose as our best conditions, the combination of TMSN3 (3 Eq.), TFA (3 Eq.) 
and H2O (5 Eq.) at room temperature (Entry 11). 
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Scheme 49. Reaction performed with different amounts and mixtures of acids and proton sources  
Entry Additive (Eq.) t (h) 
Conversion %  
(Ratio, 124a:125a:126:127:128)[a] 
1 TFA (3) 48 50,  (2.1:1:0:0:0) 
2[b] TFA (3) 22 100, (9.4:2.4:1:5.7:0) 
3 H2O (3) 22 73, (9.7:2.8:0:1:2.8) 
4[c] H2O (3) 23 23, (3:1:0:0:1.6) 
5[c] H2O (3)/TFA (3) 22 40, (5.2:1:2.4:3.2:0) 
6 H2O (3)/TFA (3) 23 100, (10.7:3.2:1:7:0) 
7 H2O (5)/ TFA (3) 22 100, (13.7:4.4:1:8.4:0) 
8 H2O (7)/ TFA (3) 22 100, (24.4:6.4:2.2:12.2:1) 
9 H2SO4 (3) 23 Decomposition 
10 H2SO4 (3)/H2O (5) 24 10, 124a 
11[d] H2O (5)/TFA (3) 22 100, (22.8:5.6:1:12:1.2) 
12[d] AcOH (5)/TFA (3) 24 100, (18.2:4.8:1:9:0) 
13[d] NH4OH(aq) 5 N /TFA (3) 22 100, (21.4:5:1.8:11.5:1) 
14[d] MeOH (5)/TFA (3) 22 96, (16.5:4.2:1:5.7:0) 
[a] Conversion was obtained by integration of a characteristic signal of each compound in the 1H NMR 
spectra of the crude of reaction in relation to the starting material observed at the end of the reaction. 
[b] This reaction was performed using the old batch of AgOTf. [c] This reaction was performed using 
as catalyst Ph3PAuCl (0.05 Eq.). [d] Reaction performed at room temperature. 
Table 6. Screening of the best reaction conditions with or without additives (proton sources).  
 With these optimum conditions in hand, a few reactions (Table 7) were set up under 
microwave irradiation,[142] in order to accelerate efficiently the synthesis of allyl azides 124a 
and 125a and trying to reduce the reaction times. Unfortunately, despite the dramatic reduction 
of reaction time and the complete conversion of the starting material, microwave heating 
seems to favour the addition of CF3CO2 ̶ and HO– to the allene, decreasing the desired allyl 
azides 124a and 125a, and therefore we decided to abandon this approach. 
61 
 
 
Scheme 50. Au(I)-catalysed addition of azides to allenes under microwave irradiation 
Entry t (h) T (o C) Conversion (%), (Ratio, 124a:125a:126:127:128)[a] 
1 5 70 100, (4.4:1.1:1.7:4.7:1) 
2 4 40 100, (11:3:1:6.5:1.1) 
3 3 40 100, (16.3:4:1.5:8:1) 
[a] Conversions and ratios were measured by 1H NMR 
Table 7. Results obtained with the best reaction conditions under microwave irradiation 
The effect of the additives, solvents, and nucleophiles in the reaction could be 
understood if we take into account their competition in solution to stabilise the cationic Au(I)-
complex as ligands or counterions.[130a] Echavarren and coworkers reported the synthesis of 
tetrazoles 129 (Scheme 51) from alkynes via C-C bond cleavage employing similar reaction 
conditions to the ones reported in this study.[143] In their work, cationic JohnPhos/Au(I)-
catalyst 130 were employed, and a further addition of a proton source (i-PrOH or AcOH) was 
used to improve the yield of tetrazole 129. They proposed that under Au(I)-catalysed 
conditions, the BrØnsted acid [JohnPhosAu(i-PrOH)]SbF6 is formed, which triggered the 
transformation to the tetrazole.  
  
 Scheme 51. Synthesis of tetrazoles via Au(I)-catalysed reaction of alkynes 
 The results obtained by the group of Echavarren, support the idea of the competition 
of ligands and counterions to stabilise the cationic Au(I)-complex, with the alcohol 
coordinated to the metal-centre generating the BrØnsted acid-catalyst. In our case, the role of 
water could be similar and the BrØnsted acid-catalyst [(PhO)3PAu(H2O)]OTf could actually 
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be the catalytically active species in our reaction conditions. There are examples reported by 
the groups of Nolan[144] or Bochmann[145] isolating and employing gold-hydroxide complexes 
(Au-OH) which support the possible formation of the [(PhO)3PAu(H2O)]OTf as our active 
catalyst species. 
 At this point it is worth noting the problems encountered with isolated yields in the 
reaction. The products obtained in our model reaction have very similar polarities, and their 
purification by column chromatography was a challenge. In addition the ratios obtained from 
NMR crudes before purification did not correspond with the isolated yields of the products 
achieved. Thus, an experiment was performed to investigate the decomposition of the allyl 
azides 124a and 125a under the reaction conditions and during purification.  
 
Scheme 52. Reaction performed to investigate the decomposition of allyl azides 124a and 125a under the reaction 
conditions 
 An inseparable mixture of the isolated allyl azides 124a and 125a (4.8:1, Entry 1, 
Table 8) was exposed to the best reaction conditions without any azide source. After 22 h, the 
solution was filtered through celite, washed with DCM and concentrated. Then, the crude of 
the reaction was weighed, a 1H NMR of the reaction crude was obtained (Entry 2, Table 8) 
and the ratios compared with the ratio of the starting mixture. It is observed, that there is a 
slight variation in the ratios before and after the reaction. The crude was then purified by flash 
column chromatography over silica gel using Hex/EtOAc (7:1). After concentration of the 
sample, only half of product was isolated confirming the loss of product during the purification 
process (Entry 3, Table 8). Once again, the 1H NMR of allyl azides revealed a small variation 
in the ratios of the isolated allyl azides 124a and 125a (Entry 3).  
Entry Weight (mg) Ratios allyl azides 124a:125a[a] 
1 (Before reaction) 20.0 (4.8:1) 
2 (After 22 h reaction, before purification) 21.1 (4.2:1) 
3 (Isolated azides 124a and 125a) 11.0 (3.6:1) 
[a] Ratios were obtained by integration of the signals of each allyl azide in the 1H NMR spectra of the 
crude of reaction. 
Table 8. Results obtained in the experiment performed to confirm the decomposition of the allyl azides 124a and 
125a under the reaction conditions and during purification.  
63 
 
 These results could suggest that allyl azides 124a and 125a interact with the slightly 
acidic silica gel during the purification step, favouring their decomposition. The 
hydroazidation reaction was performed using the model allene 96b under the same reaction 
conditions as before and the products were purified using basic alumina as the stationary phase 
(Entry 2, Table 9). As shown in Table 9, five different products could be identified in the 1H 
NMR crude, however after purification only our target allyl azides 124a and 125a as well as 
the interesting acetamide 127 were efficiently isolated, in 19% higher yield than with silica 
gel. It might be possible that the ester is hydrolysed to the alcohol and this polar allyl alcohol 
is held in the stationary phase favouring the isolation of the desired products. 
Entry 
Stationary 
phase 
Ratio, 124a:125a:126:127:128 
before purification 
Isolated yield %, ratios 
1 Silica gel (18:4.7:1.3:13:1) 
40, 124a:125a:126 (29:8:1); 
15, 127 
2 Basic alumina (20:5.2:1:12:1) 59, 124a:125a (3.7:1); 15, 127 
Table 9. Results obtained before and after purification by column chromatography using different stationary phases 
 To conclude the screening of the optimum reaction conditions, the control experiments 
were performed (Table 10).  
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Scheme 53. Control experiments 
Entry (PhO)3PAuCl AgOTf TMSN3 TFA H2O TfOH 
Conversion %, 
(Ratio)[a] 
1 -     - 0 
2 - -    - 0 
3 - - -   - 0 
4    -  - 
73 124a:125a:127: 
128 (10:2.8:1:2.8) 
5[b]     - - 50 124a:125a (2.1:1) 
6  -     0 
7 - -     0 
[a] Conversion was obtained by integration of a characteristic signal of each compound in the 1H NMR 
spectra of the crude of reaction in relation to the starting material observed at the end of the reaction. 
[b] The reaction time was 48 h. 
Table 10. Results obtained during the control experiments  
 Table 10 revealed that silver triflate is not the active catalyst in the hydroazidation 
reaction (Entry 1). However, the role of the AgOTf as halide abstractor is essential to generate 
the catalytically active species in this reaction (PhO)3PAuOTf  (Entries 4 and 5). In the absence 
of silver, (PhO)3PAuCl does not behave as a suitable catalyst to activate the allene to the 
subsequent nucleophilic attack (Entry 6). As previously stated, reactions using either TFA or 
H2O only in the presence of the phosphite-Au complex gave 73% and 50% conversion 
respectively (Entries 4 and 5), supporting the need of the combination of TFA/H2O for full 
conversion. 
 On the other hand, combination of AgOTf with H2O can generate the BrØnsted acid 
TfOH. Also, acid-catalysed reactions by BrØnsted acids to allenes are known.[146] In order to 
confirm that our nucleophilic addition to allenes is catalysed by Au(I)-complexes and not by 
BrØnsted acids, two reactions were set up. A catalytic amount of triflic acid and (PhO)3PAuCl 
were added in the absence of AgOTf, giving no conversion (Entry 6). Then, in the absence of 
gold and silver, a catalytic amount of TfOH (0.05 Eq.) was added as BrØnsted acid-catalyst, 
and again, starting material was only recovered (Entry 7). In addition, our group have 
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performed studies on the reactivity of allenes in the presence of stoichiometric amounts of 
TfOH that give rise to vinyl triflates 131 (Scheme 54). These compounds were not identified 
in the crude of the hydroazidation reaction.[147] 
   
Scheme 54. Formation of vinyl triflates employing BrØnsted acids 
2.8.2. Synthesis of allenes 
 Due to their high demand as precursors in organic chemistry, several allenes are 
commercially available and could be purchased from chemical companies such as Sigma 
Aldrich or Alfa Aesar to be employed neat in the hydroazidation reaction (See Figure 14). 
 
Figure 14. Commercially available allenic precursors employed in the gold-catalysed hydroazidation reaction 
 On the other hand, the majority of monosubstituted allenic precursors synthesised in 
the laboratory were generated via microwave assisted Crabbé homologation of the 
commercially available alkynes 138 (See Table 11 and Scheme 1 and 2 for the mechanism).[27b, 
39a] 
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Scheme 55. Synthesis of allenes via microwave assisted Crabbé homologation  
Entry Allene 139x, 94a Isolated Yields % 
1 
 139a 
49 
2 
 139b[a] 
45 
3 
 94a 
46 
4 
 139c 
53 
5 
 139d 
89 
6 
 139e[b] 
48 
7 
 139f 
35 
8 
139g 
44 
[a] This compound was synthesised by Stephanie Hohne using different concentration (0.3 M). [b] This 
compound was synthesised by Stephanie Hohne. 
Table 11. Allenes synthesised via microwave assisted Crabbé homologation.  
 The majority of 1,3-disubstituted substrates were obtained by modified Crabbé 
homologations optimised for each substrate. 1,3-Disubstituted allene 140 (Scheme 56) was 
obtained by a modified Crabbé homologation of the corresponding alkyne with zinc iodide. 
The iminium ion was preformed in situ in a Mannich type reaction from benzaldehyde and 
morpholine giving access to allene 140 in moderate yield.[28]   
67 
 
Scheme 56. Synthesis of 1,3-disubstituted allene 140 via modified Crabbé homologation of the corresponding 
alkyne 
 Alternatively, microwave heating was employed to synthesise 1,3-disubstituted 
allenes 141x (Scheme 57) via modified Crabbé homologation catalysed by CuI with alkyl 
aldehydes and Cy2NH in toluene (See Table 12).[30] 
 
Scheme 57. Synthesis of 1,3-disubstituted allenes 141x via microwave assisted Crabbé homologation 
Entry R R’ Time Allene 141x 
Isolated 
Yields (%) 
1 Bn n-Pr 3 h 30 min 
141a 
39 
2 Bn i-Pr 4 h 30 min 
141b 
28 
3 Ph(CH2)2 n-Pr 3 h 30 min 
141c 
63 
4 Ph(CH2)2 i-Pr 3 h 30 min 
141d 
77 
Table 12. Results obtained on the synthesis of 1,3-disubstituted allenes 141x via microwave assisted Crabbé 
homologation 
Following a similar methodology, 1,3-disubstituted allenes 142 and 143 were obtained 
in moderate yield by a modified cadmium(II)iodide allenylation of terminal alkynes with 
aldehydes using pyrrolidine as a base (Scheme 58. See Scheme 4 for the mechanism).[29] 
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 Scheme 58. Synthesis of 1,3-disubstituted allenes by a modified CdI2 allenylation of terminal alkynes 
The same reaction conditions were also employed to synthesise 1,1,3-trisubstituted 
allene 144 with a ketone, instead of aldehydes, and a terminal alkyne (Scheme 59. See Scheme 
4 mechanism).[29] 
 
Scheme 59. Synthesis of 1,1,3-trisubstituted allenes by a CdI2 allenylation of terminal alkynes and ketones 
2.8.3. Gold-catalysed intermolecular addition of azides to allenes  
With the best reaction conditions in hand (PhO)3PAuCl/AgOTf as catalytic system, 
TMSN3 as azide source, TFA and H2O as additives in dry DCM, the scope of the gold-
catalysed hydroazidation reaction with different allenes was explored. We observed that the 
reaction is quite general toward the formation of allyl azides 124 and 125 as major products, 
and in some cases we also isolated ketones 145 and amide 127 as side products in low yields. 
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Scheme 60. Reaction scope of the gold-catalysed hydroazidation of substituted allenes 
Entry Allene R, R’ and R’’[e] 
Isolated Yield %, 
124:125 ratio 
Isolated Yield %, 
Side products 
1 96b R = Cy 59, 124a:125a (3.7:1) 15, 127  
2 139a R = n-hexyl 48, 124b:125b (1.9:1) 16, 145a 
3[a] 139b R = n-octyl 47, 124c:125c (1.8:1) - 
4 94a R = Ph 62, 124d - 
5 139c R = (MeO2C)2CHCH2 43, 124e:125e (3.8:1) 17, 145b 
6 139d R = phthalimide-N-CH2 48, 124f; 7, 125f 32, 145c 
7[b] 139e R = (BOC)2NCH2 38, 124g - 
8[c] 120 R = R’ = Me 124h:125h (3.7:1) - 
9 140 R = Ph, R’’ = n-octyl 76, 124i - 
10 141a R = Bn, R’’ = n-Pr 67, 124j:125j (3.7:1) - 
11 141b R = Bn, R’’ = i-Pr 55, 124k:125k (1.67:1) - 
12 141c R = Ph(CH2)2, R’’ = n-Pr 70, 124l:125l (1:1.13) - 
13 141d R = Ph(CH2)2, R’’ = i-Pr 80, 124m:125m (1:1) - 
14[d] 139f R = p-CF3Ph 74, 124n - 
15[d] 142 R = p-CF3Ph, R’’ = n-Pr 67, 124o - 
16 143 R = p-ClPh, R’’ = n-octyl 72, 124p - 
[a] Run without water (0.08 M). [b] Deprotection of one Boc-group was observed under the best 
reaction condition. [c] 100% conversion; products were not isolated due to volatility issues. [d] The 
reaction was carried out at 30 ºC during 60 h. [e] R’, R’’ = H, when not stated otherwise.  
Table 13. Scope of reaction for the gold-catalysed hydroazidation reaction of substituted allenes 
 As shown in Table 13, the reaction works efficiently for mono- and 1,3-disubstituted 
allenes with different functional groups in moderate to good yields. E-Allyl azides 124 from 
the attack to the less hindered carbon of the allene are generally obtained as the main or the 
only product. In previous works on gold-catalysed hydroamination reaction of substituted 
allenes, the control of the regioselectivity on the reaction was achieved when aromatic ring 
substituents were directly linked to the allene moiety.[93, 96, 100] Our reaction follows the same 
trend, with the azide attack only occurring to the sp2-carbon opposite to the aromatic group on 
mono- and 1,3-disubstituted aryl allenes, giving only E-allyl azides 124d, 124i, 124n, 124o 
and 124p (Entries 4, 9, 14, 15 and 16). However, if the aromatic group is not directly linked 
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to the allene, the attack of the azide can happen in both sp2-carbons of the allene even with 
bulkier alkylated substituents such as i-propyl (Entries 10-13). This suggests that the electronic 
effects prevail over the steric effects controlling the regioselectivity of the reaction. 
 Generally, as shown in Table 13, the reaction works with a wide range of substituted 
allenes with different functionalities such as alkyl, aryl, nitrogen-protected or even malonate 
groups. However, substituted allenes with methoxy groups (132, 139g, 146, Figure 15) or 
linked with substituents sensitive to acidic conditions (135 and 137), decomposed under the 
reaction conditions. In addition, tri-144 and tetrasubstituted allene 133 were also tested giving 
complex mixtures with traces of the desired products as well as other side products that were 
very difficult to identify. Ethyl 2,3-butanodionate 136 and ethyl 2,3-pentanodienoate 134 
showed very slow conversion to the desired allyl azides after 5 days of reaction. 
 
[a] This allene was available in the group. 
Figure 15. Substituted allenes that did not work under the best reaction conditions 
2.8.4. Isomerisation of allyl azides 124 and 125 
 Generally, allylic azides can equilibrate in solution, even at room temperature via 
[3,3]-sigmatropic rearrangement.[148] A previous experiment performed to investigate the 
possible decomposition of allyl azides under the best reaction conditions suggested that the 
allylic azides 124a and 125a could isomerise when catalysed by gold. However, these results 
were not conclusive (see Scheme 52, Table 8). Thus, a further experiment was performed in 
order to see the possible interconversion of the allylic products. To do so, the reaction of allene 
96b under the best conditions was monitored by 1H NMR at room temperature in CDCl3. 
Plotting the conversion versus time over 12 h, it was observed that the concentration of allyl 
azide 125a increases rapidly and then decreases during the first 3 hours, as the concentration 
of the thermodynamically more stable allyl azide 124a increases (see Table 14 and Figure 16, 
allyl azides 124a and 125a during the first 3 h). It was also observed that the concentration of 
the allylic product 126, increases during the first hour and then decreases with time. Possibly 
the free azide could displace the trifluoroacetate in compound 126 to generate E-allyl azide 
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124a via SN2-type reaction. The ratio of products was maintained after 12 hours with no major 
changes observed after 22 h. 
 
Scheme 61. NMR experiment under the best reaction conditions 
Time 
(h) 
Conversion % 
96b 124a 125a 126 127 128 
0 100 0 0 0 0 0 
1 24.2 20.2 30.9 9.26 15.4 0.00 
3 0.00 53.4 17.1 4.10 24.9 0.51 
5 0.00 57.4 14.2 3.27 24.9 0.14 
7 0.00 56.7 13.5 4.04 25.7 0.13 
9 0.00 54.8 13.1 4.13 27.1 1.38 
11 0.00 54.3 12.5 4.24 27.2 1.41 
22 0.00 57.0 12.8 4.73 23.1 1.62 
Table 14. Results obtained monitoring the reaction by 1H NMR. (See appendix for further information about the 
integral values) 
 
Figure 16. Catalytic NMR experiment 
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To analyse the effect of the temperature on the interconversion, a reaction was carried 
out at 0oC for 22 h (Scheme 62). The isolated yield of the inseparable mixture of the allyl 
azides was higher than previously reported at room temperature (see Table 13, Entry 1) and 
also the ratio of allyl azide 125a was higher than the E-allyl azide 124a. As it was discussed, 
there are examples on the hydroalkoxylation reaction of allenes where the kinetically favoured 
addition of nucleophiles happens to the most hindered carbon of the allene via an outer-sphere 
mechanism under an excess of alcohol. DFT analysis revealed, that the kinetically favoured 
product is able to isomerise to the thermodynamically more stable allyl ether catalysed by 
gold-complexes (see Scheme 30).[89b, 90] Similarly in our case, we could suggest that in the 
presence of cationic phosphite-Au(I)-complexes, the kinetically favoured allyl azide product 
125a interconverts to give the thermodynamically more stable E-allyl azide 124a. 
 
Scheme 62. Reaction carried out at 0 oC during 22 h  
There are more examples where the attack to the most substituted carbon of the allene 
is favoured. In those cases, it is proposed that the intermediate Au(I)-π-allene complex formed 
during the reaction, interconverts rapidly and reversibly at room temperature between the two 
π-systems of the allene, and the product of the attack to the most substituted carbon was 
kinetically favoured affording the observed product (Scheme 31).[95] 
2.8.5. Deuterium-labelling experiments 
Deuterium-labelling experiments were performed in order to confirm the vinyl-gold 
intermediates and to understand the formation of amide 127. According to this, TFA-d and 
D2O were employed to preform in situ the deuterated hydrazoic acid. Allyl azides 124a-d and 
125a-d were obtained with high deuterium incorporation in the expected positions, supporting 
the involvement of the vinyl-gold intermediates (Scheme 63). Compounds 126-d and 128-d, 
were also detected, but the deuterium incorporation could not be accurately quantified by 
NMR, due to the low concentration of those compounds in the sample. Besides, amide 127-d 
was characterised as a mixture of compounds with different deuterium incorporation in the 
methyl group adjacent to the carbonyl group and also the amidic nitrogen (see Figures 17 and 
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18). 
 
Scheme 63. Deuterium-labelling experiments  
1H NMR in CDCl3: 
 
Figure 17. 1H NMR of the crude of the deuterium-labelling experiments 
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2H NMR in CHCl3: 
 
Figure 18. 2H NMR of deuterium-labelling experiments 
2.8.6. Formation of side products: Proposed mechanisms 
Table 13 showed that monosubstituted allenes 139a, c and d gave as side products 
ketones 145a, b and c in low yields. Based on previous investigations in the group, we propose 
that these secondary products are formed by protonation of the allenic precursor with the 
strong acid present in the reaction (147, Scheme 64) and the subsequent attack of water into 
the central carbon of the starting allene moiety to form enol 148 that tautomerises to the ketone 
145 (Scheme 64). Interestingly, the electronic nature of the allenic substituents 139a, c and d 
does not follow a trend that could explain why the formation of ketones is favoured with those 
allenic precursors. 
Amide 127 was obtained as a secondary product under different reaction conditions 
with allene 96b. After further investigation and taking into account that ketones were also 
obtained as secondary products under reaction conditions, it was postulated that amide 127 
could come from an acid- or gold-mediated Schmidt reaction from the corresponding ketone 
145 with the generated in situ hydrazoic acid (Scheme 64).[149] Due to the Lewis acidic 
character of gold, it could coordinate with the oxygen of the ketone, favouring the attack of 
the azide to the carbonyl group. Migration of one of the substituents of the ketone, extrusion 
of N2 and the subsequent attack of the water to the nitrilium ion would give rise to amide 127. 
This proposal is supported by the results of the deuteration experiments shown before. 
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Scheme 64. Proposed mechanism for acid- or gold-mediated Schmidt reaction from allenes via the corresponding 
ketone  
In order to further support this proposal, an extra experiment was carried out using a 
commercially available ethyl methyl ketone, which was submitted to reaction conditions. The 
results revealed that after 28 h, 53% conversion of amide 149 was obtained (Scheme 65).[126] 
However, further investigations are required to confirm if the reaction is actually catalysed by 
gold or by the acid.  
 
 Scheme 65. Schmidt reaction of ethyl methyl ketone under the hydroazidation reaction conditions 
It should be mentioned here two consecutives articles published a few months before 
we reported our work, by the group of Jiao, to generate nitriles 150[150] and amides 151[151] 
from alkynes catalysed by silver and gold respectively (Scheme 66).  
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Scheme 66. Silver- and gold-catalysed reactions of alkynes to give nitriles 150 and amides 151 and 152 
respectively 
It was found that in the formation of nitriles 150, traces of H2O in DMSO as solvent, 
were responsible for the Ag-C cleavage of the vinyl azide intermediate, which also supports 
our theory of the wet silver effect mentioned in the previous section.[150]  
The formation of amides 151 and 152 from alkynes via Csp2-Csp cleavage (Scheme 66 
and 67) were performed using fairly similar reaction conditions to the ones reported in our 
gold-catalysed hydroazidation of allenes. In this case, (Ph3P)AuCl/AgOTf as catalytic source, 
TFA and also H2O were used. As it is shown in the proposed mechanism (Scheme 67), 
protonolysis of the vinyl gold intermediate 153 gives access to alkenyl azide 154, which after 
protonation gives rise to resonance forms 155a and 155b, that then suffer the Schmidt 
rearrangement[149b, 152] process to give amide 152 with loss of N2.[151, 153]  
  
Scheme 67. Gold-catalysed nitrogenation of alkynes to amides and the proposed mechanism suggested  
Jiao et al. also found ketones as side products in this reaction, and they proposed a 
gold-catalysed hydration of alkynes to ketones. To test if ketones were the precursors of the 
amides in their conditions, the authors carried out the reaction of a ketone under their best 
reaction conditions, similar to ours, but they only obtained traces of 152a (Scheme 68).[151] 
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Scheme 68. Reaction carried out by the group of Jiao to investigate ketones as side products 
2.8.7. Preliminary mechanistic studies of the catalytic cycle 
 Once the formation of the vinyl-gold intermediate was confirmed by deuterium-
labelling experiments, a preliminary mechanistic study was carried out, in order to investigate 
if the reaction goes via outer- or inner-sphere mechanism.  
2.8.7.a. Synthesis of gold-azide complex 
 An inner-sphere mechanism is characterised by the coordination of a nucleophile, (N3 
- in our case) with the cationic Au(I) species, [LAu] +, to generate [LAuN3]  as an active 
catalytic complex (see Scheme 28, intermediate 77). [(Ph3P)AuN3] is a known gold complex, 
easy to synthesise[154] and is commonly used as a precursor for other ligands,[155] in organic 
synthesis[156] and frequently in photolysis chemistry.[157] However, the formation of the gold-
azido complex 154 with the phosphite ligands that would be involved in our inner-sphere cycle 
had not been reported so far. In order to generate this complex, a reaction was carried out using 
similar conditions as the one employed to generate [(Ph3P)AuN3] (Scheme 69). 
  
Scheme 69. Synthesis of gold-azide complex 154 
Figure 19. IR spectra of [(PhO)3PAuN3] 
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 This novel gold-azido complex 154 is very unstable and it has to be kept in the freezer 
and in the dark. All attempts to crystallise it were unsuccessful because it decomposes quickly. 
Thus, this complex could not be isolated and employed as a catalysts or to study its implication 
in the catalytic cycle.  
  In a further attempt to identify the gold-azido complex 154, a new reaction was carried 
out (Scheme 70) and monitored by IR, hoping that the asymmetric stretch band of the azide in 
the complex [(PhO)3PAu-N3] would be easily recognised at νas ≈ 2061 cm-1 ([(Ph3P)AuN3] = 
2050 cm-1)[155, 156b] (See Table 15). 
 
 Scheme 70. Reaction monitored by IR 
Entry Time (N3) νas (cm-1) 
1 30 min 2097.24 
2 1 h 45 min 2098. 82 
3 6 h 2098.82 
4 9 h 30 min 2101.14 
Table 15. Results obtained monitoring the reaction by IR. See appendix for the IR spectra. 
 The strong band of the azide group is present at around 2100 - 2097 cm-1 (See Table 
15). However, this band also corresponds to the band of the TMSN3 starting material and to 
the allyl azides 124a and 125a (νas = 2097 cm-1), which are the products of the reaction 
(confirmed by NMR after 22 h). If it exists, the corresponding band of the [Au-N3], would be 
overlapping with these products and therefore the identification of the gold-azido complex 154 
during the reaction will be complicated using this technique.  
2.8.7.b. Stoichiometric NMR Experiments 
After the attempts to identify the formation of the (PhO)3PAuN3 complex, a 
stoichiometric NMR study was performed to study the nature of the active species generated 
during the reaction. Three stoichiometric experiments were carried out at room temperature 
and under nitrogen varying the order in which the different components of the reactions are 
added and recording 1H, 31P NMR spectra and after each addition. 
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Experiment A:  
(PhO)3PAuCl + AgOTf + TMSN3 + 96b + TFA  
Interestingly, after addition of the TMSN3 to the cationic complex a broad peak at 106 
ppm was observed in accordance with the results obtained from the gold-azide complex 154 
[(PhO)3PAuN3] (see Scheme 69). The broad peak could indicate a rapid equilibrium between 
the complex with the TfO - and the N3- as counterions (Scheme 71 and Figure 20). Additionaly, 
a small signal at 127 ppm was observed characteristic of free phosphite. This could indicate 
displacement of phosphite ligand after addition of TMSN3, which would generate the anionic 
Au-species [(OTf)Au(N3)] – and the gold-azide complex [(PhO)3PAuN3]. After addition of the 
allene, a broad peak at 104 ppm was observed, suggesting regeneration of the [(PhO)3PAuOTf] 
complex, with possible coordination of the allene to the complex bearing the triflate and the 
N3. When TFA was added, the sharp peak of the corresponding free phosphite increased and 
a broad signal around 100 – 103 ppm appeard. This broad signal could suggest a rapid 
coordination of [(PhO)3PAu(OCOCF3)] with the allene and a complex equilibrium of ligands 
and counterions (See experiment C for further information about [(PhO)3PAu(OCOCF3)] 
complex).  
 
Scheme 71. 31P NMR-profile for stoichiometric Experiment A 
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31P NMR profile of Experiment A: 
 
Figure 20. 31P NMR profile of Experiment A 
Experiment B:  
(PhO)3PAuCl + AgOTf + 96b + TMSN3 + TFA 
 After addition of the allene to the cationic Au(I)-complex, a broad signal at 105 ppm 
was observed. This signal revealed the possible rapid coordination of the cationic Au(I)-
complex with the allene. The peak of the gold-azido compound 154 was observed after 
addition of the TMSN3 as well as a small peak corresponding to the free phosphite (127 ppm) 
which can indicate the formation of the anionic Au-species [(OTf)Au(N3)]–. After addition of 
TFA, a broad signal around 103 ppm and the sharp peak of the free phosphite suggests a similar 
complex equilibrium of the three different allene-Au(I) complexes with different counterions 
and ligands.  
127 ppm 
127 ppm 
127 ppm 
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Scheme 72. 31P NMR-profile for stoichiometric Experiment B 
31P NMR profile of Experiment B: 
 
Figure 21. 31P NMR profile of Experiment B 
Experiment C  
(PhO)3PAuCl + AgOTf + TFA + TMSN3 + 96b 
Experiment C shows that after the addition of TFA to the cationic complex, the triflate 
counterion is replaced by the TFA anion giving a shift from 104 to 99 ppm upon generating 
complex [(PhO)3PAu]+ -OCOCF3 and also the free (PhO)3P at 127 ppm. Then, when the 
TMSN3 is added, the peak at 127 ppm of the free phosphite ligand increases, which could 
suggest an equilibrium between [(PhO)3PAu]+ -OCOCF3 and the anionic complex 
[(N3)Au(OCOCF3)]-. Subsequently when the allene 96b was added broad peaks were observed 
suggesting a complex equilibrium as in experiments A and B. 
127 ppm 
127 ppm 
127 ppm 
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Scheme 73. 31P NMR-profile for stoichiometric Experiment C 
 
31P NMR profile of Experiment C: 
 
Figure 22. 31P NMR profile of Experiment C 
 It has been reported that broad signals in 31P NMR suggest the competition of the 
ligands for the metal centre, which helps to support our findings.[80] However, the broadening 
could also be indicative of di-aurated intermediates[158] and further investigations are needed 
to clarify their involvement in our case.  
 It has been proposed that the phosphite ligand coordinates weakly to the metal centre 
and it is easier to replace by other ligands.[130b] Although more evidence is needed to fully 
support an inner-sphere mechanism,[86b, 99a] it seems that in our reaction the displacement of 
the ligand and coordination of azide to the gold centre is the key for the catalytic activity. This 
could explain why other stronger σ-bonded ligands to the metal do not favour the azidation 
127 ppm 
127 ppm 
127 ppm 
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reaction, and the inferior reactivity of complexes with the phosphine or NHC-ligands 
previously used in our screening of catalysts. 
To compare the kinetic behaviour of the three systems, 1H NMR analysis was also 
performed and the reactions were followed over a period of 6 to 23 h.  
The signals used to measure integrals were: 
Starting material and 
products 
δ (ppm) Signals J values (Hz) Number of protons 
96b 5.07 q 6.50 1 
124a 3.69 d 6.70 2 
125a 3.60 t 7.73 1 
127 3.10 t 6.44 2 
128 3.38 m - 2 
126 4.77 d 6.76 2 
Table 16. Signals employed to measure the kinetic behaviour of the different species 
 Similar rates for the formation of products were observed in all the experiments after 
addition of all components, which suggest that similar catalytic species are involved in the 
reaction and supports the involvement of a complex equilibrium with exchange of ligands and 
counterions. Vinyl-gold intermediates could not be identified by 1H NMR in any of the 
experiments probably because fast protonolysis is occurring. This suggests that the rate 
limiting step in the reaction could lie on the equilibrium between the gold-catalyst, the azide, 
the allene and the rest of counterions involved in this reaction. 
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1H NMR profile of Experiment A: 
 
Figure 23. 1H NMR profile of conversion in Experiment A 
1H NMR profile of Experiment B: 
 
Figure 24. 1H NMR profile of conversion in Experiment B 
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1H NMR profile of Experiment C: 
 
Figure 25. 1H NMR profile of conversion in experiment C 
 In summary, although it is difficult to propose a full accurate mechanism for this 
reaction with only the results obtained, there are evidences that point to an inner–sphere 
process, with the possible formation of gold-azide complexes as well as a complex equilibrium 
of the different gold-complexes involving the azide, the allene and the rest of the counterions 
and ligands. However an outer-sphere mechanism cannot be completely ruled out at this point, 
and both possibilities have been included in Scheme 74 to explain our results.  
Scheme 74. Proposed mechanisms for Au(I)-catalysed intermolecular addition of azides to allenes via inner- or 
outer-sphere mechanism 
0
10
20
30
40
50
60
70
80
90
100
0 200 400 600 800 1000 1200 1400
%
 C
o
n
v
er
si
o
n
time (min)
1H NMR profile of Experiment C
96b
124a
125a
126
127
128
86 
 
2.8.8. Applicability and versatility of this transformation  
 Isotopic labelling experiments confirmed that the proton provided, by TFA performed 
the protonolysis of the vinyl-gold intermediate in this reaction (Scheme 63). However, several 
electrophiles have also been employed to break the Au-C bond.[131g, 132b, 134b, 159] In order to 
expand the potential of this methodology iodine was employed as an electrophile instead TFA, 
to generate interesting iodo-alkenyl azides.  
 In the absence of any proton source (e.g. TFA), the formation of IN3 in situ under 
reaction conditions could happen as it has been shown in the work of Hassner and coworkers 
with allenes (see Scheme 41)[117] and also with alkenes[160] without any transition metal 
complex present in the reaction. However, when we carried out a reaction under our standard 
reaction conditions in the absence of gold and silver, using NIS and TMSN3 to generate the 
IN3 in situ with the model allene 96b, no conversion to the desired iodo-alkenyl azides was 
observed, leading to recover the starting material.  
 Allenes 96b and 139b were exposed to our best reaction conditions (Scheme 75), 
replacing the TFA by the NIS, in the absence of water. However, only 71% conversion was 
achieved using (PhO)3PAuCl/AgOTf as the catalytic source (Table 17, Entry 1). 
Consequently, a new catalyst screening was performed, using NHC-Au complexes as well as 
different phosphine ligands.  
 
Scheme 75. Gold-catalysts screening for the intermolecular iodoazidation of allenes 
Entry [Au] allene Conversion (%) Isolated Yield (%) 
1 (PhO)3PAuCl 96b 71 - 
2 Ph3PAuCl 96b 100 (E/Z = 1:1) 60, Z-155a 
3[a] NHC-1 96b 84 73, Z-155a 
4[a] NHC-2 96b 78 - 
5[a] NHC-3 96b 83 65, Z-155a 
6[a] Cat-Au+ SbF6- 96b 46 - 
7[a] NHC-1 139b 100 40, Z-155b 
[a] See Figure 13 for the structure of the Au-complexes. 
Table 17. Results obtained in the gold-catalysts screening for the intermolecular iodoazidation of allenes 
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 N-heterocyclic carbenes (Table 17, Entries 3, 4, 5 and 7) gave high conversions and 
excellent regioselectivities to the desired iodo-alkenyl azides 15, product, from the attack of 
the azide to the terminal carbon of the allene. Besides, complete conversion was obtained using 
Ph3PAuCl as a catalyst to a mixture of E-155a/Z-155a (1:1). It should be mentioned, that E-
155a isomerises into Z-155a in solution after a few hours. 
 In order to show the potential of this methodology, a further orthogonal 
functionalization of allyl azide 155b was performed after the Au(I)-catalysed azidation. Thus, 
Au(I)-catalysed iodoazidation of allene 96b gave access to iodo-alkenyl azide Z-155a (Scheme 
76). The resulting product was submitted to click chemistry,[112, 161] giving the allylic triazole 
156 in moderate yield. Compound 156 was further functionalised coupling a phenyl group in 
the allylic skeleton via Suzuki-Miyaura cross-coupling[162] to achieve the complex compound 
157 in good yield. 
 
Scheme 76. Orthogonal functionalization of allenes using the Au(I)-catalysed azidation methodology 
2.8.9. Attempts to develop a gold-catalysed oxidative cross-coupling reaction of allenes 
Zhang and coworkers developed an interesting gold-catalysed oxidative cross-
coupling reaction of propargylic acetates and arylboronic acids to give α-arylenones in one-
step.[163] In their mechanistic proposal, an uncommon oxidation of the vinyl-Au(I) intermediate 
to Au(III) by an external fluorinating reagent was invoked as the key step.  
In order to improve the synthetic utility of this methodology, an attempt to a direct 
oxidative cross-coupling of the vinyl-gold intermediate generated in our reaction was 
performed under Zhang’s conditions. Unfortunately, no evidence of product 158 from the 
oxidative cross-coupling reaction was observed by NMR. It was however seen that the signals 
of the starting material 96b disappeared after 6 h, possibly due to the allene decomposition at 
80 oC (Scheme 77).  
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 Scheme 77. Reaction carried out in order to trap the vinyl-gold intermediate via oxidative cross-coupling  
A new reaction was also performed in another attempt to trap the vinyl-gold 
intermediate under our standard conditions and in absence of water and TFA, but with the 
boronic acid and selectfluor. After 6 hours, the unreacted allene 96b was recovered without 
any sign of the desired compound 158 (Scheme 78).  
  
Scheme 78. Reaction carried out in order to trap the vinyl-gold intermediate via oxidative cross-coupling under our 
best reaction conditions 
 It should be taken into account that the starting materials, the reaction conditions and 
catalytic sources employed in the work reported by Zhang are quite different to our system. 
Further investigation into trapping the vinyl-gold intermediates will be performed in the group 
in the future, also taking into account recent examples of cross-coupling reactions by 
combining gold and other metals.[76, 164] 
2.9. Conclusions  
 A novel Au(I)-catalysed intermolecular addition of azides to substituted allenes has 
been developed by using as the catalytic source (PhO)3PAuOTf, and TMSN3 with TFA to 
generate in situ hydrazoic acid, whose proton was involved in the Au-C cleavage of the vinyl-
gold intermediate. The reaction is quite general and works efficiently for monosubstituted, 1,1- 
and 1,3-disubstituted allenes obtaining moderate to good yields. Regioselectivity issues were 
solved generating E-allyl azides as the only product including aryl functional groups directly 
linked to the allene moiety. To further show the synthetic potential of this reaction, iodine was 
employed as an electrophile achieving interesting alkenyl-iodo azides.  
 Further expansion of the scope and also further analysis of the side products and the 
complete mechanistic study of this transformation will be carried out in our laboratory in the 
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future, in order to fully develop this methodology as a new synthetic tool for the formation of 
very useful allylic azides. 
2.10. Experimental section 
General experimental details 
 All reagents were purchased from commercial sources and used without further 
purification, unless noted otherwise. Solvents were dried using nitrogen atmosphere and used 
fresh every day for reaction. Deuterated solvents were acquired from Apollo Scientific or 
Fluorochem and stored over molecular sieves. All the preparative procedures were carried out 
in the absence of moisture and air under a nitrogen atmosphere, unless stated otherwise. 
Glassware, standard Schlenk tubes, and Schlenk tubes from Carousel 12 Plus Reaction Station 
from Radleys were flame-dried and flushed with nitrogen. Thin layer chromatography was 
performed on Aluminium oxide TLC-Cards with Fluorescent indicator 254 nm over 
aluminium oxide matrix from Sigma-Aldrich, and on Silica TLC-plates (60 F254 Merck).  
Components were visualized by illumination with UV light (λ = 254 nm), or by staining using 
potassium permanganate solution or phosphomolibdic acid solution in EtOH. Purification was 
performed by flash column chromatography using silica gel from Macherey-Nagel GmbH & 
Co. KG (particle size of 40 to 63 µm) as stationary phase, flash column chromatography using 
silica gel from Sigma-Aldrich, high purity grade (Merck grade 9385), pore size 60 Å, 230 - 
400 mesh particle size, flash column chromatography using Aluminium Oxide activated, basic, 
Brockmann I of pore size 58 Å, pH 9.5 ± 0.5 in H2O and over pre-coated TLC plates from 
Macherey-Nagel. GmbH & Co, Sil. G-25, 0.25 mm layer. Accurate weight were obtained with 
a Denver Instrument SI-234. Reactions under microwave irradiation were carried out in a 
Biotage Initiator+ Microwave system. The addition and treatment of cadmium iodide was 
carried out into a MBraun-workstation Globe Box, Unilab Plus/Pro-Sp/dp. 1H, 2H, 13C, 31P, 
195Pt, 19F, NMR spectra were recorded at room temperature on a Bruker Avance III 500 MHz 
NMR spectrometer, fitted with a 5 mm broadband observed, BBFOplus Z-gradient 
SmartProbeTM probe or using a Bruker Avance III nanobay 400 MHz NMR spectrometer, fitted 
with a 5 mm broadband observe BBFOplus Z-gradient probe and a Varian INOVA 300 MHz. 
Calibration was made using the deuterated solvent CDCl3 (δH = 7.26 ppm and δC = 77.16 
ppm), CD3OD (δH = 3.31 ppm and δC = 49.00 ppm), CD3CN (δH = 1.94 ppm and δC = 1.32 
ppm) Tol- d8 (δH = 2.08 ppm and δC = 20.4 ppm).[165] Chemical shifts (δ) are given in parts 
per million (ppm) and coupling constants values (J) are given in Hertz (Hz). 13C NMR was 
recorded using broad-band proton decoupling. Low resolution mass spectra were recorded 
using electrospray (ESI) technique in the positive and negative ion mode with a Shimadzu 
LCMS spectrometer. Phenomenex pre-column filter (Security Guard, ODS C18, 4 x 3 mm 
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i.d.) was used to prevent rapid deterioration of the pre-column. Elution was carried out using 
a mobile phase comprising methanol, at a flow rate of 0.2 mL min-1. All solvents were HPLC 
grade. High-resolution mass spectra were obtained from the EPSRC Mass Spectrometry 
Service at the University of Swansea by EI, NSI, ESI, APCI or ASAP techniques, using a 
Waters XEVO G2-S or Thermo Scientific LTQ Orbitrap XL. Melting points were measured 
with a BÜCHI Melting Point B-545. Infrared spectra were acquired using a Perkin Elmer 
System 400 FT-IR spectrophotometer. Solid samples were run as thin films of their solution 
in DCM. Liquid samples were run neat. Diffractometer: Rigaku AFC12 goniometer equipped 
with an enhanced sensitivity (HG) Saturn724+ detector mounted at the window of an FR-E+ 
SuperBright molybdenum rotating anode generator with HF Varimax optics (100µm focus). 
Cell determination and Data collection: CrystalClear-SM Expert 2.0 r7 (Rigaku, 2011). Data 
reduction and cell refinement & Absorption correction: Crysalis PRO 171.37.35 (Rigaku 
Oxford Diffraction 2015). Structure solution: SHELXST (G. M. Sheldrick, Acta Cryst. (2008) 
A64 112122). Structure refinement: SHELXL97 (G. M. Sheldrick (1997), University of 
Göttingen, Germany). Graphics: Mercury 3.5.1 (CCDC 2014). Publication material: WinGX: 
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849-854. 
Synthesis of chloro(triphenylphosphite)-Au(I) 
 
 The synthesis was undertaken according to the modified procedure described by Toste 
and coworkers.[166] Under N2 atmosphere, Au(III) chloride (125 mg, 0.41 mmol, 1.0 Eq.) was 
dissolved in 2.5 mL of absolute methanol. The solution was stirred for a few minutes at 0 ºC 
and under exclusion of light. Dimethyl sulfide (Me2S) (76 μl, 1.03 mmol, 2.5 Eq.) was added 
dropwise. Decolouration of the solution and formation of a white precipitate was observed 
immediately. The reaction was stirred for 1 h and then the stirring was stopped and the solid 
left to settle. The yellow solution was extracted with a syringe and the solid was washed with 
MeOH (2.0 mL), Et2O (2.0 mL), and petroleum ether (2.0 mL). The solvent was removed by 
a syringe in all cases and after the last washed, the vial was dried under vacuum for a few min. 
Dry chloroform (2.5 mL) was added to the solid and stirred in the dark at 0 ºC for a few min. 
Then, a solution of triphenylphosphite (PhO)3P (119 μl, 0.45 mmol, 1.1 Eq.) in hexane (3.7 
mL) was added dropwise whereby the white solid dissolved. The solution was stirred for 1 h 
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at room temperature. After the reaction was completed, the solvent was removed under 
vacuum, the resulting solid was triturated with hexane and filtered under vacuum. 154 mg, 
0.28 mmol of a beige powder was obtained (69%). 1H NMR (500 MHz, CDCl3, 25 oC) δ = 
7.41 (t, J = 7.9 Hz, 6H; HAr-2), 7.32 – 7.27 (m, 3H; HAr-3), 7.24 – 7.19 (m, 6H; HAr-1). 31P 
NMR (202 MHz, CDCl3, 25 oC) δ = 109.96. 
General procedure for the synthesis of allenes via Crabbe homologation assisted by 
microwave irradiation[27b] 
 Allenes 96b, 120, 132, 133, 134, 135, 136 and 137, are commercially available 
(Sigma-Aldrich) and were used without further purification.  
CuBr (0.3 Eq.) and paraformaldehyde (2.5 Eq.) were added into a previously oven-dried 
microwave vial under N2. Then the corresponding alkyne (1.0 Eq. 0.5 M) was added dissolved 
in dry 1,4-dioxane, followed by the dropwise addition of dry iPr2NH (2.0 Eq.) under inert 
atmosphere. The reaction mixture was heated at 150 oC under microwave irradiation during 
10 – 20 min until complete conversion, followed by TLC. The crude of the reaction was 
directly purified by column chromatography over silica gel using Hex or PET / Et2O or EtOAc 
as eluent.   
Synthesis of Nona-1,2-diene (139a)[167] 
   
 From 1-octyne (850 µl, 5.67 mmol), CuBr (244 mg, 1.70 mmol), paraformaldehyde 
(426 mg, 14.18 mmol), dry iPr2NH (1.6 mL, 11.34 mmol) and 12.0 mlL of dry 1,4-dioxane. 
Obtained after column chromatography, Hex/EtOAc, (90:1) then (60:1): 139a, 342 mg, 2.75 
mmol (49%): yellow liquid. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.09 (p, J = 6.7 Hz, 1H; 
H-3), 4.65 (dt, J = 6.7, 3.3 Hz, 2H; H-1), 2.04 – 1.95 (m, 2H; H-4), 1.45 – 1.36 (m, 2H; H-5), 
1.36 – 1.23 (m, 6H; H-6 to H-8), 0.89 (t, J = 6.7 Hz, 3H; H-9). 13C NMR (126 MHz, CDCl3, 
25 oC) δ = 208.7 (Cq; C-2), 90.3 (CH; C-3), 74.6 (CH2; C-1), 31.8 (CH2), 29.3 (CH2), 28.9 
(CH2), 28.4 (CH2), 22.8 (CH2; C-4 to C-8), 14.2 (CH3; C-9). 
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Synthesis of Undeca-1,2-diene (139b)[27c, 168] 
  
 From 1-decyne (653 µl, 3.60 mmol, 0.30 M), CuBr (155 mg, 1.10 mmol), 
paraformaldehyde (270 mg, 9.00 mmol), dry iPr2NH (1.0 mL, 7.20 mmol) and 12.0 mL of dry 
1,4-dioxane. Obtained after column chromatography, hexane: 139b, 245 mg, 1.61 mmol 
(45%): pale-yellow oil. 1H NMR (400 MHz, CDCl3, 25 oC) δ = 5.09 (p, J = 6.7 Hz, 1H, H-3), 
4.65 (dt, J = 6.7, 3.2 Hz, 2H, H-1), 1.96 – 2.02 (m, 2H, H-4), 1.27 – 1.42 (m, 12H), 0.88 (t, J 
= 6.9 Hz, 3H, H-11). This allene was preapared by Stefanie Hohne using modified conditions 
from the described in the general procedure. 
Synthesis of (1,2-propadien-1-yl)-benzene (94a)[169] 
  
 From phenylacetylene (538 µl, 4.90 mmol), CuBr (210 mg, 1.47 mmol), 
paraformaldehyde (368 mg, 12.24 mmol), dry iPr2NH (1.4 mL, 9.79 mmol) and 10.0 mL of 
dry 1,4-dioxane. Obtained after column chromatography, Hex / EtOAc, (90:1) then (60:1): 
94a, 262 mg, 2.25 mmol (46%): yellow liquid. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.34 – 
7.28 (m, 4H; HAr-5 and HAr-6), 7.23 – 7.17 (m, 1H; HAr-7), 6.17 (t, J = 6.8 Hz, 1H; H-1), 5.15 
(d, J = 6.8 Hz, 2H; H-3). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 209.9 (Cq; C-2), 134.1 (Cq; 
C-4), 128.8 (2 x CHAr; C-6), 127.0 (CHAr; C-7), 126.8 (2 x CHAr; C-5), 94.1 (CH; C-1), 78.9 
(CH2; C-3). 
Synthesis of dimethyl 2-(2,3-butadienyl)malonate (139c)[170] 
  
 From dimethyl propargyl malonate (1.3 mL, 8.81 mmol, 0.80 M), CuBr (759 mg, 5.29 
mmol), paraformaldehyde (1.32 g, 44.08 mmol), dry iPr2NH (4.9 mL, 35.26 mmol) and 11.0 
mL of dry 1,4-dioxane. Obtained after column chromatography, Hex / EtOAc, (6:1) then (4:1): 
139c, 860 mg, 4.67 mmol (53%): yellow oil. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.13 (p, 
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J = 6.7 Hz, 1H; H-2), 4.72 (dt, J = 6.7, 3.2 Hz, 2H; H-4), 3.74 (s, 6H; H-7), 3.51 (t, J = 7.5 Hz, 
1H; H-5), 2.59 (ddt, J = 7.5, 6.7, 3.2 Hz, 2H; H-1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 
208.8 (Cq; C-3), 169.4 (2 x Cq; C-6), 86.7 (CH; C-2), 76.4 (CH2; C-4), 52.7 (2 x CH3; C-7), 
51.4 (CH; C-5), 27.5 (CH2; C-1). 
Synthesis of N-[2-(2,3-butadien-1-yl)-]phtalamide (139d)[27b, 171] 
  
 From N-propargylphthalimide (870 mg, 4.69 mmol), CuBr (202 mg, 1.41 mmol), 
paraformaldehyde (352 mg, 11.74 mmol), dry iPr2NH (1.3 mL, 9.39 mmol) and 10.0 mL of 
dry 1,4-dioxane. Obtained after column chromatography, Hex / EtOAc, (5:1): 139d, 836 mg, 
4.20 mmol (89%): white solid. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.86 (m, 2H; HAr-7 or 
HAr-8), 7.72 (m, 2H; HAr-7 or HAr-8), 5.27 (m, 1H; H-1), 4.80 (dt, J = 6.5, 3.1 Hz, 2H; H-3), 
4.30 (dt, J = 6.0, 3.1 Hz, 2H; H-4). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 208.8 (Cq; C-2), 
168.0 (2 x Cq; C-5), 134.1 (2 x CHAr; C-7 or C-8), 132.3 (2 x Cq; C-6), 123.5 (2 x CHAr; C-7 
or C-8), 86.4 (CH2; C-1), 78.0 (CH2; C-3), 36.3 (CH2; C-4). 
Synthesis of 4-(1,2-propadien-1-yl)-α,α,α-trifluorotoluene (139f)[172] 
  
 From 4-ethynyl-α,α,α-trifluorotoluene (575 µl, 3.53 mmol), CuBr (152 mg, 1.06 
mmol), paraformaldehyde (265 mg, 8.82 mmol), dry iPr2NH (990 µl, 7.05 mmol) and 7.4 mL  
of dry 1,4-dioxane. Obtained after column chromatography, Hex / EtOAc (90:1): 139f, 225 
mg, 1.22 mmol (35%): yellow oil. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.55 (d, J = 8.2 Hz, 
2H; HAr-6), 7.39 (d, J = 8.2 Hz, 2H; HAr-5), 6.19 (t, J = 6.8 Hz, 1H; H-3), 5.22 (d, J = 6.8 Hz, 
2H; H-1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 210.6 (Cq, C-2), 138.1 (Cq, C-4), 128.9 (q, 
JC-F = 32.3 Hz; Cq-7), 126.9 (2 x CHAr; C-5), 125.7 (q, JC-F = 3.8 Hz; 2 x CHAr-6), 124.4 (q, JC-
F = 271.8 Hz; CF3), 93.4 (CH; C-3), 79.5 (CH2; C-1). 
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Synthesis of 1-(1,2-propadien-1-yl)-4-methoxybenzene (139g)[173] 
  
 From 1-ethynyl-4-methoxybenzene (834 µl, 6.43 mmol), CuBr (277 mg, 1.93 mmol), 
paraformaldehyde (483 mg, 16.08 mmol), dry iPr2NH (1.8 mL, 12.86 mmol) and 12.0 mL of 
dry 1,4-dioxane. Obtained after column chromatography, Hex / EtOAc, (90:1) then (40:1): 
139g, 416 mg, 2.85 mmol (44%): yellow liquid. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.25 
– 7.20 (m, 2H; HAr-5), 6.88 – 6.83 (m, 2H; HAr-6), 6.13 (t, J = 6.8 Hz, 1H; H-3), 5.12 (d, J = 
6.8 Hz, 2H; H-1), 3.80 (s, 3H; H-8). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 209.5 (Cq, C-2), 
158.9 (Cq, C-7), 127.9 (2 x CHAr; C-5), 126.3 (Cq, C-4), 114.3 (2 x CHAr; C-6), 93.5 (CH; C-
3), 78.9 (CH2; C-1), 55.5 (CH3; C-8). 
Synthesis of 1,3-disubstituted allenes from 1-alkynes and aldehydes[10a] 
Synthesis of 1,2-undecadien-1-yl-benzene (140)[174] 
 
 The synthesis was undertaken according to the procedure described by Ma and co-
workers.[10a] Zinc Iodide (ZnI2) (1.8 g, 5.79 mmol, 0.8 Eq.) was added under N2 into a flamed-
dried two-necks round bottom flask equipped with a condenser. Benzaldehyde (1.3 mL, 13.02 
mmol, 1.8 Eq.) and 1-decyne (1.3 mL, 7.23 mmol, 1.0 Eq., 0.24 M) were added sequentialy 
dissolved in dry toluene under N2 flow. The suspension was stirred at room temperature for 5 
min. Then dry morpholine (0.9 mL, 10.12 mmol, 1.4 Eq.) was added dropwise under N2. The 
reaction mixture was refluxed at 130 oC during 7 h 30 min. After cooled down, the solution 
was filtered through a pad of silica gel over celite (1:1), washed with Et2O (30 mL) and 
concentrated under vacuum. The crude was purified by column chromatography over silica 
gel using hexane as eluent. 140, 823 mg, 3.61 mmol was obtained as a yellow-pail oil (50%). 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.33 – 7.27 (m, 4H; HAr-13 and HAr-14), 7.22 – 7.14 
(m, 1H; HAr-15), 6.15 – 6.10 (m, 1H; H-1), 5.57 (q, J = 6.7 Hz, 1H; H-3), 2.16 – 2.09 (m, 2H; 
H-4), 1.54 – 1.44 (m, 2H; H-5), 1.40 – 1.33 (m, 2H; H-6), 1.33 – 1.21 (m, 8H), 0.92 – 0.84 (m, 
3H; H-11). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 205.3 (Cq; C-2), 135.3 (Cq; C-12), 128.7 
(2 x CHAr; C-14), 126.7 (CHAr; C-15), 126.7 (2 x CHAr; C-13), 95.3 (CH; C-3), 94.7 (CH; C-
95 
 
1), 32.0 (CH2), 29.5 (CH2), 29.5 (CH2), 29.3 (CH2; C-6), 29.3 (CH2; C-5), 28.9 (CH2; C-4), 
22.8 (CH2), 14.3 (CH3; C-11). 
Experimental procedure for the microwave-assisted modified Crabbé homologation 
applied to the synthesis of 1,3-disubstituted allenes  
 The synthesis was undertaken according to the procedure described by Mukai and co-
workers.[30] Alkyne (1.0 Eq., 0.5 M), aldehyde (1.5 Eq.), cyclohexylamine (Cy2NH) (1.51 Eq.), 
copper(I) iodide (CuI) (0.1 Eq.), and toluene were added to a microwave vial. The vessel was 
sealed, and the reaction mixture was heated at 200 °C under microwave irradiation until 
complete conversion, followed by TLC. After cooling, the mixture was filtered through celite, 
washed with DCM and concentrated under vacuum. The crude of reaction was purified by 
column chromatography over silica gel using Hex or PET / Et2O or EtOAc as eluent.  
 
Synthesis of hepta-2,3-dienyl-benzene (141a) 
  
 From 3-phenyl-1-propyne (294 µl, 2.37 mmol), butyraldehyde (320 µl, 3.55 mmol), 
Cy2NH (711 µl, 3.57 mmol), CuI (45 mg, 0.24 mmol) and 4.7 mL of toluene. Obtained after 
column chromatography using Hex / EtOAc (90:1) as eluent: 141a, 160 mg, 0.93 mmol (39%): 
yellow oil. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.32 – 7.27 (m, 2H; HAr-10), 7.25 – 7.22 
(m, 2H; HAr-9), 7.22 – 7.16 (m, 1H; HAr-11), 5.28 – 5.20 (m, 1H; H-1 or H-3), 5.17 – 5.08 (m, 
1H; H-1 or H-3), 3.34 (dd, J = 7.0, 2.7 Hz, 2H; H-7), 2.02 – 1.93 (m, 2H; H-4), 1.42 (sex, J = 
7.3 Hz, 2H; H-5), 0.92 (t, J = 7.3 Hz, 3H; H-6). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 204.7 
(Cq, C-2), 140.8 (Cq, C-8), 128.6 (2 x CHAr; C-9 or C-10), 128.5 (2 x CHAr; C-9 or C-10), 126.2 
(CHAr; C-11), 91.4 (CH; C-1 or C-3), 90.4 (CH; C-1 or C-3), 36.1 (CH2; C-7), 31.1 (CH2; C-
4), 22.5 (CH2; C-5), 13.8 (CH3; C-6). IR (Film, cm-1): ν̃ = 3063 (C-HAr), 3028 (C-HAr), 2959 
(C-HAlkane), 2929 (C-HAlkane), 2872 (C-HAlkane), 1962 (C=C=C), 1494, 1454, 1260, 882, 741 (C-
HAr(bend)), 697. HRMS (FTMS + p APCI (NEAT)): Calc. for C13H17 [M+H]+: 173.1325. Found: 
173.1324. 
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Synthesis of (5-methyl-hexa-2,3-dienyl)-benzene (141b) 
  
 From 3-phenyl-1-propyne (294 µl, 2.37 mmol), isobutyraldehyde (324 µl, 3.55 
mmol), Cy2NH (711 µl, 3.57 mmol), CuI (45 mg, 0.24 mmol) and 4.7 mL of toluene. Obtained 
after column chromatography using Hex / EtOAc (90:1) as eluent: 141b, 113 mg, 0.66 mmol 
(28%): yellow oil. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.32 – 7.28 (m, 2H; HAr-10), 7.26 
– 7.23 (m, 2H; HAr-9), 7.23 – 7.18 (m, 1H; HAr-11), 5.34 – 5.27 (m, 1H; H-3 or H-1), 5.18 – 
5.11 (m, 1H; H-3 or H-1), 3.35 (dd, J = 6.9, 2.8 Hz, 2H; H-7), 2.32 – 2.22 (m, 1H; H-4), 0.99 
(d, J = 6.9 Hz, 3H; H-5 or H-6), 0.99 (d, J = 6.8 Hz, 3H; H-5 or H-6). 13C NMR (126 MHz, 
CDCl3, 25 oC) δ = 203.0 (Cq, C-2), 140.8 (Cq, C-8), 128.7 (2 x CHAr; C-9 or C-10), 128.4 (2 x 
CHAr; C-9 or C-10), 126.2 (CHAr; C-11), 99.1 (CH; C-1 or C-3), 91.8 (CH; C-1 or C-3), 36.2 
(CH; C-4), 28.1 (CH2; C-7), 22.7 (CH3; C-5 or C-6), 22.6 (CH3; C-5 or C-6). IR (Film, cm-1): 
ν̃ = 3029 (C-HAr), 2963 (C-HAlkane), 2928 (C-HAlkane), 1955 (C=C=C), 1725, 1608 (C=CAr), 
1452, 1261, 1080, 1027, 800, 699 (C-HAr(bend)). HRMS (FTMS + p APCI (NEAT)): Calc. for 
C13H17 [M+H]+: 173.1325. Found: 173.1324.  
Synthesis of octa-3,4-dienyl-benzene (141c) 
  
 From 4-phenyl-1-butyne (297 µl, 2.11 mmol), butyraldehyde (286 µl, 3.17 mmol), 
Cy2NH (634 µl, 3.19 mmol), CuI (40 mg, 0.21 mmol) and 4.2 mL of toluene. Obtained after 
column chromatography using hexane as eluent: 141c, 248 mg, 1.33 mmol (63%): yellow oil. 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.31 – 7.26 (m, 2H; HAr-11), 7.22 – 7.16 (m, 3H; HAr-
10 and HAr-12), 5.16 – 5.11 (m, 1H; H-1), 5.11 – 5.04 (m, 1H; H-3), 2.72 (t, J = 7.7 Hz, 2H; 
H-8), 2.35 – 2.25 (m, 2H; H-7), 1.99 – 1.86 (m, 2H; H-4), 1.44 – 1.32 (m, 2H; H-5), 0.95 – 
0.88 (m, 3H; H-6). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 204.2 (Cq; C-2), 142.1 (Cq; C-9), 
128.7 (2 x CHAr; C-10), 128.4 (2 x CHAr; C-11), 125.9 (CHAr; C-12), 91.5 (CH; C-3), 90.3 
(CH; C-1), 35.6 (CH2; C-8), 31.1 (CH2; C-4), 30.9 (CH2; C-7), 22.5 (CH2; C-5), 13.8 (CH3; C-
6). IR (Film, cm-1): ν̃ = 3086 (C-HAr), 3063 (C-HAr), 3027, 2959 (C-HAlkane), 2929 (C-HAlkane), 
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2871 (C-HAlkane), 1962 (C=C=C), 1604 (C=CAr), 1454, 876. HRMS (FTMS + p APCI 
(NEAT)): Calc. for C14H19 [M+H]+: 187.1481. Found: 187.1480. 
Synthesis of (6-methyl-hepta-3,4-dienyl)-benzene (141d) 
  
 From 4-phenyl-1-butyne (270 µl, 1.92 mmol), isobutyraldehyde (263 µl, 2.88 mmol), 
Cy2NH (576 µl, 2.90 mmol), CuI (37 mg, 0.19 mmol) and 3.8 mL of toluene. Obtained after 
column chromatography using hexane as eluent: 141d, 277 mg, 1.49 mmol (77%): yellow oil. 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.31 – 7.26 (m, 2H; HAr-11), 7.23 – 7.17 (m, 3H; HAr-
10 and HAr-12), 5.23 – 5.17 (m, 1H; H-1), 5.16 – 5.11 (m, 1H; H-3), 2.73 (t, J = 7.8 Hz, 2H; 
H-8), 2.36 – 2.28 (m, 2H; H-7), 2.29 – 2.20 (m, 1H; H-4), 0.99 (d, J = 6.7 Hz, 6H; H-5 and H-
6). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 202.5 (Cq; C-2), 142.1 (Cq; C-9), 128.6 (2 x CHAr; 
C-10), 128.4 (2 x CHAr; C-11), 125.9 (CHAr; C-12), 99.2 (CH; C-3), 91.7 (CH; C-1), 35.7 
(CH2; C-8), 31.0 (CH2; C-7), 28.1 (CH; C-4), 22.6 (2 x CH3; C-5 and C-6). IR (Film, cm-1): 
ν̃ = 3086 (C-HAr), 3027 (C-HAr), 2960 (C-HAlkane), 2925 (C-HAlkane), 2866 (C-HAlkane), 1960 
(C=C=C), 1604 (C=CAr), 1454, 1363 (iPr), 872. HRMS (FTMS + p APCI (NEAT)): Calc. for 
C14H19 [M+H]+: 187.1481. Found: 187.1480. 
Experimental procedure for a modified Crabbé homologation with CdI2 applied to the 
synthesis of 1,3-disubstituted allenes 
Synthesis of 4-(1,2-hexadien-1-yl)-α,α,α-trifluorotoluene (142) 
  
 The synthesis was undertaken according to a modified procedure described by Ma and 
coworkers.[29] To a flame-dried Schlenk tube, cadmium iodide (CdI2) (861 mg, 2.35 mmol, 0.8 
Eq.) was added inside a globe box. The Schlenk tube was then taken out, dried under vacuum 
with a flame until the white CdI2 turned to yellow-green. Allowed to cool. Dry toluene (12.0 
mL), 4-ethynyl-α,α,α-trifluorotoluene (479 µl, 2.94 mmol, 1.0 Eq.), butyraldehyde (477 µl, 
5.29 mmol, 1.8 Eq.) and pyrrolidine (343 µl, 4.11 mmol, 1.4 Eq.) were added sequentially 
under N2 flow. The Schlenk tube was then equipped with a condenser and placed in a pre-
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heated oil bath at 130 oC. The reaction mixture was heated at this temperature during 4 h. After 
cooled down, the crude was filtered through a pad of celite / silica gel (1:1), washed with Et2O 
(30 mL) and concentrated under vacuum. The crude of the reaction was purified by column 
chromatography over silica gel using hexane as eluent. 142, 202 mg, 0.89 mmol was obtained 
as a yellow oil (30%). 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.53 (d, J = 8.2 Hz, 2H; HAr-9), 
7.38 (d, J = 8.2 Hz, 2H; HAr-8), 6.15 (dt, J = 6.7, 3.0 Hz, 1H; H-1), 5.63 (q, J = 6.7 Hz, 1H; H-
3), 2.17 – 2.09 (m, 2H; H-4), 1.56 – 1.47 (m, 2H; H-5), 0.98 (t, J = 7.4 Hz, 3H; H-6). 13C NMR 
(126 MHz, CDCl3, 25 oC) δ = 206.3 (Cq, C-2), 139.3 (Cq, C-7), 128.6 (q, JC-F = 32.1 Hz; Cq-
10), 126.8 (2 x CHAr; C-8), 125.6 (q, JC-F = 3.8 Hz; 2x CHAr-9), 124.4 (q, JC-F = 274.9 Hz; 
CF3), 95.6 (CH; C-1), 93.9 (CH; C-3), 30.7 (CH2; C-4), 22.4 (CH2; C-5), 13.9 (CH3; C-6). 19F 
NMR (471 MHz, CDCl3, 25 oC) δ = - 62.36. IR (Film, cm-1): ν̃ = 3025 (C-HAr), 2966 (C-
HAlkane), 2927 (C-HAlkane), 2853 (C-HAlkane), 1954 (C=C=C), 1618 (C=CAr), 1457 (C-HAlkane), 
1325 (C-F), 1166, 1126, 1067. HRMS (FTMS + ASAP (OIL)): Calc. for C13H12F3 [M-H]+: 
225.0886. Found: 225.0887. 
Synthesis of 1-chloro-4-(1,2-nonadien-1-yl)-benzene (143)[175] 
 
 From 1-octyne (937 µl, 6.35 mmol, 1.0 Eq.), cadmium iodide (CdI2) (1.9 g, 5.08 
mmol, 0.8 Eq.), 4-chlorobenzaldehyde (1.6 g, 11.43 mmol, 1.8 Eq.), pyrrolidine (742 µl, 8.89 
mmol, 1.4 Eq.) and dry toluene (26.0 mL). Obtained after column chromatography using 
hexane as eluent: 143, 431 mg, 1.84 mmol (29%): yellow oil. 1H NMR (500 MHz, CDCl3, 25 
oC) δ = 7.27 – 7.24 (m, 2H; HAr-12), 7.23 – 7.19 (m, 2H; HAr-11), 6.08 (dt, J = 6.6, 3.0 Hz, 1H; 
H-1), 5.58 (q, J = 6.6 Hz, 1H; H-3), 2.16 – 2.09 (m, 2H; H-4), 1.51 – 1.43 (m, 2H; H-5), 1.40 
– 1.33 (m, 2H; H-6), 1.33 – 1.22 (m, 4H; H-7 and H-8), 0.88 (t, J = 6.9 Hz, 3H; H-9). 13C 
NMR (126 MHz, CDCl3, 25 oC) δ = 205.4 (Cq, C-2), 133.9 (Cq, C-10 or C-13), 132.2 (Cq, C-
10 or C-13), 128.8 (2 x CHAr; C-12), 127.9 (2 x CHAr; C-11), 95.7 (CH; C-1), 93.8 (CH; C-3), 
31.8 (CH2; C-7 or C-8), 29.2 (CH2; C-5), 29.0 (CH2; C-6), 28.8 (CH2; C-4), 22.8 (CH2; C-7 or 
C-8), 14.2 (CH3; C-9). 
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Synthesis of (3-methyl-1,2-pentadien-1-yl)-benzene (144)[176] 
  
 The synthesis was undertaken according to the procedure described by Ma and co-
workers.[29] To a flame-dried Schlenk tube, cadmium iodide (CdI2) (574 mg, 1.57 mmol, 0.8 
Eq.) was added inside a globe box. The Schlenk tube was then taken out, dried under vacuum 
with a flame until the white CdI2 turned to yellow-green. Allow to dry. Dry toluene (10.0 mL), 
phenylacetylene (215 µl, 1.96 mmol, 1.0 Eq.), 2-butanone (193 µl, 2.15 mmol, 1.1 Eq.) and 
pyrrolidine (180 µl, 215 mmol, 1.1 Eq.) were added sequentially under N2 flow. The Schlenk 
tube was then equipped with a condenser and placed in a pre-heated oil bath at 130 oC. The 
reaction mixture was heated at this temperature during 4 h. After cooled down, the solution 
was filtered through a pad of celite / silica gel (1:1), washed with Et2O (20 mL) and 
concentrated under vacuum. The crude of the reaction was purified by column 
chromatography over silica gel using hexane as eluent. 144, 188 mg, 1.19 mmol was obtained 
as a yellow oil (61%). 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.28 – 7.24 (m, 4H; HAr-8 and 
HAr-9), 7.18 – 7.11 (m, 1H; HAr-10), 6.10 – 6.04 (m, 1H; H-1), 2.14 – 2.02 (m, 2H; H-5), 1.80 
(d, J = 2.8 Hz, 3H; H-4), 1.05 (t, J = 7.4 Hz, 3H; H-6). 13C NMR (126 MHz, CDCl3, 25 oC) δ 
= 202.5 (Cq, C-2), 136.3 (Cq, C-7), 128.6 (2 x CHAr; C-8 or C-9), 126.6 (2 x CHAr; C-8 or C-
9), 126.5 (CHAr; C-10), 105.6 (Cq, C-3), 94.6 (CH; C-1), 27.3 (CH2; C-5), 18.9 (CH3; C-4), 
12.4 (CH3; C-6). 
General procedure for gold-catalysed hydroazidation of allenes under best reaction 
conditions 
 (PhO)3PAuCl, (0.05 Eq.) and AgOTf (0.05 Eq.) were added into a previously vacuum-
dried Schlenk flask under N2. The solids were dissolved in a small amount of dry 
dichloromethane and stirred for a few minutes at 0 ºC to preform the cationic complex. Then, 
the corresponding allene (1.0 Eq., 0.41M - absolute concentration) was added dropwise neat 
or dissolved in dry DCM at 0 ºC. TMSN3 (3.0 Eq.), distilled water (5.0 Eq.), and CF3COOH 
(3.0 Eq.) were sequencially added dropwise at 0 ºC. The mixture was warmed up and stirred 
at room temperature until complete conversion, followed by TLC. The crude was filtered 
through celite and washed with dichloromethane. The solvent was removed under vacuum, 
and the product was purified by column chromatography over basic alumina using Hex / Et2O 
or EtOAc as eluent. 
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Yields were lowered in some cases due to purification issues. 
 All the products obtained were air stable and in solution, but we kept them in the fridge 
or freezer and in the dark to avoid decompostion. 
Synthesis of allyl azides 124a, 125a and N-cyclohexylmethyl-acetamide 127 
 
 From allene 96b (119 µl, 0.82 mmol), (PhO)3PAuCl (22 mg, 0.04 mmol), silver triflate 
(10 mg, 0.04 mmol), TMSN3 (323 µl, 2.45 mmol), distilled water (74 µl, 4.09 mmol), 
trifluoroacetic acid (196 µl, 2.45 mmol) and 2.0 mL of dry DCM. Obtained after column 
chromatography, Hex / EtOAc, (90:1) then (2:1): 124a:125a (3.7:1) as an inseparable mixture, 
80 mg, 0.48 mmol (59%): pale-yellow oil, and 127, 19 mg, 0.12 mmol (15%): yellow oil. 
(3-Azido-1-propenyl)-cyclohexane (124a) 
  
1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.73 – 5.68 (m, 1H; H-3), 5.44 (dtd, J = 15.4, 6.7, 1.3 
Hz, 1H; H-2), 3.69 (d, J = 6.7 Hz, 2H; H-1), 2.05 –  1.97 (m, 1H; H-4), 1.77 –  1.63 (m, 5H), 
1.32 –  0.94 (m, 5H). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 143.2 (CH; C-3), 120.3 (CH; C-
2), 53.1 (CH2; C-1), 40.6 (CH; C-4), 32.9 (2 x CH2; C-5 and C-9), 26.2 (CH2; C-7), 26.1 (2 x 
CH2; C-6 and C-8).  
(1-Azido-allyl)-cyclohexane (125a) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.79 – 5.74 (m, 1H; H-2), 5.31 – 5.21 (m, 2H; H-1), 
3.60 (t, J = 7.7 Hz, 1H; H-3), 1.69 – 1.78 (m, 5H), 1.41 – 1.35 (m, 1H; H-4), 0.83 – 1.30 (m, 
5H). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 134.6 (CH; C-2), 119.0 (CH2; C-1), 71.1 (CH; 
C-3), 41.8 (CH; C-4), 29.5 (CH2), 29.4 (CH2), 26.4 (CH2), 26.1 (CH2), 26.0 (CH2). 
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124a and 125a as inseparable mixture. IR (Film, cm-1): ν̃ = 2924 (C-HAlkane), 2097 (N=N=N), 
1646 (C=CH2), 1450, 1260, 971 (C=C(Bend)), 802. MS (ESI+ in MeOH): m/z (%): 138.0 [M-
N2+H]+. HRMS (FTMS + APCI): Calc. for C9H16N3 [M+H]+: 166.1339. Found: 166.1336. 
Calc. for C9H16N1 [M-N2+H]+: 138.1277. Found: 138.1276. 
N-Cyclohexylmethyl-acetamide (127)[177] 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.50 (bs, 1H; NH), 3.09 – 3.05 (t, J = 6.4 Hz, 2H; H-
3), 1.98 (s, 3H, H-1), 1.78 – 1.62 (m, 5H), 1.50 – 1.38 (m, 1H; H-4), 1.29 – 1.09 (m, 3H), 0.99 
– 0.83 (m, 2H). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 170.2 (Cq; C-2), 46.0 (CH2; C-3), 38.0 
(CH; C-4), 30.9 (CH2), 26.5 (CH2), 25.9 (CH2), 23.5 (CH3; C-1). IR (Film, cm-1): ν̃ = 3592 (N-
H), 3090, 2922 (C-HAlkane), 2851 (C-HAlkane), 1680 (C=O), 1560 (N-H(Bend)), 1448, 1301, 991. 
HRMS (FTMS + APCI (OIL + NH4OAc)): Calc. for C9H18O1N1 [M+H]+: 156.1383. Found: 
156.1380. 
Synthesis of allyl azides 124b and 125b and 2-nonanone 145a 
 
 From allene 139a (100 mg, 0.80 mmol), (PhO)3PAuCl (22 mg, 0.04 mmol), silver 
triflate (10 mg, 0.04 mmol), TMSN3 (318 µl, 2.42 mmol), distilled water (73 µl, 4.02 mmol), 
trifluoroacetic acid (193 µl, 2.42 mmol) and 2.0 mL of dry DCM. Obtained after column 
chromatography, Hex / Et2O, (60:1) then (2:1): 124b:125b (1.9:1) as an inseparable mixture, 
65 mg, 0.38 mmol (48%): pale-yellow oil, and 145a, 9 mg, 0.06 mmol (16%): pale-yellow 
liquid.  
1-Azido-2-nonene (124b) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.79 – 5.72 (m, 1H; H-3), 5.51 (dtt, J = 15.0, 6.7, 1.4 
Hz, 1H; H-2), 3.70 (d, J = 6.7 Hz, 2H; H-1), 2.12 – 2.05 (m, 2H; H-4), 1.43 – 1.35 (m, 2H; H-
5), 1.35 – 1.23 (m, 6H), 0.88 (t, J = 6.6 Hz, 3H; H-9). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 
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137.5 (CH; C-3), 122.8 (CH; C-2), 53.1 (CH2; C-1), 32.4 (CH2; C-4), 31.8 (CH2; C-5), 29.2 
(CH2), 28.9 (CH2), 22.7 (CH2), 14.2 (CH3; C-9).  
3-Azido-1-nonene (125b) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.74 – 5.69 (m, 1H; H-2), 5.28 – 5.24 (m, 2H; H-1), 
3.83 – 3.77 (m, 1H; H-3), 1.59 – 1.46 (m, 2H; H-4), 1.44 – 1.38 (m, 2H; H-5), 1.35 – 1.23 (m, 
6H), 0.91 – 0.85 (m, 3H; H-9). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 136.1 (CH; C-2), 118.0 
(CH2; C-1), 65.3 (CH; C-3), 34.4 (CH2; C-4), 29.1 (CH2; C-5), 29.0 (CH2), 25.6 (CH2), 22.7 
(CH2), 14.2 (CH3; C-9). 
124b and 125b as inseparable mixture. IR (Film, cm-1): ν̃ = 3068 (C-HAlkene), 2958, 2929 (C-
HAlkane), 2857 (C-HAlkane), 2097 (N=N=N), 1643 (C=C), 1237, 969. HRMS (FTMS + APCI 
((DCM)/MeOH + NH4OAc)): Calc. for C9H18N1 [M-N2+H]+: 140.1434. Found: 140.1430 
2-nonanone (145a)[178] 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 2.41 (t, J = 7.5 Hz, 2H; H-3), 2.13 (s, 3H; H-1), 1.61 
– 1.52 (m, 2H; H-4), 1.33 – 1.20 (m, 8H), 0.88 (t, J = 7.0 Hz, 3H; H-9). 13C NMR (126 MHz, 
CDCl3, 25 oC) δ = 209.6 (Cq; C-2), 44.0 (CH2; C-3), 31.8 (CH2), 30.19 (CH2), 29.3 (CH2), 29.2 
(CH2), 24.0 (CH2), 22.8 (CH2), 14.2 (CH3; C-9). 
Synthesis of allyl azides 124c and 125c 
 
 From allene 139b (50 mg, 0.33 mmol, 0.08 M), (PhO)3PAuCl (9 mg, 0.02 mmol), 
silver triflate (4 mg, 0.02 mmol), TMSN3 (131 µl, 0.98 mmol), trifluoroacetic acid (75 µl, 0.98 
mmol) and 4.0 mL of dry DCM. Obtained as inseparable mixture after column 
chromatography, hexane, then Hex / Et2O, (5:1): 124c:125c (1.8:1), 30 mg, 0.15 mmol (47%): 
colourless oil. 
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1-Azido-2-undecene (124c) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.79 – 5.72 (m, 1H; H-3), 5.55 – 5.49 (m, 1H; H-2), 
3.69 (d, J = 6.7 Hz, 2H; H-1), 2.11 – 2.06 (m, 2H; H-4), 1.61 – 1.46 (m, 2H; H-5), 1.40 – 1.27 
(m, 10H), 0.88 (t, J = 6.8 Hz, 3H; H-11). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 137.7 (CH; 
C-3), 123.0 (CH; C-2), 53.3 (CH2; C-1), 32.6 (CH2; C-4), 32.2 (CH2), 29.8 (CH2), 29.6 (CH2), 
29.4 (CH2), 29.4 (CH2), 23.0 (CH2), 14.4 (CH3; C-11).  
3-Azido-1-undecene (125c)  
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.77 – 5.72 (m, 1H; H-2), 5.28 – 5.24 (m, 2H; H-1), 
3.83 – 3.79 (m, 1H; H-3), 1.59 – 1.23 (m, 12H), 0.88 (t, J = 6.8 Hz, 3H; H-11). Protons of 
124c overlapped with protons of 125c. 13C NMR (126 MHz, CDCl3, 25 oC) δ = 136.3 (CH; C-
2), 118.2 (CH2; C-1), 65.5 (CH; C-3), 34.6 (CH2), 32.2 (CH2), 30.1 (CH2), 29.8 (CH2), 29.6 
(CH2), 29.6 (CH2), 26.1 (CH2), 14.4 (CH3; C-11). 
124c and 125c as inseparable mixture. IR (Film, cm-1): ν̃ = 2957 (C-HAlkane), 2926 (C-HAlkane), 
2855 (C-HAlkane), 2098 (N=N=N), 1645 (C=C), 1242, 970. HRMS (FTMS + APCI) Calc. for 
C11H22N [M-N2+H]+: 168.1747. Found: 168.1743. Calc. for C11H22N3 [M+H]+: 196.1808. 
Found: 196.1805. This synthesis was made by Stefanie Hohne. 
Synthesis of (3-azido-1-propenyl)-benzene (124d)[120c, 179] 
  
 From allene 94a (100 mg, 0.86 mmol), (PhO)3PAuCl (23 mg, 0.04 mmol), silver 
triflate (11 mg, 0.04 mmol), TMSN3 (340 µl, 2.58 mmol), distilled water (78 µl, 4.30 mmol), 
trifluoroacetic acid (207 µl, 2.58 mmol) and 2.1 mL of dry DCM. Obtained after column 
chromatography, Hex / Et2O, (20:1): 124d, 85 mg, 0.53 mmol (62%): yellow oil. 1H NMR 
(500 MHz, CDCl3, 25 oC) δ = 7.44 – 7.39 (m, 2H; HAr-5), 7.37 – 7.32 (m, 2H; HAr-6), 7.31 – 
7.27 (m, 1H; HAr-7), 6.66 (d, J = 15.8 Hz, 1H; H-3), 6.25 (dt, J = 15.8, 6.7 Hz, 1H; H-2), 3.95 
(dd, J = 6.7, 0.7 Hz, 2H; H-1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 136.1 (Cq; C-4), 134.7 
(CH; C-3), 128.8 (2 x CHAr; C-5), 128.3 (CHAr; C-7), 126.8 (2 x CHAr; C-6), 122.5 (CH; C-2), 
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53.2 (CH2; C-1). IR (Film, cm-1): ν̃ = 3029 (C-HAlkene), 2993, 2927 (C-HAlkane), 2099 (N=N=N), 
1702, 1654 (C=C), 1598, 1492, 1235, 967. MS-EI: C9H9N3 m/z (%) 159 [M+] (3), 118 (31), 
117 (100), 115 (32), 105 (20), 91 (28), 77 (20). 
Synthesis of allyl azides 124e, 125e and 2-(3-oxo-butyl)-malonic acid dimethyl ester 145b 
 
 From allene 139c (100 mg, 0.54 mmol), (PhO)3PAuCl (15 mg, 0.03 mmol), silver 
triflate (7 mg, 0.03 mmol), TMSN3 (214 µl, 1.63 mmol), distilled water, (49 µl, 2.72 mmol), 
trifluoroacetic acid (130 µl, 1.63 mmol) and 1.3 mL of dry DCM. Obtained after column 
chromatography, Hex / EtOAc, (30:1) then (2:1): 124e:125e (3.8:1) as inseparable mixture, 
53 mg, 0.23 mmol (43%): yellow oil, and 145b, 19 mg, 0.09 mmol (17%): yellow oil. 
2-(4-Azido-2-butenyl)-malonic acid dimethyl ester (124e) 
  
1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.78 – 5.68 (m, 1H; H-3 or H-2), 5.68 – 5.59 (m, 1H; 
H-3 or H-2), 3.74 (s, 6H; H-7 and H-8), 3.69 (d, J = 6.3 Hz, 2H; H-1), 3.47 (t, J = 7.5 Hz, 1H; 
H-5), 2.68 (m, 2H; H-4). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 169.2 (2 x Cq; C-6), 131.6 
(CH; C-3), 126.5 (CH; C-2), 52.8 (CH2; C-1), 52.5 (CH; C-5), 51.5 (CH2; C-4), 31.6 (CH3; C-
7 or C-8), 29.9 (CH3; C-7 or C-8).  
2-(2-Azido-3-butenyl)-malonic acid dimethyl ester (125e) 
  
1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.63 – 5.60 (m, 1H; H-2), 5.35 – 5.31 (m, 2H; H-1), 
3.75 (s, 6H; H-7 and H-8), 3.57 – 3.05 (m, 1H; H-3), 3.46 – 3.42 (m, 1H; H-5), 2.19 – 2.03 
(m, 2H; H-4). 13C NMR signals could not be extracted from the spectra of the mixture 2e+2e’ 
due to the low concentration of 2e’. 
124e and 125e as inseparable mixture: IR (Film, cm-1): ν̃ = 2924 (C-HAlkane), 2853 (C-HAlkane), 
2099 (N=N=N), 1736 (C=O), 1630 (C=C), 1437, 1260 (C-O), 973, 801, 749. MS (ESI+ in 
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MeOH): m/z = 225.05 C9H15KO4 [M-N3+K+H]+. HRMS (FTMS + p NSI ((DCM)/MeOH + 
NH4OAc)): Calc. for C9H17N4O4 [M+NH4]+: 245.1244 Found: 245.1247. 
2-(3-Oxo-butyl)-malonic acid dimethyl ester (145b)[180] 
  
1H NMR (500 MHz, CDCl3, 25 oC, TMS) δ = 3.72 (s, 6H; H-7), 3.43 (t, J = 7.2 Hz, 1H; H-5), 
2.53 (t, J = 7.2 Hz, 2H; H-3), 2.17 (m, 2H; H-4), 2.13 (s, 3H; H-1). 13C NMR (126 MHz, 
CDCl3, 25 oC) δ = 207.2 (Cq; C-2), 169.7 (2  Cq; C-6), 52.7 (2 x CH3; C-7), 50.4 (CH; C-5), 
40.5 (CH2; C-3), 30.1 (CH3; C-1), 22.6 (CH2; C-4). IR (Film, cm-1): ν̃ = 2941 (C-HAlkane), 2854 
(C-HAlkane), 1732 (C=O), 1436, 1275 (C-O), 1156 (C-O), 750. HRMS (FTMS + p APCI 
((DCM)/MeOH + NH4OAc)): Calc. for C9H18NO5 [M+NH4]+: 220.1179 Found: 220.1176. 
Synthesis of allyl azides 124f, 125f and N-(3-oxo-butyl)-phtalimide 145c 
 
 From allene 139d (100 mg, 0.50 mmol), (PhO)3PAuCl (14 mg, 0.02 mmol), silver 
triflate (6 mg, 0.02 mmol), TMSN3 (198 µl, 1.51 mmol), distilled water (45 µl, 2.51 mmol), 
trifluoroacetic acid (172 µl, 1.51 mmol) and 1.2 mL of dry DCM. Obtained after column 
chromatography, Hex / EtOAc, (10:1) then (2:1): 124f, 55 mg, 0.23 mmol (48%): yellow oil; 
125f, 9 mg, 0.04 mmol (7%): yellow oil; 145c, 35 mg, 0.16 mmol (32%): white solid. 
N-(4-Azido-2-butenyl)-phtalimide (124f) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.89 – 7.84 (m, 2H; HAr-7 or HAr-8), 7.75 – 7.71 (m, 
2H; HAr-7 or HAr-8), 5.89 – 5.73 (m, 1H; H-3), 5.83 (dtt, J = 15.4, 5.6, 1.1 Hz, 1H; H-2), 4.33 
(dd, J = 5.6, 1.1 Hz, 2H; H-4), 3.77 (d, J = 5.6 Hz, 2H; H-1); 13C NMR (126 MHz, CDCl3, 25 
oC) δ = 167.9 (2 x Cq; C-5), 134.2 (2 x CHAr; C-7 or C-8), 132.2 (2 x Cq; C-6), 128.4 (CH; C-
3), 127.4 (CH; C-2), 123.5 (2 x CHAr; C-7 or C-8), 52.1 (CH2; C-1), 38.9 (CH2; C-4). IR (Film, 
cm-1): ν̃ = 3070 (C-HAlkene), 2922 (C-HAlkane), 2851 (C-HAlkane), 2097 (N=N=N), 1771 (C=O), 
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1710, 1626 (C=C), 1466, 1426, 1391, 1187, 949. HRMS (FTMS + p NSI ((DCM)/MeOH + 
NH4OAc)): Calc. for C12H14N5O2 [M+NH4]+: 260.1142 Found: 260.1145. 
N-(2-Azido-3-butenyl)-phtalimide (125f) 
  
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.89 – 7.85 (m, 2H; HAr- 7 or HAr-8), 7.77 – 7.69 (m, 
2H; HAr-7 or HAr-8), 5.86 – 5.77 (m, 1H; H-2), 5.42 – 5.38 (m, 1H; H-1), 5.38 – 5.36 (m, 1H; 
H-1), 4.37 – 4.30 (m, 1H; H-3), 3.83 (dd, J = 13.9, 8.3 Hz, 1H; H-4), 3.72 (dd, J = 13.9, 6.3 
Hz, 1H; H-4). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 168.2 (2 x Cq; C-5), 134.3 (2 x CHAr; 
C-7 or C-8), 132.7 (CH; C-2), 132.0 (2 x Cq, C-6), 123.7 (2 x CHAr; C-7 or C-8), 121.2 (CH2; 
C-1), 62.5 (CH; C-3), 40.9 (CH2; C-4). IR (Film, cm-1): ν̃ = 3034 (C-HAlkene), 2923 (C-HAlkane), 
2852 (C-HAlkane), 2098 (N=N=N), 1771 (C=O), 1717, 1614 (C=CH2), 1466, 1426, 1391, 717. 
HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for C12H14N5O2 [M+NH4]+: 
260.1142 Found: 260.1143. 
N-(3-Oxo-butyl)-phtalimide (145c)[181] 
  
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.86 – 7.81 (m, 2H; HAr-7 or HAr-8), 7.74 – 7.68 (m, 
2H; HAr-7 or HAr-8), 3.98 – 3.93 (m, 2H; H-4), 2.87 (t, J = 7.4 Hz; 1H, H-3), 2.18 (s, 3H; H-
1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 205.9 (Cq; C-2), 168.2 (2 x Cq; C-5), 134.2 (2 x 
CHAr; C-7 or C-8), 132.2 (2 x Cq; C-6), 123.4 (2 x CHAr; C-7 or C-8), 41.7 (CH2; C-4), 33.1 
(CH2; C-3), 30.1 (CH3; C-1). IR (Film, cm-1): ν̃ = 3095 (C-HAr), 2957 (C-HAlkane), 2926 (C-
HAlkane), 2856 (C-HAlkane), 1709 (C=O), 1634 (C=CAr), 1467, 1435, 1260, 1029. HRMS (FTMS 
+ p APCI ((DCM)/MeOH + NH4OAc)): Calc. for C12H12NO3 [M+H]+: 218.0812 Found: 
218.0810. M.P. = 111 – 113 ºC. 
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Synthesis of (4-azido-2-butenyl)-carbamic acid tert-butyl ester (124g) 
   
 From allene 139e (100 mg, 0.39 mmol), (PhO)3PAuCl (11 mg, 0.02 mmol), silver 
triflate (5 mg, 0.02 mmol), TMSN3 (154 µl, 1.17 mmol), distilled water (35 µl, 1.96 mmol), 
trifluoroacetic acid (94 µl, 1.17 mmol) and 957 µl of dry DCM. Obtained after column 
chromatography, Hex / EtOAc, (10:1): 124g, 32 mg, 0.15 mmol (38%): yellow oil. 1H NMR 
(500 MHz, CDCl3, 25 oC) δ = 5.80 – 5.76 (m, 1H; H-3 or H-2), 5.76 – 5.71 (m, 1H; H-3 or H-
2), 4.15 – 4.11 (m, 2H; H-4 or H-1), 4.11 – 4.06 (m, 2H; H-4 or H-1), 1.47 (s, 9H; H-7). 13C 
NMR (126 MHz, CDCl3, 25 oC) δ = 154.5 (Cq; C-5), 126.0 (CH; C-2 or C-3), 125.9 (CH; C-2 
or C-3), 79.4 (Cq; C-6), 53.2 (CH2; C-1 or C-4), 53.0 (CH2; C-1 or C-4), 28.7 (3 x CH3; C-7). 
IR (Film, cm-1): ν̃ = 3332 (N-H), 2976 (C-HAlkane), 2925 (C-HAlkane), 2853 (C-HAlkane), 2100 
(N=N=N), 1706 (C=O), 1685 (C=C), 1609 (N-H(Bend)), 1410, 1368 (t-Bu), 1257, 1170, 887. 
HRMS could not be obtained due to rapid decomposition of this product. 
Synthesis of allyl azides 124h and 125h 
  
 From allene 120 (20 mg, 0.29 mmol), (PhO)3PAuCl (8 mg, 0.01 mmol), silver triflate 
(4 mg, 0.01 mmol), TMSN3 (116 µl, 0.88 mmol), distilled water (26 µl, 1.47 mmol), 
trifluoroacetic acid (70 µl, 0.88 mmol) and 718 µl of dry DCM. Obtained: 100% conversion 
124h:125h (3.7:1). This product could not be isolated due to volatility issues. 
1-Azido-3-methyl-2-butene (124h)[120d, 120e] 
  
1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.35 – 5.29 (m, 1H; H-2), 3.76 (d, J = 7.5 Hz, 2H; H-
1), 1.79 (s, 3H; H-4 or H-5), 1.71 (s, 3H; H-4 or H-5). 13C NMR (126 MHz, CDCl3, 25 oC) δ 
= 130.7 (Cq; C-3), 117.3 (CH; C-2), 48.3 (CH2; C-1), 25.7 (CH3; C-4 or C-5), 18.0 (CH3; C-4 
or C-5).  
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3-Azido-3-methyl-1-butene (125h) 
   
1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.85 (dd, J = 17.3, 10.6 Hz, 1H; H-2), 5.22 (dd, J = 
17.3, 0.5 Hz, 1H; H-1), 5.16 (dd, J = 10.6, 0.5 Hz, 1H; H-1), 1.33 (s, 6H; H-4 and H-5). 13C 
NMR (126 MHz, CDCl3, 25 oC) δ = 141.1 (CH; C-2), 114.0 (CH2; C-1), 62.4 (Cq; C-3), 26.0 
(2 x CH3; C-4 and C-5). 
124h and 125h as inseparable mixture. IR (Film, cm-1): ν̃ = 2962 (C-HAlkane), 2905 (C-HAlkane), 
2109 (N=N=N), 1679 (C=C), 1587, 1484, 1261, 1092, 1025, 940. 
Synthesis of (3-azido-1-undecenyl)-benzene (124i) 
 From allene 140 (100 mg, 0.44 mmol), (PhO)3PAuCl (12 mg, 0.02 mmol), silver 
triflate (6 mg, 0.02 mmol), TMSN3 (173 µl, 1.31 mmol), distilled water (39 µl, 2.19 mmol), 
trifluoroacetic acid (105 µl, 1.31 mmol) and 1.1 mL of dry DCM. Obtained after column 
chromatography, using as eluent hexane: 124i, 91 mg, 0.33 mmol (76%): yellow oil. 1H NMR 
(500 MHz, CDCl3, 25 oC) δ = 7.43 – 7.40 (m, 2H; HAr-13), 7.37 – 7.32 (m, 2H; HAr-14), 7.30 
– 7.26 (m, 1H; HAr-15), 6.61 (d, J = 15.8 Hz, 1H; H-11), 6.12 (dd, J = 15.8, 8.1 Hz, 1H; H-
10), 4.00 (q, J = 7.2 Hz, 1H; H-9), 1.70 – 1.56 (m, 2H; H-8), 1.45 – 1.36 (m, 2H; H-7), 1.36 – 
1.23 (m, 10H), 0.91 – 0.87 (m, 3H; H-1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 136.2 (Cq; 
C-12), 133.2 (CH; C-11), 128.8 (2 x CHAr; C-14), 128.2 (CHAr; C-15), 127.5 (CH; C-10), 
126.8 (2 x CHAr; C-13), 65.1 (CH; C-9), 34.9 (CH2; C-8), 32.0  (CH2; C-7), 29.6 (CH2), 29.4 
(CH2), 29.4 (CH2), 26.1 (CH2), 22.8 (CH2), 14.2 (CH3; C-1). IR (Film, cm-1): ν̃ = 3061 (C-
HAlkene), 3028 (C-HAr), 2957 (C-HAlkane), 2927 (C-HAlkane), 2856 (C-HAlkane), 2097 (N=N=N), 
1599 (C=C), 1494 (C-HAlkane), 1466, 1450, 1260, 1095, 966, 803, 749 (C=C(Bend)), 692. HRMS 
(FTMS + p APCI ((DCM)/MeOH + NH4OAc)): Calc. for C17H26N1 [M–N2+H]+: 244.2060 
Found: 244.2056. Calc. for C17H25 [M–N3]+: 229.1951 Found: 229.1948. 
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Synthesis of allyl azides 124j and 125j 
 
 From allene 141a (100 mg, 0.58 mmol), (PhO)3PAuCl (16 mg, 0.03 mmol), silver 
triflate (7 mg, 0.03 mmol), TMSN3 (229 µl, 1.74 mmol), distilled water (52 µl, 2.90 mmol), 
trifluoroacetic acid (139 µl, 1.74 mmol) and 1.4 mL of dry DCM. Obtained as inseparable 
mixture after column chromatography, using as eluent hexane: 124j:125j (1.3:1), 84 mg, 0.39 
mmol (67%): yellow oil. 
(4-Azido-2-heptenyl)-benzene (124j) 
  
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.35 – 7.25 (m, 2H; HAr), 7.25 – 7.22 (m, 1H; HAr-11), 
7.21 – 7.17 (m, 2H; HAr), 5.90 – 5.84 (m, 1H; H-6), 5.49 – 5.44 (m, 1H; H-5), 3.84 (q, J = 7.3 
Hz, 1H; H-4), 3.49 – 3.38 (m, 2H; H-7), 1.59 – 1.44 (m, 2H; H-3), 1.44 – 1.33 (m, 2H; H-2), 
0.88 (t, J = 7.3 Hz, 3H; H-1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 139.7 (Cq; C-8), 133.7 
(CH; C-6), 129.5 (CH; C-5), 128.7 (2 x CHAr), 128.7 (2 x CHAr), 126.8 (CHAr; C-11), 64.5 
(CH; C-4), 38.7 (CH2; C-7), 36.8 (CH2; C-3), 22.4 (CH2; C-2), 13.9 (CH3; C-1).  
(2-Azido-3-heptenyl)-benzene (125j) 
  
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.35 – 7.28 (m, 2H; HAr), 7.25 – 7.22 (m, 1H; HAr-11), 
7.21 – 7.17 (m 2H; HAr), 5.70 – 5.63 (m, 1H; H-4), 5.43 – 5.39 (m, 1H; H-5), 4.05 (q, J = 7.3 
Hz, 1H; H-6), 2.80 (d, J = 7.3 Hz, 2H; H-7), 2.08 – 2.00 (m, 2H; H-3), 1.44 – 1.33 (m, 2H; H-
2), 0.92 (t, J = 7.3 Hz, 3H; H-1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 137.7 (Cq; C-8), 
135.9 (CH; C-4), 129.6 (2 x CHAr), 128.5 (2 x CHAr), 127.3 (CH; C-5), 126.4 (CHAr; C-11), 
65.9 (CH; C-6), 41.5 (CH2; C-7), 34.4 (CH2; C-3) 19.3 (CH2; C-2), 13.6 (CH3; C-1). 
124j and 125j as inseparable mixture. IR (Film, cm-1): ν̃ = 3098 (C-HAlkene), 3045 (C-HAr), 
2960 (C-HAlkane), 2931 (C-HAlkane), 2873 (C-HAlkane), 2097 (N=N=N), 1603 (C=C), 1454 (C-
110 
 
HAlkane), 1237, 970, 747 (C=C(Bend)), 698. HRMS (FTMS + p APCI (OIL + NH4OAc)): Calc. 
for C13H21N4 [M+NH4]+: 233.1761 Found: 233.1760. 
Synthesis of allyl azides 124k and 125k  
 
 From allene 141b (86 mg, 0.50 mmol), (PhO)3PAuCl (14 mg, 0.02 mmol), silver 
triflate (6 mg, 0.02 mmol), TMSN3 (197 µl, 1.50 mmol), distilled water (45 µl, 2.50 mmol), 
trifluoroacetic acid (120 µl, 1.50 mmol) and 1.2 mL of dry DCM. Obtained as an inseparable 
mixture after column chromatography, using as eluent hexane: 124k:125k (1.67:1), 59 mg, 
0.27 mmol (55%): yellow oil. 
(4-Azido-5-methyl-2-hexenyl)-benzene (124k) 
  
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.34 – 7.29 (m, 2H; HAr), 7.25 – 7.17 (m, 3H; HAr), 
5.88 (dtd, J = 15.2, 6.9, 0.6 Hz, 1H; H-6), 5.48 (ddt, J = 15.2, 8.5, 1.5 Hz, 1H; H-5), 3.63 (dd, 
J = 8.5, 6.9 Hz, 1H; H-4), 3.48 – 3.44 (m, 2H; H-7), 1.79 – 1.67 (m, 1H; H-3), 0.95 (d, J = 6.9 
Hz, 3H; H-1 or H-2), 0.91 (d, J = 6.9 Hz, 3H; H-1 or H-2). 13C NMR (126 MHz, CDCl3, 25 
oC) δ = 139.8 (Cq; C-8), 134.8 (CH; C-6), 128.7 (2 x CHAr), 128.7 (2 x CHAr), 127.8 (CH; C-
5), 126.4 (CHAr; C-11), 71.1 (CH; C-4), 38.8 (CH2; C-7), 32.7 (CH; C-3), 19.0 (CH3; C-1 or 
C-2), 19.0 (CH3; C-1 or C-2).  
(2-Azido-5-methyl-3-hexenyl)-benzene (125k) 
  
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.36 – 7.28 (m, 2H; HAr), 7.25 – 7.18 (m, 3H; HAr), 
5.64 (ddd, J = 15.4, 6.8, 0.6 Hz, 1H; H-4), 5.37 (ddd, J = 15.4, 8.1, 1.3 Hz, 1H; H-5), 4.06 – 
4.00 (m, 1H; H-6), 2.83 – 2.79 (m, 2H; H-7), 2.37 – 2.28 (m, 1H; H-3), 1.00 (d, J = 6.8 Hz, 
3H; H-1 or H-2), 0.99 (d, J = 6.8 Hz, 3H; H-1 or H-2). 13C NMR (126 MHz, CDCl3, 25 oC) δ 
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= 143.0 (CH; C-4), 137.7 (Cq; C-8), 129.6 (2 x CHAr), 128.5 (2 x CHAr), 126.8 (CHAr; C-11), 
124.1 (CH; C-5), 65.8 (CH; C-6), 41.5 (CH2; C-7), 31.0 (CH; C-3), 22.5 (CH3; C-1 or C-2), 
22.4 (CH3; C-1 or C-2). 
124k and 125k as inseparable mixture. IR (Film, cm-1): ν̃ = 3064(C-HAlkene), 3030 (C-HAr), 
2962 (C-HAlkane), 2929 (C-HAlkane), 2095 (N=N=N), 1610 (C=C), 1454 (C-HAlkane), 1260, 1094, 
1029, 803, 699 (C=C(Bend)). HRMS (FTMS + p APCI (OIL + NH4OAc)): Calc. for C13H21N4 
[M+NH4]+: 233.1761 Found: 233.1760. 
Synthesis of allyl azides 124l and 125l 
 From allene 141c (100 mg, 0.54 mmol), (PhO)3PAuCl (15 mg, 0.03 mmol), silver 
triflate (7 mg, 0.03 mmol), TMSN3 (212 µl, 1.61 mmol), distilled water (48 µl, 2.69 mmol), 
trifluoroacetic acid (129 µl, 1.61 mmol) and 1.3 mL of dry DCM. Obtained as inseparable 
mixture after column chromatography, using as eluent hexane: 124l:125l (1:1.13), 85 mg, 0.37 
mmol (70%): yellow oil.  
(5-Azido-3-octenyl)-benzene (124l) 
 
1H NMR (500 MHz, CDCl3, 25 oC, TMS) δ = 7.33 – 7.27 (m, 2H; HAr), 7.23 – 7.16 (m, 3H; 
HAr), 5.77 – 5.68 (m, 1H; H-6), 5.41 – 5.33 (m, 1H; H-5), 3.78 – 3.74 (m, 1H; H-4), 2.77 – 
2.70 (m, 2H; H-8), 2.47 – 2.37 (m, 2H; H-7), 1.55 – 1.47 (m, 2H; H-3), 1.36 – 1.25 (m, 2H; 
H-2), 0.90 (t, J = 7.4 Hz, 3H; H-1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 141.5 (Cq; C-9), 
134.3 (CH; C-6), 128.7 (CH; C-5), 128.7 (2 x CHAr), 128.5 (2 x CHAr), 126.1 (CHAr; C-12), 
64.6 (CH; C-4), 36.8 (CH2; C-3), 35.8 (CH2; C-8), 34.1 (CH2; C-7), 19.2 (CH2; C-2), 13.8 
(CH3; C-1). 
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(3-Azido-4-octenyl)-benzene (125l)  
  
1H NMR (500 MHz, CDCl3, 25 oC, TMS) δ = 7.33 – 7.27 (m, 2H; HAr), 7.23 – 7.16 (m, 3H; 
HAr), 5.74 – 5.67 (m, 1H; H-4), 5.44 – 5.38 (m, 1H; H-5), 3.82 – 3.78 (m, 1H; H-6), 2.70 – 
2.65 (m, 2H; H-8), 2.11 – 2.05 (m, 2H; H-3), 1.91 – 1.75 (m, 2H; H-7), 1.47 – 1.41 (m, 2H; 
H-2), 0.93 (t, J = 7.4 Hz; 3H, H-1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 141.3 (Cq; C-9), 
136.0 (CH; C-4), 128.6 (4 x CHAr; C-10 and C-11), 127.6 (CH; C-5), 126.2 (CHAr; C-12), 64.1 
(CH; C-6), 36.4 (CH2; C-7), 34.4 (CH2; C-3), 32.2 (CH2; C-8), 22.4 (CH2; C-2), 13.7 (CH3; C-
1).  
124l and 125l as inseparable mixture. IR (Film, cm-1): ν̃ = 3064 (C-HAlkene), 3028 (C-HAr), 2960 
(C-HAlkane), 2932 (C-HAlkane), 2873 (C-HAlkane), 2095 (N=N=N), 1604 (C=C), 1455 (C-HAlkane), 
1238, 1030, 970, 747 (C=C(Bend)). HRMS (FTMS+ p APCI (OIL + NH4OAc)): Calc. for 
C14H23N4 [M+NH4]+: 247.1917. Found 247.1917, Calc. for C14H20N1 [M–N2+H]+: 202.1590. 
Found 202.1591. 
Synthesis of allyl azides 124m and 125m 
 
 From allene 141d (100 mg, 0.54 mmol), (PhO)3PAuCl (15 mg, 0.03 mmol), silver 
triflate (7 mg, 0.03 mmol), TMSN3 (212 µl, 1.61 mmol), distilled water (48 µl, 2.69 mmol), 
trifluoroacetic acid (129 µl, 1.61 mmol) and 1.3 mL of dry DCM. Obtained as inseparable 
mixture after column chromatography, using as eluent hexane: 124m:125m (1:1), 98 mg, 0.43 
mmol (80%): yellow oil. 
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(5-Azido-6-methyl-3-heptenyl)-benzene (124m)  
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.33 – 7.27 (m, 2H; HAr), 7.23 – 7.16 (m, 3H; HAr), 
5.76 – 5.71 (m, 1H; H-6), 5.43 – 5.37 (m, 1H; H-5), 3.55 (dd, J = 8.5, 6.8 Hz, 1H; H-4), 2.80 
– 2.71 (m, 2H; H-8), 2.49 – 2.40 (m, 2H; H-7), 1.71 – 1.63 (m, 1H; H-2), 0.90 (d, J = 6.8 Hz, 
3H; H-1 or H-3), 0.84 (d, J = 6.8 Hz, 3H; H-1 or H-3). 13C NMR (126 MHz, CDCl3, 25 oC) δ 
= 141.3 (Cq; C-9), 135.3 (CH; C-6), 128.6 (2 x CHAr), 128.5 (2 x CHAr), 126.9 (CH; C-5), 
126.2 (CHAr; C-12), 71.3 (CH; C-4), 35.9 (CH2; C-8), 34.1 (CH2; C-7), 32.6 (CH; C-2), 19.0 
(CH3; C-1 or C-3), 18.9 (CH3; C-1 or C-3).  
(3-Azido-6-methyl-4-heptenyl)-benzene (125m) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.33 – 7.27 (m, 2H; HAr), 7.23 – 7.16 (m, 3H; HAr), 
5.71 – 5.67 (m, 1H; H-4), 5.38 – 5.32 (m, 1H; H-5), 3.80 – 3.73 (m, 1H; H-6), 2.71 – 2.64 (m, 
2H; H-8), 2.39 – 2.32 (m, 1H; H-2), 1.91 – 1.75 (m, 2H; H-7), 1.04 (dd, J = 6.8, 2.0 Hz, 6H; 
H-1 and H-3). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 143.2 (CH; C-4), 141.5 (Cq; C-9), 128.6 
(4 x CHAr; C-10 and C-11), 126.1 (CHAr; C-12) 124.4 (CH; C-5), 64.0 (CH; C-6), 36.4 (CH2; 
C-7), 32.2 (CH2; C-8), 31.1 (CH; C-2), 22.6 (CH3; C-1 or C-3), 22.5 (CH3; C-1 or C-3). 
124m and 125m as inseparable mixture. IR (Film, cm-1): ν̃ = 3064 (C-HAlkene), 3028 (C-HAr), 
2961 (C-HAlkane), 2927 (C-HAlkane), 2870 (C-HAlkane), 2095 (N=N=N), 1603 (C=C), 1454 (C-
HAlkane), 1367 (iPr), 1241, 971, 747 (C=C(Bend)). HRMS (FTMS+ p APCI (OIL + NH4OAc)): 
Calc. for C14H23N4 [M+NH4]+: 247.1917. Found: 247.1917. 
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Synthesis of 1-(3-azido-1-propenyl)-4-trifluoromethyl-benzene (124n)[121b] 
  
 From allene 139f (100 mg, 0.54 mmol), (PhO)3PAuCl (15 mg, 0.03 mmol), silver 
triflate (7 mg, 0.03 mmol), TMSN3 (214 µl, 1.63 mmol), distilled water (49 µl, 2.72 mmol), 
trifluoroacetic acid (186 µl, 1.63 mmol) and 1.3 mL of dry DCM. The reaction was then 
warmed up at 30 oC during 55 h. Obtained after column chromatography using Hex / Et2O 
(80:1) as eluent. 124n, 91 mg, 0.40 mmol (74%): pale-yellow oil. 1H NMR (500 MHz, CDCl3, 
25 oC) δ = 7.59 (d, J = 8.2 Hz, 2H; HAr-6), 7.50 (d, J = 8.2 Hz, 2H; HAr-5), 6.69 (d, J = 15.8 
Hz, 1H; H-3), 6.33 (dt, J = 15.8, 6.4 Hz, 1H; H-2), 3.99 (dd, J = 6.4, 0.8 Hz, 2H; H-1). 13C 
NMR (126 MHz, CDCl3, 25 oC) δ = 139.6 (Cq; C-4), 132.9 (CH; C-3), 130.1 (q, JC-F = 32.4 
Hz, Cq; C-7), 126.9 (2 x CHAr; C-5), 125.8 (q, JC-F = 3.8 Hz, 2 x CHAr-6), 125.4 (CH; C-2), 
124.2 (q, JC-F = 271.9 Hz, CF3) , 52.9 (CH2; C-1). 19F NMR (471 MHz, CDCl3) δ = - 62.59. IR 
(Film, cm-1): ν̃ = 3098 (C-HAlkene), 3042 (C-HAr), 2927 (C-HAlkane), 2855 (C-HAlkane), 2102 
(N=N=N), 1616 (C=C), 1415 (C-HAlkane), 1326 (C-F), 1124, 1016, 748 (C=C(Bend)).  
Synthesis of 1-(3-azido-1-hexenyl)-4-trifluoromethyl-benzene (124o) 
  
 From allene 142 (100 mg, 0.44 mmol), (PhO)3PAuCl (12 mg, 0.02 mmol), silver 
triflate (6 mg, 0.02 mmol), TMSN3 (174 µl, 1.32 mmol), distilled water (40 µl, 2.21 mmol), 
trifluoroacetic acid (106 µl, 1.32 mmol) and 1.1 mL of dry DCM. The reaction was then 
warmed up at 30 oC during 60 h. Obtained after column chromatography using pentane / Et2O 
(80:1) as eluent. 124o, 79 mg, 0.30 mmol (67%): yellow oil. 1H NMR (500 MHz, CDCl3, 25 
oC) δ = 7.59 (d, J = 8.2 Hz, 2H; HAr-9), 7.50 (d, J = 8.2 Hz, 2H; HAr-8), 6.64 (d, J = 15.8 Hz, 
1H; H-6), 6.20 (dd, J = 15.8, 7.8 Hz, 1H; H-5), 4.07 – 4.01 (m, 1H; H-4), 1.71 – 1.55 (m, 2H; 
H-3), 1.51 – 1.37 (m, 2H; H-2), 0.96 (t, J = 7.3 Hz, 3H; H-1). 13C NMR (126 MHz, CDCl3, 25 
oC) δ = 139.7 (Cq, C-7), 131.7 (CH; C-6), 130.2 (CH; C-5), 130.0 (q, J C-F = 32.5 Hz; Cq; C-
10), 127.9 (2 x CHAr; C-8), 125.8 (q, J C-F = 3.8 Hz; 2 x CHAr; C-9), 124.2 (q, J C-F = 271.9 Hz; 
CF3), 64.4 (CH; C-4), 36.9 (CH2; C-3), 19.3 (CH2; C-2), 13.9 (CH3; C-1). 19F NMR (471 MHz, 
CDCl3) δ = - 62.58. IR (Film, cm-1): ν̃ = 3088 (C-HAlkene), 3021 (C-HAr), 2963 (C-HAlkane), 2936 
(C-HAlkane), 2876 (C-HAlkane), 2100 (N=N=N), 1617 (C=C), 1325 (C-F), 1166, 1067, 967, 748 
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(C=C(Bend)). HRMS (FTMS + p APCI (OIL + NH4OAc)): Calc. for C13H15F3N [M–N2+H]+: 
242.1151. Found: 242.1148. Calc. for C13H14F3 [M–N3]+: 227.1042. Found: 227.1040. Calc. 
for C13H14F3N3 [M]+: 269.1140. Found: 269.1143. 
Synthesis of 1-(3-azido-1-nonenyl)-4-chloro-benzene (124p)  
 
 From allene 143 (107 mg, 0.46 mmol), (PhO)3PAuCl (12 mg, 0.02 mmol), silver 
triflate (6 mg, 0.02 mmol), TMSN3 (180 µl, 1.37 mmol), distilled water (41 µl, 2.28 mmol), 
trifluoroacetic acid (109 µl, 1.37 mmol) and 1.1 mLof dry DCM. Obtained after column 
chromatography using Hex / Et2O (80:1) as eluent. 124p, 91 mg, 0.33 mmol (72%): yellow 
oil. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.34 – 7.32 (m, 2H; HAr-12), 7.31 – 7.29 (m, 2H; 
HAr-11), 6.55 (d, J = 15.8 Hz, 1H; H-9), 6.08 (dd, J = 15.8, 8.0 Hz, 1H; H-8), 4.01 – 3.95 (m, 
1H; H-7), 1.70 – 1.53 (m, 2H; H-6), 1.44 – 1.21 (m, 8H), 0.89 (t, J = 7.0 Hz, 3H; H-1). 13C 
NMR (126 MHz, CDCl3, 25 oC) δ = 134.7 (Cq; C-10 or C-13), 133.9 (Cq; C-10 or C-13), 131.9 
(CH; C-9), 129.0 (2 x CHAr), 128.2 (CH; C-8), 128.0 (2 x CHAr), 64.9 (CH; C-7), 34.9 (CH2; 
C-6), 31.8 (CH2; C-5), 29.1 (CH2; C-4), 26.0 (CH2; C-3), 22.7 (CH2; C-2), 14.2 (CH3; C-1). 
IR (Film, cm-1): ν̃ = 3082 (C-HAlkene), 3011 (C-HAr), 2956 (C-HAlkane), 2929 (C-HAlkane), 2857 
(C-HAlkane), 2097 (N=N=N), 1603 (C=C), 1491 (C-HAlkane), 1238, 1091, 967, 750 (C=C(Bend)). 
HRMS (T: +p EI) : Calc. for C15H2135ClN [M–N2+H]+: 250.1357. Found: 250.1354. Calc. for 
C15H2137ClN [M–N2+H]+: 252.1328. Found: 252.1323. Calc. for C15H2035Cl [M–N3]+: 
235.1248. Found: 235.1247. Calc. for C15H2037Cl [M–N3]+: 237.1219. Found: 237.1215. 
C15H2035ClN3 [M]+: 277.1346 Found: 277.1346. 
Gold-catalysed Schmidt reaction of ethyl methyl ketone[182] 
   
 (PhO)3PAuCl (16 mg, 0.03 mmol, 0.05 Eq.) and silver triflate (8 mg, 0,03 mmol, 0.05 
Eq.) were added under N2 into a vacuum-dried Schlenk flask. The solids were dissolved in 1.4 
mL of dry DCM and stirred for a few minutes at 0 ºC. Then ethyl methyl ketone (62 µl, 0.58 
mmol, 1.0 Eq., 0.41 M – absolute concentration) was added dropwise at 0 ºC. TMSN3 (229 µl, 
1.74 mmol, 3.0 Eq.), distilled water (52 µl, 2.90 mmol, 5.0 Eq.) and CF3COOH, (139 µl, 1.74 
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mmol, 3.0 Eq.) were sequentially added dropwise at 0 ºC. The mixture was then warmed up at 
room temperature and stirred for 28 h. The crude was filtered through celite, and washed with 
dichloromethane. The solvent was removed under vacuum, and the crude was analysed 
without purification by 1H NMR. A 53% conversion to N-ethylacetamide 149 was 
observed.[183] 1H NMR (500 MHz, CDCl3, 25 ºC) δ = 6.87 (bs, 1H; NH), 3.41 – 3.32 (m, 2H; 
H-3), 2.17 (s, 3H; H-1), 1.19 (t, J = 7.2 Hz, 3H; H-4). 
Experimental procedure for the deuteration experiment 
 
 
 (PhO)3PAuCl (22 mg, 0.04 mmol, 0.05 Eq.) and silver triflate (10.5 mg, 0.04 mmol, 
0.05 Eq.) were added into a washed with D2O and flame-vacuum-dried Schlenk flask under 
N2. The solids were dissolved in dry DCM (2.0 mL) and stirred for a few minutes at 0 ºC. 
Then, allene 96b (119 µl, 0.82 mmol, 1.0 Eq., 0.41 M – absolute concentration) was added 
dropwise to the Schlenk flask. TMSN3 (323 µl, 2.45 mmol, 3.0 Eq.), D2O (74 µl, 4.09 mmol 
5.0 Eq.) and TFA-d (189 µl, 2.45 mmol, 3.0 Eq.) were sequencially added dropwise at 0 ºC. 
The mixture was then warmed up at room temperature and stirred during 22 h. The crude was 
filtered through celite and the solvent was removed under vacuum. The mixture was analysed 
by 1H and 2H NMR in CDCl3 without purification. 
We observed deuterium incorporation in the following positions: 
124a-d: the signal at 5.44 ppm showed 80% of deuterium incorporation. 
125a-d: the signal at 5.76 ppm showed 80% of deuterium incorporation. 
127-d: we observed deuterium incorporation at the amidic proton 6.18 ppm, before purification 
and a mixture of d0, d1, d2, d3 in the signal at 1.98 ppm (methyl group). 
General procedure for gold-catalysed iodoazidation of allenes 
 The Au(I)-complex (0.05 Eq.), silver triflate (0.05 Eq.) and NIS (1.05 Eq.) were added 
into a vacuum-dried Schlenk flask under N2. The corresponding allene (1.0 Eq., 0.1 M) in dry 
DCM and TMSN3 (3.0 Eq.) were added sequentially and stirred for a few minutes at 0 ºC. The 
mixture was then warmed up at 30 oC and stirred until complete conversion, followed by TLC. 
The crude was filtered through celite and washed with DCM. The solvent was removed under 
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vacuum, and the product was purified by column chromatography over silica gel using Hex / 
Et2O as eluent. 
Synthesis of (3-azido-2-iodo-1-propenyl)-cyclohexane (Z-155a) 
  
 From allene 96b (60 µl, 0.41 mmol, 0.41 M), Ph3PAuCl (10 mg, 0.02 mmol), silver 
triflate (5 mg, 0.02 mmol), TMSN3 (163 µl, 1.23 mmol), NIS (96 mg, 0.43 mmol.) and 4.0 mL 
of dry DCM. The reaction was then warmed up at 30 oC during 20 h. Obtained after column 
chromatography, Hex / EtOAc (50:1) then (20:1) then (1:1). Z-155a, 72 mg, 0.25 mmol (60%): 
pale-yellow oil. 1H NMR (400 MHz, CDCl3, 25o C) δ = 5.68 (d, J = 8.6 Hz, 1H; H-3), 4.05 (s, 
2H; H-1), 2.22 – 2.32 (m, 1H; H-4), 1.63 – 1.77 (m, 5H), 1.11 – 1.40 (m, 5H). 13C NMR (101 
MHz, CDCl3, 25 oC) δ = 145.2 (CH; C-3), 96.6 (Cq; C-2), 62.7 (CH2; C-1), 45.2 (CH; C-4), 
31.6 (2 x CH2; C-5), 25.9 (CH2; C-7), 25.6 (2 x CH2; C-6). IR (Film, cm-1): ν̃ = 3011 (C-
HAlkene), 2926 (C-HAlkane), 2815 (C-HAlkane), 2096 (N=N=N), 1635 (C=C), 1448 (C-HAlkane), 
1318, 1029, 893, 838. MS (ESI+ in MeOH): m/z (%) = 264.0 [M-N2+H]+. HRMS (FTMS + p 
APCI ((DCM)/MeOH + NH4OAc)): Calc. for C9H18IN4 [M+NH4]+, 309.0569. Found, 
309.0571.  
Synthesis of 1-azido-2-iodo-2-undecene (Z-155b)  
 
 From allene 139b (50 mg, 0.33 mmol, 0.08 M), NHC-1 (10 mg, 0.02 mmol), silver 
triflate (4 mg, 0.02 mmol), TMSN3 (131 µl, 0.99 mmol), NIS (76 mg, 0.34 mmol) and 4.0 mL 
of dry DCM. The reaction was then warmed up at 30 oC and stirred during 4 days. Obtained 
after column chromatography, Hex / EtOAc, (100:1). Z-155b, 42 mg, 0.13 mmol (40%): 
yellow oil. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.87 (tt, J = 6.6, 0.9 Hz, 1H; H-3), 4.08 (s, 
2H; H-1), 2.18 (m, 2H; H-4), 1.30 – 1.27 (m, 12H), 0.88 (t, J = 6.9 Hz, 3H; H-11). 13C NMR 
(126 MHz, CDCl3, 25 oC) δ = 139.2 (CH; C-3), 98.2 (Cq; C-2), 61.5 (CH2; C-1), 34.9 (CH2; 
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C-4), 30.8 (CH2), 28.3 (CH2), 28.2 (CH2), 28.1 (CH2), 27.0 (CH2), 21.6 (CH2), 13.1 (CH3; C-
11). IR (Film, cm-1): ν̃ = 2955 (C-HAlkane), 2925 (C-HAlkane), 2855 (C-HAlkane), 2099 (N=N=N), 
1639 (C=C), 1465 (C-HAlkane), 1269, 889, 829, 722 (C=C(Bend)). MS (ESI+ in MeOH): m/z = 
321.0 [M]+, 322.0 [M+H]+. HRMS (FTMS p APCI (DCM + NH4OAc)): Calc. for C11H20IN3 
[M+], 321.0696. Found, 321.0693. Calc. for C11H21IN [M-N2+H]+, 294.0713. Found, 
294.0714. This synthesis was performed by Stefanie Hohne.  
Orthogonal functionalization of allenes using the gold-catalysed azidation methodology 
 
 1-(3-Cyclohexyl-2-iodo-allyl)-4-phenyl-1H-[1,2,3]triazoles (156). Copper(II) 
sulfate pentahydrate (9 mg, 0.04 mmol, 0.15 Eq.), sodium ascorbate (38 mg, 0.19 mmol, 0.8 
Eq.) and tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) (19 mg, 0.04 mmol, 0.15 
Eq.) were added into a (2.0-5.0 mL) microwave vial. Then (Z)-(3-azido-2-iodoprop-1-en-1-
yl)cyclohexane Z-155a (70 mg, 0.24 mmol 1.0 Eq.) dissolved in 3.0 mL of DMF and 
phenylacetylene (30 µl, 0.24 mmol, 1.0 Eq.) were added. The microwave vial was sealed and 
the suspension was heated in the microwave at 70 °C for 1 h. The reaction mixture was 
quenched with water and extracted with DCM (x 3). The combined organic phases were dried 
over anhydrous sodium sulfate and filtered. After removing the solvent in vacuum the product 
was purified by column chromatography over silica gel with Hex / EtOAc (5:1) then (3:1) as 
eluent. 156, 54 mg, 0.14 mmol was obtained as a pale-yellow solid (57%). 1H NMR (500 MHz, 
CDCl3, 25o C) δ = 7.77 (d, J = 7.5 Hz, 2H; HAr-11), 7.72 (s, 1H; H-8), 7.35 (t, J = 7.5 Hz, 2H; 
HAr-12), 7.26 (t, J = 7.5 Hz, 1H; HAr-13), 5.70 (d, J = 8.5 Hz ,1H; H-3), 5.17 (s, 2H; H-1), 2.20 
(m, 1H; H-4), 1.68 – 1.62 (m, 4H; H-5), 1.17 – 1.11 (m, 6H; H-6 and H-7). 13C NMR (126 
MHz, CDCl3, 25o C) δ = 147.9 (Cq; C-9), 146.5 (CH; C-3), 130.5 (Cq; C-10), 128.8 (2 x CHAr; 
C-12), 128.2 (CHAr; C-13), 125.7 (2 x CHAr; C-11), 119.5 (CH; C-8), 95.3 (Cq; C-2), 61.7 
(CH2; C-1), 45.1 (CH; C-4), 31.1 (2 x CH2; C-5), 25.7 (CH2; C-7), 25.3 ( 2 x CH2; C-6). IR 
(Film, cm-1): ν̃ = 3023 (C-HAlkene), 2923 (C-HAlkane), 2850 (C-HAlkane), 1638 (C=C), 1447 (C-
HAlkane), 1345, 1225, 1075, 1044, 973, 762 (C=C(Bend)). HRMS (FTMS p NSI ((DCM / MeOH 
+ NH4OAc)): Calc. for C17H20IN3 [M+H]+, 394.0775. Found, 394.0775.  
1-(3-Cyclohexyl-2-phenyl-allyl)-4-phenyl-1H-[1,2,3]triazoles (157). Phenylboronic acid 
(22 mg, 0.18 mmol, 2.0 Eq.), PdCl2 (0.8 mg, 0.005 mmol, 0.05 Eq.), PPh3 (2.4 mg, 0.009 
mmol, 0.1 Eq.) and CsF (27 mg, 0.18 mmol, 2.0 Eq.) were added into a N2 flushed Schlenk 
flask. Then (Z)-1-(3-cyclohexyl-2-iodoallyl)-4-phenyl-1H-1,2,3-triazole 156 (36 mg, 0.09 
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mmol, 1.0 Eq.) dissolved in a mixture of toluene : EtOH : H2O (1.3 mL : 1.3 mL : 0.4 mL) 
was added. The mixture was degassed by bubbling N2 into the solution for 5 minutes and then 
stirred at 80 °C for 18 h. The reaction mixture was quenched with H2O and extracted with 
DCM (x 3). The combined organic phases were dried over anhydrous sodium sulfate and 
filtered. After removing the solvent in vacuum the product was purified by column 
chromatography over silica gel and Hex / EtOAc (5:1) as eluent. 157, 26 mg, 0.07 mmol, was 
obtained as a white-yellow solid (85%). 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.68 (dd, J = 
7.4, 1.2 Hz, 2H; HAr-11), 7.47 (s, 1H; H-8), 7.31(t, J = 7.4 Hz, 2H; HAr-12), 7.27 – 7.20 (m, 
2H; HAr-16), 7.20 – 7.13 (m, 2H; HAr-13 and HAr-17), 7.00 (dd, J = 6.8, 1.5 Hz, 2H; HAr-15), 
5.54 (d, J = 10.1 Hz; 1H, H-3), 5.11 (s, 2H; H-1), 2.04 – 1.98 (m, 1H; H-4), 1.62 – 1.57 (m, 
5H), 1.09 – 1.02 (m, 5H). 13C NMR (126 MHz, CDCl3, 25 ºC) δ = 147.7 (Cq, C-9), 139.8 (CH; 
C-3), 137.5 (Cq, C-14), 133.2 (Cq, C-2), 130.9 (Cq; C-10), 128.8 (2 x CHAr), 128.7 (2 x CHAr), 
128.4 (2 x CHAr), 128.1 (CHAr; C-13), 127.7 (CHAr; C-17), 125.8 (2 x CHAr; C-11), 119.5 (CH; 
C-8), 57.9 (CH2; C-1), 37.7 (CH; C-4), 33.1 (2 x CH2; C-6), 25.9 (CH2; C-7), 25.5 (2 x CH2; 
C-5). IR (Film, cm-1): ν̃ = 3098 (C-HAr), 2924 (C-HAlkane), 2850 (C-HAlkane), 1646 (C=C), 1608 
(C=CAr), 1444 (C-HAlkane), 1338, 1225, 973, 764 (C=C(Bend)). HRMS (FTMS p APCI ((DCM) 
/ MeOH + NH4OAc)): Calc. for C23H25N3 [M+H]+, 344.2127. Found, 344.2121. M. P. = 128 
– 130 ºC. This synthesis was performed by María Paz Muñoz.  
Attempts to trap the vinyl-gold intermediate via oxidative cross-coupling 
 
The oxidative cross-coupling was attempted using Zhang’s conditions:[184] 
 Ph3PAuCl (10 mg, 0.02 mmol, 0.05 Eq.), selectfluor (290 mg, 0.82 mmol, 2.0 Eq.) 
and PhB(OH)2 (200 mg, 1.64 mmol, 4.0 Eq.) were added into a vacuum-dried Schlenk flask 
under N2. The solids were dissolved in 8.2 mL of a mixture MeCN / H2O (20:1) and stirred for 
a few minutes at 0 ºC. Then, 96b (60 µl, 0.41 mmol, 1.0 Eq., 0.05 M – absolute concentration) 
and TMSN3 (161 µl, 1.23 mmol, 3.0 Eq.) were added dropwise at 0 ºC (ice bath). The mixture 
was then warmed up at 80 ºC following the reaction by TLC. After 6 h the crude was filtered 
through a pad of celite / MgSO4, washed with DCM and concentrated under vacuum. The 
crude was analysed by NMR. However no signals corresponding of the expected product 158 
were observed. The allene signals disappeared possibly by decomposition at 80 oC. 
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A second experiment was carried out under the conditions of our azidation reaction: 
 (PhO)3PAuCl, (11 mg, 0.02 mmol, 0.05 Eq.), silver triflate (5 mg, 0.02 mmol, 0.05 
Eq.), selectfluor (290 mg, 0.82 mmol, 2.0 Eq.) and PhB(OH)2 (200 mg, 1.64 mmol, 4.0 Eq.) 
were added into a vacuum-dried Schlenk flask under N2. The solids were dissolved in 1.0 mL 
of dry DCM and stirred for a few minutes at 0 ºC. Then, allene 96b (60 µl, 0.41 mmol, 1.0 
Eq., 0.41 M – absolute concentration) and TMSN3 (161 µl, 1.23 mmol, 3.0 Eq.) were added 
dropwise at 0 ºC. The mixture was warmed up at room temperature, following the reaction by 
TLC. After 6 h the crude was filtered through celite, washed with DCM and concentrated 
under vacuum. The crude was analysed by NMR. Signals of the unreacted allene and phenyl 
boronic acid were observed. 
Synthesis of gold-azide complex (154) 
 
 (PhO)3PAuCl (15 mg, 0.03 mmol, 1.0 Eq., 0.015 M), and AgOTf (7 mg, 0.03 mmol, 
1.0 Eq.) were dissolved in 2.0 mL of dry DCM under N2. An excess of TMSN3 (29 l, 0.22 
mmol, 8.0 Eq.) was added and the mixture was stirred at room temperature for 1 h. The reaction 
crude was filtered through celite and concentrated under vacuum. The solid was washed with 
hexane to remove the excess of azide to give (PhO)3PAuN3 (154) as a gummy oil. This 
complex has to be kept in the fridge and in the dark but decomposed very quickly. No HRMS 
could be obtained due to fast decomposition. All the attempts to crystallise the complex have 
failed so far. 1H NMR (500 MHz, CDCl3, 25 ºC) δ = 7.43 (app t, J = 7.4 Hz, 6H), 7.31 (tq, J = 
7.4, 1.2 Hz, 3H), 7.23 (app dd, J = 7.4, 1.2 Hz, 6H). 31P NMR (202 MHz, CDCl3, 25o C): δ = 
105.8 ppm. IR (Film, cm-1): ν̃ = 2060 (N=N=N).[156b, 185] 
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Catalytic NMR experiment 
 
 (PhO)3PAuCl, (0.05 Eq., 22 mg, 0.04 mmol), AgOTf, (0.05 Eq., 10.5 mg, 0.04 mmol) 
and (1 Eq., 119 µl, 0.82 mmol) of allene 96b in CDCl3 (2.0 mL, 0.41 mM) were added into a 
dried-vacuum Schlenk flask under innert atmosphere and stirred for a few minutes at 0ºC. 
Then, TMSN3, (3.0 Eq., 323 µl, 2.45 mmol), distilled water, (5.0 Eq., 74 µl, 4.09 mmol), and 
trifluoroacetic acid, (3.0 Eq., 196 µl, 114.02 mmol) were added dropwise at 0 ºC. The mixture 
was then warmed up and stirred at room temperature during 22 h. Samples (0.1 mL) were 
extracted directly from the Schlenk according to the time with a syringe and diluted with 
CDCl3 for the NMR experiment.   
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Chapter 3.  
Platinum-catalysed carbo- and 
heterocyclisation of 1,5-bisallenes. 
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3.1. Introduction 
 In this chapter, platinum catalysts and the new reactivity we have encountered with 
1,5-bisallenes will be studied in depth. Platinum is known to be the most precious metal. Its 
high value resides from its extensive use in industrial applications and the scarce amount 
extracted in mines. 
 Platinum is a malleable and ductile metal, very heavy and with excellent high 
temperature features. Moreover, this metal is unaffected by air or water (corrosion resistant) 
and HCl or HNO3. However, it can be dissolved in aqua regia, concentrated acids and alkalis. 
Because of its inactivity to air and water, platinum is a suitable metal to be employed in 
jewellery or in medical devices, sensors, thermocouples, petrochemical reforming, silicone 
industry and in high temperature engineering.[186] Half of the bulk extracted of this novel metal 
is employed as a catalysts in vehicles, because it is highly effective in oxidation reactions it 
can transform harmful emissions of carbon monoxide into CO2 and H2O due to its high melting 
point.  
 Platinum also has a remarkable use in coordination chemistry. The cis-
diaminedichloro-platinum(II) and its derivatives are currently the most widely used anticancer 
drugs. In contrast, platinum salts can produce negative health effects such as DNA alterations, 
damage to organs, or even cancer.[187] In catalysis, platinum has been essential in 
heterogeneous catalytic reactions.[188] However, platinum complexes have also been employed 
in homogeneous catalysis. They are generally considered as a π-acid, activating unsaturated 
moieties such as alkenes, alkynes, dienes and allenes, they are also involved in 
cycloisomerisations, intra- and intermolecular additions to the activated π-systems as well as 
being applied to the synthesis of bioactive natural products.[189] 
 The wide versatility of platinum is remarkable in many branches of the chemistry. 
However, following the trend of the present thesis only the platinum-catalysed intermolecular 
addition of external nucleophiles to allenes will be covered.  
 Platinum and gold display similar reactivities with allenes, and in both cases their 
general behaviour is as a Lewis acid, activating the π-systems of the allene, favouring the 
nucleophilic addition to the activated allenic carbon.  
 Generally, platinum-allene interactions occur via η2-coordination, with a symmetric 
or unsymmetric coordination such as 159, 160, 161 (Figure 26) depending on the electronic 
properties of the ligand or the allene’s substituents.[190] However, η1-coordination modes with 
the platinum only coordinated to the central carbon of the allene have also been proposed, such 
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as η1-bent-allene 164, the allyl cation 162 or the zwitterionic carbene 163, recently postulated 
by our group (Figure 26).[191]  
 
Figure 26. Platinum-allene coordination modes 
3.2. Platinum-catalysed intermolecular reactions of allenes 
 Intramolecular formation of C-C or C-X bonds (X = heteroatoms) catalysed by 
platinum is a well-known method for cycloisomerisations towards the formation of carbo- and 
heterocycles with high atom economy and excellent yields.[189b, 189d, 189e, 192] In contrast, the 
intermolecular addition of external nucleophiles to allenes catalysed by platinum complexes 
is less explored; therefore, this chapter will outline this interesting topic.  
 The first intermolecular addition of nucleophiles to allenes catalysed by platinum 
complexes was reported by the group of Panunzi in 1978,[193] using amines as nucleophiles 
and dimethylallene as the substrate. In this case, platinum complexes activate the less hindered 
C=C of the allene, favouring the subsequent attack of the amine to afford the isolated platinum 
σ-alkenyl complexes (Ph3P)PtCl2(η1-Me2C=CCH2NR3) 165 (Scheme 79). This intermediate 
was then exposed to acidic conditions (HCl) to give the desired E-allyl amines 166. Similar 
results have been obtained by the group of Widenhoefer, using Pt(dppf)Cl2/AgOTf as the 
catalytic source, exclusively with monoallenes as substrates (Scheme 79). The authors 
proposed an outer-sphere mechanism in this reaction, where η2-coordination of the catalytic 
platinum complex with the less hindered double bond of the allene drives the addition of 
alkylated secondary amines generating a Z-vinyl-platinum intermediate, which after Pt-C 
cleavage forms E-allyl amines 167.  
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Scheme 79. Platinum-catalysed intermolecular addition of nitrogen nucleophiles. 
 Oxygen nucleophiles were also employed by the group of Panunzi,[194] using 1,1-
dimethylallene 120 and phe. However, instead of the expected oxygen attack to the allene, the 
phenol behaves as an electron-rich aromatic nucleophile leading to the attack at the less 
hindered sp2-carbon of the allene to form the vinyl-platinum intermediate 168 (Scheme 80), 
and giving the corresponding allylated product 169 as well as chroman derivatives 170 in low 
yields. The authors proposed, that the allylated derivative 169 is obtained first, and this cyclises 
to chromane 170. Also, if the phenol acts as an oxygen nucleophile, the intermediate generated 
from oxygen attack to the hindered carbon of the allene 171 and a subsequent Claisen 
rearrangement also can generate the allylated product 169.  
 
Scheme 80. Platinum-catalysed alkenylation of phenols with 1,1-dimethylallenes 
 Our group has developed a new platinum-catalysed addition of nucleophiles to allenes, 
showing a different reactivity than previously observed. In this reaction, a selective double 
addition of alcohols or indoles to the terminal double bond of the allene moiety gives rise to 
aliphatic acetals 172[191a] or bisindolyl derivatives 173[191b] respectively (Scheme 81). The 
initially proposed mechanism suggested the coordination of platinum via the sp-carbon of the 
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allene 174 as a zwitterionic platinum carbene, followed by the addition of the nucleophile to 
the terminal C=C of the allene 175, generating the platinum carbene. Then, 1,2-H shift 
supported by the nucleophile, activates the terminal sp2-carbon of the intermediate 176 to the 
second nucleophilic attack, giving after protodemetalation the desired acetal 172 or bisindol 
derivative 173. Mechanistic studies are ongoing in the group at the moment and a more 
complex mechanistic picture has been uncovered. 
 
Scheme 81. Platinum-catalysed double addition to allenes of alcohols and indoles as nucleophiles 
 Another example of double addition to allenes catalysed by platinum(0) has been 
reported by the group of Miyaura using diborons as nucleophiles.[195] The regioselectivity of 
the addition is influenced by size of the ligands on the metal (phosphine ligands) and the 
electronic nature of the substituents on the allene. High steric hindrance, forces the addition to 
the terminal and central carbons of the allene 177 (Scheme 82). In contrast, smaller phosphine 
ligands and monosubstituted allenes favour the attack to the most hindered C=C and the central 
carbon of the allene 178. DFT calculations were also performed confirming the high electronic 
influence on the B-B addition to monosubstituted allenes.[196] This group postulate that 
monosubstituted allenes with EDG (Me or NH2) favour the insertion of B-B to the internal π-
system of the allene. In contrast, for EWG (CN) the terminal one is preferred over the internal 
C=C. These electronic influences could be explained on concept of charge transfer from the 
π-system of the allene and “d” orbitals involved from the metal. 
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Scheme 82. Platinum-catalysed intermolecular diboration of allenes 
3.3. Introduction to the chemistry of bisallenes 
 As it has been shown, allenes are involved in many reaction processes displaying 
different reactivities. However, if two conjugated or non-conjugated cumulated alkenes are 
linked, the versatility of these systems hugely increases, offering the possibility of developing 
new methodologies with high atom economy in carbo- and heterocyclisations,[24a, 48, 197] or 
being incorporated in the scaffold of natural products.[198]  
The first reported bisallene 179 (Figure 27) was synthesised by Marvel and coworkers 
in 1936.[199] 1,1,6,6-tetraphenyl-1,2,4,5-hexatetraene 180 was obtained by Khun and Fischer 
[200] in 1961, then in 1967 Jacobs and Prempree [201] obtained  the conjugated bisallene 181.[48] 
 
Figure 27. First reported bisallenes 179, bisallene synthesised by Kuhn and Fischer 180, bisallene developed by 
Jacobs and Prempree 181  
As it is shown in Figure 27, conjugated bisallenes were initially investigated. 
However, non-conjugated bisallenes (182, 184 and 186 Figure 28) are the most employed 
nowadays due to their high versatility in cyclisation chemistry. Non-conjugated bisallenes can 
be linked by a wide variety of tethers such as alkyl chains 182, chains containing heteroatoms 
(S, N, O) 184 and epoxides or aziridines 186, incorporating extra functionalities into the 
skeleton of these structures (Figure 28). 
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Figure 28. Examples of conjugated and non-conjugated bisallenes linked by different tethers [48] 
3.4. Reactivity of 1,5-bisallenes 
The rapid development of the chemistry of bisallenes has given rise to an extensive 
number of reports about the synthesis and reactivity of these substrates.[48, 197c, 202] Bisallenic 
intermediates generated in situ via [2,3]-sigmatropic rearrangements from bispropargyl 
derivatives have also been employed effectively in the synthesis of complex carbo- and 
heterocycles.[203] Moreover, base-catalysed rearrangement of bis(π-conjugated propargyl) 
derivatives is also used to generate carbocycles in situ through bisallenic intermediates.[204]  
In the present thesis, only the synthesis and chemistry of non-conjugated 1,5-
bisallenes 184 will be covered (Figure 28). These motifs are involved in cycloadditions, cyclo- 
and carbometalations, radical or even multicomponent cascade reactions[205] to generate 5-7 
membered rings displaying interesting reactivities.[197b] Scheme 83 shows an overview of the 
many possible cyclisation modes among the 4 π-systems reported in the literature.  
Intramolecular [2+2] cycloaddition is one of the most explored reactions of allenes to 
generate cyclobutenes or cyclobutanes, which concern 4 possible cyclisation modes: head-to-
head 187, tail-to-tail 188, tail-to-head 189 and head-to-tail 190 (Scheme 83).[197f, 206] On the 
other hand, carbocyclisations mediated by transition-metals such as Rh,[207] Pd[206c, 207b, 208] or 
Cu[209] are also a powerful tool to create new C-C bonds using 1,5-bisallenes as substrates. In 
this case, the metal can coordinate with the bisallene forming metalacycles via reactions tail-
to-tail 192 (Scheme 83) forming 7-membered rings, head-to-head 193, or tail-to-head 194 
where the metal coordinates between the terminal C=C of one allene and the external π-system 
of the other allene moiety. Reductive elimination on those metalacycles would give similar 
products to the thermal cycloadditions. 
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Scheme 83. Coordination modes and reactivities in the chemistry of 1,5-bisallenes  
  Besides, 5-membered ring derivatives have also been synthesised using non-
conjugated 1,5-bisallenes via radical cyclisation 196,[210] as well as platinum-catalysed 
reductive cyclisation under hydrogenation conditions 191.[211] Finally, an uncommon gold-
catalysed twisted head-to-head carbocyclisation has been reported to give intriguing bicycles 
195 in high yields when nitrogen containing groups were used as tethers in the bisallenes.[212]  
3.4.1. Thermal carbocyclisation of 1,5-bisallenes 
Thermally induced cyclisation of bisallenes is a well-known method for the formation 
of 4-membered rings via formal [2+2] cycloaddition. However, so far there are only two 
examples that employ 1,5-bisallenes.[206c, 213] In both cases, the tail-to-tail cyclisation mode 
(188, Scheme 83) gives access to bicyclic products 198 and 199 (Scheme 84). This synthesis 
is sensitive to reaction conditions such as concentration of 197, as well as the tethers employed 
to link the two allene moieties, where higher yields are obtained in the presence of bulky 
groups such as (SO2Ph)2C and (CO2Me)2C it is probably due to the Thorpe-Ingold effect.[197a, 
214] The proposed mechanism suggests the formation of bicycles 198, 199 and 200 (Scheme 
84) via diradical intermediates 201, 202 and 203. Products 198 and 199 can be generated by 
exo- or endocyclic diradical intermediates 201 and 202 respectively. Interestingly, SO2Ph and 
n-C4H9 groups incorporated in the internal 3-position of the allene (R’), induce a remarkable 
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effect in the [2+2] cycloaddition reaction, generating bicycle 199 and also product 200 via 
head-to-head cyclisation of diradical intermediate 203 (Scheme 84).[197a]    
Scheme 84. Thermally induced carbocyclisation of 1,5-bisallenes and proposed mechanism 
3.4.2. Transition metal-catalysed reactions of 1,5-bisallenes 
Carbocyclisation of diynes, enynes, dienes or allenenes catalysed by metals such as 
(Rh, Pd and Au) is a well-known method to form carbo- and heterocyclic products in good 
yields, and high stereoselectives.[189e, 215] Nowadays, electrophilic activation of allenes by 
transition metals to obtain complex molecules is extensively used.[24c, 202, 216] As a consequence, 
the next few pages will outline the high reactivity and atom economy of non-conjugated 
bisallenes with metals.  
The proposed mechanism to obtain bicycle[3.2.0] 205 via thermal diradical 
endocyclisation of bisallene 197 with bulky groups in the tether is shown in Scheme 84 in the 
previous section.[206c] Alternatively, the formation of compound 205 has also been reported by 
the same authors in the reaction of bisallenes 204 catalysed by Pd(0) through a head-to-head 
coordination of the metal with the bisallene, forming palladacycle 206 (Scheme 85). The 
intermediate 206 then undergoes reductive elimination to achieve the desired product 205. 
K2CO3 and nBu4NI are essential to generate bicycle[3.2.0] 205 in good yields. It is likely that 
nBu4NI is involved in a ligand exchange process which facilitates the reductive elimination 
step.[206c]  
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Scheme 85. Palladium(0)-catalysed intramolecular [2+2] cycloaddition reaction of 1,5-bisallenes 
Bisallene 207 (Scheme 86) was employed in the group of Ma to obtain 7-membered 
rings 208 in the presence of Rh(I) catalysts. In this case, a plausible mechanism suggests a tail-
to-tail cyclometalation to form 209. Regioselective β-hydride elimination 210, followed by 
reductive elimination achieved the 7-membered ring 208 in good yields.[207a] In order to show 
the synthetic utility of conjugated triene 208, the same authors described a few examples of 
their reaction with dienophiles to obtain complex tricyclic compounds 211 in excellent yields 
via Rh-catalysed [4+2] cycloaddition.[217] 
 
Scheme 86. Rh(I)-catalysed cyclisation of 1,5-bisallenes to obtain 7-membered rings. Synthesis of complex 
tricyclic compounds 211 via [4+2] cycloaddition of 208 with dienophiles 
Palladium and rhodium catalysts have been used in the biscyclisation of symmetrical 
212a and unsymmetrical 1,5-bis(1,2-allenylketones) 212b to obtain furo[3,4]azepine 
derivatives 213a, 213b and 214a (Scheme 87). Symmetrical bisallenylketones 212a in the 
presence of Pd(II) afforded bicycle 213a as well as its regioisomer 214a in a ratio (90:10) with 
a moderate yield. However, Rh(I) catalysts give access to a highly selective biscyclisation of 
bisallene 212a to afford furo[3,4]azepine derivatives 213a as the only isomer in a high yield. 
In addition, the reaction of unsymmetrical bisallenylketones 212b was also catalysed by Rh(I) 
to selectively achieve product 213b in good yields.[197a, 207b] The author suggested that both 
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metals trigger the cycloisomerisation of one 1,2-allenyl ketone moiety via intermediate 215 
(Scheme 87). Then, palladium(II)-catalysed carbometalation of the other allene moiety forms 
the π-allyl intermediate 216, which after protonolysis affords products 213a and 214a. In 
contrast, the oxophilicity of rhodium favours intermediate 217 that after protonolysis gives 
access to bicycles 213 only.[197a, 207b]  
 
Scheme 87. Pd(II)- and Rh(I)-catalysed biscyclisation of symmetrical and unsymmetrical 1,5-bis(1,2-
allenylketones) to obtain furo[3,4]azepine derivatives 
1,ω-Bisallenols have also been employed to obtain 2,5-dihydrofuran-fused bicycles in 
the presence of palladium(II)-complexes. The mechanism was related to the one proposed in 
Scheme 87, via π-allylpalladium (see intermediates 216 and 217, Scheme 87).[208] 
The use of gold in electrophilic activation of bisallenes is surprisingly scarce in 
comparison with monoallenes as it was shown in the previous chapter. However, the group of 
Chung described an uncommon twisted head-to-head [2+2] cycloaddition obtaining 
azabicyclo[3.1.1] heptanes 219 in high yields from bisallenes with nitrogen-containing groups 
in the tether (Scheme 88). It is noteworthy the high sensitivity of the process to reaction 
conditions, catalyst and also the substrate, as it works only with the cationic IPrAu-complex 
and N-tethered analogs 218.[212] DFT calculations proposed that the cationic gold species 
coordinates, with an internal π-system of one of the allenes, which make it more subsceptible 
for attack than the other allenyl moiety generating an unsual gold-metallacycle intermediate 
220 (Scheme 88). After reductive elimination from 220, the gold complex remains coordinated 
with the C=C as well as with the nitrogen 221, to then give product 219.[212]  
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Scheme 88. Gold-catalysed twisted head-to-head [2+2] cycloadditions of 1,5-bisallenes to obtain bicycle 219. 
Proposed mechanisms to the synthesis of compound 219 
3.4.3. Transition metal-catalysed reactions of 1,5-bisallenes adding an additional partner 
In addition to the previous carbocyclisations with 1,5-bisallenes catalysed by 
transition metals, the ring-construction process can also take place in presence of additional 
compounds (CO, organic compounds, H2, or external nucleophiles) that are incorporated in 
the resulting molecule. 
The first example reported was a palladium(0)-catalysed addition-cyclisation reaction 
using as additives (trimethylsilyl)tributylstannane to generate 5-membered rings 223 and 224 
(Scheme 89).[218] Stereoselectivity issues were found during the cyclisation process, mainly 
due to sensitivity to reaction conditions, reagents and steric factors. Germylstannanes were 
also employed showing similar reactivities.[210b] In both cases, cis-products 224 are favoured 
when SnBu3 or GeBu3 are used. In contrast the trans-isomers 223 were obtained in the presence 
of bulkier “R” groups such as TMS or GePh3. It is important to note the greater steric effect of 
TMS in comparison with Bu3Sn, mainly due to the short distance of Si-C bond, which 
increases the size of the group. The mechanism goes through an oxidative addition to generate 
Bu3SnPdR species, which reacts with the bisallene to generate the σ,π-allylpalladium 
complexes 229 or 226. Intermediate 229 is favoured when the bulky “R” = TMS is employed, 
generating the vinyl-PdSnBu3 intermediate 230, which after reductive elimination give access 
to the trans- products 223. In contrast, the cis-224 are favoured when a rapid carbocyclisation 
of intermediate 225 and / or through σ,π-allylpalladium intermediate 226, generates the vinyl-
PdSnBu3 227, giving rise to the desired cis-products via reductive elimination. In addition, if 
intermediates 227 and 230 undergo long reaction processes, [2+2] cycloaddition would 
generate bicycle[3.2.0] 205 (Scheme 88). 
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Scheme 89. Palladium(0)-catalysed cyclisation of 1,5-bisallenes with tributylstannane derivatives 
Interestingly, the group of Ma has reported a highly efficient methodology to 
synthesise steroid derivatives in the reaction of 1,5-bisallenes catalysed by trans-
[RhCl(CO)(PPh3)2] where the additional partner was the same or a different bisallene. For 
example, compound 231 (Scheme 90) was obtained by reaction of two 1,5-bisallenes 204c, 
achieving higher yields if a lower concentration of the substrate was utilised.[219] With the 
optimised conditions in hand, the synthesis of heterosteroids 232 was also achieved using two 
different 1,5-bisallenes. As a result, three different products 232a,b,c were isolated in 
moderate yields.[220] Bisallene 204c in the presence of monoallene 139c under the same 
reaction conditions, gave rise to an attractive bicycle with an exocyclic conjugated diene 233 
in its scaffold. This product 233, was alkylated and subsequently cyclised via a Diels-Alder 
reaction to achieve tetracyclic skeletons diastereoselectively.[197a, 221]  
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Scheme 90. Synthesis of heterosteroid derivatives catalysed by Rh(I) with 1,5-bisallenes 
Two plausible mechanisms were proposed by the authors. Both would start with the 
formation of rhodacycles 234 and 238 (Scheme 91) from bisallene 204c (Scheme 90). Then, 
carbometallation with the second bisallene would generate intermediates 235 and 239, which 
after reductive elimination would give rise to species 236 and 240. Subsequently, the 
conjugated diene incorporated in the scaffold of the bicycle and the last allene moiety can 
undergo a Diels-Alder reaction to achieve steroid 237.[219] 
 
Scheme 91. Proposed mechanisms for the rhodium-catalysed synthesis of steroid derivatives with 1,5-bisallenes 
1,5-bisallenes have also been employed in a Pauson-Khand type reaction catalysed by 
rhodium or cobalt/rhodium nanoparticles. Thus, transition metal-catalysed [2+2+1] 
cycloaddition reactions in presence of CO give access to cyclopentenone-fused bicyclic 
products 242 and 244, in moderate to good yields, as well as the product from a [2+2] 
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cycloaddition 245 (Scheme 92).[206c] One of the first works of this Pauson-Khand 
transformation was reported by the group of Chung,[222] who was able to achieve 
cyclopentenone 242 in the presence of Co/Rh heterobimetallic nanoparticles and the essential 
CO atmosphere  in moderate yields (Scheme 92). It should be mentioned that 7-membered 
ring 243 was obtained using substituted bisallene 207 under these reaction conditions. On the 
other hand, Mukai and coworkers[223] also reported this [2+2+1] cycloaddition under carbon 
monoxide atmosphere, affording the Pauson-Khand type products 244 (Scheme 92), catalysed 
by Rh(I). Bis(phenylsulfonylallene) derivatives were employed in this work, and the 
voluminous SO2Ph group in the bisallene scaffold was essential to avoid the formation of 
rhodacycles 234 and 238 (Scheme 91), as well as carry out the [2+2+1] carbonylative 
cycloaddition under smooth conditions. A proposed mechanism was also reported, where the 
Pauson-Khand type [2+2+1] and [2+2] cycloaddition products would come from tail-to-tail 
metal-coordinative cyclisation to generate rhodacycle 246. From this intermediate, reductive 
elimination would give rise to bicycle 245. On the other hand, the insertion of CO would give 
247 and the subsequent reductive elimination would form cyclopentenone 248, which 
isomerizes via 1,3-H shift, possibly to decrease the ring strain of the 1,3-diene intermediate 
248, to give the desired products 242 and 244. 
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Scheme 92. Transition metal catalysed Pauson-Khand type reactions of 1,5-bisallenes and its mechanistic insight  
5-Membered rings 249 (Scheme 93) have also been obtained via regio- and cis-
diastereoselective reductive cyclisation of 1,5-bisallenes catalysed by platinum-hydride 
complexes generated in situ under hydrogenation conditions. In an attempt to confirm the 
mechanism, reaction with D2 was performed. Deuterio-platinum complex 250 initiates the 
deuteriometalation of one allene moiety, this gives access to the allyl-platinum intermediate 
251, which coordinates with the internal π-system of the other allene moiety 252 to create a 
new C-C bond 253. Subsequently, protodemetalation of the vinyl-platinum complex 253 with 
D2 generates the desired cis-cyclopentane derivative 249 in moderate yields and regenerate the 
catalytic Pt-D.[211] 
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Scheme 93. Regio- and stereoselective reductive cyclization of 1,5-bisallenes under hydrogenation conditions 
catalysed by platinum complexes 
Transition metal-catalysed addition of nucleophiles to allenes is the main approach of 
the present thesis, thus, it is essential to mention the only intermolecular addition of 
nucleophiles to 1,5-bisallenes catalysed by metals reported so far. In this work, the group of 
Ma developed the synthesis of regio- and stereoselective 10-membered ring heterocycles 255 
catalysed by palladium(0), with aryliodides 254, Ag3PO4 as an additive, amines as 
nucleophiles and K3PO4 as a base (Scheme 94). A proposed mechanism was also reported by 
the authors, which suggests a sequential inter-/intramolecular reaction of 1,5-bisallenes 
triggered by the nucleophilic attack of the amine to two π-allylpalladium intermediates 256 
and 258 (Scheme 94). Carbopalladation of one allene moiety with the preformed Ar-Pd-I 
complex generates stereoselectively the anti-π-allylpalladium intermediate 256, due to steric 
interactions of the “Ar” group incorporated. Intermolecular nucleophilic attack of the amine 
to π-allyl-Pd 256 would form intermediate 257. Then, the carbopalladation of the other allene 
moiety gives access to a new anti-π-allylpalladium intermediate 258, favouring the 
regioselective intramolecular attack of the nucleophile, achieving product 255a.[224]   
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Scheme 94. Palladium-catalysed sequential inter-, intramolecular reaction of 1,5-bisallenes to obtain 10-
membered rings.  
3.4.4. Radical cyclisation of 1,5-bisallenes  
As well as addition of external partners in the metal-catalysed examples, it is important 
to note the reactivity reported in the addition of free radicals to 1,5-bisallenes without any 
metal involved in the reaction. Thus, trans-fused cyclopentane derivatives 261 (Scheme 95) 
can be obtained selectively in presence of a catalytic amount of AIBN, with incorporation of 
tosyl and bromides or tosyl and selenophenyl groups in the scaffold of the 5-membered ring. 
As shown in the proposed mechanism (Scheme 95) a tosyl radical, generated in situ is added 
to the sp-carbon of one allene 262 in the propagation step. This triggers the stereoselective 
radical C-C bond formation with the other allene moiety 263, creating a new radical in the 
central carbon of the allene, which is trapped by selenophenyl or bromide radicals, giving 
access to the trans-product 261.[197a, 210a] 
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Scheme 95. Synthesis of trans-fused cyclopentane derivatives via radical C-C bond formation with 1,5-bisallenes 
as substrates 
3.5. Aims and objectives 
The aim of this work was to investigate the novel reactivity of 1,5-bisallenes with 
transition metal-catalysts, to synthesise 7-membered rings with the incorporation of an oxygen 
group into the skeleton of the final product. These structures are commonly integrated in the 
core of many natural products and in important biologically active molecules, especially in 
terpene and sesquiterpene families (Figure 29).[225] The construction of these medium size 
rings is still a challenge for organic chemists, in comparison with the formation of 5 to 6-
membered rings, due to ring strain and entropic reasons.[225c, 226] 7-Membered rings have also 
been obtained previously in reactions of 1,5-bisallenes catalysed by Rh(I) (See Scheme 87 and 
93)[207a] or by a thermal [2+2] cycloaddition (See Scheme 84) between the two terminal π–
systems of the bisallene (tail-to-tail).[206c] 
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Figure 29. Natural products and biologically active molecules with a 7-membered ring in their core bearing an 
additional oxygen functional group. (+)-frondosin B,[227] schisanwilsonene A,[228] (±)-microstegiol,[229] 
guanacastepene A,[230] tremulenediol A,[231] (+)-aphanamol,[225d] cortistatin A[232]  
3.6. Results and discussion 
3.6.1. Synthesis of starting materials  
3.6.1.a. Synthesis of the simplest symmetrical monosubstituted bisallenic precursors 
The skeleton of the simplest non-conjugated 1,5-bisallene used in this work is formed 
by two allenes linked through a methylene group to heteroatoms (oxygen and nitrogen) or 
carbon-based tethers such as (CO2Me)2C or (PhO2S)2C. The synthesis of these bisallenic 
precursors was generally carried out in two steps: bispropargylation of the commercially 
available tether with propargyl bromide, followed by the formation of the 1,5-bisallene via 
microwave assisted Crabbé homologation.[27b] 
 Formation of N-tethered bispropargyl derivatives 265x (Scheme 96) was performed 
using two sets of conditions (See Table 18), deprotonation of the amine derivatives 264 with 
K2CO3 under reflux overnight (method A) or assisted by microwave irradiation at 130 oC 
during 3 h (method B). As shown in Table 18, microwave heating reduced drastically the 
reaction time and also higher yields were obtained in comparison with method A (See Entries 
1, 3 and 6). Subsequently, the synthesis of N-tethered 1,5-bisallenes 204a, 260 and 266x was 
performed via microwave assisted Crabbé homologation.  
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Scheme 96. Synthesis of the simplest N-tethered 1,5-bisallenes via microwave assisted Crabbé homologation 
[a] Reaction time 12 min. [b] Synthesised using deuterated paraformaldehyde (CD2O)n. Bisallene 204-
d4 was fully deuterated in the two terminal positions of the two allenes. 
Table 18. Formation of bispropargyl derivatives 265x. Synthesis of N-tethered 1,5-bisallenes 204a, 260 and 266x 
via microwave assisted Crabbé homologation 
Oxygen-tethered bisallene 259 was synthesised directly from the commercially 
available dipropargyl ether 267 via microwave assisted Crabbé homologation (Scheme 97). 
Entry R 
265x Isolated Yield (%) Bisallene  
204a, 260 or 266x 
Isolated Yield (%) Method A Method B 
1 
 
265a, 92 265a, 99 
204a, 70 
204a-d4, 61[a],[b] 
2 
 
265c, 95 265c, 64 266c, 73[a] 
3 
 
265d, 72 265d, 98 266d, 93 
4 
 
265e, 93 - 266e, 52 
5 
 
265f, 92 - 266f, 52 
6 
 
265g, 95 265g, 99 266g, 63 
7 
 
265i, 45 - 266i, 63 
8 
 
265j, 95 - 260, 68 
9 
 
- 265k, 95 266k, 60 
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Scheme 97. Synthesis of bis(2,3-butadienyl) ether 259 via microwave assisted Crabbé homologation 
Bispropargylation of dimethylmalonate with NaH in dry THF at 0 oC and the 
subsequent Crabbé homologation assisted by microwaves gave access to 1,5-bisallene 204b 
in moderate yield (Scheme 98). 
 
Scheme 98. Synthesis of bispropargyl derivative 268 and the formation of bisallene 204b via microwave assisted 
Crabbé homologation 
Bisallene 271 (Scheme 99) was obtained in three steps starting with reduction of 
bispropargylic malonate 268 with LiAlH4, dimethylation of diol 269, and finally microwave 
assisted Crabbé homologation to generate the allenic precursor 271 from bispropargylic 
derivative 270.  
 
Scheme 99. Synthesis of bisallene 271 
3.6.1.b. Synthesis of unsymmetrical 1,5-bisallenes 
Unsymmetrical mono/disubstituted 1,5-bisallenes were synthesised employing p-
toluensulfonamide as tether in all the examples. This primary sulfonamide 272 was protected 
with di-tert-butyl dicarbonate to obtain product 273 (Scheme 100). Propargylation of the 
protected amide 273 gave rise to propargyl sulfonamide derivative 274, which underwent 
microwave assisted Crabbé homologation to give allene 275 in moderate yield. Deprotection 
of the substituted amide with TMSCl/MeOH gave access to monosubstituted allene 276, which 
was used as the starting material for the coupling with 1,1-disubstituted allenols via Mitsunobu 
reaction (See Scheme 101 and 104).[212, 233]   
144 
 
 
Scheme 100. Synthesis of allenic precursor 276  
Synthesis of 1,1-disubstituted allenols 279 (Scheme 101) was carried out in two steps 
starting with bromination via Appel reaction[234] of substituted 2-propyn-1-ol 277 to give γ-
substituted prop-2-ynyl bromide derivatives 278, and indium-mediated Barbier-type reaction 
of propargyl derivatives 278, to give 279a and 279b in moderate yields.[54a]  
 
Scheme 101. Synthesis of substituted allenolic precursors 279 from 2-propyn-1-ol derivatives 277 
Allene 276 (Scheme 102) and the substituted allenols 279a and 279b were assembled 
to generate non-symmetrical 1,5-bisallenes 280a and 280b via Mitsunobu reaction.  
 
Scheme 102. Synthesis of non-symmetrical monosubstituted 1,5-bisallenes 280a and 280b 
Non-symmetrical bisallene 283 with a methyl group in the carbon next to the nitrogen, 
was synthesised using as starting material propargylic p-toluenesulfonamide 274 (Scheme 
103). Deprotection of the amine under acidic conditions (281), propargylation with 3-bromo-
1-butyne (282) followed by Crabbé homologation, gave access to bisallene 283 in moderate 
yield. 
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   Scheme 103. Synthesis of non-symmetrical monosubstituted 1,5-bisallene 283 
The synthesis of non-symmetrical bisallene 207 (Scheme 104), was carried out via 
Mitsunobu reaction using as a precursor, allene 276 and the substituted allenol 285 previously 
synthesised by an SN2’ type reaction from the propargylic derivative 284.[207a] 
Scheme 104. Synthesis of allenol precursor 285. Synthesis of disubstituted 1,5-bisallene 207 
Oxygen-tethered bisallene 289 (Scheme 105), disubstituted with two phenyl groups 
on the carbon adjacent to the oxygen, was synthesised using as the starting material 
commercially available benzophenone. Alkynylation with ethynyltrimethylsilane gave 
compound 286. Deprotection of the alkyne with TBAF (287) and propargylation of the alcohol 
gave access to the bispropargylic ether 288. Then, microwave assisted Crabbé homologation 
of compound 288 generated bisallene 289 in moderate yield. 
Scheme 105. Synthesis of oxygen-tethered bisallene 289 
Unsymmetrical bisallene 292 was synthesised in two steps from propargylic p-
toluensulfonamide 274 (Scheme 106). In the first step, a modified cadmium-mediated 
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allenylation of terminal alkynes with aldehydes gave traces of allene 291.[29] Due to the harsh 
conditions employed, deprotected allene 290 was also isolated although in low yield. This 
allene 290 and disubstituted allenol 285 gave access to the unsymmetrical bisallene 292 via 
Mitsunobu reaction.  
 
Scheme 106. Synthesis of trisubstituted bisallene 292 
Symmetrically substituted bisallene 293 was synthesised via cadmium-mediated 
bisallenilation of bispropargylic sulfonamide 265a with acetone in low yield (Scheme 107).[29] 
  
Scheme 107. Cadmium-mediated synthesis of tetrasubstituted bisallene 293 
In a different approach, carbon-based thether 1,5-bisallenes 296 were synthesised by 
palladium-catalysed oxidative addition of allenyl acetates 294 to dimethyl malonate 295a or 
bis(phenylsulfonyl)methane 295b following a described procedure (Scheme 108).[207a] 
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 Scheme 108. Synthesis of allenyl acetate 294 and carbon-based bisallenes 296a and 296b.  
3.6.2. Catalysts screening 
 Bisallenes 204a and 204b were employed as model substrates in a preliminary catalyst 
screening in the search for new reactivity of these compounds in presence of methanol as 
solvent and as nucleophile, towards the synthesis of ideally 7-membered rings of the type of 
299, with an additional methoxy group incorporated in the final skeleton (Scheme 109 and 
Table 19). 
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Scheme 109. Reaction of 1,5-bisallenes with different transition metal-catalysts 
 [a] The reaction was carried out during 18 h. 
Table 19. Results obtained from the reaction of 1,5-bisallenes 204a and 204b in the presence of different transition 
metalcomplexes. This screening was performed by Dr María Paz Muñoz 
Entry Bisallene [M] (x Eq.) Products, Isolated Yield, % 
1 204b PtCl2 (0.1) 204b, 40 
2 204b Fe(CO)5 (0.1) No reaction 
3 204b NiCl2 (0.1) No reaction 
4 204b PdCl2 (0.1) No reaction 
5 204b [RhCl(cod)]2 (0.1) Polymer 
6 204a PtCl2 (0.1) 298a, 19; 299a, 4; 300a, 33  
7 204a Fe(CO)5 (0.1) No reaction 
8 204a NiCl2 (0.1) No reaction 
9 204a PdCl2 (0.1) No reaction 
10 204a [RhCl(cod)]2 (0.1) No reaction 
11[a] 204a Ph3PAuMe (0.1), MeSO3H (0.2) 297, 7; 301, 59; 302, 18 
12[a] 204a AgNO3 (0.1) No reaction 
13[a] 204a CuCl (0.1) No reaction 
14[a] 204a FeCl3·H2O (0.1) No reaction 
15[a] 204a Hg(NO3)2 (Excess) No reaction 
16[a] 204a Fe(NO3)3·9H20 (0.1) No reaction 
17[a] 204a 
[(CH3CN)3RuCp]PF6  (0.1); 
CeCl3 (0.1) 
Complex mixture 
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 No reaction was observed with the following transition metal-catalysts: Fe(0) and 
Fe(III) (Entries 2, 7, 14 and 16), Ni(II) (Entries 3 and 8), Pd(II) (Entries 4 and 9), Rh(I) (Entries 
5 and 10), Ag(I) (Entry 12), Cu(I) (Entry 13), Hg(II) (Entry 15), Ru(II) (Entry 16).  
 Transition metals with remarkable Lewis acidic character, Pt(II) (Entries 1 and 6) and 
Au(I) (Entry 11), reacted with the bisallenes 204a and 204b (See Table 19). Au(I)-catalyst 
gave access to compounds 297, 301 and 302 in moderate yields. Allylic products 301 and 302 
(Scheme 109) were generated by a gold-catalysed intermolecular addition of MeOH to the 
terminal position of both allenes (301), or addition to one terminal[85a, 86a, 87a] and one 
internal[85b, 89a] position of the allenes (302). (See previous chapter, gold-catalysed 
intermolecular addition of alcohols to allenes).[87b, 235] 3-Pyrroline 297 was also isolated as a 
product of reaction using cationic Au(I) as the catalyst. This 5-membered ring could be 
obtained by cleavage of a N-C bond with the concomitant loss of the allene chain, in an 
unknown process. Then, subsequent attack of the nitrogen to the activated terminal position of 
the other allene via 5-endo-dig cyclisation 303 would generate the vinyl gold intermediate 304, 
which after protonolysis gives product 297 (See Scheme 110). The cleavage of the N-C bond 
with loss of one allenyl chain could be involved in the decomposition of these bisallenes in the 
reaction with platinum catalysts that will be discussed further in the next few pages. No other 
cyclisation products were observed with Au(I)-catalysts under these conditions and therefore 
we abandoned this line of investigation. 
  
Scheme 110. Proposed mechanism for the formation of 3-pyrroline 297 
 The desired 7-membered ring 299a with an alkoxy group incorporated into its skeleton 
was only achieved when platinum(II) dichloride was employed as catalyst in presence of 
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bisallene 204a. Additionally, the linear triene 298a, was also obtained and products 300a 
(Entry 6) and 300b (Entry 1) were also observed as main products by an unusual platinum-
catalysed double dihydroalkoxylation of each allene of the bisallenes 204a and 204b 
respectively. This new reactivity opened new research avenues in the group and the reaction 
with alcohols and indoles as nucleophiles that has been mentioned in the introduction (see 
scheme 82), is currently being investigated and exploited.[191a] 
 In order to optimise the formation of the cyclic product in the platinum-catalysed 
reaction, I perfomed a new screening of platinum-complexes with different silver salts, as 
halogen abstractors to preform in situ the cationic complexes with different counterions, in the 
presence of MeOH and bisallenes 204a and 204b (See Scheme 111 and Table 20). 
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Scheme 111. Reaction of bisallenes with different platinum complexes 
[a] The reaction was carried out in toluene, using 4 Eq. of MeOH. [b] The reaction was carried out at 
room temperature. [c] Reaction time 20 h. [d] Products were purified with new high purity silica gel. 
Table 20. Results obtained from the reaction of 1,5-bisallenes 204a and 204b in the presence of different platinum 
complexes 
 The results shown in Table 20 suggest that the selectivity towards the cyclic products 
is very sensitive to reaction conditions and platinum complexes. The formation of cationic 
platinum(II) and platinum(IV) complexes avoided the formation of the bisacetal products 300 
but a new 6-membered ring 305 was also observed in different amounts depending on the 
Entry Bisallene 
[Pt] 
(0.05 Eq.) 
AgX 
(0.1 Eq.) 
Products, 
Isolated Yield, % 
1 204a PtCl2 - 298a, 37; 299a, 4; 300a, 33 
2[a],[c] 204a PtCl2 - 300a, 66 
3[c] 204a PtCl2(MeCN)2 - 298a, 36; 299a, 5; 300a, 14 
4[c] 204a PtCl4 - 300a, 74 
5[c] 204a PtCl2(MeCN)2 AgOTf 298a, 24; 305a, 17 
6 204a PtCl4 AgOTf 297, 11; 299a, 20; 305a, 5 
7 204a PtCl2(MeCN)2 AgSbF6 297, 10; 298a, 9; 299a, 18; 305a, 8 
8 204a PtCl2(MeCN)2 NaBArF 297, 16; 298a, 34; 299a, 13; 305a, 11 
9[c] 204a PtCl2(MeCN)2 AgNTf2 297, 19; 298a, 16; 299a, 9; 305a, 5 
10[c] 204a PtCl2(MeCN)2 NaBPh4 297, 3; 205a, 4 
11[b],[c] 204a PtCl4 AgOTf 297, 24; 298a, 8; 299a, 7; 305a, 16 
12 
204a K[Pt(C2H4)Cl3 · 
H2O 
AgSbF6 305a, 4; Complex mixture 
13 204b PtCl2(MeCN)2 AgSbF6 299b, 11; 305b, 7 
14[d] 204a PtCl2(MeCN)2 AgSbF6 298a, 30; 299a, 13; 305a, 11 
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cationic platinum complexes employed (Table 20). The use of AgOTf and AgSbF6 to form the 
cationic complexes gave the best selectivity towards the 7-membered rings 299b (Entry 13) 
and 299a (Entries 5, 6 and 14), with also formation of triene 298a. Besides, it was observed 
that products were not very stable to column chromatography and probably this could explain 
the low isolated yields obtained. In order to solve this issue, a new high purity silica gel was 
used as stationary phase obtaining better yields in comparison with those previously obtained 
(see comparison of Entry 7 and Entry 14, Table 20). 
 The highest selectivity towards 7-membered cycle 299a was obtained using 
PtCl2(MeCN)2 as catalyst (0.05 Eq.) and 0.1 Eq. of AgOTf as halide abstractor, in MeOH at 
70 oC (See Table 20, Entry 5), and these were chosen as the optimum reaction conditions to 
study the scope of the reaction with different 1,5-bisallenes. We first used different 
sulfonamide derivatives as tethers in order to study the effect of the electronic nature of the 
bisallene in the reaction (see Scheme 112 and Table 21).  
 
Scheme 112. Platinum-catalysed alkoxycyclisation of sulfonamide derivatives 
[a] Products 298e and 305e were isolated by prep-TLC  
Table 21. Results obtained with sulfonamide derivatives under the best reaction conditions so far 
 As it is observed in Table 21, the strong electron withdrawing influence of nitro group 
in para position avoids formation of the 6-membered ring (Entry 2). The 7-Membered ring is 
not formed when the strong donating group MeO- is used (Entry 4). The triene 298x was 
formed as main product in most of the cases except when a chloride group in para position of 
aromatic ring was used, which favoured the formation of the two cyclic products (Entry 5). 
Entry Bisallene X 
Isolated Yields, % 
298x 299x 305x 
1 204a Me 298a, 30 299a, 13 305a, 11 
2 266c NO2 298c, 29 299c, 25 - 
3 266d H 298d, 18 299d, 8 305d, 11 
4[a] 266e MeO 298e, 4 - 305e, 4 
5 266f Cl 298f, 8 299f, 27 305f, 13 
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However, it is important to highlight the low yields obtained in all the cases, even when high 
purity silica gel is employed to isolate the products. These results suggest that possibly the 
starting material is decomposing under reaction conditions as mentioned in the work reported 
by Jang and coworkers.[211]  
 In order to enhance the selectivity as well as the isolated yield we decided to perform 
a new screening of conditions. 
3.6.3. Solvent Screening 
 Previous results confirmed that cationic platinum complexes, pre-formed from 
PtCl2(MeCN)2, were essential to avoid the formation of the bisacetals 300 leading to the 
synthesis towards 6-membered cycle 305 or 7-membered cycle 299 (See Table 20). However, 
all the reactions were performed using methanol as solvent and as the nucleophile so far. In 
order to check the possible influence of the concentration of methanol in the reaction, a 
screening of different ratios of MeOH in THF were studied using standard bisallene 204a (see 
Table 22). In this screening AgSbF6 was used as halide abstractor. 
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Scheme 113. Platinum(II)-catalysed carbocyclisation of 1,5-bisallenes with different ratios of MeOH in THF or 
MeCN 
[a] The reaction was carried out at room temperature. [b] The concentration of the bisallene was 0.2 M. 
[c] The reaction was performed using PtCl4 (0.05 Eq.) and AgSbF6 (0.1 Eq.) as catalyst. [d] The reaction 
was heated at 90 oC. [e] 100% conversion observed in all the reactions.  
Table 22. Results obtained after screening of different proportions of MeOH in THF and MeCN 
 The reaction was very sensitive to modifications on the ratios of THF/MeOH. When 
the amount of MeOH descreases in comparison to THF, the formation of the 6-membered ring 
305a was preferred over the formation of the 7-membered ring 299a. The mixture THF/MeOH 
(9:1) gave cyclic compound 305a as main product, even employing different concentrations 
of the bisallene 204a (Entries 4 and 7). Formation of 298a was observed in all the reactions. 
Comparing the ratio of products before and after purification, it was clear that purification 
issues were still present (compare ratio of products before and after purification in Entry 5, for 
example).  
 The results shown in Table 22 also revealed that the reaction gives less selectivity at 
room temperature (Entry 1). Moreover, cationic platinum(IV)-complex (Entry 8), with the 
mixture THF/MeOH (9:1) gave access to a rapid conversion to bisacetal 300a in good yield, 
but not to the heterocycles 299a and 305a.  
Entry 
Solvents 
(ratio) 
t (h) 
NMR Ratio (298x:299x:300x:305x) 
before purification / Isolated Yield, %[e] 
1[a] MeOH 30 (9.1:1:0:3.2) 
2 THF:MeOH (1:1) 5 (4.1:1:0:10) 
3 THF:MeOH (5:1) 5 (5.6:1:0:24) 
4 THF:MeOH (9:1) 2 h 40 min (1:0:0:2.7) / 298a, 11; 305a, 39 
5 THF:MeOH (18:1) 4 (1.7:0:0:1) / 298a, 37; 305a, 36 
6 THF:MeOH (30:1) 7 (1:0:0:1.6) 
7[b] THF:MeOH (9:1) 1 h 30 min (1:0:0:1.5) / 298a, 7; 305a, 33 
8[c] THF:MeOH (9:1) 1 h 45 min 300a, 71 
9[d] 
MeCN:MeOH 
(18:1) 
26 298a; 20% conversion 
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 Vinylcyclohexanes derivatives 305 are important building blocks in the synthesis of 
natural products.[128c, 236] Besides, cyclisation to give 6-membered rings is less common in 1,5-
bisallene chemistry (see introduction of this chapter). Therefore, we decided to explore the 
scope of the reaction using the optimised conditions for the formation of substituted 
vinylcyclohexanes with MeOH as nucleophile in a 9:1 mixture of THF:MeOH.  
3.6.4. Scope of platinum-catalysed alkoxycyclisation reaction of 1,5-bisallenes 
 With an efficient mixture of solvents as well as the suitable catalyst in hand, the scope 
of this transformation was explored with several bisallenes.  
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Scheme 114. Platinum-catalysed alkoxycyclisation of 1,5-bisallenes under the best reaction conditions 
[a] Complete conversion unless otherwise stated. [b] Obtained as inseparable mixture. [c] Conversion 
< 100 %. 
Table 23. Scope of platinum-catalysed alkoxycyclisation of 1,5-bisallenes  
 Vinylcyclohexene derivatives 305x were observed with all the bisallenes employed. 
Electron donating groups (Entries 1, 3, 4, 7 and 8, Table 23) favoured the formation of 6-
membered rings 305x and trienes 298x in moderate to low isolated yields. In contrast, electron 
withdrawing groups (Entries 2, 5 and 6) gave mixtures of the cyclic products and trienes 298x 
in low isolated yields. A new 7-membered cycle 306c, isomer of 299c was identified in the 
reaction of the nitro derivative (Entry 2). Besides, an isomer 305f’of vinylcyclohexene 
derivative 305f was obtained using chloride derivative 266f. Bisallene 207, sterically hindered 
Entry Bisallenes t (h) 
Ratio (298x:299x:305x:305’x:306x) 
before purification / Isolated Yield, %[a] 
1 204a; Z = TsN; R = H 
2 h 40 
min 
(1:0:2.7:0:0) / 298a, 11; 305a, 39 
2 
266c; Z = p-NO2-PhSO2N; 
R = H 
2 h 10 
min 
(3.6:2.4:1:0:1.6) / (298c+306c (4:1)), 30;[b] 
299c, 25 
3 
266d; Z = PhSO2N; 
R = H 
2 h 15 
min 
(3.4:0:1.5:1:0) / (298d+305’d (1.1:1)), 43;[b] 
305d, 19 
4 
266e; Z = p-MeO-PhSO2N; 
R = H 
1 h 30 
min 
(2:0:1:0:0) / 298e, 44; 305e, 26 
5 
266f; Z = p-Cl-PhSO2N;  
R = H 
2 h 25 
min 
(1:4.5:6.3:3.2:0) / 298f, 2; 299f+305f’ (1.5:1), 
31[b]; 305f, 17 
6 
266g; Z = p-CF3-PhSO2N;  
R = H 
2 h 
(1.1:1.2:2.1:1:0) / 298g, 1; 299g+305g’ 
(traces) 5;[b] 305g, 6 
7 
266i; Z = CH3SO2N; 
R = H 
1 h 30 
min 
(10.4:1:3.8:0:0) / 298i+305i (1:2.9), 31;[b] 
299i, traces 
8 207; Z = TsN; R = Me > 48 h[c] 305l, 16 
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in one allene led the nucleophilic attack to the non-substituted allene, giving as the only 
product the 6-membered cycle 305l in low yield (Entry 8).  
 When we tried the platinum-catalysed alkoxycyclisation of 1,5-bisallenes with other 
tethers different from sulfonamides, we observed complex reaction mixtures as shown in Table 
24. With the more substituted bisallenes long reaction times (Entry 5, Table 24) or microwave 
heating were employed without success (Entries 6 and 7). 
 
Scheme 115. Unsuccesful alkoxycyclisation of 1,5-bisallenes under the best reaction conditions so far 
[a] Reaction was carried out under microwave irradiation.  
Table 24. Unsuccesful alkoxycyclisation of 1,5-bisallenes under the best reaction conditions so far 
 These results emphasised the important role of sulfonamide groups as tethers in 
bisallene chemistry.[207a, 213, 223b] In our hands, only sulfonamide-tethered bisallenes reacted 
under the optimal reaction conditions. However, it is worth remembering that using MeOH as 
solvent and as nucleophile, bisallene 204b with dimethylmalonate as tether gave the 
cyclisation products, in low isolated yields (Entry 13, Table 20). 
 Although we showed improved selectivity towards a specific cyclisation mode, the 
low yields and limited scope were still a challenge in this methodology. We therefore decided 
to use internal references to report NMR yields and compare with yields of isolated products. 
We also investigated the decomposition of the starting material under the reaction conditions, 
and we performed a new screening of platinum-complexes under optimal reaction conditions 
for the formation of the 6-membered rings. 
Entry Bisallenes t (h) T oC Products 
1 204b; Z = (CO2Me)2C; R = R1 = H > 48 h 70 Traces of 299b and 305b 
2 260j; Z = PhN; R, R1 = H > 24 h 70 Complex mixture 
3 266k; Z = p-Br-PhN; R, R1 = H > 24 h 70 Complex mixture 
4 289; Z = O; R = H; R1 = Ph > 24 h 70 Complex mixture 
5 293; Z = TsN; R = Me, R1 = H 40 h 90 Complex mixture 
6[a] 296a;  Z = (CO2Me)2C; R = Me; R1 = H 10 h 90 Complex mixture 
7[a] 296b;  Z = (PhO2S)2C; R = Me; R1 = H 4 h 90 Complex mixture 
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3.6.5. Internal references to quantify NMR yields  
 Quantification by 1H NMR spectroscopy is a simple and robust technique commonly 
used nowadays.[237] In this approach, an internal standard, consisting of a known amount of a 
compound chemically inert and soluble in the solvent employed is added. All the products of 
the reaction can be quantified at the same time, providing that clean isolated signals for each 
can be analysed in the 1H NMR spectra, by comparing their integrals with the integral of the 
internal standard.  
 We tried several known internal standards under the optimal reaction conditions using 
bisallene 266c as starting material: TBDMSCl, hexamethyldisilane, ferrocene, 3,4,5-
trichloropyridine and dimethyl sulfone. However, the first three were not suitable for our 
quantification due to different reasons: accurate integration of the silane derivatives was 
difficult due to the strong signals of these derivatives; there was overlap of the signals of the 
ferrocene with signals from the reaction products; so we discharged them as internal standards. 
Coordination of the 3,4,5-trichloropyridine to the platinum displacing the acetonitrile ligands 
changed the reaction course. However, a stock solution with a known amount of 3,4,5-
trichloropyridine in CDCl3 was prepared and a sample added as internal standard to the crude 
of reaction allowed us to measure accurately the integrals of the products of reaction. In 
addition, dimethyl sulfone was also employed as internal standard added from the beginning 
to the reaction media, not interfering during the reaction process. 
3.6.6. Experiments to study the level of decomposition of the starting material under 
reaction conditions 
 As it was mentioned before, the group of Jang in the platinum-catalysed reductive 
cyclisation of 1,5-bisallenes, confirmed the decomposition of the starting material under their 
reaction conditions.[211] It was also reported that substituents at the allene terminus slow down 
the rate of decomposition of the allenes.[238]  
 In order to quantify the grade of decomposition of starting material under our reaction 
conditions, model bisallene 204a was used in three different experiments with modifications 
on the parameters of the reaction: 
  Experiment A: the reaction was performed in absence of the platinum-catalyst. After 
6 hours, the NMR yield was measured using as internal reference and accurate volume of a 
stock solution of 3,4,5-trichloropyridine in CDCl3 added to the crude of the reaction. Low 
decomposition levels of the bisallene were observed (Scheme 116).  
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Scheme 116. Experiment A. Reaction carried out to observed the decomposition of starting material without the 
platinum-catalyst 
  Experiment B: the reaction was performed using bisallene 204a, platinum-catalyst, 
and THF-d8, without halide abstractor during the first 22 hours in an NMR tube, heated and 
stirred in an oil bath and monitored by 1H NMR using as internal reference dimethyl sulfone 
(2.869 ppm) (Scheme 117).  
 
Scheme 117. Experiment B, was performed to quantify the level of decomposition of the starting material in 
absence of nucleophile and halide abstractor.  
 Figure 30 shows the 1H NMR spectra of experiment B, obtained during the first 22 
hours without silver salt. The concentration of the bisallene was plot over time to show the 
rate of decomposition of bisallene 204a under reaction conditions (Figure 31). It was observed 
that 40% of bisallene had disappeared after 3 h, 55% after 8.5 h and 22 h later only 26% of the 
starting material remains in solution. After 22 h, 0.1 Eq. of AgSbF6 was added to the NMR 
tube under inert atmosphere. Inmediately after the addition and 4 hours later, two 1H NMR 
spectra were run, observing a much faster decomposition of 204a after formation the cationic 
platinum-complex (Figure 30 and 31-orange dots).  
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Figure 30. Results obtained monitoring the reaction by 1H NMR of experiment B shown in Scheme 118 
 
Figure 31. Results obtained in experiment B (orange) and C (blue) 
 Experiment C: the reaction was performed using the model bisallene 204a, preforming 
in situ the cationic platinum-complex in THF-d8 in absence of MeOH in an NMR tube, heated 
and stirred in an oil bath and monitored by 1H NMR using dimethyl sulfone as internal 
reference (Scheme 118). 
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Scheme 118. Experiments C to quantify the grade of decomposition of 1,5-bisallenes without nucleophile 
 1H NMR spectra of experiment C (Figure 32), and the plot of the concentration of the 
bisallene over time (Figure 31-blue dots), showed a much rapid decomposition of the starting 
material in only 3 hours of reaction in the presence of the cationic complex. 
 
 
Figure 32. Results obtained monitoring by 1H NMR of experiment C shown in Scheme 118  
 It should be noted that the tosyl group of the sulfonamide does not disappear during 
the reaction. In contrast, the signals corresponding to the allenic skeleton desapeared under 
reaction conditions supporting the loss of the allenyl chain mentioned in the formation of 
compound 297 in Scheme 110 (See Figure 30 and 32). The rapid decomposition of starting 
material in the presence of the cationic complex suggests that the reaction has to be completed 
in a short time. Therefore, a new search for a better platinum catalysts able to perform the 
cyclisation faster and under milder conditions was carried out. 
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3.6.7. New screening of platinum catalysts   
 Platinum catalysts 308, 310 and 312 were purchased from commercial sources and 
were used without further purification. Catalyts 307[239] and 311[240] were synthesised by Dr 
Quiros in our laboratory. PtCl2(dppp) 309 was synthesised from PtCl2 using known 
methodologies.[241]   
  
Figure 33. Platinum(II)-catalysts tested under reaction conditions. 
 In contrast with the electron withdrawing character of nitrile ligand employed so far, 
strong electron donating pyridine ligands such as 311 and 312 were used. Additionaly, 
uncommon platinum(II)-pentacoordinate complex 307 with strong electron donation from the 
ligand to the metal centre was also tested. Reactions with complexes containing a labile 
ethylene ligand that can be displaced by allenes were tested and compare in the reaction with 
and without halide abstractors, hoping that the π-systems of the allene η2-bounded to the 
neutral platinum complex will be efficiently activated for the nucleophilic attack triggering the 
expected carbocyclisation of the bisallenes. Furthermore, bulky ligands such as (dppp) 309,[241] 
bridging chloride ligands 310 and chelating ethylenediamine ligand (en) 308 were also 
employed in this screening.  
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Scheme 119. Reaction conditions to the new screening of platinum-catalysts 
[a] 100% conversion. [b] NMR yield. [c] Not 100 % conversion. 
Table 25. Results obtained after new screening of platinum-complexes under reaction conditions 
 A complex mixture was obtained when platinum complex 312 was employed in the 
reaction (Entry 2, Table 25). Unsuccesful results were also achieved with platinum catalysts 
307 and 311 (Entries 4 and 6). High selectivity and moderate yield of triene 298a was obtained 
with catalyst 307 in the presence of 0.1 Eq. of AgSbF6 (Entry 3). Di-μ-chloro-
dichlorobis(ethylene)diplatinum(II) 310 (Entry 7) gave in good yield bisacetal 300a. 6-
Membered cycle 305a and triene 298a where obtained in low yields using platinum complexes 
308 and 311 (Entries 1 and 5 respectively). The new screening of platinum catalysts revealed 
that electron donor ligands or bulky phosphines do not favour any cyclisation mode. Thus, the 
electron withdrawing nature of nitrile ligands and AgSbF6 as halide abstractor seems to be the 
best combination to lead the reaction towards the desired products. 
3.6.8. Scope with different oxygen-nucleophiles 
 This methodology is extremely sensitive to reaction conditions (catalysts, counterions, 
solvents). Despite all the extensive screening described so far, the nature of the nucleophile 
has not been mentioned yet. In this regard, n-PrOH, EtOH and H2O were used under optimal 
conditions employing PtCl2(MeCN)2/AgSbF6 as catalyst and bisallene 204a as the model 
substrate.  
Entry [Pt] AgX t (h) 
Isolated yields (%)[a] 
298a 300a 305a 
1 308 AgSbF6 2 h 40 min 15 - 18 
2 312 AgSbF6 6 h Complex mixture 
3 307 AgSbF6 2 h 53[b] - - 
4 307 - > 27 h Complex mixture[c] 
5 311 AgSbF6 2 h 24 - 16 
6 311 - 16 h Complex mixture 
7 310 - 20 h - 83[b] - 
8 309 AgSbF6 24 h No reaction 
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Scheme 119. Platinum-catalysed alkoxy- and hydroxycyclisations of 1,5-bisallenes 
[a] 100% conversion. [b] NMR yield using 3, 4, 5-trichloropyridine as internal standard added to the 
crude of reaction 
Table 26. Results obtained after platinum-catalysed reaction of 1,5-bisallenes with n-PrOH, EtOH and H2O as 
nucleophiles 
 6-Membered rings 317 and 318, as well as the corresponding trienes 313 and 314 were 
obtained when n-PrOH and EtOH were used as nucleophiles (Entries 1 and 2, Table 26). 
However, with water as the nucleophile, high selectivity to the 7-membered cycles (316a and 
319a, Entry 3) was observed in moderate yield. Additionally, triene 315a was obtained in only 
2% in this reaction. These results showing the divergent reactivity towards the 7-membered 
cycles prompted us to investigate further H2O as nucleophile in the reaction. 
3.6.9. Optimisation conditions using H2O as nucleophile  
 Following the trend of the previous mixtures of THF/MeOH, a small screening of 
ratios of water in different solvents was performed. To do so, we employed PtCl2(MeCN)2 and 
AgSbF6 as catalytic source and the model bisallene 204a at 70 oC.  
 
 
 
 
 
 
Entry Nucleophile t (h) Isolated Yields, %[a] 
1 n-PrOH 1 h 40 min 313, 24; 317, 20 
2 EtOH 1 h 45 min 314, 20; 318, 23 
3[b] H2O 5 h 30 min 315a, 2; 316a, 16; 319a, 21 
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Scheme 120. Optimisation of the ratio solvent:H2O for the platinum-catalysed hydroxycyclisation of 1,5-bisallene 
204a 
[a] 100% conversion of starting material. [b] NMR yield using 3,4,5-trichloropyridine as internal 
standard added to the crude of reaction. [c] As in Table 26, entry 3. 
Table 27. Results obtained under reaction conditions using different ratio of solvents and water as nucleophile 
 The best results for the formation of product 319a were obtained when a mixture of 
THF:H2O (18:1) was employed (Entry 2, Table 27). Isomer 316a and triene 315a were 
obtained in all the cases, being the triene the only product detected when only 3 Eq. of H2O 
were added (Entry 4). Toluene and 1,4-dioxane did not give better results (Entries 5 and 6).  
3.6.10. Screening of platinum-catalysts with the new conditions using H2O as nucleophile 
 With the optimal mixture of solvents achieved in the previous step (Entry 2, Table 
27), a new screening of platinum-catalysts was also performed with water, using bisallene 
204a as the starting material (Table 28). Unfortunately, none of the platinum complexes tested 
enhanced neither the selectivity nor the yields of the desired products. Also, the bisaldehyde 
320a generated by platinum-catalysed dihydroxylation of each of the allenes was observed in 
reactions without the silver salt present (Entries 3, 4, 5 and 6).[191a]  
 
 
 
Entry 
Solvent:H2O 
(ratio) 
t (h) 
NMR Yields, %[a],[b] 
315a 316a 319a 
1[c] THF:H2O (9:1) 5 h 30 min 2 16 21 
2 THF:H2O (18:1) 5 h 45 min 2 7 33 
3 THF:H2O (20:1) 5 h 22 11 17 
4 THF:H2O (3 Eq.) 26 h 31 - - 
5 Toluene:H2O (18:1) > 48 h Complex mixture 
6 1,4-dioxane:H2O (18:1) 4 h 6 1 1 
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Scheme 121. Screening of platinum-catalysts with the new optimal conditions using water as nucleophile 
[a] The reaction was carried out without halide abstractor. [b] R = (p-OMe(C6H4)).  
Table 28. Screening of platinum-complexes using water as nucleophile 
3.6.11. Scope of platinum-catalysed hydroxycyclisation reaction of 1,5-bisallenes 
 The scope of the reaction was studied with water as nucleophile and several substituted 
1,5-bisallenes using the best conditions so far for the formation of the 7-membered rings 
(Scheme 122, Table 29). 
 
 
Entry [Pt] t (h) 
NMR Yields (%) 
315a 316a 319a 320a 204a 
1 308 PtCl2(en) 23 h 5 6 17 - - 
2 312 PtCl2(bipy) > 48 h No reaction 
3 PtCl2(MeCN)2[a] 4 h - - - 91 - 
4 
307 
PtCl2(C2H4)(RNCHCHNR)[a],[b] 
26 h 0 6 10 4 5 
5 310 [Pt2Cl2(μ-Cl)2(C2H4)2][a] > 48 h 0 6 4 21 9 
6 321 [PtCl(terpy)]Cl[a] 50 h 0 0 0 5 64 
7 322 [PtCl(terpy)]SbF6 53 h 6 4 9 - 30 
8 323 cis/trans-PtCl2(PPh3)2 24 h No reaction 
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Scheme 122. Scope platinum-catalysed hydroxycyclisation of 1,5-bisallenes under the best reaction conditions 
[a] 100% conversion. [b] Obtained as inseparable mixture. [c] Microwave heating 90 oC. [d] Not 100 
% conversion. 
Table 29. Results obtained with bisallenic precursors after optimised reaction conditions  
 7-membered cyclisation products 319x were obtained as the main products with non-
substituted N-tethered bisallenes, in inseparable mixtures with isomers 316x and trienes 315x 
(Table 29). It should be mentioned, that electron-withdrawing groups on the tether avoided the 
formation of triene 315 (Entries 2 and 5). The triene was also not observed when malonate 
was used as tether (Entry 7). Formation of 6-membered rings 324x was obtained when bulky 
substituents were incorporated on the terminal carbon of the bisallenes (Entries 10 and 11). 
Tetraene 326o was also isolated from bisallene 207 (Scheme 123), possibly formed by loss of 
water from the triene 315o, originally formed in the reaction, due to the harsher conditions 
employed (Entry 10, Table 29). 
Entry Bisallene t (h) 
Products (ratios after purification)/ 
Isolated Yields, %[a] 
1 204a 5 h 45 min 315a:316a:319a (1:1.4:5)/ 41[b] 
2 266c 5 h 316c:319c (1:1.1)/ 54[b] 
3 266d 5 h 30 min 315d:316d:319d (2:1:3.8)/ 53[b] 
4 266f 22 h 315f:316f:319f (1:4.7:6.9)/ 35[b] 
5 266g 4 h 30 min 316g:319g (1:2.6)/ 34[b] 
6 266i 5 h 30 min 315i:316i:319i (3:1:3)/ 52[b] 
7 204b 30 h 324b:325b (1:1.3)[c]/ 11[b]; 316b, 9 
8 280a 24 h + 6 h[c] 315l, 8 
9 283 24 h 316m:319m (1:1.4)/ 21[b]; 315m:315m’ (1.2:1) 22[b] 
10 207 6 h[c] 324o, 28; 326o, 24 
11 293 48 h[d] 324p, 16 
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 Scheme 123. Proposed formation of tetraene 326o from triene 315o 
 When malonate was used as tether, as well as the 7-membered cycle 316b, the 6-
membered ring 324b was obtained in low yield in an inseparable mixture with its conjugated 
isomer 325b (Entry 7, Table 29). Formation of 324b and 325b could be explained by 
isomerisation of π-allyl-Pt complexes formed during the reaction similarly to the isomerisation 
between 7-membered cycles that will be mentioned later on in this chapter.[242]  
 Triene 315l was obtained as the only product in low yield when bisallene 280a with 
an aromatic ring on the internal position of one allene was exposed to optimal reaction 
conditions (Entry 8).  
 Substituted bisallene 283 with a methyl group adjacent to the N-tether gave in low 
yield an inseparable mixture of the isomeric 7-membered rings 316m and 319m, as well as 
two isomeric trienes 315m and 315m’ (Entry 9, Table 29). Products 316m, 319m and 315m 
come from the attack of the water to the terminal position of the non-substituted allene, while 
addition of water to the most hindered allene will explain the unexpected formation of triene 
315m’.  
 Other substituted 1,5-bisallenes were also tested under optimal conditions with 
unsuccessful results. In all the cases complex mixtures were observed by 1H NMR (Scheme 
124).  
  
 Scheme 124. Unsuccesful alkoxycyclisation of 1,5-bisallenes under the best reaction conditions so far 
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3.6.12. New optimization studies  
 The remarkable increase in selectivity towards 7-membered rings 316 and 319 with 
H2O as the nucleophile should be highlighted. Although still not very high, possibly due to 
decomposition of the starting materials under the reaction conditions, the isolated yields of the 
cycles containing the OH functionality were improved despite the difficulties in the 
purification by column chromatography. However, no control over the formation of isomer 
316 or 319, and considerable amounts of the triene 315, were still present in many cases. 
Trying to improve further this reaction with H2O as nucleophile, we decided to investigate the 
effect of the concentration of H2O in THF that showed a great improvement in the case of the 
MeOH.  
 An additional screening of the reaction using different ratios of THF:H2O was carried 
out using PtCl2(MeCN)2/AgSbF6 as catalytic source and model bisallene 204a. 
  
Scheme 125. Platinum-catalysed hydroxycyclisation of bisallenes with the different ratios of THF:H2O 
[a] All the NMR yields were measured using as internal standard 3,4,5-trichloropyridine added to the 
crude of reaction. [b] 100% conversion of starting material. [c] The products were isolated as 
inseparable mixture and the ratio was measured after purification. [d] These results were obtained in 
the previous solvents screening [e] Reaction was carried out using 0.06 M as absolute concentration.  
Table 30. Results obtained after the screening of different proportions of solvents and nucleophile 
 Selectivity towards the 7-membered cycle 319a with the exocyclic double bond was 
achieved with the increment of water in the reaction, with the best results and complete 
conversion to the cycles with no formation of the triene achieved when a mixture THF:H2O 
(1:3) was used during 12 hours (Entry 5). However, it is worth noting that the reaction time 
was slower, which has some implications in the decomposition of the starting material and 
Entry 
THF:H2O 
(ratio) 
t (h) 
NMR Yields (%)[a][b] 
315a 316a 319a 
1[d] (18:1) 5 h 45 min 315a:316a:319a (1:1.4:5)/ 41[c] 
2[d] (9:1) 5 h 30 min 2 16 21 
3[e] (3:1) 12 h 2 7 33 
4 (1:1) 20 h 2 7 47 
5 (1:3) 12 h 316a:319a (1:9.8)/ 43[c] 
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yields. Thus, in a new attempt to decrease the reaction time under these new conditions, a new 
screening of platinum complexes previously synthesised in the lab such as cis-PtCl2(PhCN)2, 
trans-PtCl2(PhCN)2 and trans-PtCl2(MeCN)2), or from commercial sources (cis-
PtCl2(MeCN)2)  was performed, in which we changed the substituents on the nitrile ligands 
and their configuration around of the platinum. 
 
Scheme 126. Reaction screening of platinum complexes with nitrile ligands 
[a] NMR yields using 3,4,5-trichloropyridine as internal reference added to the crude of reaction. [b] 
100% conversion of starting material. [c] Microwave heating at 60 oC. [d] The products were isolated 
as inseparable mixture and the ratio was measured after purification. 
Table 31. Results obtained after the screening of different platinum-complexes under the new optimal conditions 
 Although full consumption of the starting material was observed with shorter times, 
yields of the cycles were still very low. A small trend between the trans- and cis-PtCl2(RCN)2 
was observed, with the cis-platinum complex giving faster reactions. These results support the 
importance of the cis- and trans-isomerisation in square planar configurations on d8 transition 
metal complexes, and suggest that a cis-complex is the best pre-catalyst in our case, and 
isomerisation of the trans to cis- in solution before the catalytic cycle to form the products.  
 In a final attempt to decrease the decomposition of the starting material, two 
experimental procedures were designed to incorporate the use of an automatic syringe pump. 
The bisallene or the cationic complex were added slowly to the reaction mixture, in order to 
minimise their interaction. 
 Experiment 1: Bisallene 204a was dissolved in dry THF and added slowly using the 
automatic syringe pump to a microwave vial containing the preformed catalytic complex and 
Entry [Pt] [Ag] t (h) 
NMR yields (%)[a],[b] 
316a 319a 
1 cis-PtCl2(MeCN)2 AgSbF6 12 h 316a:319a (1:9.8)/ 43[d] 
2 trans-PtCl2(PhCN)2 AgSbF6 8 h 5 9 
3 cis-PtCl2(PhCN)2 AgSbF6 6 h 5 18 
4 cis-PtCl2(MeCN)2 AgPF6 6 h 15 min 7 25 
5[c] cis-PtCl2(MeCN)2 AgSbF6 1 h 30 min 5 34 
6 trans-PtCl2(MeCN)2 AgSbF6 20 h 316a:319a (1:8.4)/ 38[d] 
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the water under inert atmosphere. Unfortunately, after complete conversion of the starting 
material, the yield did not improve. However it should be noted that the selectivity of the 
reaction to the desired cyclic products remains, with the 7-membered ring 319a being the 
major product of reaction. 
  
Scheme 127. Experiment performed to minimise the loss of starting material under reaction conditions supported 
by an automatic syringe pump 
 Experiment 2: The cationic complex [Pt(MeCN)2]2- 2[SbF6]+ was preformed in a 
Schlenk tube with dry THF during 15 min at room temperature. The complex in solution was 
decantated and added to a different Schlenk under inert atmosphere containing a mixture of 
water (1.5 mL), dry THF (0.1 mL) and bisallene 204a, via the syringe pump at 50 μl per hour. 
Not 100% conversion, decomposition and low NMR yields of 7-membered rings were 
observed after 22 h, and therefore we did not use this experimental procedure in our further 
studies.  
 
Scheme 128. Experiment carried out adding sequentially the load of platinum-complex in solution previously 
preformed in order to avoid the rapid decomposition of the starting material 
 As no further improvement was achieved, we decided to re-investigate the scope of 
the reaction of several 1,5-bisallenes with the latest conditions with cis-PtCl2(MeCN)2/AgSbF6 
and a 1:3 ratio of THF:H2O (Scheme 129, Table 32). 
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Scheme 129.Scope of the platinum-catalysed hydroxycyclisation of 1,5-bisallenes 
[a] The products were obtained as inseparable mixture. [b] The reaction was carried out at 55 oC. [c] 
Microwave heating 70 oC. [d] 100% conversion 
Table 32. Screening of substrates under the best reaction conditions using THF:H2O (1:3) as mixture of solvents 
 N-Sulfonamide derivatives (Entries 1 – 7, Table 32) displayed excellent selectivity 
towards 7-membered rings 316x and 319x. In all the examples, cyclisation 319x prevails over 
the other products in moderate yields, and triene 315 is mainly avoided. It is interesting to 
highlight the good result with bisallene 266e, with the para-MeO-sulfonamide, which gave a 
complex mixture in the previous conditions with THF:H2O (18:1) (See Table 29), supporting 
the huge sensitivity of this methodology to modifications in the reaction conditions. Under 
these conditions, the bisallene bearing the electron withdrawing NO2 group (Entry 3) gave, in 
addition to the 7-membered cycles, bicycle-[3.2.0] 328c.[206c, 213] O-tethered bisallene 259 
(Entry 8) also reacted under these conditions, obtaining the triene 315q and traces of the cyclic 
compound 319q, however only triene 315q could be isolated after column chromatography. 
Traces of the product 319r were also observed on the NMR-crude, however it decomposed 
Entry Bisallenes t (h) 
315x:316x:319x (ratio)/ 
Isolated Yield, %[a] 
1 204a; Z = TsN; R, R’ = H 12 h (0:1:9.8)/ 43 
2 266d; Z = PhSO2N; R, R’ = H 12 h (0:1:7.8)/ 52 
3 266c; Z = p-NO2-PhSO2N; R, R’ = H 6 h (0:1:5.9)/ 35; 328c, 3 
4 266f, Z = p-Cl-PhSO2N; R, R’ = H 22 h (0:1:7.6)/ 46 
5 266e, Z = p-OMe-PhSO2N; R, R’ = H 12 h (0:1:10)/ 42 
6 266g, Z = p-CF3-PhSO2N; R, R’ = H 12 h (0:1:8.5)/ 52 
7 266i, Z = CH3SO2N; R, R’ = H 12 h (2.1:1:8.5)/ 31 
8[b] 259, Z = O; R, R’ = H 1 h 30 min 315q, 13; 319q (traces) 
9[c] 280b; Z = TsN; R = H;  R’ = Me 15 h 30 min 319r (traces) 
10 204b; Z = (CO2Me)2C; R, R’ = H 24 h 316b:319b:324b (3.1:1:9.3)/ 6 
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after purification (Entry 9, Table 32). A carbon-based tether was also employed (Entry 10), 
giving mixtures of the 6- and 7-membered rings as inseparable mixture in low yield.   
Complex mixtures were obtained with the 1,5-bisallenes shown in Table 33.  
  
 Scheme 130. Bisallenic precursors that did not work under catalytic conditions 
[a] Microwave heating 70 oC.  
Table 33. Unsuccesful alkoxycyclisation of 1,5-Bisallenes under the best reaction conditions so far  
3.6.13. Mechanistic insights and deuterium-labelling experiments 
 In order to gain some insight into the mechanism of the reactions, we first studied the 
stability of the products and the possible interconversion between the isomeric cycles and the 
triene during the reaction under platinum catalysis. Thus, isolated triene 298c was re-submitted 
to the reaction conditions with MeOH as nucleophile in a mixture THF:MeOH, 9:1 (Scheme 
131). We observed that triene 298c did not decompose or cyclise during the reaction after 22 
h at 70 oC. This experiment also suggests that the low yields obtained in the isolation of triene 
298 can come from decomposition or other issues during the purification by column 
chromatography with silica gel. 
 
 
Scheme 131. Reaction performed to observed the decomposition level of product 298c under reaction conditions 
Entry 1,5-bisallenes t (h) 
1 272; Z = (MeOCH2)2C; R, R’, R’’, R’’’ = H 19  h 
2 280a; Z = TsN; R, R’, R’’ = H;  R’’’ = Ph > 48 h 
3 283; Z = TsN; R = Me;  R’, R’’, R’’’ = H 9 h 40 min 
4[a] 207; Z = TsN; R, R’’, R’’’ = H; R’ = Me 24 h 
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 We also tried the study of the interconversion between the two 7-membered rings 316a 
and 319a in solution and their possible decomposition under reaction conditions with and 
without the cationic platinum complex. However, due to the problems with the isolation of 
these compounds as previously mentioned, the results obtained were not conclusive.  
 Nevertheless, an additional experiment was performed to support the possible 
interconversion of the 7-membered cycles. In this case, the reaction was monitored directly by 
1H NMR using an internal standard (dimethyl sulfone). To do so, an NMR tube was loaded 
with bisallene 266c, the cationic platinum complex, PtCl2(MeCN)2/AgSbF6, a mixture THF-
d8:D2O (1:3) and the reference dimethyl sulfone under nitrogen. The mixture was heated at 52 
oC in the spectrometer (note the lower temperature due to experimental set up in the NMR). 
The reaction was monitored by 1H NMR every 30 min during 12 h. As expected, 7-membered 
ring 319c-d was formed as main product, however, triene 315c-d was also observed in 
considerable amount in contrast with the results obtained with water as nucleophile in the 
bigger scale reaction at 70 oC (Entry 3, Table 32).  
Scheme 132. Monitoring reaction by 1H NMR using as internal reference dimethyl sulfide 
 Figure 40 shows the 1H NMR spectra acquired during the reaction at 52 oC. It should 
be highlighted the low resolution of the NMR spectra during the first 3 hours of reaction, 
possibly due to the high concentration of water and fluxional behaviour of the allene(s)-
platinum complexes. This experiment was repeated twice showing a similar profile at the 
beginning of the reaction. Although integrals of the bisallene 266c could not be accurately 
measured, we were able to extract some data to show the consumption of bisallene (Figure 
35). The integrals of the three products of the reaction could be accurately measured and the 
concentrations calculated using the internal reference dimethyl sulfone. The profile of the 
reaction is shown in figure 35. Fast consumption of the bisallene 266c was observed at the 
beginning of the reaction, but analysis of the mass balance showed that not all the starting 
material was forming the observed products, confirming again the decomposition of the 
bisallenes in the presence of cationic platinum complexes. Interstingly, no full conversion was 
observed, and traces of the bisallene are observed even at longer times. Formation of products 
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315c-d and 316c-d is mainly achieved during the first 15000 s (4 - 5 hours), then concentration 
of both seems to be stabilised, which would ruled out that 315c-d as intermediate in the 
formation of the isomeric 319c-d or interconversion between the two cycles once they are 
formed. On the other hand, 7-membered ring 319c-d is obtained as main product, in a fast 
process at the beginning of the reaction and then at a slower rate, which could indicate catalyst 
decomposition.  
 
 
Figure 34. 1H NMR acquired during the reaction into the NMR at 52 oC under the best reaction conditions 
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Figure 35. Data plot with the results obtained monitoring the reaction of bisallenes by 1H NMR 
 In order to get an insight into the intermediates involved in these new catalytic cycles, 
deuterium-labelling experiments were performed using MeOD and D2O as nucleophiles in 
THF-d8, N-sulfonamide bisallenes 204a and 266d, and PtCl2(MeCN)2/AgSbF6 as catalyst.  
 1,5-Bisallene 204a was reacted under optimal reaction conditions with MeOD as the 
nucleophile to give the monodeuterated compound 305a-d (42% D) and triene 298a-d with 
high deuterium incorporation in the sulfonimidic nitrogen (> 95% D).  
 
Scheme 133. Deuterium-labelling experiment using MeOD as nucleophile 
 
 
 
0
0,01
0,02
0,03
0,04
0,05
0,06
0,07
0,08
0,09
0,1
0 10000 20000 30000 40000 50000 60000
C
o
n
ce
n
tr
a
ti
o
n
  
(M
)
t (s)
266c
316c
319c
315c
177 
 
1H NMR in CDCl3: 
 
Figure 36. 1H NMR of deuterium-labelling experiments 
2H NMR in CHCl3: (traces of THF and THF-d
8 present) 
 
Figure 37. 2H NMR of deuterium-labelling experiments  
THF-d8 
THF 
THF 
THF-d8 
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 1H NMR (Figure 36) and 2H NMR (Figure 37) revealed the incorporation of deuterium 
on the internal position of the exocyclic vinyl group in compound 305a-d. This suggests that 
protodemetalation of a vinyl-platinum intermediate 329 (Scheme 134) could be taking place 
in the final step of the catalytic cycle. This intermediate could be formed by attack of the 
MeOD to the terminal carbon of one allene, triggering the concomitant tail-to-head (external 
– internal π-systems of the bisallene) 6-exo-trig cyclisation of the bisallene 204a (Scheme 
134), which after Pt-C cleavage with deuterium gives 6-membered ring 305a-d. Besides, triene 
298a-d was also formed in the reaction, displaying high deuterium incorporation in the N-D 
bond. We propose, that this compound comes from the elimination reaction of intermediate 
platinum complex 330 and / or 331, formed by 7-endo or exo-dig cyclisation triggered by the 
attack of the MeOD to the terminal carbon of the allene (Scheme 134). These cyclisations 
could also happen stepwise, by attack of the nucleophile to the terminal carbon of the allene 
to form an acyclic vinyl-platinum intermediate that undergoes carbocyclisation with the other 
allene to give the two intermediates. 
 
Scheme 134. Proposal mechanism to synthesise 6-membered ring 305a-d via tail-to-head 6-exo-trig cyclisation 
and the formation of triene 298a-d by the elimination reaction from its intermediates platinum-complexes 329, 330 
and or 331. 
 On the other hand, bisallene 266d was employed as substrate in the deuterium-
labelling experiment using D2O as nucleophile under the optimal conditions with the mixture 
THF-d8:D2O (1:3). 
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Scheme 135. Deuterium-labelling experiments using D2O as nucleophile 
 Deuterium incorporation into the 7-membered cycle 319d-d was observed in the 
internal allylic position of the exocyclic double bond. Besides, mono, di or tri-deuteration was 
obtained in the exocyclic methyl group of 316d-d. Triene 315d-d was also formed in low yield, 
with high deuterium incorporation in the nitrogen (Figure 38 and 39).  
1H NMR in CDCl3: 
    
 
Figure 38. 1H NMR of deuterium-labelling experiments 
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2H NMR in CHCl3: (traces of THF-d
8 were present) 
 
Figure 39. 2H NMR of deuterium-labelling experiments 
 These results suggest the attack of the water to the terminal carbon of one allene 
triggering a 7-endo- or exo-dig cyclisation in a tail-to-head or tail-to-tail mode to give the 
isomeric allyl-Pt intermediates 330 and 331 (Scheme 136). Irreversible protodemetalation of 
the Pt-C bond in both intermediates will lead to 319d-d and 316d-d respectively. As it has 
been discussed in the previous experiment monitoring the reaction by 1H NMR (See Figure 34 
and 35) the isomerisation of cycles 316 and 319 in solution was not observed. Deuterium 
experiments also showed no deuterium scrambling after complete conversion of the three 
products, which supports the non-intercoversion of the final cycles. However, interconversion 
of the allyl-Pt intermediates cannot be completely ruled out. The allyl-Pt intermediates 330 
and 331 will also explain the formation of the triene 315d-d by irreversible elimination aided 
by the electron withdrawing properties of the sulfonamide as in the case of the methanol 
(Scheme 136).  
THF-d8 
THF-d8 
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Scheme 136. Proposed mechanisms to generated 7-membered cycles 316d-d and 319d-d and triene 315d-d  
 Deuterated 1,5-bisallene 204a-d4 in the terminal positions of the allene was reacted 
under optimal conditions with H2O as nucleophile, to obtained 316a-d4 and 319a-d4, with no 
significant loss of deuterium in the expected positions. No deuterium incorporation was 
detected on C-5 and C-2 in the skeleton of both cycles, which again suggests that the two 7-
membered cycles 316 and 319 do not interconvert under reaction conditions. 
 
Scheme 137. Reaction carried out under optimal conditions using deuterated bisallene 204a-d4 
 Further mechanistic studies to understand the different reactivity of water and 
alcohols, the sensitivity of the reaction to the different parameters studied, as well as the 
elimination and protodemetalation steps are currently being carried out in the group. Intra- 
versus intermolecular protodemetalation steps, as well as the possibility of alternative 
mechanisms involving Pt-hydrides are being considered. 
3.7. Conclusions 
 We have discovered a new platinum-catalysed carbocyclisation of 1,5-bisallenes to 
give 6- or 7-membered cycles with an extra oxygen nucleophile incorporated in the skeleton 
of rings, depending on the nucleophile used.  
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 The reaction works better with cationic platinum complexes bearing electron-
withdrawing ligands and with bisallenes containing a sulfonamide as the tether. However, the 
reaction is very sensitive to slight modifications of these parameters, and complete selectivity 
is still a challenge. Rapid decomposition of the model bisallenic starting material under 
catalytic conditions has been proven by NMR experiments, with isolation no higher than 60%. 
 Deuterium-labelling experiments confirmed the involvement of allyl- or vinyl-
platinum intermediates in the different cyclisation modes observed to synthesise 7-membered 
rings via 7-exo- and 7-endo-dig cyclisations, and 6-membered rings via 6-exo-trig cyclisation. 
A possible mechanism for the formation of the trienes has been proposed via elimination from 
the key allyl-platinum intermediates.  
 Selectivity of the reaction using MeOH, the scope with different bisallenes and also 
the mechanistic study of this reaction are in progress in our group.  
.  
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3.8. Experimental section 
Synthesis of cis-bis(acetonitrile)dichloroplatinum(II) and trans-
bis(acetonitrile)dichloroplatinum(II)[243]  
 
 Platinum(II) chloride (PtCl2) (200 mg, 0.75 mmol, 1.0 Eq.) was added under N2 into 
a flamed-dried Schlenk flask. Dry MeCN (2.0 mL, 38.30 mmol, 50.0 Eq.) was added. The 
Schlenk was equipped with a condenser and the solution was refluxed at 90 oC for 4 h. The 
crude of reaction was filtered, under vacuum, obtaining trans-
bis(acetonitrile)dichloroplatinum(II) as a grey solid (108 mg, 0.31 mmol, 41%). The mother 
liquor was concentrated, under vacuum, obtaining of cis-bis(acetonitrile)dichloroplatinum(II) 
as a yellow solid (53 mg, 0.15 mmol, 20%). Cis-[PtCl2(MeCN)2] 1H NMR (400 MHz, CDCl3, 
25 ºC) δ = 2.17 (s, 6H). 195Pt NMR (108 MHz, CDCl3, 25 oC) δ = - 2684.72. IR (Film, cm-1): 
ν̃ = 2923 (C-HAlkane), 2351 (C≡N), 2339 (C≡N), 1406, 1354, 1019, 772. Trans-[PtCl2(MeCN)2] 
195Pt NMR (108 MHz, Tol, 25 ºC) δ = - 2789.32. IR (Film, cm-1): ν̃ = 2925, 2338 (C≡N), 1409, 
1359, 1019. 
Synthesis of cis and trans-bis(benzonitrile)dichloroplatinum(II)[244] 
 
 Platinum(II) dichloride (PtCl2) (40 mg, 0.15 mmol, 1.0 Eq.) and neat benzonitrile (1.7 
mL, 0.02 mmol, 0.1 Eq.) were added to a flame-dried Schlenk flask under N2. The solution 
was refluxed at 100 oC during 1 h. The suspension was cooled down, filtered through celite 
and concentrated under vacuum. Then, the yellow solid was treated with hot benzene and 
filtered under vacuum. The insoluble cis-[PtCl2(PhCN)2] was washed with petroleum ether 
and dried under vacuum. Obtained 8 mg, 0.02 mmol (11%) as a yellow solid. The mother 
liquor was concentrated obtaining trans-[PtCl2(PhCN)2] as a white solid, 23 mg, 0.05 mmol 
(32%). Cis-[PtCl2(PhCN)2]. 1H NMR (500 MHz, CDCl3, 25 ºC) δ = 7.80 (dd, J = 8.2, 1.2 Hz, 
2H; o-Ph), 7.77 – 7.72 (m, 1H; p-Ph), 7.60 – 7.54 (m, 2H; m-Ph). 13C NMR (126 MHz, CDCl3, 
25 ºC) δ = 135.3 (CHAr; p-Ph), 133.8 (CHAr; m-Ph), 129.5 (CHAr; o-Ph), 119.4 (Cq; Ph), 109.1 
(Cq; CN). 195Pt NMR (108 MHz, CDCl3, 25 ºC) δ = - 2514.0. IR (Film, cm-1): ν̃ = 3097 (C-
HAr), 3061 (C-HAr), 3038 (C-HAr), 2286 (C≡N), 1592, 1446, 1199, 998, 761, 683.  Trans-
[PtCl2(PhCN)2] 1H NMR (500 MHz, CDCl3, 25 ºC) δ = 7.83 – 7.78 (m, 2H; o-Ph), 7.77 – 7.72 
(m, 1H; p-Ph), 7.57 (t, J = 8.1 Hz, 2H; m-Ph).13C NMR (126 MHz, CDCl3, 25 ºC) δ = 135.4 
(CHAr; p-Ph), 133.9 (CHAr; m-Ph), 129.6 (CHAr; o-Ph). (Cq; Ph) and (Cq; CN) could not be 
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identified due to the low concentration of the sample. 195Pt NMR (108 MHz, CDCl3, 25 ºC) δ 
= - 2488.00. IR (Film, cm-1): ν̃ = 3096 (C-HAr), 3033 (C-HAr), 2288 (C≡N), 1592, 1446, 1120, 
762. 
Synthesis of cis/trans-dichlorobis(triphenylphosphine)platinum (II)[245] 
 
 The synthesis was undertaken according to the procedure described by Oemke and co-
workers.[245] Potassium tetrachloroplatinate (K2[PtCl4]) (47 mg, 0.11 mmol, 1.0 Eq.) and 
triphenylphosphine (PPh3) (60 mg, 0.23 mmol, 2.0 Eq.) were added to a microwave vial under 
normal atmosphere and dissolved in 2.6 mL of DCM. The vial was sealed and the reaction was 
heated at 145 ºC under microwave irradiation during 13 h. To the yellow solution was added 
slowly Et2O and then the suspension was cooled down at 0 ºC (ice bath) during 10 min. The 
white powder was filtered and washed with small portions of Et2O. The product was 
recrystallized from CHCl3 and heptane. Obtained as a white powder, 46 mg, 0.06 mmol (51%). 
Cis/Trans(2:1)[PtCl2(PPh3)2], 31P NMR (202 MHz, CDCl3, 25 ºC) δ = 21.81Trans (PPh3), 
14.31Cis (PPh3), 13.27Cis (d, JP-Pt = 2785.3 Hz). 195Pt NMR (108 MHz, CDCl3, 25 oC) δ = - 
4172.9(Trans), - 4581.8(Cis). 
Synthesis of [1,3-bis(diphenylphosphino)propane]dichloroplatinum (II) (309)[245] 
 
 The synthesis was undertaken according to the procedure described by Bennett and 
co-workers.[246] Platinum(II) dichloride (PtCl2) (70 mg, 0.26 mmol, 1.0 Eq.) and 1,3-
bis(diphenylphosphino)propane (dppp) (108 mg, 0.26 mmol, 1.0 Eq.) were added to a flame-
dried Schlenk flask under N2. The solids were dissolved in 10.0 mL dry CHCl3. Then, the 
Schlenk was equipped with a condenser and the suspension was refluxed during 3 h. Then 
over the warm solution was added n-hexane to obtain a white precipitate. The solid was filtered 
and washed with n-hexane. Obtained as a white solid 309, 178 mg, 0.26 mmol (99%). 1H NMR 
(500 MHz, CDCl3, 25 ºC) δ = 7.81 – 7.73 (m, 8H; HAr-2), 7.48 – 7.44 (m, 4H; HAr-1), 7.43 – 
7.37 (m, 8H; HAr-8), 2.61 – 2.40 (m, 4H; H-4), 2.13 – 1.94 (m, 2H; H-5). 31P NMR (202 MHz, 
CDCl3, 25 ºC) δ = - 5.59 (d, JP-Pt = 3407.6 Hz). 
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Synthesis of chloro (2,2’,6’,2’’-terpyridine) platinum chloride (321)[247] 
 
 Potassium tetrachloroplatinate (K2[PtCl4]) (300 mg, 0.72 mmol, 1.0 Eq., 0.12 M) was 
added dissolved in 6.0 mL of distilled H2O in a two-necks round bottom flask with a condenser. 
The mixture was stirred at room temperature during 5 min. Then, dimethylsulfide (Me2S) was 
added dropwise and the solution was refluxed at 85 oC during 1 h. The yellow solution was 
cooled down at room temperature, extracted with DCM (x 3), washed with brine, dried over 
MgSO4 anhydrous and concentrated under vacuum. Cis/trans-[PtCl2(SMe)2] was obtained, 
207 mg, 0.53 mmol (73%) as a yellow solid. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 2.58(Trans) 
(s, 6H; 2 x Me), 2.58(Trans) (d, JH-Pt = 50.6 Hz,), 2.47(Cis) (s, 6H; 2 x Me), 2.47(Cis) (d, JH-Pt = 41.0 
Hz). 195Pt NMR (108 MHz, CDCl3, 25 oC) δ = - 3396.3(Trans).195Pt NMR (108 MHz, CDCl3, 25 
oC) δ = - 3396.3(Cis) 
 Cis/trans-[PtCl2(SMe)2] (45 mg, 0.12 mmol, 1.0 Eq.) was dissolved in 2.0 mL of a 
mixture MeOH : H2O (90:1) in a two-necks round bottom flask with a condenser. The 
suspension was warmed up at 60 ºC during 10 min. Terpyridine (terpy) (29 mg, 0.12 mmol, 
1.1 Eq.) was dissolved in 300 µl of MeOH and added to the round bottom flask. The mixture 
was refluxed at 80 ºC during 45 min. The orange solution was cooled down at room 
temperature and concentrated under vacuum. The red-orange residue was dissolved in boiling 
methanol to remove the excess of terpy and cooled down at room temperature. The product 
was precipitated adding 50 mL of Et2O and then filtered under vacuum. Obtained 34 mg, 0.06 
mmol (55%) 321 as a red solid. 1H NMR (500 MHz, CD3OD, 25 ºC) δ = 9.16 – 9.11 (m, 2H; 
H-1), 8.58 – 8.43 (m, 7H; H-3, H-4, H-5 and H-6), 7.92 (m, 2H; H-2). IR (Film, cm-1): ν̃ = 
3087 (Terpy), 2929 (Terpy), 1605, 1474 (Terpy), 1401, 779.  
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Synthesis of chloro (2,2’:6’,2’’-terpyridine)-hexafluoroantimonate platinum (322)[247-248] 
 
 [PtCl(terpy)]Cl 321 (10 mg, 0.02 mmol, 1.0 Eq.) was dissolved in 2.0 mL of MeOH 
in a microwave vial under normal atmosphere, changing the colour immediately from red to 
bright yellow. The vial was sealed and the mixture was heated at 70 oC during 5 min. Then 
AgSbF6 (6 mg, 0.02 mmol, 1.0 Eq.) was added dissolved in 1.0 mL of MeOH. The suspension 
was heated at 70 ºC during 30 min. The solution was cooled down and concentrated under 
vacuum. Obtained 8 mg, 0.01 mmol, as a yellow-orange solid 322 (61%). 1H NMR (500 MHz, 
CD3CN, 25 oC) δ = 9.05 (d, J = 5.8 Hz, 2H; H-6), 8.65 – 8.60 (m, 2H; H-5), 8.60 – 8.55 (m, 
4H; H-3 and H-4), 8.50 (t, J = 7.9 Hz, 1H; H-1), 8.01 – 7.95 (m, 2H; H-2). IR (Film, cm-1): 
ν̃ = 3066 (Terpy), 3011 (Terpy), 1607, 1475 (Terpy), 1399, 772, 653. 
Synthesis of N-bispropargyl derivatives 
Procedure (a): 
 Potassium carbonate (K2CO3) (5.0 Eq.) was added into a flame-dried two-necks round 
bottom flask equipped with a condenser under N2 atmosphere. The corresponding substituted 
primary amine (1.0 Eq., 0.26 M – absolute concentration) was added dissolved in dry 
acetonitrile under N2. The suspension was stirred at room temperature for 3 min and then 
propargyl bromide (80% in toluene, 3.0 Eq.) was added dropwise. The reaction mixture was 
heated at 90 – 95 oC until complete conversion, followed by TLC. The crude was quenched 
with H2O at 0 oC (ice bath) and extracted with Et2O (x 3). The ether extracts were combined 
and washed with brine, dried over MgSO4 anhydrous and concentrated under vacuum. The 
product was purified by column chromatography over silica gel using Hex or PET / Et2O or 
EtOAc as eluent. 
Procedure (b): 
 Potassium carbonate (K2CO3) (5.0 Eq.) was added into a previously vacuum-dried 
microwave vial under N2 conditions. Then the corresponding substituted primary amine (1.0 
Eq., 0.26 M – absolute concentration) was added dissolved in dry acetonitrile under N2. The 
suspension was stirred at room temperature during 3 min and then propargyl bromide (80% in 
toluene, 3.0 Eq.) was added dropwise under N2. The vial was sealed under inert atmosphere 
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and the reaction mixture was heated under microwave irradiation at 130 oC during 3 h. The 
crude was quenched with H2O at 0 oC (ice bath) and extracted with Et2O (x 3). The ether 
extracts were combined and washed with brine, dried over MgSO4 and concentrated under 
vacuum. The product was obtained without further purification.  
Synthesis of 4-methyl-N,N-di-prop-2-ynyl-benzenesulfonamide (265a)[249] 
 
 Procedure (a). From p-toluenesulfonamide (4.0 g, 23.51 mmol), K2CO3 (16.2 g, 
117.57 mmol), propargyl bromide (7.9 mL, 70.54 mmol) and 92.0 mL of dry acetonitrile. 
Obtained without further purification a brown solid 265a, 5.3 g, 21.64 mmol (92%). Procedure 
(b). From p-toluenesulfonamide (450 mg, 2.63 mmol), K2CO3 (1.8 g, 13.14 mmol), propargyl 
bromide (877 µl, 7.88 mmol) and 10.0 mL of dry acetonitrile. Obtained without further 
purification a brown solid 265a, 642 mg, 2.59 mmol (99%). 1H NMR (500 MHz, CDCl3, 25 
oC) δ = 7.72 (d, J = 8.2 Hz, 2H; HAr-5), 7.30 (d, J = 8.2 Hz, 2H; HAr-6), 4.17 (d, J = 2.4 Hz, 
4H; H-1), 2.43 (s, 3H; H-8), 2.15 (t, J = 2.4 Hz, 2H; H-3). 13C NMR (101 MHz, CDCl3, 25 oC) 
δ = 144.1 (Cq; C-4 or C-7), 135.3 (Cq; C-4 or C-7), 129.7 (2 x CHAr; C-6), 128.0 (2 x CHAr; C-
5), 76.3 (2 x Cq; C-2), 74.2 (2 x CH; C-3), 36.3 (2 x CH2; C-1), 21.7 (CH3; C-8). 
Synthesis of N,N-di-prop-2-ynyl-benzenesulfonamide (265d) 
 
 Procedure (a). From benzenesulfonamide (1.0 g, 6.36 mmol), K2CO3 (4.4 g, 31.81 
mmol), propargyl bromide (2.1 mL, 19.08 mmol) and 24.0 mL of dry acetonitrile. Obtained 
after column chromatography, Hex / EtOAc, (6:1) then (4:1), 1.1 g, 4.50 mmol (72%): 265d 
white solid. Procedure (b). From benzenesulfonamide (600 mg, 3.82 mmol), K2CO3 (2.6 g, 
19.08 mmol), propargyl bromide (1.3 mL, 11.45 mmol) and 14.0 mL of dry acetonitrile. 
Obtained without further purification a brown solid 265d, 1.4 g, 6.23 mmol (98%). 1H NMR 
(500 MHz, CDCl3, 25 oC) δ = 7.87 – 7.81 (m, 2H; HAr-5), 7.63 – 7.57 (m, 1H; HAr-7), 7.55 – 
7.48 (m, 2H; HAr-6), 4.18 (d, J = 2.4 Hz, 4H; H-1), 2.14 (t, J = 2.4 Hz, 2H; H-3). 13C NMR 
(126 MHz, CDCl3, 25 oC) δ = 138.3 (Cq; C-4), 133.3 (CHAr; C-7), 129.1 (2 x CHAr; C-5), 128.0 
(2 x CHAr; C-6), 76.2 (2 x Cq; C-2), 74.2 (2 x CH; C-3), 36.4 (2 x CH2; C-1). IR (Film, cm-1): 
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ν̃ = 3264 (C≡CH), 3073 (C-HAr), 2994, 2942 (C-HAlkane), 2891 (C-HAlkane), 2121 (C≡C), 1449 
(C-HAlkane), 1339 (S=O), 1164 (S=O), 1071 (C-N), 889. HRMS (FTMS + p NSI 
((DCM)/MeOH + NH4OAc)): Calc. for C12H12NO2S [M+H]+: 234.0583. Found: 234.0583. 
M.P. = 68 – 70 oC. 
Synthesis of 4-nitro-N,N-di-prop-2-ynyl-benzenesulfonamide (265c) 
 
 Procedure (a). From 4-nitrobenzenesulfonamide (1.0 g, 4.95 mmol), K2CO3 (3.4 g, 
24.76 mmol), propargyl bromide (1.7 mL, 14.86 mmol) and 26.0 mL of dry acetonitrile. 
Obtained without further purification an orange solid 265c, 1.3 g, 4.70 mmol (95%). 
Procedure (b). From 4-nitrobenzenesulfonamide (600 mg, 2.97 mmol), K2CO3 (2.0 g, 14.83 
mmol), propargyl bromide (991 µl, 8.90 mmol) and 13.0 mL of dry acetonitrile. Obtained 
without further purification an orange solid 265c, 524 mg, 1.88 mmol (64%). 1H NMR (500 
MHz, CDCl3, 25 oC) δ = 8.47 – 8.29 (m, 2H; HAr-5), 8.07 – 8.01 (m, 2H; HAr-6), 4.23 (d, J = 
2.4 Hz, 4H; H-1), 2.19 (t, J = 2.4 Hz, 2H; H-3). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 150.5 
(Cq; C-7), 144.3 (Cq; C-4), 129.2 (2 x CHAr; C-6), 124.3 (2 x CHAr; C-5), 75.6 (2 x Cq; C-2), 
74.9 (2 x CH; C-3), 36.6 (2 x CH2; C-1). IR (Film, cm-1): ν̃ = 3269 (C≡CH), 3104 (C-HAr), 
3069 (C-HAr), 2998 (C-HAlkane), 2118 (C≡C), 1607 (C=CAr), 1530 (N-O), 1350 (S=O), 1167 
(S=O), 1061 (C-N), 931. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for 
C12H10N2O4SNa [M+Na]+: 301.0253. Found: 301.0258. M. P. = 113 – 115 oC. 
Synthesis of 4-methoxy-N,N-di-prop-2-ynyl-benzenesulfonamide (265e) 
 
 Procedure (a). From 4-methoxybenzenesulfonamide (1.4 g, 7.53 mmol), K2CO3 (5.2 
g, 37.66 mmol), propargyl bromide (2.5 mL, 22.60 mmol) and 29.0 mL of dry acetonitrile. 
Obtained after column chromatography, Hex / EtOAc (5:1) then (3:1): 265e, 1.8 g, 7.00 mmol 
(93%): white solid. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.79 – 7.74 (m, 2H; HAr-5), 6.99 – 
6.94 (m, 2H; HAr-6), 4.16 (d, J = 2.4 Hz, 4H; H-1), 3.87 (s, 3H; H-8), 2.16 (t, J = 2.4 Hz, 2H; 
H-3). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 163.5 (Cq; C-7), 130.2 (2 x CHAr; C-5), 129.8 
(Cq; C-4), 114.2 (2 x CHAr; C-6), 76.4 (2 x Cq; C-2), 74.2 (2 x CH; C-3), 55.8 (CH3; C-8), 36.3 
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(2 x CH2; C-1). IR (Film, cm-1): ν̃ = 3290 (C≡CH), 3104 (C-HAr), 3014 (C-HAr), 2897 (C-
HAlkane), 2846 (C-HAlkane), 2125 (C≡C), 1596 (C=CAr), 1498, 1350 (S=O), 1262 (C-O), 1159 
(S=O), 1096 (C-N), 1027 (C-O), 805. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): 
Calc. for C13H14NO3S [M+H]+: 264.0689. Found: 264.0686. M.P. = 49 – 51 oC. 
Synthesis of 4-chloro-N,N-di-prop-2-ynyl-benzenesulfonamide (265f) 
 
 Procedure (a). From 4-chlorobenzenesulfonamide (1.0 g, 5.31 mmol), K2CO3 (3.7 g, 
26.54 mmol), propargyl bromide (1.8 mL, 15.92 mmol) and 25.0 mL of dry acetonitrile. 
Obtained after column chromatography, Hex / EtOAc (4:1): 265f, 1.3 g, 4.86 mmol (92%): 
yellow-white solid. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.81 – 7.75 (m, 2H; HAr-5), 7.52 – 
7.45 (m, 2H; HAr-6), 4.18 (d, J = 2.4 Hz, 4H; H-1), 2.18 (t, J = 2.4 Hz, 2H; H-3). 13C NMR 
(126 MHz, CDCl3, 25 oC) δ = 139.9 (Cq; C-7), 136.9 (Cq; C-4), 129.4 (2 x CHAr; C-5), 129.4 
(2 x CHAr; C-6), 76.0 (2 x Cq; C-2), 74.5 (2 x CH; C-3), 36.4 (2 x CH2; C-1). IR (Film, cm-1): 
ν̃ = 3295 (C≡CH), 3097 (C-HAr), 2987, 2935 (C-HAlkane), 2857 (C-HAlkane), 2122 (C≡C), 1587 
(C=CAr), 1355 (S=O), 1166 (S=O), 1096 (C-N), 893. HRMS (FTMS + p NSI ((DCM)/MeOH 
+ NH4OAc)): Calc. for C12H135ClNO2S [M+H]+: 268.0194. Found: 268.0197. Calc. for 
C12H137ClNO2S [M+H]+: 270.0163. Found: 270.0163. M.P. = 65 – 67 oC. 
Synthesis of N,N-di-prop-2-ynyl-4-trifluoromethyl-benzenesulfonamide (265g) 
 
 Procedure (a). From 4-(trifluoromethyl)benzenesulfonamide (377 mg, 1.67 mmol), 
K2CO3 (1.1 g, 8.37 mmol), propargyl bromide (560 µl, 5.02 mmol) and 22.0 mL of dry 
acetonitrile. Obtained without further purification a brown solid 265g, 479 mg, 1.59 mmol 
(95%). Procedure (b). From 4-(trifluoromethyl)benzenesulfonamide (347 mg, 1.54 mmol), 
K2CO3 (1.1 g, 7.70 mmol), propargyl bromide (514 µl, 4.62 mmol) and 7.0 mL of dry 
acetonitrile. Obtained without further purification a brown solid 265g, 461 mg, 1.53 mmol 
(99%). 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.98 (d, J = 8.2 Hz, 2H; HAr-5), 7.79 (d, J = 8.2 
Hz, 2H; HAr-6), 4.20 (d, J = 2.4 Hz, 4H; H-1), 2.17 (t, J = 2.4 Hz, 2H; H-3). 13C NMR (126 
MHz, CDCl3, 25 oC) δ = 142.0 (Cq; C-4), 128.5 (2 x CHAr; C-5), 126.3 (q, JC-F = 3.5 Hz; 2 x 
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CHAr; C-6), 75.8 (2 x Cq; C-2), 74.6 (2 x CH; C-3), 36.5 (2 x CH2; C-1). Signals (Cq; C-7) and 
(Cq; CF3) could not be identified. 19F NMR (471 MHz, CDCl3, 25 oC) δ = - 63.11. IR (Film, 
cm-1): ν̃ = 3291 (C≡CH), 3104 (C-HAr), 3060 (C-HAr), 2936 (C-HAlkane), 2856 (C-HAlkane), 2124 
(C≡C), 1323 (S=O), 1168 (S=O), 1133 (C-F), 1095 (C-N), 843. HRMS (FTMS + p NSI 
((DCM)/MeOH + NH4OAc)): Calc. for C13H11F3NO2S [M+H]+: 302.0457. Found: 302.0453. 
M.P. = 44 – 46 oC.  
Synthesis of N,N-di-prop-2-ynyl-methanesulfonamide (265i) 
 
 Procedure (a). From methanesulfonamide (2.3 g, 24.42 mmol), K2CO3 (16.9 g, 122.09 
mmol), propargyl bromide (8.2 mL, 73.26 mmol) and 30.0 mL of dry acetonitrile. Obtained 
after column chromatography using PET / EtOAc as eluent (10:1) then (5:1) a yellow solid 
265i, 1.8 g, 10.78 mmol (45%). 1H NMR (500 MHz, CDCl3, 25 oC) δ = 4.19 (d, J = 2.4 Hz, 
4H; H-1), 2.97 (s, 3H; H-4), 2.39 (t, J = 2.4 Hz, 2H; H-3). 13C NMR (126 MHz, CDCl3, 25 oC) 
δ = 76.8 (2 x Cq; C-2), 74.7 (2 x CH; C-3), 38.7 (CH3; C-4), 36.6 (2 x CH2; C-1). IR (Film, 
cm-1): ν̃ = 3288 (C≡CH), 2979 (C-HAlkane), 2933 (C-HAlkane), 2853 (C-HAlkane), 2120 (C≡C), 
1347 (S=O), 1155 (S=O), 1080 (C-N), 951, 892. HRMS (FTMS + p NSI ((DCM)/MeOH + 
NH4OAc)): Calc. for C7H10NO2S [M+H]+: 172.0427. Found: 172.0426. M.P. = 35 – 36 oC.  
Synthesis of phenyl-di-prop-2-ynyl-amine (265j)[250] 
 
 Procedure (a). From aniline (1.0 mL, 10.97 mmol), K2CO3 (7.6 g, 54.87 mmol), 
propargyl bromide (2.9 mL, 32.92 mmol) and 42.0 mL of dry acetonitrile. Obtained without 
further purification a yellow solid 265j, 1.8 g, 10.40 mmol (95%). 1H NMR (500 MHz, CDCl3, 
25 oC) δ = 7.32 – 7.27 (m, 2H; HAr-6), 7.00 – 6.95 (m, 2H; HAr-5), 6.92 – 6.87 (m, 1H; HAr-7), 
4.13 (d, J = 2.3 Hz, 4H; H-1), 2.25 (t, J = 2.3 Hz, 2H; H-3). This data matched the reported 
for this compound. 
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Synthesis of (4-bromo-phenyl)-di-prop-2-ynyl-amine (265k) 
 
 Procedure (b). From 4-bromoaniline (353 mg, 2.07 mmol), K2CO3 (1.4 g, 10.33 
mmol), propargyl bromide (690 µl, 6.20 mmol) and 17.0 mL of dry acetonitrile. Obtained 
without further purification a yellow solid 265k, 1.8 g, 10.40 mmol (95%). 1H NMR (500 
MHz, CDCl3, 25 oC) δ = 7.40 – 7.35 (m, 2H; HAr-6), 6.87 – 6.78 (m, 2H; HAr-5), 4.09 (d, J = 
2.4 Hz, 4H; H-1), 2.26 (t, J = 2.4 Hz, 2H; H-3). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 146.8 
(Cq; C-4), 132.1 (2 x CHAr; C-6), 117.4 (2 x CHAr; C-5), 112.2 (Cq; C-7), 78.9 (2 x Cq; C-2), 
73.1 (2 x CH; C-3), 40.7 (2 x CH2; C-1). IR (Film, cm-1): ν̃ = 3292 (C≡CH), 3080 (C-HAr), 
3045 (C-HAr), 2926 (C-HAlkane), 2833 (C-HAlkane), 2115 (C≡C), 1592 (C=CAr), 1495, 1227, 1161 
(C-N), 948, 902, 811. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for 
C12H1079BrN [M]+: 246.9991. Found: 246.9994. Calc. for C12H1081BrN [M]+: 248.9971. Found: 
248.9971. Calc. for C12H1179BrN [M+H]+: 248.0025. Found: 248.0070. Calc. for C12H1181BrN 
[M+H]+: 250.0004. Found: 251.0082. 
Synthesis of dimethyl 2,2-di(prop-2-ynyl)malonate (268)[249] 
 
 To a suspension of sodium hydride (NaH) (60% mineral oil, 2.3 g, 57.75 mmol, 2.2 
Eq.) in dry THF (40.0 mL) at 0 oC (ice bath), was added dropwise dimethylmalonate (5.0 mL, 
43.75 mmol, 1.0 Eq., 1.1 M). After 5 min stirring, propargyl bromide (80% in toluene, 7.3 mL, 
65.63 mmol, 2.5 Eq.) was added and the resulting solution was warmed up at room temperature 
and stirred during 17 h. The solution was quenched with NaHCO3(ac) (15 mL) at 0 oC (ice bath), 
extracted with EtOAc (x 3), washed with brine, dried over MgSO4 anhydrous and concentrated 
under vacuum. The product 268 was obtained without further purification as a brown solid 
(5.5 g, 26.25 mmol, 99%). 1H NMR (500 MHz, CDCl3, 25 oC) δ = 3.77 (s, 6H; H-6), 3.01 (d, 
J = 2.6 Hz, 4H; H-1), 2.04 (t, J = 2.6 Hz, 2H; H-3). 13C NMR (101 MHz, CDCl3, 25 oC) δ = 
169.2 (2 x Cq; C-5), 78.4 (2 x Cq; C-2), 71.9 (2 x CH; C-3), 56.6 (Cq; C-4), 53.3 (2 x CH3; C-
6), 22.8 (2 x CH2; C-1). 
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Synthesis of 4,4-bis-methoxymethyl-hepta-1,6-diyne (270)[251] 
 The synthesis was undertaken according to the procedure described by Malacria and 
coworkers.[251] To a suspension of lithium aluminium hydride (LiAlH4) (325 mg, 8.56 mmol, 
3.0 Eq.) in dry Et2O (8.0 mL) at 0 oC (ice bath), was added dimethyl 2,2-di(prop-2-
ynyl)malonate 268 (594 mg, 2.85 mmol, 1.0 Eq., 0.16 M – absolute concentration) dissolved 
in 10.0 mL of dry Et2O under N2. The solution was warmed up at room temperature and stirred 
during 5 h. The excess of LiAlH4 was quenched at 0 °C (ice bath) adding H2O (2.0 mL), an 
aqueous NaOH solution (2.0 mL, 15% w/w), and then H2O (2.0 mL). The white suspension 
was filtered over celite, washed with DCM (20 mL), dried over MgSO4 anhydrous and 
concentrated under vacuum. 2,2-Di-prop-2-ynyl-propane-1,3-diol 269[252] was obtained 
without further purification as a white solid (378 mg, 2.48 mmol, 87%). 1H NMR (500 MHz, 
CDCl3, 25 oC) δ = 3.75 (s, 4H; H-5), 2.38 (d, J = 2.7 Hz, 4H; H-1), 2.05 (t, J = 2.7 Hz, 2H; H-
3). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 80.4 (2 x Cq; C-2), 71.3 (2 x CH; C-3 or CH2; C-
5), 66.8 (2 x CH; C-3 or CH2; C-5), 42.2 (Cq; C-4), 21.9 (2 x CH2; C-1).  
 To a suspension of NaH (60% mineral oil, 219 mg, 5.46 mmol, 2.2 Eq.) in dry THF 
(4.0 mL) at 0 oC (ice bath), was added 2,2-di-prop-2-ynyl-propane-1,3-diol 269 (378 mg, 2.48 
mmol, 1.0 Eq., 0.31 M – absolute concentration) dissolved in dry THF (4.0 mL). After 5 min, 
iodomethane (773 µl, 12.42 mmol, 5.0 Eq.) was added and the resulting solution was stirred 
at room temperature during 6 h. The mixture was quenched with NH4Cl(ac) (5 mL) at 0 oC (ice 
bath), extracted with Et2O (x 3), washed with brine, dried over MgSO4 anhydrous and 
concentrated under vacuum. The product 270 was obtained without further purification as a 
yellow oil (447 mg, 2.48 mmol, 100%). 1H NMR (500 MHz, CDCl3, 25 oC) δ = 3.36 (s, 4H; 
H-5), 3.35 (s, 6H; H-6), 2.35 (d, J = 2.7 Hz, 4H; H-1), 1.98 (t, J = 2.7 Hz, 2H; H-3). 13C NMR 
(126 MHz, CDCl3, 25 oC) δ = 80.9 (2 x Cq; C-2), 73.6 (2 x CH2; C-5), 70.5 (2 x CH; C-3), 59.6 
(2 x CH3; C-6), 41.8 (Cq; C-4), 22.0 (2 x CH2; C-1). 
General procedure for the synthesis of 1,5-bisallenes by microwave-assisted Crabbé 
homologation from bispropargyl derivatives[27b] 
 CuBr (0.6 Eq.) and paraformaldehyde (5.0 Eq.) were added into a oven-dried 
microwave vial under N2. Then the corresponding bispropargylic derivative (1.0 Eq., 0.5 M – 
absolute concentration) was added dissolved in dry 1,4-dioxane, followed by the addition of 
iPr2NH (4.0 Eq.) dropwise under inert atmosphere. The reaction mixture was heated at 150 oC 
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under microwave irradiation during 10 – 20 min until complete conversion, followed by TLC. 
The crude of the reaction was purified by column chromatography over silica gel using Hex 
or PET / Et2O or EtOAc as eluent.   
Synthesis of N,N-di-buta-2,3-dienyl-4-methyl-benzenesulfonamide (204a)[210a, 253] 
 
 From compound 265a (1.6 g, 6.38 mmol), CuBr (549 mg, 3.83 mmol), 
paraformaldehyde (958 mg, 31.88 mmol), iPr2NH (3.6 mL, 25.51 mmol) and 13.0 mL of dry 
1,4-dioxane. Obtained after column chromatography, PET / EtOAc, (7:1), 204a, 1.2 g, 4.46 
mmol (70%): yellow solid. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.72 – 7.68 (m, 2H; HAr-
6), 7.29 (d, J = 8.2 Hz, 2H; HAr-7), 4.97 – 4.90 (m, 2H; H-2), 4.71 (dt, J = 6.6, 2.4 Hz, 4H; H-
4), 3.90 (dt, J = 7.0, 2.4 Hz, 4H; H-1), 2.42 (s, 3H; H-9). 13C NMR (126 MHz, CDCl3, 25 oC) 
δ = 209.8 (2 x Cq; C-3), 143.4 (Cq; C-8), 137.7 (Cq; C-5), 129.8 (2 x CHAr; C-7), 127.3 (2 x 
CHAr; C-6), 85.8 (2 x CH; C-2), 76.3 (2 x CH2; C-4), 45.8 (2 x CH2; C-1), 21.7 (CH3; C-9). 
Synthesis of d4-N,N-di-buta-2,3-dienyl-4-methyl-benzenesulfonamide (204a-d
4) 
 
 From compound 265a (410 mg, 1.66 mmol), CuBr (143 mg, 0.99 mmol), 
paraformaldehyde-d2 (265 mg, 8.28 mmol, 98% D), iPr2NH (928 µl, 6.62 mmol) and 3.3 mL 
of dry 1,4-dioxane. Obtained after column chromatography, PET / EtOAc, (20:1) then (7:1) 
then (4:1): 204a-d4, 284 mg, 1.02 mmol (61%): white solid. 1H NMR (500 MHz, CDCl3, 25 
oC) δ = 7.73 – 7.68 (m, 2H; HAr-8), 7.29 (d, J = 8.2 Hz, 2H; HAr-7), 4.94 (t, J = 7.1 Hz, 2H; H-
2), 4.73 – 4.68 (m, D-5, >90 %D), 3.90 (d, J = 7.1 Hz, 4H; H-1), 2.42 (s, 3H; H-10). 13C NMR 
(126 MHz, CDCl3, 25 oC) δ = 209.9 (2 x Cq; C-3), 143.4 (Cq; C-9), 137.7 (Cq; C-6), 129.8 (2 
x CHAr; C-8), 127.3 (2 x CHAr; C-7), 86.0 (2 x CH; C-2), 45.8 (2 x CH2; C-1), 21.7 (CH3; C-
10). Cq; C-4 could not be found due to deuteration. 2H NMR (77 MHz, CDCl3, 25 oC), δ = 
4.74 (s, 4D; D-5). IR (Film, cm-1): ν̃ = 3079 (C-HAr), 2924 (C-HAlkane), 2865 (C-HAlkane), 1938 
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(C=C=C), 1597 (C=CAr), 1345 (S=O), 1161 (S=O), 1095 (C-N), 941, 814. HRMS (FTMS + p 
NSI ((DCM)/MeOH + NH4OAc)): Calc. for C15H14D4NO2S [M+H]+: 280.1304. Found: 
280.1300. M.P. = 49 – 50 oC. 
Synthesis of N,N-di-buta-2,3-dienyl-benzenesulfonamide (266d) 
 
 From compound 265d (1.0 g, 4.32 mmol), CuBr (372 mg, 2.59 mmol), 
paraformaldehyde (649 mg, 21.61 mmol), iPr2NH (2.4 mL, 17.29 mmol) and 9.0 mL of dry 
1,4-dioxane. Obtained after column chromatography, Hex / EtOAc (12:1): 266d, 707 mg, 2.71 
mmol (63%): yellow solid. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.84 – 7.80 (m, 2H; HAr-
6), 7.60 – 7.54 (m, 1H; HAr-8), 7.53 – 7.48 (m, 2H; HAr-7), 4.99 – 4.89 (m, 2H; H-2), 4.71 (dt, 
J = 6.6, 2.4 Hz, 4H; H-4), 3.92 (dt, J = 6.9, 2.4 Hz, 4H; H-1). 13C NMR (126 MHz, CDCl3, 25 
oC) δ = 209.8 (2 x Cq; C-3), 140.7 (Cq; C-5), 132.7 (CHAr; C-8), 129.2 (2 x CHAr; C-7), 127.3 
(2 x CHAr; C-6), 85.7 (2 x CH; C-2), 76.4 (2 x CH2; C-4), 45.8 (2 x CH2; C-1). IR (Film, cm-
1): ν̃ = 3065 (C-HAr), 2991, 2924 (C-HAlkane), 2862 (C-HAlkane), 1954 (C=C=C), 1342 (S=O), 
1160 (S=O), 1095 (C-N), 851, 749. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): 
Calc. for C14H16NO2S [M+H]+: 262.0896. Found: 262.0897. M.P. = 38 – 40 oC. 
Synthesis of N,N-di-buta-2,3-dienyl-4-nitro-benzenesulfonamide (266c) 
 
 From compound 265c (524 mg, 1.88 mmol), CuBr (162 mg, 1.13 mmol), 
paraformaldehyde (283 mg, 9.43 mmol), iPr2NH (1.1 mL, 7.54 mmol) and 3.8 mL of dry 1,4-
dioxane. Obtained after column chromatography, PET / EtOAc, (30:1) then (7:1) then (4:1): 
266c, 423 mg, 1.38 mmol (73%): yellow solid. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 8.35 
(d, J = 8.9 Hz, 2H; HAr-6), 8.01 (d, J = 8.9 Hz, 2H; HAr-7), 4.96 (p, J = 6.8 Hz, 2H; H-2), 4.74 
(dt, J = 6.8, 2.4 Hz, 4H; H-4), 3.96 (dt, J = 6.8, 2.4 Hz, 4H; H-1). 13C NMR (126 MHz, CDCl3, 
25 oC) δ = 209.9 (2 x Cq; C-3), 150.1 (Cq; C-8), 146.8 (Cq; C-5), 128.5 (2 x CHAr; C-7), 124.5 
(2 x CHAr; C-6), 85.4 (2 x CH; C-2), 76.9 (2 x CH2; C-4), 45.9 (2 x CH2; C-1). IR (Film, cm-
1): ν̃ = 3108 (C-HAr), 2933 (C-HAlkane), 1954 (C=C=C), 1528 (N-O), 1348 (S=O), 1157 (S=O), 
195 
 
1062 (C-N), 855. HRMS (FTMS + p APCI (DCM)): Calc. for C14H15N2O4S [M+H]+: 
307.0747. Found: 301.0748. M.P. = 68 – 69 oC.  
Synthesis of N,N-di-buta-2,3-dienyl-4-methoxy-benzenesulfonamide (266e) 
 
 From compound 265e (596 mg, 2.26 mmol), CuBr (195 mg, 1.36 mmol), 
paraformaldehyde (340 mg, 11.31 mmol), iPr2NH (1.3 mL, 9.04 mmol) and 4.5 mL of dry 1,4-
dioxane. Obtained after column chromatography, Hex / EtOAc, (5:1): 266e, 342 mg, 1.17 
mmol (52%): brown oil. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.78 – 7.72 (m, 2H; HAr-6), 
6.99 – 6.93 (m, 2H; HAr-7), 4.98 – 4.91 (m, 2H; H-2), 4.72 (dt, J = 6.8, 2.4 Hz, 4H; H-4), 3.89 
(dt, J = 6.8, 2.4 Hz, 4H; H-1), 3.87 (s, 3H; H-9). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 209.8 
(2 x Cq; C-3), 162.9 (Cq; C-8), 132.3 (Cq; C-5), 129.4 (2 x CHAr; C-7), 114.3 (2 x CHAr; C-6), 
85.8 (2 x CH; C-2), 76.3 (2 x CH2; C-4), 55.7 (CH3; C-9), 45.8 (2 x CH2; C-1). IR (Film, cm-
1): ν̃ = 3066 (C-HAr), 2941 (C-HAlkane), 2840 (C-HAlkane), 1954 (C=C=C), 1596 (C=CAr), 1498, 
1341 (S=O), 1260 (C-O), 1156 (S=O), 1095 (C-N), 836, 756. HRMS (FTMS + p NSI 
((DCM)/MeOH + NH4OAc)): Calc. for C15H18NO3S [M+H]+: 292.1002. Found: 292.0997. 
Synthesis of N,N-di-buta-2,3-dienyl-4-chloro-benzenesulfonamide (266f) 
 
 From compound 265f (575 mg, 2.07 mmol), CuBr (178 mg, 1.24 mmol), 
paraformaldehyde (310 mg, 10.34 mmol), iPr2NH (1.2 mL, 8.27 mmol) and 4.0 mL of dry 1,4-
dioxane. Obtained after column chromatography, Hex / EtOAc, (6:1): 266f, 318 mg, 1.07 
mmol (52%): white solid. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.79 – 7.73 (m, 2H; HAr-6), 
7.50 – 7.45 (m, 2H; HAr-7), 4.95 (p, J = 6.8 Hz, 2H; H-2), 4.73 (dt, J = 6.8, 2.5 Hz, 4H; H-4), 
3.91 (dt, J = 6.8, 2.5 Hz, 4H; H-1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 209.9 (2 x Cq; C-
3), 139.3 (Cq; C-8), 139.1 (Cq; C-5), 129.5 (2 x CHAr; C-7), 128.8 (2 x CHAr; C-6), 85.6 (2 x 
CH; C-2), 76.6 (2 x CH2; C-4), 45.8 (2 x CH2; C-1). IR (Film, cm-1): ν̃ = 3090 (C-HAr), 2991 
(C-HAlkane), 2925 (C-HAlkane), 2862 (C-HAlkane), 1954 (C=C=C), 1585 (C=CAr), 1476, 1344 
(S=O), 1161 (S=O), 1086 (C-N), 849, 617. HRMS (FTMS + p APCI (DCM)): Calc. for 
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C14H15NO2S35Cl [M+H]+: 296.0507 Found: 296.0504. Calc. for C14H15NO2S37Cl [M+H]+: 
298.0476 Found: 298.0471. M. P. = 37 – 39 oC.  
Synthesis of N,N-di-buta-2,3-dienyl-4-trifluoromethyl-benzenesulfonamide (266g) 
 
 From compound 265g (461 mg, 1.53 mmol), CuBr (132 mg, 0.92 mmol), 
paraformaldehyde (230 mg, 7.66 mmol), iPr2NH (860 µl, 6.13 mmol) and 3.1 mL of dry 1,4-
dioxane. Obtained after column chromatography, PET / EtOAc, (20:1): 266g, 319 mg, 0.97 
mmol (63%): yellow oil. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.95 (d, J = 8.2 Hz, 2H; HAr-
6), 7.77 (d, J = 8.2 Hz, 2H; HAr-7), 4.96 (p, J = 6.7 Hz, 2H; H-2), 4.72 (dt, J = 6.7, 2.4 Hz, 4H; 
H-4), 3.94 (dt, J = 6.7, 2.4 Hz, 4H; H-1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 209.8 (2 x 
Cq; C-3), 144.4 (Cq; C-5), 134.3 (q, JC-F = 33.2 Hz, Cq; C-8), 127.8 (2 x CHAr; C-6), 126.4 (q, 
JC-F = 3.6 Hz, 2 x CHAr-7), 85.5 (2 x CH; C-2), 76.7 (2 x CH2; C-4), 45.8 (2 x CH2; C-1). The 
signal of Cq; CF3 could not be extracted from the spectra.19F NMR (471 MHz, CDCl3, 25 oC) 
δ = - 63.04 (CF3). IR (Film, cm-1): ν̃ = 3107 (C-HAr), 3073 (C-HAr), 2927 (C-HAlkane), 2860 (C-
HAlkane), 1956 (C=C=C), 1348 (S=O), 1166 (S=O), 1134 (C-F), 1063 (C-N), 1017, 846. HRMS 
(FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for C15H15F3NO2S [M+H]+: 330.0770. 
Found: 330.0771.  
Synthesis of N,N-di-buta-2,3-dienyl-methanesulfonamide (266i) 
 
 From compound 265i (1.2 g, 6.91 mmol), CuBr (105 mg, 0.73 mmol), 
paraformaldehyde (230 mg, 6.09 mmol), iPr2NH (3.9 mL, 27.64 mmol) and 13.8 mL of dry 
1,4-dioxane. Obtained after column chromatography, PET / EtOAc, (7:1) then (4:1): 266i, 868 
mg, 4.36 mmol (63%): orange oil. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.14 (p, J = 6.7 Hz, 
2H; H-2), 4.84 (dt, J = 6.7, 2.4 Hz, 4H; H-4), 3.92 (dt, J = 6.7, 2.4 Hz, 4H; H-1), 2.89 (s, 3H; 
H-5). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 209.9 (2 x Cq; C-3), 86.0 (2 x CH; C-2), 76.8 (2 
x CH2; C-4), 45.5 (2 x CH2; C-1), 40.5 (CH3; C-5). IR (Film, cm-1): ν̃ = 2987 (C-HAlkane), 2919 
(C-HAlkane), 2853 (C-HAlkane), 1953 (C=C=C), 1436 (C-HAlkane), 1323 (S=O), 1145 (S=O), 1062 
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(C-N), 961, 844. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for C9H14NO2S 
[M+H]+: 200.0740. Found: 200.0741. 
Synthesis of N,N-di-2,3-butadien-1-yl-benzenamine (260)[212] 
 
 From compound 265j (1.8 g, 10.40 mmol), CuBr (895 mg, 6.24 mmol), 
paraformaldehyde (1.6 g, 51.99 mmol), iPr2NH (5.9 mL, 41.59 mmol) and 13.0 mL of dry 1,4-
dioxane. Obtained after column chromatography, Hex / EtOAc, (13:1): 260, 1.4 g, 7.08 mmol 
(68%): brown oil. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.24 – 7.19 (m, 2H; HAr-7), 6.76 (m, 
2H; HAr-6), 6.71 (t, J = 7.3 Hz, 1H; HAr-8), 5.18 (p, J = 6.6 Hz, 2H; H-2), 4.76 (dt, J = 6.6, 2.8 
Hz, 4H; H-4), 3.98 (dt, J = 6.6, 2.8 Hz, 4H; H-1). 13C NMR (75 MHz, CDCl3, 25 oC) δ = 209.2 
(2 x Cq; C-3), 148.0 (Cq; C-5), 129.2 (2 x CHAr; C-7), 117.0 (CHAr; C-8), 113.2 (2 x CHAr; C-
6), 87.1 (2 x CH; C-2), 76.2 (2 x CH2; C-4), 49.6 (2 x CH2; C-1). 
Synthesis of (4-bromo-phenyl)-di-buta-2,3-dienyl-amine (266k) 
 
 From compound 265k (247 mg, 1.00 mmol), CuBr (86 mg, 0.60 mmol), 
paraformaldehyde (150 mg, 5.00 mmol), iPr2NH (560 µl, 4.00 mmol) and 2.0 mL of dry 1,4-
dioxane. Obtained after column chromatography, Hex / EtOAc, (40:1) then (10:1): 266k, 163 
mg, 0.59 mmol (60%): yellow oil. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.30 – 7.26 (m, 2H; 
HAr-7), 6.64 – 6.58 (m, 2H; HAr-6), 5.14 (p, J = 6.2 Hz, 2H; H-2), 4.80 – 4.72 (m, 4H; H-4), 
3.94 (dt, J = 6.2, 2.9 Hz, 4H; H-1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 209.1 (2 x Cq; C-
3), 147.1 (Cq; C-5), 131.9 (2 x CHAr; C-7), 114.8 (2 x CHAr; C-6), 108.8 (Cq; C-8), 86.8 (2 x 
CH; C-2), 76.6 (2 x CH2; C-4), 49.7 (2 x CH2; C-1). IR (Film, cm-1): ν̃ = 3060 (C-HAr), 2987 
(C-HAlkane), 2924 (C-HAlkane), 2870 (C-HAlkane), 1953 (C=C=C), 1591 (C=CAr), 1497 (C-HAlkane), 
1353, 1222, 847. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for C14H15N79Br 
[M+H]+: 276.0382. Found: 276.0380. Calc. for C14H15N81Br [M+H]+: 278.0358. Found: 
276.0358.  
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Synthesis of 2,2-di-2,3-butadien-1-yl-1,3-dimethyl malonate (204b)[41] 
 
 From compound 268 (600 mg, 2.88 mmol), CuBr (248 mg, 1.73 mmol), 
paraformaldehyde (433 mg, 14.42 mmol), iPr2NH (1.6 mL, 11.53 mmol) and 5.8 mL of dry 
1,4-dioxane. Obtained after column chromatography, PET / EtOAc, (20:1) then (6:1): 204b, 
226 mg, 1.08 mmol (38%): yellow oil. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 4.93 (tt, J = 8.0, 
6.7 Hz, 2H; H-2), 4.66 (dt, J = 6.7, 2.4 Hz, 4H; H-4), 3.72 (s, 6H; H-7), 2.64 (dt, J = 8.0, 2.4 
Hz, 4H; H-1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 210.2 (2 x Cq; C-3), 171.1 (2 x Cq; C-
6), 84.2 (2 x CH; C-2), 74.8 (2 x CH2; C-4), 58.0 (Cq; C-5), 52.6 (2 x CH3; C-7), 32.1 (2 x 
CH2; C-1).  
Synthesis of 5,5-bis-methoxymethyl-nona-1,2,7,8-tetraene (271) 
 
 From 4,4-bis-methoxymethyl-hepta-1,6-diyne 270 (447 mg, 2.48 mmol), CuBr (214 
mg, 1.49 mmol), paraformaldehyde (373 g, 12.40 mmol), iPr2NH (1.4 mL, 9.92 mmol) and 5.0 
mL of dry 1,4-dioxane. Obtained after column chromatography, PET / EtOAc, (30:1): 271, 
108 mg, 0.52 mmol (21%): yellow oil. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.05 (tt, J = 8.2, 
6.7 Hz, 2H; H-2), 4.62 (dt, J = 6.7, 2.4 Hz, 4H; H-4), 3.31 (s, 6H; H-7), 3.21 (s, 4H; H-6), 2.04 
(dt, J = 8.2, 2.4 Hz, 4H; H-1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 210.1 (2 x Cq; C-3), 
85.3 (2 x CH; C-2), 74.9 (2 x CH2; C-4 or C-6), 73.7 (2 x CH2; C-4 or C-6), 59.4 (2 x CH3; C-
7), 42.7 (Cq; C-5), 31.6 (2 x CH2; C-1). IR (Film, cm-1): ν̃ = 2983 (C-HAlkane), 2923 (C-HAlkane), 
2890 (C-HAlkane), 2855 (C-HAlkane), 1955 (C=C=C), 1735, 1459 (C-HAlkane), 1107 (C-O), 967, 
840. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for C13H21O2 [M+H]+: 
209.1536. Found: 209.1536. 
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Synthesis of bis(2,3-butadienyl) ether (259)[210, 254] 
 
 From compound 267 (600 µl, 6.97 mmol), CuBr (600 mg, 4.19 mmol), 
paraformaldehyde (1.0 g, 34.88 mmol), iPr2NH (3.9 mL, 27.90 mmol) and 14.0 mL of dry 1,4-
dioxane. Obtained after column chromatography, PET / Et2O, (20:1): 259, 783 mg, 6.41 mmol 
(92%): yellow liquid. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.24 (p, J = 6.8 Hz, 2H; H-2), 
4.79 (dt, J = 6.8, 2.4 Hz, 4H; H-4), 4.04 (dt, J = 6.8, 2.4 Hz, 4H; H-1). 13C NMR (126 MHz, 
CDCl3, 25 oC) δ = 209.5 (2 x Cq; C-3), 87.7 (2 x CH; C-2), 75.8 (2 x CH2; C-4), 67.7 (2 x CH2; 
C-1).  
Synthesis of 4-methyl-N,N-bis-(4-methyl-penta-2,3-dienyl)-benzenesulfonamide (293) 
 
 The synthesis was undertaken according to the procedure described by Ma and co-
workers.[29] To a flame-dried Schlenk tube CdI2 (1.2 g, 3.24 mmol, 1.6 Eq.) was added inside 
a globe box. Then the Schlenk was taken out the globe box and dried under vacuum with a 
flame until the white CdI2 turned to yellow-green and allow to cool down. 4-Methyl-N,N-di-
prop-2-ynyl-benzenesulfonamide 265a (500 mg, 2.02 mmol, 1.0 Eq., 0.24 M) dissolved dry 
toluene (8.3 mL), dry acetone (327 µl, 4.45 mmol, 2.2 Eq.) and pyrrolidine (372 µl, 4.45 mmol, 
2.2 Eq.) were added sequentially under N2 flow. The Schlenk tube was then equipped with a 
condenser and placed in a pre-heated oil bath at 130 oC during 4 h. After cooled down, the 
reaction mixture was filtered through a pad of celite / silica gel (1:1), washed with Et2O (30 
mL) and concentrated under vacuum. The crude of the reaction was purified by column 
chromatography over silica gel using Hex / Et2O as eluent. 110 mg, 0.36 mmol was obtained 
of 293 as a white solid (18%). 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.71 (d, J = 8.2 Hz, 2H; 
HAr-8), 7.27 (d, J = 8.2 Hz, 2H; HAr-9), 4.81 – 4.74 (m, 2H; H-2), 3.81 (d, J = 6.9 Hz, 4H; H-
1), 2.41 (s, 3H; H-11), 1.64 (d, J = 2.8 Hz, 12H; H-5 and H-6). 13C NMR (126 MHz, CDCl3, 
25 oC) δ = 203.6 (2 x Cq; C-3), 143.1 (Cq; C-10), 138.2 (Cq; C-7), 129.8 (2 x CHAr; C-9), 127.3 
(2 x CHAr; C-8), 96.6 (2 x Cq; C-4), 84.4 (2 x CH; C-2), 46.1 (2 x CH2; C-1), 21.6 (CH3; C-
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11), 20.5 (4 x CH3; C-5 and C-6). IR (Film, cm-1): ν̃ = 3098 (C-HAr), 3065 (C-HAr), 2986 (C-
HAlkane), 2924 (C-HAlkane), 2856 (C-HAlkane), 1975 (C=C=C), 1736, 1603 (C=CAr), 1446 (C-
HAlkane), 1346 (S=O), 1162 (S=O), 1100 (C-N), 984, 902, 817. HRMS (FTMS + p NSI 
((DCM)/MeOH + NH4OAc)): Calc. for C19H25NO2SNa [M+Na]+: 354.1498. Found: 354.1500. 
M.P. = 45 – 46 oC.  
Synthesis of N-(buta-2,3-dienyl)-4-methylphenylsulfonamide (276)[255] 
 To a suspension of p-toluensulfonamide 272 (4.0 g, 23.36 mmol, 1.0 Eq., 0.41 M – 
absolute concentration) in dry THF (37.0 mL) was added dropwise NEt3 (3.9 mL, 28.04 mmol, 
1.2 Eq.) and N,N-dimethylaminopyridine (DMAP) (57 mg, 0.47 mmol, 0.02 Eq.) under N2. 
Then, di-tert-butyl dicarbonate (5.1 g, 23.36 mmol, 1.0 Eq.) dissolved in dry THF (20.0 mL) 
was added dropwise. The white suspension was stirred at room temperature during 17 h. The 
mixture was then quenched with a solution of HCl (20 mL, 0.2 M) at 0 oC (ice bath), and the 
product was extracted with EtOAc (x 3), washed with H2O, brine (x 2), dried over MgSO4 
anhydrous and concentrated under vacuum. N-[(4-methylphenyl)sulfonyl]-,1,1-dimethylethyl 
ester carbamic acid 273[256] was obtained without further purification (6.0 g, 22.09 mmol, 
95%): white solid. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.90 (d, J = 8.2 Hz, 2H; HAr-5), 7.34 
(d, J = 8.2 Hz, 2H; HAr-6), 7.10 (bs, 1H; NH), 2.45 (s, 3H; H-8), 1.39 (s, 9H; H-3). 13C NMR 
(126 MHz, CDCl3, 25 oC) δ = 149.1 (Cq; C-1), 144.9 (Cq; C-7), 136.0 (Cq; C-4), 129.7 (2 x 
CHAr; C-6), 128.4 (2 x CHAr; C-5), 84.2 (Cq; C-2), 28.0 (3 x CH3; C-3), 21.8 (CH3; C-8). 
 To a suspension of K2CO3 (4.3 g, 31.33 mmol, 2.5 Eq.) in dry MeCN (40.0 mL) was 
added 273, (3.4 g, 12.53 mmol, 1.0 Eq., 0.19 M – absolute concentration) dissolved in dry 
MeCN (27.0 mL) under N2. The solution was stirred at room temperature for 3 min and then 
propargyl bromide (80% in toluene, 1.8 mL, 16.29 mmol, 1.3 Eq.) was added dropwise. The 
reaction mixture was refluxed at 95 oC during 20 h. The solution was quenched with H2O at 0 
oC (ice bath), extracted with Et2O (x 3), washed with brine, dried over MgSO4 anhydrous and 
concentrated under vacuum. N-[(4-methylphenyl)sulfonyl]-N-2-propyn-1-yl-,1,1-
dimethylethyl ester carbamic acid 274[257] was obtained without further purification (3.0 g, 
201 
 
9.74 mmol, 78%): brown solid. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.93 – 7.88 (m, 2H; 
HAr-8), 7.31 (d, J = 8.2 Hz, 2H; HAr-9), 4.63 (d, J = 2.4 Hz, 2H; H-1), 2.44 (s, 3H; H-11), 2.32 
(t, J = 2.4 Hz, 1H; H-3), 1.35 (s, 9H; H-6). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 150.3 (Cq; 
C-4), 144.6 (Cq; C-10), 136.7 (Cq; C-7), 129.4 (2 x CHAr; C-9), 128.4 (2 x CHAr; C-8), 85.1 
(Cq; C-2), 79.0 (Cq; C-5), 72.2 (CH; C-3), 35.8 (CH2; C-1), 28.0 (3 x CH3; C-6), 21.8 (CH3; 
C-11). IR (Film, cm-1): ν̃ = 3285 (C≡CH), 3094 (C-HAr), 2983 (C-HAlkane), 2936 (C-HAlkane), 
2132 (C≡C), 1732 (C=O), 1598 (C=CAr), 1360 (S=O), 1312 (t-Bu), 1280 (C-O), 1156 (S=O), 
1071 (C-N), 913, 847. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for 
C15H19NO4SNa [M+Na]+: 332.0927. Found: 332.0924. M.P. = 70 – 72 oC.  
 CuBr (335 mg, 2.34 mmol, 0.3 Eq.) and paraformaldehyde (585 mg, 19.47 mmol, 2.5 
Eq.) were added into a oven-dried microwave vial under N2. Then the compound 274 (2.4 g, 
7.79 mmol, 1.0 Eq., 0.5 M) dissolved in 15.6 mL of dry 1,4-dioxane and dry iPr2NH (2.2 mL, 
15.58 mmol, 2.0 Eq.) were added sequentially dropwise under inert atmosphere. The reaction 
mixture was heated at 150 oC under microwave irradiation during 15 min. The product 275[255] 
was purified by column chromatography over silica gel using PET / EtOAc (7:1) as eluent. 1.6 
g, 5.09 mmol was obtained as a yellow oil (65%). 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.84 
– 7.80 (m, 2H; HAr-9), 7.33 – 7.28 (m, 2H; HAr-10), 5.29 (p, J = 6.4 Hz, 1H; H-2), 4.79 (dt, J 
= 6.4, 2.7 Hz, 2H; H-4), 4.46 (dt, J = 6.4, 2.7 Hz, 2H; H-1), 2.44 (s, 3H; H-12), 1.36 (s, 9H; 
H-7).13C NMR (126 MHz, CDCl3, 25 oC) δ = 209.2 (Cq; C-3), 150.8 (Cq; C-5), 144.3 (Cq; C-8 
or C-11), 137.4 (Cq; C-8 or C-11), 129.3 (2 x CHAr; C-10), 128.3 (2 x CHAr; C-9), 87.5 (CH; 
C-2), 84.4 (CH2; C-4), 67.2 (CH2; C-1), 45.3 (Cq; C-6), 28.0 (CH3; C-12), 21.8 (3 x CH3; C-
7). 
 The deprotection step was undertaken according to the procedure described by Gore 
and coworkers.[258] To a solution of 275 (1.6 g, 5.10 mmol, 1.0 Eq.) in MeOH (3.1 mL, 15.0 
Eq.) was added dropwise trimethylsilyl chloride (TMSCl) (9.7 mL, 76.44 mmol, 15.0 Eq.) and 
stirred for 37 h at room temperature. Then, the reaction was quenched with NaHCO3(aq) (50 
mL), extracted with DCM (x 3), washed with NaHCO3(aq), brine, dried over MgSO4 anhydrous 
and concentrated under vacuum. The resulting crude was purified by column chromatography 
over silica gel using PET / EtOAc (4:1) as eluent. 970 mg, 4.35 mmol was obtained as a white 
solid 276 (86%).[37] 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.75 (d, J = 8.2 Hz, 2H; HAr-6), 
7.31 (d, J = 8.2 Hz, 2H; HAr-7), 5.07 (p, J = 6.6 Hz, 1H; H-2), 4.77 (dt, J = 6.6, 3.3 Hz, 2H; H-
4), 4.46 (bs, 1H; NH), 3.63 – 3.56 (m, 2H; H-1), 2.43 (s, 3H; H-9). 13C NMR (126 MHz, 
CDCl3, 25 oC) δ = 208.1 (Cq; C-3), 143.7 (Cq; C-8), 137.2 (Cq; C-5), 129.9 (2 x CHAr; C-7), 
127.3 (2 x CHAr; C-6), 87.3 (CH; C-2), 78.3 (CH2; C-4), 41.5 (CH2; C-1), 21.7 (CH3; C-9). 
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Synthesis of N-buta-2,3-dienyl-4-methyl-N-(1-methyl-buta-2,3-dienyl)-
benzenesulfonamide (283)[222, 259] 
 CF3COOH (2.1 mL, 27.80 mmol, 4.3 Eq.) was added dropwise to a solution of 274 
(2.0 g, 6.46 mmol, 1.0 Eq., 0.65 M) in 10.0 mL of DCM at 0 oC (ice bath). The resulting 
solution was warmed up to room temperature and stirred during 2 h. The reaction was 
quenched with NaHCO3(aq), extracted with EtOAc (x 3), washed with  NaHCO3(aq) (20 mL), 
brine (20 mL), dried over MgSO4 anhydrous, and concentrated under vacuum. The crude was 
purified by column chromatography over silica gel using Hex / EtOAc (6:1) as eluent. 4-
methyl-N-2-propyn-1-yl-benzenesulfonamide 281[257] was obtained as a white solid (1.2 g, 
5.62 mmol, 87%). 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.80 – 7.75 (m, 2H; HAr-5), 7.34 – 
7.29 (m, 2H; HAr-6), 4.51 (bt, J = 5.3 Hz, 1H; NH), 3.84 (dd, J = 6.1, 2.5 Hz, 2H; H-1), 2.44 
(s, 3H; H-8), 2.11 (t, J = 2.5 Hz, 1H; H-3). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 144.0 (Cq; 
C-7), 136.7 (Cq; C-4), 129.9 (2 x CHAr; C-6), 127.6 (2 x CHAr; C-5), 78.1 (Cq; C-2), 73.2 (CH; 
C-3), 33.1 (CH2; C-1), 21.7 (CH3; C-8). 
 K2CO3 (668 mg, 4.83 mmol, 2.5 Eq.) and 281 (404 mg, 1.93 mmol, 1.0 Eq., 0.23 M) 
were added into a vacuum-dried microwave vial under N2. Then, 8.4 mL of dry MeCN were 
added and the suspension was stirred at room temperature for 3 min. 3-Bromo-1-butyne (279 
µl, 2.90 mmol, 1.5 Eq.) was added dropwise under N2. The vial was sealed under N2 and the 
reaction mixture was heated under microwave irradiation at 125 oC during 3 h. The crude was 
quenched with H2O at 0 oC (ice bath), extracted with Et2O (x 3), washed with brine, dried over 
MgSO4 anhydrous and concentrate under vacuum. The product 282[260] was obtained without 
further purification as a brown solid (504 mg, 1.93 mmol, 100%). 1H NMR (500 MHz, CDCl3, 
25 oC) δ = 7.79 – 7.74 (m, 2H; HAr-9), 7.29 (d, J = 8.2 Hz, 2H; HAr-10), 4.89 (qd, J = 7.1, 2.3 
Hz, 1H; H-1), 4.21 (dd, J = 18.4, 2.3 Hz, 1H; H-4), 4.01 (dd, J = 18.4, 2.5 Hz, 1H; H-4), 2.42 
(s, 3H; H-12), 2.22 (d, J = 2.3 Hz, 1H; H-3), 2.21 (t, J = 2.3 Hz, 1H; H-6), 1.54 (d, J = 7.1 Hz, 
3H; H-7). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 143.8 (Cq; C-11), 136.5 (Cq; C-8), 129.7 (2 
x CHAr; C-10), 127.8 (2 x CHAr; C-9), 81.0 (Cq; C-2 or C-5), 80.0 (Cq; C-2 or C-5), 73.9 (CH; 
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C-3), 72.6 (CH; C-6), 46.3 (CH; C-1), 33.6 (CH2; C-4), 22.1 (CH3; C-7), 21.7 (CH3; C-12). IR 
(Film, cm-1): ν̃ = 3286 (C≡CH), 3069 (C-HAr), 3039 (C-HAr), 2987 (C-HAlkane), 2932 (C-
HAlkane), 2864 (C-HAlkane), 2125 (C≡C), 1600 (C=CAr), 1339 (S=O), 1157 (S=O), 1106 (C-N), 
1037, 896. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for C14H16NO2S [M]+: 
262.0896. Found: 262.0892. 
 CuBr (166 mg, 1.16 mmol, 0.6 Eq.) and paraformaldehyde (290 mg, 9.65 mmol, 5.0 
Eq.) were added into a oven-dried microwave vial under N2. Then 282 (504 mg, 1.93 mmol, 
1.0 Eq., 0.5 M) dissolved in 3.9 mL of dry 1,4-dioxane and dry iPr2NH (1.1 mL, 7.72 mmol, 
4.0 Eq.) were added dropwise under inert atmosphere. The reaction mixture was heated at 150 
oC under microwave irradiation during 10 min. The crude of the reaction was purified by 
column chromatography over silica gel using PET / EtOAc (20:1) then (7:1) as eluent. 309 
mg, 1.07 mmol was obtained as an orange oil 283 (55%).[222, 259] 1H NMR (500 MHz, CDCl3, 
25 oC) δ = 7.74 – 7.70 (m, 2H; HAr-11), 7.28 (d, J = 8.2 Hz, 2H; HAr-12), 5.23 – 5.15 (m, 1H; 
H-6), 4.98 – 4.93 (m, 1H; H-2), 4.79 – 4.74 (m, 2H; H-4), 4.74 – 4.70 (m, 2H; H-8), 4.66 – 
4.58 (m, 1H; H-1), 3.88 (ddt, J = 15.8, 6.0, 2.8 Hz, 1H; H-5), 3.74 (ddt, J = 15.8, 7.3, 2.4 Hz, 
1H; H-5), 2.42 (s, 3H; H-14), 1.22 (d, J = 6.9 Hz, 3H; H-9). 13C NMR (126 MHz, CDCl3, 25 
oC) δ = 208.8 (Cq; C-3 or C-7), 208.7 (Cq; C-3 or C-7), 143.3 (Cq; C-13), 138.3 (Cq; C-10), 
129.7 (2 x CHAr; C-12), 127.3 (2 x CHAr; C-11), 91.9 (CH; C-2), 89.5 (CH; C-6), 77.8 (CH2; 
C-4), 76.3 (CH2; C-8), 51.8 (CH; C-1), 42.8 (CH2; C-5), 21.6 (CH3; C-14), 18.8 (CH3; C-9). 
Synthesis of (1-buta-2,3-dienyloxy-buta-2,3-dienyl)-dibenzene (289) 
 
 To a solution of ethynyltrimethylsilane (980 µl, 6.79 mmol, 1.5 Eq.) in dry THF (10.0 
mL) at -78 °C (dry ice / acetone) was added n-Buli (2.5 M in hexane, 2.7 mL, 6.78 mmol, 1.5 
Eq.), and the mixture was stirred during 30 min at this temperature. Then, benzophenone (824 
mg, 4.52 mmol, 1.0 Eq., 0.23 M – absolute concentration) dissolved in dry THF (10.0 mL) 
was added dropwise to the flask under N2 and stirred at - 78 °C for 30 min. The solution was 
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warmed up at room temperature and stirred for 20 h. The reaction was quenched with H2O, 
extracted with Et2O (x 3), washed with brine, dried with MgSO4 anhydrous and concentrated 
under vacuum. The product 286[261] was obtained without further purification as a yellow oil 
(1.0 g, 3.61 mmol, 80%). 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.63 – 7.59 (m, 4H; HAr-6), 
7.35 – 7.30 (m, 4H; HAr-7), 7.29 – 7.23 (m, 2H; HAr-8), 2.84 (bs, 1H; OH), 0.23 (s, 9H; H-4). 
13C NMR (126 MHz, CDCl3, 25 oC) δ = 144.9 (2 x Cq; C-5), 128.4 (4 x CHAr; C-6 or C-7), 
127.8 (2 x CHAr; C-8), 126.1 (4 x CHAr; C-6 or C-7), 107.8 (Cq; C-2), 92.1 (Cq; C-1), 74.8 (Cq; 
C-3), 0.00 (3 x CH3; C-4). 
 To a solution of 286 (1.0 g, 4.63 mmol, 1.0 Eq., 0.33 M – absolute concentration) in 
THF (7.0 mL) at 0 oC (ice bath) was added dropwise a solution TBAF . 3H2O in THF (7.0 mL). 
The mixture was stirred at 0 oC (ice bath) during 1 h 30 min. The crude was concentrated under 
vacuum and the product was purified by column chromatography over silica gel using Hex / 
EtOAc, (6:1) then (2:1): 287[262] 962 mg, 4.62 mmol (100%): orange solid. 1H NMR (400 
MHz, CDCl3, 25 oC) δ = 7.64 – 7.59 (m, 4H; HAr-5), 7.38 – 7.32 (m, 4H; HAr-6), 7.31 – 7.26 
(m, 2H; HAr-7), 2.89 (s, 1H; H-3), 2.78 (s, 1H; OH). 13C NMR (101 MHz, CDCl3, 25 oC) δ = 
144.5 (2 x Cq; C-4), 128.5 (4 x CHAr; C-6), 128.0 (2 x CHAr; C-7), 126.1 (4 x CHAr; C-5), 86.5 
(Cq; C-2), 75.7 (CH; C-3), 74.5 (Cq; C-1). 
 To a suspension of NaH (60% mineral oil, 164 mg, 4.11 mmol, 1.4 Eq.) in dry THF 
(8.0 mL) at 0 oC (ice bath) was added 287 (611 mg, 2.93 mmol, 1.0 Eq., 0.21 M – absolute 
concentration) dissolved in dry THF (6.0 mL). After 10 min, propargyl bromide (80% in 
toluene, 490 µl, 4.40 mmol 1.5 Eq.) was added and the resulting solution was stirred at room 
temperature during 17 h. The mixture was quenched with NH4Cl(aq) (10 mL) at 0 oC (ice bath), 
extracted with Et2O (x 3), washed with brine, dried over MgSO4 anhydrous and concentrated 
under vacuum. The product 288 was purified by column chromatography over silica gel using 
Hex / EtOAc, (90:1) then (15:1), (300 mg, 1.22 mmol, 42%): yellow oil. 1H NMR (500 MHz, 
CDCl3, 25 oC) δ = 7.58 – 7.55 (m, 4H; HAr-8), 7.35 – 7.30 (m, 4H; HAr-9), 7.29 – 7.25 (m, 2H; 
HAr-10), 4.19 (d, J = 2.5 Hz, 2H; H-1), 2.94 (s, 1H; H-6), 2.42 (t, J = 2.5 Hz, 1H; H-3). 13C 
NMR (126 MHz, CDCl3, 25 oC) δ = 142.3 (2 x Cq; C-7), 128.4 (4 x CHAr; C-9), 128.2 (2 x 
CHAr; C-10), 126.8 (4 x CHAr; C-8), 82.5 (Cq; C-2 or C-5), 80.2 (Cq; C-2 or C-5), 78.6 (Cq, C-
3 or C-6), 74.0 (Cq, C-3 or C-6), 53.5 (CH2; C-1). IR (Film, cm-1): ν̃ = 3290 (C≡CH), 3068 (C-
HAr), 3033 (C-HAr), 2963 (C-HAlkane), 2914 (C-HAlkane), 2866 (C-HAlkane), 2118 (C≡C), 1489, 
1261 (C-O), 1027 (C-O), 867. HRMS (FTMS + p APCI (OIL + NH4OAc)): Calc. for C18H14O 
[M]+: 246.1039. Found: 246.1035. Calc. for C18H13O [M-H]+: 245.0961. Found: 245.0957. 
Calc. for C18H15O [M+H]+: 247.1117. Found: 247.1114. 
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 CuBr (105 mg, 0.73 mmol, 0.6 Eq.) and paraformaldehyde (230 mg, 6.09 mmol, 5.0 
Eq.) were added into a oven-dried microwave vial under N2. Then compound 288 (300 mg, 
1.22 mmol, 1.0 Eq., 0.5 M) dissolved in 2.5 mL of dry 1,4-dioxane and dry iPr2NH (683 µl, 
4.87 mmol, 4.0 Eq.) were added sequentially dropwise under inert atmosphere. The reaction 
mixture was heated at 150 oC under microwave irradiation during 10 min. The crude of the 
reaction was purified by column chromatography over silica gel using Hex / EtOAc (20:1) as 
eluent. (1-Prop-2-ynyloxy-prop-2-ynyl)-bis(benzene) 289,[255] was obtained as a yellow oil 
(114 mg, 0.41 mmol, 34%). 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.45 – 7.41 (m, 4H; HAr-
10), 7.32 – 7.28 (m, 4H; HAr-11), 7.25 – 7.20 (m, 2H; HAr-12), 5.83 (t, J = 6.7 Hz, 1H; H-6), 
5.32 (p, J = 6.6 Hz, 1H; H-2), 4.79 (d, J = 6.7 Hz, 2H; H-8), 4.79 (dt, J = 6.6, 2.8 Hz, 2H; H-
4), 3.94 (dt, J = 6.6, 2.8 Hz, 2H; H-1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 209.0 (Cq; C-3 
or C-7), 208.8 (Cq; C-3 or C-7), 144.5 (2 x Cq; C-9), 128.0 (4 x CHAr; C-11), 127.5 (4 x CHAr; 
C-10), 127.3 (2 x CHAr; C-12), 95.3 (CH; C-6), 88.9 (CH; C-2), 83.6 (Cq; C-5), 78.2 (CH2; C-
8), 76.0 (CH2; C-4), 62.3 (CH2; C-1). IR (Film, cm-1): ν̃ = 3060 (C-HAr), 3032 (C-HAr), 2926 
(C-HAlkane), 2861 (C-HAlkane), 1959 (C=C=C), 1661 (C=CAr), 1450 (C-HAlkane), 1053, 1032 (C-
O), 851. HRMS (FTMS + p APCI (OIL + NH4OAc)): Calc. for C20H19O [M+H]+: 275.1430. 
Found: 275.1426. 
Synthesis of 4-methyl-penta-2,3-dien-1-ol (285)[263] 
 
 This synthesis was undertaken according to the procedure described by Poli and co-
workers.[263c] p-Toluenesulfonic acid monohydrate (p-TsOH) (571 mg, 3.0 mmol, 0.01 Eq.) 
and 300 mL of dry DCM were added to a 500 mL round bottom flask under inert atmosphere. 
The temperature was cooled down at 0 oC (ice bath) and 2-methyl-3-butyn-2-ol (29.0 mL, 300 
mmol, 1.0 Eq., 1.0 M) was added. The mixture was stirred at 0 oC during 5 min. Then 3,4-
dihydro-2H-pyran (30.0 mL, 330 mmol, 1.1 Eq.) was added neat dropwise at 0 oC. The reaction 
mixture was stirred at the same temperature during 5 h. The solution was quenched with a 
saturated solution of NaHCO3(aq) at 0 oC, extracted with DCM (x 3), washed with brine, dried 
over MgSO4 anhydrous and concentrated under vacuum. The crude was purified by column 
chromatography over silica gel using Hex / Et2O (90:1) then (20:1) as eluent. Compound 
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333[263c] was obtained as a colourless oil (28.9 g, 145.7 mmol, 49%). 1H NMR (500 MHz, 
CDCl3, 25 oC) δ = 5.06 (dd, J = 5.0, 3.4 Hz, 1H; H-6), 4.00 – 3.90 (m, 1H; H-10), 3.56 – 3.45 
(m, 1H; H-10), 2.43 (s, 1H; H-1), 1.90 – 1.78 (m, 1H; H-9), 1.77 – 1.66 (m, 1H; H-7), 1.60 – 
1.51 (m, 4H; 1 x H-7, 2 x H-8 and 1 x H-9), 1.54 (s, 3H; H-4 or H-5), 1.50 (s, 3H; H-4 or H-
5). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 96.3 (CH; C-6), 86.5 (Cq; C-2), 72.0 (CH; C-1), 
71.0 (Cq; C-3), 63.5 (CH2; C-10), 32.0 (CH2; C-7), 30.7 (CH3; C-4 or C-5), 29.9 (CH3; C-4 or 
C-5), 25.5 (CH2; C-8), 20.6 (CH2; C-9).  
 Compound 333 (6.0 g, 35.66 mmol, 1.0 Eq., 1.1 M) was added dissolved in 33.0 mL 
of dry Et2O into a flame-dried Schlenk flask under N2. The solution was stirred during 5 min 
at - 78 oC (dry ice / acetone). Then n-Buli (16.0 mL, 39.23 mmol, 1.1 Eq.) was added 
cautiously, maintaining the temperature under - 60 oC during the addition. The reaction 
mixture was stirred at - 78 oC during 45 min. Then, paraformaldehyde (3.21 g, 106.99 mmol, 
3.0 Eq.) was added in small portions under N2. After 15 min the solution was warmed up at 
room temperature and stirred until complete conversion, following the reaction by TLC. The 
reaction was quenched with H2O at 0 oC, extracted with Et2O (x 3), washed with brine, dried 
over MgSO4 anhydrous and concentrated under vacuum. The product was purified by column 
chromatography over silica gel using Hex / Et2O (4:1) then (2:1) as eluent. Compound 284[263c, 
264] was obtained as a colourless oil (7.0 g, 35.31 mmol, 99%). 1H NMR (500 MHz, CDCl3, 25 
oC) δ = 5.05 (dd, J = 4.9, 3.3 Hz, 1H; H-7), 4.28 (s, 2H; H-1), 3.98 – 3.89 (m, 1H; H-11), 3.55 
– 3.44 (m, 1H; H-11), 2.34 (bs, 1H; OH), 1.89 – 1.75 (m, 1H; H-10), 1.75 – 1.64 (m, 1H; H-
8), 1.57 – 1.49 (m, 4H; 1 x H-8, 2 x H-9 and 1 x H-10), 1.52 (s, 3H; H-5 or H-6), 1.47 (s, 3H; 
H-5 or H-6). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 95.9 (CH; C-7), 88.0 (Cq; C-3), 82.5 (Cq; 
C-2), 71.0 (Cq; C-4), 63.2 (CH2; C-11), 51.1 (CH2; C-1), 32.0 (CH2; C-8), 30.6 (CH3; C-5 or 
C-6), 30.0 (CH3; C-5 or C-6), 25.5 (CH2; C-9), 20.3 (CH2; C-10). 
 Compound 284 (7.8 g, 39.40 mmol, 1.0 Eq., 0.21 M) dissolved in dry Et2O (67.0 mL) 
was added dropwise under N2 to a flame-dried round bottom flask with a suspension of LiAlH4 
(4.5 g, 118.20 mmol, 3.0 Eq.) in dry Et2O (120.0 mL) at 0 °C (ice bath). Then the solution was 
warmed up at room temperature and stirred during 6 h, followed by TLC. The excess of LiAlH4 
was quenched at 0 °C adding H2O (4.0 mL), an aqueous NaOH solution (4.0 mL, 15 % w/w), 
and then H2O (8.0 mL). The white suspension was filtered on celite, and washed with Et2O 
(100 mL). The organic layer was dried over MgSO4 anhydrous and concentrated under 
vacuum. The product was purified by column chromatography over silica gel using Hex / Et2O 
(10:1) then (4:1) as eluent. The compound 285 was obtained as a yellow-pale oil (2.4 g, 24.92 
mmol, 63%). 1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.23 – 5.15 (m, 1H; H-1), 4.07 (d, J = 5.6 
Hz, 2H; H-6), 1.72 (d, J = 2.6 Hz, 6H; H-4 and H-5), 1.42 (bs, 1H; OH). 13C NMR (126 MHz, 
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CDCl3, 25 oC) δ = 200.6 (Cq; C-2), 90.0 (CH; C-1), 61.1 (CH2; C-6), 20.7 (2 x CH3; C-4 and 
C-5). 
Synthesis of N-(buta-2,3-dienyl)-N-(4-methylpenta-2,3-dienyl) 4-tolylsulfonamide 
(207)[265] 
 The synthesis was undertaken according to the procedure described by Chung and co-
workers.[222] To a flame-dried Schlenk flask were added sequentially 5.0 mL of dry THF, 
diisopropyl azadicarboxilate (DIAD) (208 µl, 1.05 mmol, 1.1 Eq.) and triphenylphosphine 
(PPh3) (277 mg, 1.05 mmol, 1.1 Eq.) under N2 flow. The yellow suspension was stirred 15 min 
at room temperature. Then compound 276 (214 mg, 0.96 mmol, 1.0 Eq., 0.1 M – absolute 
concentration) and allenol 285 (94 mg, 0.96 mmol, 1.0 Eq.) were added dissolved in dry THF 
(5.0 mL) under N2 flow. The reaction was stirred at room temperature until complete 
conversion, followed by TLC. The solution was concentrated under vacuum and purified by 
column chromatography over silica gel using Hex / Et2O (90:1) as eluent. The compound 207 
was obtained as a white solid (262 mg, 0.86 mmol, 90%). 1H NMR (500 MHz, CDCl3, 25 oC) 
δ = 7.72 – 7.68 (m, 2H; HAr-12), 7.28 (d, J = 8.2 Hz, 2H; HAr-13), 4.94 (p, J = 6.8 Hz, 1H; H-
2), 4.80 – 4.73 (m, 1H; H-6), 4.70 (dt, J = 6.8, 2.4 Hz, 2H; H-4), 3.90 (dt, J = 6.8, 2.4 Hz, 2H; 
H-1), 3.82 (d, J = 6.9 Hz, 2H; H-5), 2.42 (s, 3H; H-15), 1.64 (d, J = 2.8 Hz, 6H; H-9 and H-
10). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 209.6 (Cq; C-3 or C-7), 203.6 (Cq; C-3 or C-7), 
143.3 (Cq; C-14), 137.9 (Cq; C-11), 129.8 (2 x CHAr; C-13), 127.3 (2 x CHAr; C-12), 96.9 (Cq; 
C-8), 86.0 (CH; C-2), 84.3 (CH; C-6), 76.2 (CH2; C-4), 46.6 (CH2; C-5), 45.3 (CH2; C-1), 21.6 
(CH3; C-15), 20.5 (2 x CH3; C-9 and C-10).  
 
 
 
 
 
 
208 
 
Synthesis of N-(buta-2,3-dienyl)-4-methyl-N-(2-phenylbuta-2,3 
dienyl)benzenesulfonamide (280a)[222] 
 To a solution of 277a (1.5 mL, 11.98 mmol, 1.0 Eq., 0.1 M) in 120.0 mL of dry DCM 
at 0 oC (ice bath), were added tetrabromomethane (CBr4) (4.8 g, 14.37 mmol, 1.2 Eq.) and 
triphenylphospine (PPh3) (3.8 g, 14.37 mmol, 1.2 Eq.) in small portions under N2 flow. The 
solution was warmed up at room temperature and stirred during 18 h. The solvent was 
evaporated under vacuum and the crude was purified by column chromatography over silica 
gel using PET / Et2O (6:1) as eluent. Compound 278a[266] was obtained as a yellow oil (2.3 g, 
11.98 mmol, 100%). 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.40 – 7.35 (m, 2H; HAr-5), 7.29 
– 7.22 (m, 3H; HAr-6 and HAr-7), 4.10 (s, 2H; H-1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 
132.0 (2 x CHAr; C-5), 129.0 (CHAr; C-7), 128.5 (2 x CHAr; C-6), 122.3 (Cq; C-4), 86.9 (Cq; C-
2), 84.4 (Cq; C-3), 15.4 (CH2; C-1). 
 This synthesis was undertaken according to the procedure described by Alcaide and 
co-workers.[55] To an aqueus solution of paraformaldehyde (37% w/w H2O, 492 µl, 6.40 mmol, 
1.0 Eq.) in a mixture THF:NH4Cl(aq) (1:5), (20 mL) at 0 o C (ice bath) was added indium powder 
(4.4 g, 38.40 mmol, 6.0 Eq.) in small portions. This mixture was stirred vigorously during 3 
min. Then 278a (3.7 g, 19.20 mmol, 3.0 Eq.) dissolved in 23.0 mL of the mixture (THF: 
NH4Cl(aq)) was added dropwise at 0 oC. The reaction was warmed up at room temperature and 
stirred during 19 h. Then, 15 mL of H2O was added and the white solution was extracted with 
Et2O (x 4), washed with brine, dried over MgSO4 anhydrous and concentrated under vacuum. 
The crude was purified by column chromatography over silica gel using PET / Et2O (4:1) as 
eluent. The compound 279a[267] was obtained as a yellow oil (238 mg, 1.63 mmol, 25%). 1H 
NMR (500 MHz, CDCl3, 25 oC) δ = 7.43 (d, J = 7.8 Hz, 2H; HAr-6), 7.35 (t, J = 7.8 Hz, 2H; 
HAr-7), 7.27 – 7.21 (m, 1H; HAr-8), 5.26 (t, J = 2.7 Hz, 2H; H-1), 4.58 (t, J = 2.7 Hz, 2H; H-
4). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 207.7 (Cq; C-2), 133.9 (Cq; C-5), 128.8 (2 x CHAr; 
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C-7), 127.4 (CHAr; C-8), 126.3 (2 x CHAr; C-6), 106.1 (Cq; C-3), 80.5 (CH2; C-1), 61.7 (CH2; 
C-4). 
 To a flame-dried Schlenk flask were added sequentially 3.0 mL of dry THF, 
diisopropyl azadicarboxilate (DIAD) (354 µl, 1.80 mmol, 1.1 Eq.) and triphenylphosphine 
(PPh3) (471 mg, 1.80 mmol, 1.1 Eq.) under N2 flow. The yellow suspension was stirred 15 
min. Then, 276 (364 mg, 1.63 mmol, 1.0 Eq., 0.2 M) and 279a (239 mg, 1.63 mmol, 1.0 Eq.) 
were added dissolved in dry THF (5.5 mL) under N2 flow. The reaction was stirred at room 
temperature until complete conversion, followed by TLC. The crude of reaction was 
concentrated under vacuum and purified by column chromatography over silica gel using PET 
/ EtOAc (7:1) as eluent. Compound 280a[44a] was obtained as a yellow oil (136 mg, 0.39 mmol, 
24%). 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.70 (d, J = 8.2 Hz, 2H; HAr-14), 7.48 – 7.44 
(m, 2H; HAr), 7.34 – 7.30 (m, 2H; HAr), 7.29 (d, J = 7.9 Hz, 2H; HAr), 7.25 – 7.21 (m, 1H; HAr-
12), 5.05 (t, J = 2.5 Hz, 2H; H-8), 4.85 (p, J = 6.7 Hz, 1H; H-2), 4.63 (dt, J = 6.7, 2.5 Hz, 2H; 
H-4), 4.33 (t, J = 2.5 Hz, 2H; H-5), 3.86 (dt, J = 6.7, 2.5 Hz, 2H; H-1), 2.43 (s, 3H; H-17). 13C 
NMR (126 MHz, CDCl3, 25 oC) δ = 210.0 (Cq; C-3 or C-7), 209.6 (Cq; C-3 or C-7), 143.5 
(CqAr), 137.3 (CqAr), 133.8 (CqAr), 129.8 (2 x CHAr), 128.7 (2  x CHAr), 127.6 (2 x CHAr), 127.4 
(CHAr; H-12), 126.6 (2 x CHAr), 100.8 (Cq; C-6), 85.3 (CH; C-2), 79.1 (CH2; C-4 or C-8), 76.1 
(CH2; C-4 or C-8), 47.2 (CH2; C-1 or C-5), 45.8 (CH2; C-1 or C-5), 21.7 (CH3; C-17). 
Synthesis of N-2,3-butadien-1-yl-4-methyl-N-(2-methyl-2,3-butadien-1-yl)- 
benzenesulfonamide (280b)[212] 
 
 To a solution of 277b (800 µl, 10.69 mmol, 1.0 Eq., 0.1 M) in 106.0 mL of dry DCM 
at 0 oC (ice bath), were added tetrabromomethane (CBr4) (4.3 g, 12.83 mmol, 1.2 Eq.) and 
triphenylphospine (PPh3) (3.4 g, 12.83 mmol, 1.2 Eq.) in small portions under N2 flow. The 
solution was warmed up at room temperature and stirred 17 h. The solvent was evaporated 
under vacuum and the mixture was purified by column chromatography over silica gel using 
PET / Et2O (20:1) as eluent. Compound 278b[268] was obtained as a yellow liquid (1.3 g, 9.76 
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mmol, 91%). 1H NMR (500 MHz, CDCl3, 25 oC) δ = 3.84 (q, J = 2.5 Hz, 2H), 1.82 (t, J = 2.5 
Hz, 3H). 13C NMR (101 MHz, CDCl3, 25 oC) δ = 83.9 (Cq; C-3), 74.5 (Cq; C-2), 15.8 (CH2; 
C-1), 4.1 (CH3; C-4). 
 This synthesis was performed according to the procedure described by Alcaide and 
co-workers.[55] To a solution of paraformaldehyde (37% w/w H2O, 868 µl, 11.65 mmol, 1.0 
Eq.) in a mixture THF:NH4Cl(aq) (1:5), (20 mL) at 0 o C (ice bath) was added indium powder 
(8.0 g, 69.93 mmol, 6.0 Eq.) in small portions. This mixture was stirred vigorously during 3 
min and then 278b (4.6 g, 34.96 mmol, 3.0 Eq.) dissolved 29.0 mL of the mixture 
THF:NH4Cl(aq) (1:5) was added dropwise at 0 oC. The reaction was warmed up at room 
temperature and stirred during 22 h. 18 mL of H2O was added and the white solution was 
extracted with Et2O (x 4), washed with brine, dried with MgSO4 anhydrous and concentrated 
under vacuum. The crude was purified by column chromatography over silica gel using Et2O 
as eluent. Product 279b[269] was obtained as a yellow liquid (321 mg, 3.82 mmol, 34%). 1H 
NMR (500 MHz, CDCl3, 25 oC) δ = 4.81 (sep J = 3.1 Hz, 2H; H-1), 4.03 (bt, J = 3.1 Hz, 2H; 
H-4), 1.72 (t, J = 3.1 Hz, 3H; H-5). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 204.8 (Cq; C-2), 
99.7 (Cq; C-3), 77.3 (CH2; C-1), 63.9 (CH2; C-4), 15.3 (CH3; C-5). 
 To a flame-dried Schlenk flask were added sequentially 2.0 mL of dry THF, 
diisopropyl azadicarboxilate (DIAD) (186 µl, 0.95 mmol, 1.1 Eq.) and triphenylphosphine 
(PPh3) (248 mg, 0.95 mmol, 1.1 Eq.) under N2 flow. The yellow suspension was stirred 15 
min. Then, 276 (192 mg, 0.86 mmol, 1.0 Eq., 0.1 M – absolute concentration) and allenol 279b 
(72 mg, 0.86 mmol, 1.0 Eq.) were added dissolved in 6.0 mL of dry THF under N2 flow. The 
reaction was stirred at room temperature until complete conversion, followed by TLC. The 
crude of reaction was concentrated under vacuum and purified by column chromatography 
over silica gel using PET / Et2O (10:1) as eluent. Product 280b was obtained as a white solid 
(184 mg, 0.64 mmol, 74%). 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.72 – 7.67 (m, 2H; HAr-
11), 7.29 (d, J = 8.2 Hz, 2H; HAr-12), 4.87 – 4.80 (m, 1H; H-2), 4.66 (dt, J = 6.6, 2.4 Hz, 2H; 
H-4), 4.63 – 4.58 (m, 2H; H-8), 3.87 (dt, J = 7.2, 2.4 Hz, 2H; H-1), 3.81 (t, J = 2.4 Hz, 2H; H-
5), 2.42 (s, 3H; H-14), 1.67 (t, J = 3.1 Hz, 3H; H-9). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 
209.8 (Cq; C-3 or C-7), 207.8 (Cq; C-3 or C-7), 143.3 (Cq; C-13), 137.8 (Cq; C-10), 129.8 (2 x 
CHAr; H-12), 127.3 (2 x CHAr; H-11), 94.1 (Cq; C-6), 85.2 (CH; C-2), 76.0 (CH2; C-4), 75.2 
(CH2; C-8), 50.3 (CH2; C-5), 45.8 (CH2; C-1), 21.7 (CH3; C-14), 16.0 (CH3; C-9). 
 
 
211 
 
Synthesis of N-[4-(4-chloro-phenyl)-buta-2,3-dienyl]-4-methyl-N-(4-methyl-penta-2,3-
dienyl)-benzenesulfonamide (292) 
 
 The first step was undertaken according to a modified procedure described by Ma and 
co-workers.[29] To a flame-dried microwave vial, CdI2 (1.0 g, 2.74 mmol, 0.8 Eq.) was added 
inside a globe box. Then the vial was sealed and dried under vacuum with a flame until the 
white CdI2 turned to yellow-green. Then allow to cool. Compound 274 (1.1 g, 3.42 mmol, 1.0 
Eq., 0.3 M – absolute concentration) and 4-chlorobenzaldehyde (529 mg, 3.76 mmol, 1.1 Eq.) 
dissolved in 10.0 mL of dry toluene and pyrrolidine (314 µl, 3.76 mmol, 1.1 Eq.) were added 
sequentially under N2 flow. The reaction mixture was heated by microwave irradiation at 140 
oC during 3 h. After cooled down, the reaction mixture was filtered through a pad of celite / 
silica gel (1:1), washed with Et2O (15 mL) and concentrated under vacuum. The crude of the 
reaction was purified by column chromatography over silica gel using Hex / EtOAc (20:1) 
then (15:1) then (4:1) as eluent. Product 290 (142 mg, 0.42 mmol, 12%, brown oil) and 291, 
(21 mg, 0.05 mmol, 2%, brown oil) were obtained. (290) 1H NMR (500 MHz, CDCl3, 25 oC) 
δ = 7.74 (d, J = 8.2 Hz, 2H; HAr-6), 7.28 (d, J = 8.6 Hz, 2H; HAr-12), 7.25 (d, J = 8.2 Hz, 2H; 
HAr-7), 7.12 (d, J = 8.6 Hz, 2H; HAr-11), 6.18 (dt, J = 6.1, 3.1 Hz, 1H; H-4), 5.55 (q, J = 6.1 
Hz, 1H; H-2), 4.53 (bt, J = 5.9 Hz, 1H; NH), 3.71 (m, 2H; H-1), 2.42 (s, 3H; H-9). 13C NMR 
(126 MHz, CDCl3, 25 oC) δ = 204.8 (Cq; C-3), 143.8 (Cq; C-8), 137.0 (Cq; C-5), 133.3 (Cq; C-
13), 131.9 (Cq; C-10), 129.9 (2 x CHAr; C-11), 129.0 (2 x CHAr; C-7), 128.2 (2 x CHAr; C-12), 
127.3 (2 x CHAr; C-6), 97.2 (CH; C-4), 92.6 (CH; C-2), 41.6 (CH2; C-1), 21.7 (CH3; C-9). IR 
(Film, cm-1): ν̃ = 3441 (N-H), 3098 (C-HAr), 2981 (C-HAlkane), 2927 (C-HAlkane), 2857 (C-
HAlkane), 1953 (C=C=C), 1492 (C-HAlkane), 1360 (S=O), 1155 (S=O), 1090 (C-N), 1013, 835. 
HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for C17H1735ClNO2S [M+H]+: 
334.0663. Found: 334.0664, Calc. for C17H1737ClNO2S [M+H]+: 336.0632. Found: 336.0632. 
(291) 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.80 (d, J = 8.2 Hz, 2H; HAr-6), 7.29 – 7.25 (m, 
2H; HAr), 7.25 – 7.19 (m, 4H; HAr), 6.21 (dt, J = 6.2, 2.6 Hz, 1H; H-4), 5.76 (q, J = 6.2 Hz, 
1H; H-2), 4.56 (d, J = 2.6 Hz, 1H; H-1), 4.55 (dd, J = 2.6, 1.0 Hz, 1H; H-1), 2.44 (s, 3H; H-
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9), 1.29 (s, 9H; H-16). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 206.1 (Cq; C-3), 150.7 (Cq; C-
14), 144.4 (Cq; C-8), 137.4 (Cq; C-5), 132.9 (Cq; C-13), 132.4 (Cq; C-10), 129.3 (2 x CHAr; C-
11), 128.8 (2 x CHAr; C-7), 128.5 (2 x CHAr; C-12), 128.2 (2 x CHAr; C-6), 96.5 (CH; C-4), 
92.7 (CH; C-2), 84.7 (Cq; C-15), 45.2 (CH2; C-1), 27.9 (3 x CH3; C-16), 21.8 (CH3; C-9). IR 
(Film, cm-1): ν̃ = 3096 (C-HAr), 3054 (C-HAr), 2987 (C-HAlkane), 2925 (C-HAlkane), 2853 (C-
HAlkane), 1953 (C=C=C), 1729 (C=O), 1491 (C-HAlkane), 1360 (S=O), 1257 (C-O), 1155 (S=O), 
1014 (C-O), 813. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for 
C22H2835ClN2O4S [M+NH4]+: 451.1453. Found: 451.1450. Calc. for C22H2837ClN2O4S 
[M+NH4]+: 453.1423. Found: 453.1418. 
 To a flame-dried Schlenk flask were added sequentially 2.0 mL of dry THF, 
diisopropyl azadicarboxilate (DIAD) (92 µl, 0.47 mmol, 1.1 Eq.) and triphenylphosphine 
(PPh3) (123 mg, 0.47 mmol, 1.1 Eq.) under N2 flow. The yellow suspension was stirred 15 
min. Then, 290 (142 mg, 0.42 mmol, 1.0 Eq., 0.04 M – absolute concentration) and allenol 
285 (42 mg, 0.42 mmol, 1.0 Eq.) were added dissolved in 8.0 mL of dry THF under N2 flow. 
The reaction was stirred at room temperature until complete conversion, followed by TLC. 
The crude of reaction was concentrated under vacuum and purified by column chromatography 
over silica gel using Hex / EtOAc (30:1) then (15:1) then (10:1) as eluent. Product 292 was 
obtained as a yellow oil (44 mg, 0.11 mmol, 25%). 1H NMR (500 MHz, CDCl3, 25 oC) δ = 
7.71 (d, J = 8.2 Hz, 2H; HAr-16), 7.28 (d, J = 8.2 Hz, 2H; HAr-17), 7.26 – 7.23 (m, 2H; HAr-
10), 7.16 – 7.12 (m, 2H; HAr-11), 6.09 (dt, J = 6.5, 2.3 Hz, 1H; H-4), 5.42 (q, J = 6.5 Hz, 1H; 
H-2), 4.77 – 4.68 (m, 1H; H-6), 4.03 (ddd, J = 15.0, 6.5, 2.3 Hz, 1H; H-1), 3.97 (ddd, J = 15.0, 
7.3, 2.3 Hz, 1H; H-1), 3.90 (dd, J = 14.8, 7.3 Hz, 1H; H-5), 3.80 (dd, J = 14.8, 7.3 Hz, 1H; H-
5), 2.41 (s, 3H; H-19), 1.51 (d, J = 2.7 Hz, 3H; H-13), 1.51 (d, J = 2.7 Hz, 3H; H-14). 13C 
NMR (126 MHz, CDCl3, 25 oC) δ = 206.4 (Cq; C-3 or C-7), 203.8 (Cq; C-3 or C-7), 143.4 (Cq), 
137.8 (Cq), 132.9 (Cq; C-9 or C-12), 132.3 (Cq; C-9 or C-12), 129.9 (2 x CHAr; C-17), 128.9 
(2 x CHAr; C-10), 128.2 (2 x CHAr; C-11), 127.3 (2 x CHAr; C-16), 97.0 (Cq; C-8), 95.2 (CH; 
C-4), 91.3 (CH; C-2), 84.0 (CH; C-6), 46.7 (CH2; C-5), 45.1 (CH2; C-1), 21.7 (CH3; C-19), 
20.4 (2 x CH3; C-13 and C-14). IR (Film, cm-1): ν̃ = 3069 (C-HAr), 3035 (C-HAr), 2980 (C-
HAlkane), 2922 (C-HAlkane), 2854 (C-HAlkane), 1951 (C=C=C), 1641, 1597 (C=CAr), 1491 (C-
HAlkane), 1346 (S=O), 1159 (S=O), 1093 (C-N), 1014, 900, 835. HRMS (FTMS + p NSI 
((DCM)/MeOH + NH4OAc)) Calc. for C23H2535ClNO2S [M+H]+: 414.1289. Found: 414.1288. 
Calc. for C23H2537ClNO2S [M+H]+: 416.1259. Found: 416.1257. 
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Synthesis of dimethyl 2,2-bis-(4-methyl-penta-2,3-dienyl)-malonate (296a)[265] 
 
 The synthesis was followed according to the procedure described by Tsuji and 
coworkers.[270] To a solution of allenol 285 (440 mg, 4.45 mmol, 1.0 Eq., 0.5 M) in pyridine 
(9.0 mL) was added in small portions 4-dimethylaminopyridine (DMAP) (27 mg, 0.22 mmol, 
0.05 Eq.). Then acetic anhydride (846 µl, 8.96 mmol, 2.0 Eq.) was added dropwise and the 
reaction was stirred during 17 h at room temperature. The reaction was quenched with 
NaHCO3(aq) (25 mL) at 0 oC (ice bath), extracted with Et2O (x 4), washed with HCl (0,2 M) (x 
3), washed once with brine, dried over MgSO4 anhydrous and concentrated under vacuum. 
The product 294 was obtained without further purification.[265, 270] (621 mg, 4.43 mmol, 99%): 
yellow oil. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.13 – 5.06 (m, 1H; H-1), 4.50 (d, J = 6.8 
Hz, 2H; H-6), 2.06 (s, 3H; H-8), 1.70 (d, J = 2.8 Hz, 6H; H-4 and H-5). 13C NMR (126 MHz, 
CDCl3, 25 oC) δ = 203.5 (Cq; C-2), 171.0 (Cq; C-7), 97.4 (Cq; C-3), 84.9 (CH; C-1), 63.5 (CH2; 
C-6), 21.2 (CH3; C-8), 20.4 (2 x CH3; C-4 and C-5). 
 The synthesis was undertaken according to a procedure described by Ma and 
coworkers.[271] To a flame-dried Schlenk flask were added sequentially Pd(PPh3)4 (43 mg, 0.04 
mmol, 0.025 Eq.) in dry DCM (7.0 mL), 294 (631 mg, 4.50 mmol, 3.0 Eq.) dissolved in 8.0 
mL of dry DCM and dimethylmalonate (172 µl, 1.50 mmol, 1.0 Eq., 0.1 M – absolute 
concentration) dropwise and under N2. Then the mixture was cooled down at 0 o C (ice bath) 
and stirred at this temperature during 5 min. NaH (60% mineral oil, 180 mg, 4.50 mmol, 3.0 
Eq.) was added in small portions under N2 flow. The reaction was warmed up at room 
temperature and stirred during 22 h. The reaction was quenched at 0 oC with NH4Cl(aq) (10 
mL), extracted with DCM (x 3), washed with brine, dried over MgSO4 anhydrous and 
concentrated under vacuum. The product was purified by column chromatography using PET 
/ EtOAc (60:1) then (40:1) as eluent. 296a (267 mg, 0.91 mmol, 61%): yellow oil. 1H NMR 
(500 MHz, CDCl3, 25 oC) δ = 4.81 – 4.72 (m, 2H; H-2), 3.71 (s, 6H; H-9), 2.60 (d, J = 7.7 Hz, 
4H; H-1), 1.65 (d, J = 2.9 Hz, 12H; H-5 and H-6). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 
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204.0 (2 x Cq; C-3), 171.4 (2 x Cq; C-8), 95.2 (2 x Cq; C-4), 82.8 (2 x CH; C-2), 58.2 (Cq; C-
7), 52.5 (2 x CH3; C-9), 32.5 (2 x CH2; C-1), 20.6 (4 x CH3; C-5 and C-6). 
Synthesis of [[2,2-bis-(4-methyl-penta-2,3-dienyl]-bis(sulfonyl)]-bis-benzene (296b) 
 
 The synthesis was undertaken according to a procedure described by Ma and 
coworkers.[271] To a flame-dried Schlenk flask was added Pd(OAc)2 (13 mg, 0.06 mmol, 0.05 
Eq.) and  triphenylphosphine (PPh3) (30 mg, 0.11 mmol, 0.10 Eq.) dissolved in dry DCM (5.0 
mL). The solution was stirred for few minutes. Then, allene 294 (474 mg, 3.38 mmol, 3.0 Eq.) 
dissolved in 6.5 mL of dry DCM and neat bis(phenylsulfonyl)methane (334 mg, 1.13 mmol, 
1.0 Eq., 0.1 M – absolute concentration) were added under N2 flow. Then the mixture was 
cooled down at 0 oC (ice bath) and stirred at this temperature during 5 min. NaH (60% mineral 
oil, 135 mg, 3.38 mmol, 3.0 Eq.) was added in small portions under N2 flow. The reaction was 
warmed up at room temperature and stirred during 20 h. The reaction was quenched at 0 oC 
with NH4Cl(aq) (10 mL), extracted with DCM (x 3), washed with brine, dried over MgSO4 
anhydrous and concentrated under vacuum. The product was purified by column 
chromatography using PET / EtOAc (4:1) as eluent. 296b (100 mg, 0.22 mmol, 19%): brown 
gummy oil. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 8.12 – 8.07 (m, 4H; HAr-9), 7.73 – 7.67 
(m, 2H; HAr-11), 7.61 – 7.55 (m, 4H; HAr-10), 5.23 – 5.11 (m, 2H; H-2), 3.02 (d, J = 7.1 Hz, 
4H; H-1), 1.71 (d, J = 2.8 Hz, 12H; H-6 and H-7). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 
204.1 (2 x Cq; C-3), 137.2 (2 x Cq; C-8), 134.6 (2 x CHAr; C-11), 131.6 (4 x CHAr; C-10), 128.6 
(4 x CHAr; C-9), 96.6 (2 x Cq; C-4 or 2 x CH; C-2), 91.1 (2 x Cq; C-4 or 2 x CH; C-2), 81.9 
(Cq; C-5), 29.1 (2 x CH2; C-1), 20.3 (4 x CH3; C-6 and C-7). IR (Film, cm-1): ν̃ = 3097 (C-
HAr), 3069 (C-HAr), 2980 (C-HAlkane), 2925 (C-HAlkane), 2854 (C-HAlkane), 1971 (C=C=C), 1602 
(C=CAr), 1447 (C-HAlkane), 1330 (S=O), 1311, 1146 (S=O), 1079, 1000, 858. HRMS (FTMS + 
p NSI ((DCM)/MeOH + NH4OAc)): Calc. for C25H32NO4S2 [M+NH4]+: 474.1767. Found: 
474.1760. 
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General procedure for platinum-catalysed alkoxycyclisation of 1,5-bisallenes under the 
best conditions found 
 To a microwave vial were added PtCl2(MeCN)2 (0.05 Eq.) and AgSbF6 (0.1 Eq.). Then 
the vial was closed with a stopper and flushed with N2 during 3 min. A small amount of dry 
THF was added and the solution was stirred at room temperature for a few minutes to preform 
the cationic complex. The corresponding 1,5-bisallene (1.0 Eq., 0.09 M – absolute 
concentration) dissolved in dry THF and dry MeOH (THF:MeOH 9:1) were added 
sequentially under N2. Then the vial was sealed under N2 and placed in a pre-heated oil bath 
at 70 oC until completed conversion, following the reaction by TLC. The crude was filtered 
through celite, washed with dichloromethane and concentrated under vacuum. The mixture 
was purified by column chromatography using (Sigma-Aldrich Silica gel) and PET, Hex / 
Et2O, EtOAc as eluents.   
Synthesis of products 298a and 305a  
 
 From 1,5-bisallene 204a (50 mg, 0.18 mmol), PtCl2(MeCN)2 (3 mg, 0.01 mmol), 
silver hexafluoroantimonate (6 mg, 0.02 mmol), dry MeOH (200 µl, 4.94 mmol) and 1.8 mL 
of dry THF. Obtained after column chromatography using Hex / EtOAc (8:1) then (6:1) then 
(4:1) as eluent: 305a, 22 mg, 0.07 mmol (39%): yellow oil, and 298a, 6 mg, 0.02 mmol (11%): 
yellow oil. 
4-Methoxymethyl-1-(toluene-4-sulfonyl)-3-vinyl-1,2,3,6-tetrahydro-pyridine (305a) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.59 (d, J = 8.2 Hz, 2H; HAr-11), 7.25 (d, J = 8.2 Hz, 
2H; HAr-12), 5.73 (ddd, J = 17.1, 10.2, 8.5 Hz, 1H; H-6), 5.62 – 5.58 (m, 1H; H-4), 5.11 – 5.05 
(m, 2H; H-7), 3.82 – 3.78 (m, 1H; H-8), 3.78 – 3.72 (m, 1H; H-5), 3.60 (dd, J = 12.3, 0.8 Hz, 
1H; H-8), 3.35 (dd, J = 11.4, 3.6 Hz, 1H; H-1), 3.32 – 3.26 (m, 1H; H-5), 3.19 (s, 3H; H-9), 
2.89 – 2.83 (m, 1H; H-2), 2.80 (dd, J = 11.4, 4.1 Hz, 1H; H-1) 2.36 (s, 3H; H-14). 13C NMR 
(126 MHz, CDCl3, 25 oC) δ = 143.7 (Cq; C-13), 137.0 (CH; C-6), 135.3 (Cq; C-10), 133.3 (Cq; 
C-3), 129.8 (2 x CHAr; C-12), 127.9 (2 x CHAr; C-11), 120.1 (CH; C-4), 117.3 (CH2; C-7), 
73.5 (CH2; C-8), 58.1 (CH3; C-9), 47.8 (CH2; C-1), 44.9 (CH2; C-5), 40.5 (CH; C-2), 21.7 
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(CH3; C-14). IR (Film, cm-1): ν̃ = 3097 (C-HAlkene), 3072 (C-HAr), 2924 (C-HAlkane), 2858 (C-
HAlkane), 1737 (C=C), 1640 (C=CH2), 1597 (C=CAr), 1456 (C-HAlkane), 1344 (S=O), 1210 (C-
O), 1165 (S=O), 1093 (C-N), 958, 820. HRMS (FTMS + APCI (DCM + NH4OAc)): Calc. For 
C9H18ON [M+H]+: 325.1589. Found: 325.1580. 
N-(3-Methoxymethyl-4-methylene-hexa-2,5-dienyl)-4-methyl benzenesulfonamide 
(298a) 
 
1H NMR (300 MHz, CDCl3, 25 oC) δ = 7.72 (d, J = 8.2 Hz, 2H; HAr-11), 7.29 (d, J = 8.2 Hz, 
2H; HAr-12), 6.29 (dd, J = 17.4, 10.4 Hz, 1H; H-5), 5.62 (t, J = 7.0 Hz, 1H; H-2), 5.17 (s, 1H; 
H-9), 5.05 (d, J = 10.4 Hz, 1H; H-6), 5.03 (d, J = 17.4 Hz, 1H; H-6), 4.89 (s, 1H; H-9), 4.56 
(bt, J = 5.9 Hz, 1H; NH), 3.85 – 3.77 (s, 2H; H-7), 3.54 – 3.43 (m, 2H; H-1), 3.28 (s, 3H; H-
8), 2.42 (s, 3H; H-14). 13C NMR (75 MHz, CDCl3, 25 oC) δ = 143.6 (Cq; C-13), 143.5 (Cq; C-
10), 139.8 (Cq; C-3 or C-4), 137.1 (CH; C-5), 129.8 (2 x CHAr; C-12), 127.3 (2 x CHAr; C-11), 
123.6 (CH; C-2), 118.8 (CH2; C-9), 116.4 (CH2; C-6), 75.1 (CH2; C-7), 58.3 (CH3; C-8), 41.6 
(CH2; C-1), 21.6 (CH3; C-14). IR (Film, cm-1): ν̃ = 3282 (N-H), 3098 (C-HAlkene), 3082, 3061 
(C-HAr), 2925 (C-HAlkane), 2855 (C-HAlkane), 1727 (C=C), 1598 (C=CAr), 1450 (C-HAlkane), 1310 
(S=O), 1240 (C-O), 1161 (S=O), 1094 (C-N), 911. HRMS (ESI-HRMS): Calc. for 
C16H25O3N2S [M+NH4]+: 325.1589 Found: 325.1580. 
Synthesis of products 299d, 305d and 305’d 
 
 From 1,5-bisallene 266d (206 mg, 0.79 mmol), PtCl2(MeCN)2 (14 mg, 0.04 mmol), 
silver hexafluoroantimonate (27 mg, 0.08 mmol), dry MeOH (866 µl, 21.40 mmol) and 7.8 
mL of dry THF. Obtained after column chromatography using PET / EtOAc (10:1) then (7:1) 
then (4:1) as eluent: 305d, 48 mg, 0.16 mmol (21%): colourless oil; and 299d:305’d (1.1:1) as 
inseparable mixture, 33 mg, 0.39 mmol (15%): yellow oil.  
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1-Benzenesulfonyl-4-methoxymethyl-3-vinyl-1,2,3,6-tetrahydro-pyridine (305d) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.81 – 7.77 (m, 2H; HAr-11), 7.62 – 7.57 (m, 1H; HAr-
13), 7.56 – 7.51 (m, 2H; HAr-12), 5.80 (ddd, J = 17.1, 10.2, 8.4 Hz, 1H; H-6), 5.69 – 5.66 (m, 
1H; H-4), 5.18 – 5.12 (m, 2H; H-7), 3.89 – 3.85 (m, 1H; H-8), 3.85 – 3.81 (m, 1H; H-5), 3.70 
– 3.65 (m, 1H; H-8), 3.45 (dd, J = 11.4, 3.4 Hz, 1H; H-1), 3.42 – 3.35 (m, 1H; H-5), 3.26 (s, 
3H; H-9), 2.97 – 2.91 (m, 1H; H-2), 2.89 (dd, J = 11.4, 4.1 Hz, 1H; H-1). 13C NMR (126 MHz, 
CDCl3, 25 oC) δ = 136.9 (CH; C-6), 136.4 (Cq; C-3), 135.3 (Cq; C-10), 132.9 (CHAr; C-13), 
129.2 (2 x CHAr; C-12), 127.8 (2 x CHAr; C-11), 120.0 (CH; C-4), 117.4 (CH2; C-7), 73.5 
(CH2; C-8), 58.2 (CH3; C-9), 47.8 (CH2; C-1), 44.8 (CH2; C-5), 40.5 (CH; C-2). IR (Film, cm-
1): ν̃ = 3097 (C-HAlkene), 3065 (C-HAr), 2963 (C-HAlkane), 2923 (C-HAlkane), 2852 (C-HAlkane), 
1710 (C=C), 1607 (C=CAr), 1457 (C-HAlkane), 1321 (S=O), 1150 (C-O), 1133 (S=O), 1081 (C-
N), 961. HRMS (FTMS + p NSI (DCM) / MeOH + NH4OAc)): Calc. for C15H20O3NS [M+H]+: 
294.1158. Found: 294.1161. 
1-Benzenesulfonyl-4-methoxymethyl-5-methyl-2,7-dihydro-1H-azepine (299d) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.84 – 7.77 (m, 2H; HAr-11), 7.60 – 7.54 (m, 1H; HAr-
13), 7.54 – 7.46 (m, 2H; HAr-12), 5.84 (t, J = 7.0 Hz, 1H; H-2), 5.77 – 5.71 (m, 1H; H-5), 3.90 
(s, 2H; H-7), 3.61 (d, J = 7.0 Hz, 2H; H-1), 3.58 (d, J = 7.1 Hz, 2H; H-6), 3.15 (s, 3H; H-8), 
1.78 (s, 3H; H-9). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 145.5 (Cq; C-3 or C-4), 142.7 (Cq; 
C-3 or C-4), 139.1 (Cq; C-10), 132.7 (CHAr; C-13), 129.2 (2 x CHAr; C-12), 127.6 (2 x CHAr; 
C-11), 124.2 (CH; C-2), 124.1 (CH; C-5), 73.5 (CH2; C-7), 58.0 (CH3; C-8), 43.9 (CH2; C-1), 
43.6 (CH2; C-6), 19.7 (CH3; C-9). The HAr from the aromatic ring and the H-7 from the CH2 
are overlapped with signals from compound 305’d  
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1-Benzenesulfonyl-3-ethylidene-4-methoxymethyl-1,2,3,6-tetrahydro-pyridine (305’d) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.84 – 7.77 (m, 2H; HAr-11), 7.60 – 7.54 (m, 1H; HAr-
13), 7.54 – 7.46 (m, 2H; HAr-12), 5.66 – 5.63 (m, 1H; H-4), 5.62 (q, J = 7.1 Hz, 1H; H-6), 3.93 
(s, 2H; H-1), 3.90 (s, 2H; H-8), 3.85 – 3.81 (m, 2H; H-5), 3.23 (s, 3H; H-9), 1.75 (d, J = 7.1 
Hz, 3H; H-7). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 137.2 (Cq; C-10), 133.2 (Cq; C-3), 132.9 
(CHAr; C-13), 129.0 (2 x CHAr; C-12), 128.4 (Cq; C-2), 127.8 (2 x CHAr; C-11), 121.3 (2 x CH; 
C-4 and C-6), 72.6 (CH2; C-8), 58.1 (CH3; C-8), 45.2 (CH2; C-1), 43.8 (CH2; C-5), 13.4 (CH3; 
C-7). The HAr from the aromatic ring and the H-8 from the CH2 are overlapped with signals 
from compound 299d  
299d and 305’d as inseparable mixture. IR (Film, cm-1): ν̃ = 3098 (C-HAlkene), 3070 (C-HAr), 
2920 (C-HAlkane), 2850 (C-HAlkane), 2825 (C-HAlkane), 1732 (C=C), 1447 (C-HAlkane), 1335 
(S=O), 1231 (C-O), 1164 (S=O), 1091 (C-N), 746. HRMS (FTMS+ p NSI ((DCM) / MeOH 
+ NH4OAc)): Calc. for C15H18NO3S [M-2H+H]+: 292.1002. Found: 292.1000. 
Synthesis of products 298c, 299c and 306c  
 
 From 1,5-bisallene 266c (55 mg, 0.18 mmol), PtCl2(MeCN)2 (3 mg, 0.01 mmol), silver 
hexafluoroantimonate (6 mg, 0.02 mmol), dry MeOH (200 µl, 4.86 mmol) and 1.8 mL of dry 
THF. Obtained after column chromatography using Hex / EtOAc (8:1) as eluent: 299c, 15 mg, 
0.04 mmol (25%): yellow solid; and 298c:306c (4:1) as inseparable mixture, 18 mg, 0.05 
mmol (30%): yellow oil.  
4-Methoxymethyl-5-methyl-1-(4-nitro-benzenesulfonyl)-2,7-dihydro-1H-azepine (299c) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 8.38 – 8.35 (m, 2H; HAr-11 or HAr-12), 8.01 – 7.98 (m, 
2H; HAr-11 or HAr-12), 5.89 (t, J = 7.0 Hz, 1H; H-2), 5.75 (tq, J = 7.0, 1.3 Hz, 1H; H-5), 3.92 
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(s, 2H; H-7), 3.64 (d, J = 7.0 Hz, 2H; H-1), 3.63 (d, J = 7.0 Hz, 2H; H-6), 3.22 (s, 3H; H-8), 
1.80 (s, 3H; H-9). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 150.2 (Cq; C-10 or C-13) 146.0 (Cq; 
C-10 or C-13), 145.3 (Cq; C-3 or C-4), 143.3 (Cq; C-3 or C-4), 128.7 (2 x CHAr; C-11), 124.5 
(2 x CHAr; C-12), 123.5 (CH; C-5), 123.2 (CH; C-2), 73.4 (CH2; C-7), 58.3 (CH3; C-8), 43.9 
(CH2; C-6), 43.6 (CH2; C-1), 19.8 (CH3; C-9). IR (Film, cm-1): ν̃ = 3111 (C-HAlkene), 3070 (C-
HAlkene), 3032 (C-HAr), 2924 (C-HAlkane), 2854 (C-HAlkane), 1741 (C=C), 1531 (N-O), 1350 
(S=O), 1164 (S=O), 1091 (C-N), 1011 (C-O), 920, 855.  HRMS (FTMS + p NSI (DCM)) Calc. 
for C15H18O5N2S [M+H]+: 339.1009. Found: 339.1005.  
N-(3-Methoxymethyl-4-methylene-hexa-2,5-dienyl)-4-nitro-benzenesulfonamide (298c) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 8.35 (d, J = 8.8 Hz, 2H; HAr-11 or HAr-12), 8.02 (d, J 
= 8.8 Hz, 2H; HAr-11 or HAr-12), 6.32 (dd, J = 17.4, 10.5 Hz, 1H; H-5), 5.63 (t, J = 7.0 Hz, 
1H; H-2), 5.21 (s, 1H; H-9), 5.09 (d, J = 10.5 Hz, 1H; H-6), 5.04 (d, J = 17.4 Hz, 1H; H-6), 
4.91 (s, 1H; H-9), 4.53 (bt, J = 5.7 Hz, 1H; NH), 3.82 (s, 2H; H-7), 3.60 – 3.55 (m, 2H; H-1), 
3.31 (s, 3H; H-8). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 150.2 (Cq; C-10 or C-13), 146.2 
(Cq; C-10 or C-13), 143.6 (Cq; C-3 or C-4), 140.9 (Cq; C-3 or C-4), 137.2 (CH; C-5), 128.5 (2 
x CHAr; C-11 or C-12), 124.5 (2 x CHAr; C-11 or C-12), 122.2 (CH; C-2), 119.1 (CH2; C-9), 
116.5 (CH2; C-6), 74.9 (CH2; C-7), 58.6 (CH3; C-8), 41.7 (CH2; C-1).  
5-Methoxymethyl-4-methylene-1-(4-nitro-benzenesulfonyl)-2,3,4,7-tetrahydro-1H-
azepine (306c) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 8.27 (d, J = 8.8 Hz, 2H; HAr-11 or HAr-12), 7.94 (d, J 
= 8.8 Hz, 2H; HAr-11 or HAr-12), 5.78 (t, J = 4.9 Hz, 1H; H-2), 4.94 (s, 1H; H-9), 4.83 (s, 1H; 
H-9), 4.11 (d, J = 4.9 Hz, 2H; H-1), 3.81 (d, J = 0.9 Hz, 2H; H-7), 3.53 (t, J = 6.4 Hz, 2H; H-
6), 3.27 (s, 3H; H-8), 2.52 (t, J = 6.4 Hz, 2H; H-5). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 
142.5 (Cq; C-10 or C-13), 140.2 (Cq; C-10 or C-13), 128.8 (2 x CHAr; C-11 or C-12), 125.5 
(Cq; C-3 or C-4), 124.1 (2 x CHAr; C-11 or C-12), 115.9 (CH2; C-9), 74.6 (CH2; C-7), 58.4 
(CH3; C-8), 49.0 (CH2; C-6), 44.9 (CH2; C-5) 36.2 (CH2; C-1). Due to the low concentration 
of the compound one quarternary carbon could not be found.  
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298c and 306c as inseparable mixture. IR (Film, cm-1): ν̃ = 3508 (N-H), 3110 (C-HAlkene), 2925 
(C-HAlkane), 2855 (C-HAlkane), 1716 (C=C), 1611 (C=CAr), 1531 (N-O), 1454 (C-HAlkane), 1350 
(S=O), 1210 (C-O), 1164 (S=O), 1094 (C-N), 918, 859, 742.0. HRMS (FTMS + p NSI 
(DCM)): Calc. for C15H19O5N2S [M+H]+: 339.1009 Found: 339.1008. M.P. = 83 – 85 oC. 
Synthesis of products 298e and 305e   
 
 From 1,5-bisallene 266c (74 mg, 0.25 mmol), PtCl2(MeCN)2 (4 mg, 0.01 mmol), silver 
hexafluoroantimonate (9 mg, 0.02 mmol), dry MeOH (280 µl, 6.91 mmol) and 2.2 mL of dry 
THF. Obtained after column chromatography using Hex / EtOAc (5:1) then (3:1) then (1:1) as 
eluent: 305e, 22 mg, 0.07 mmol (26%): yellow oil; and 298e, 36 mg, 0.11 mmol (44%): yellow 
oil. 
1-(4-Methoxy-benzenesulfonyl)-4-methoxymethyl-3-vinyl-1,2,3,6-tetrahydro-pyridine 
(305e) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.74 – 7.69 (m, 2H; HAr-11), 7.01 – 6.97 (m, 2H; HAr-
12), 5.80 (ddd, J = 17.1, 10.1, 8.5 Hz, 1H; H-6), 5.70 – 5.64 (m, 1H; H-4), 5.17 – 5.14 (m, 1H; 
H-7), 5.14 – 5.11 (m, 1H; H-7), 3.87 (s, 3H; H-14), 3.89 – 3.84 (m, 1H; H-8), 3.84 – 3.77 (m, 
1H; H-5), 3.68 (dd, J = 12.3, 0.7 Hz, 1H; H-8), 3.41 (dd, J = 11.4, 3.6 Hz, 1H; H-1), 3.41 – 
3.34 (m, 1H; H-5), 3.26 (s, 3H; H-9), 2.96 – 2.90 (m, 1H; H-2), 2.87 (dd, J = 11.4, 4.1 Hz, 1H; 
H-1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 163.2 (Cq; C-13), 137.0 (CH; C-6), 135.3 (Cq; 
C-10), 129.9 (2 x CHAr; C-11), 128.0 (Cq; C-3), 120.1 (CH; C-4), 117.3 (CH2; C-7), 114.3 (2 x 
CHAr; C-12), 73.5 (CH2; C-8), 58.2 (CH3; C-9), 55.8 (CH3; C-14), 47.8 (CH2; C-1), 44.9 (CH2; 
C-5), 40.5 (CH; C-2). IR (Film, cm-1): ν̃ = 3095 (C-HAlkene), 3054 (C-HAr), 2921 (C-HAlkane), 
2856 (C-HAlkane), 2820 (C-HAlkane), 1732 (C=C), 1594 (C=CAr), 1460 (C-HAlkane), 1344 (S=O), 
1257 (C-O), 1153 (S=O), 1091 (C-N), 960. HRMS (FTMS + p NSI ((DCM) / MeOH + 
NH4OAc)): Calc. for C16H22O4NS [M+H]+: 324.1264. Found: 324.1265.  
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4-Methoxy-N-(3-methoxymethyl-4-methylene-hexa-2,5-dienyl)-benzenesulfonamide 
(298e) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ =7.77 (d, J = 8.8 Hz, 2H; HAr-11), 6.96 (d, J = 8.8 Hz, 
2H; HAr-12), 6.31 (dd, J = 17.3, 10.5 Hz, 1H; H-5), 5.63 (t, J = 6.6 Hz, 1H; H-2), 5.18 (s, 1H; 
H-9), 5.09 – 5.00 (m, 2H; H-6), 4.89 (s, 1H; H-9), 4.34 – 4.30 (m, 1H; NH), 3.87 (s, 3H; H-
14), 3.82 (s, 2H; H-7), 3.48 (t, J = 6.6 Hz, 2H; H-1), 3.30 (s, 3H; H-8). 13C NMR (126 MHz, 
CDCl3, 25 oC) δ = 163.0 (Cq; C-13), 143.7 (Cq; C-3 or C-4), 139.9 (Cq; C-10), 137.2 (CH; C-
5), 131.7 (Cq; C-3 or C-4), 129.4 (2 x CHAr; C-11), 123.5 (CH; C-2), 118.9 (CH2; C-9), 116.4 
(CH2; C-6), 114.3 (2 x CHAr; C-12), 75.2 (CH2; C-7), 58.4 (CH3; C-8), 55.8 (CH3; C-14), 41.6 
(CH2; C-1). IR (Film, cm-1): ν̃ = 3540 (N-H), 2964 (C-HAlkane), 2920 (C-HAlkane), 2852 (C-
HAlkane), 1744 (C=C), 1712, 1632 (C=CAr), 1596, 1448 (C-HAlkane), 1312 (S=O), 1260 (C-O), 
1156 (S=O), 1100 (C-N). HRMS (FTMS + p NSI ((DCM) / MeOH + NH4OAc)): Calc. for 
C16H22O4NS [M+H]+: 324.1264. Found: 324.1266. 
Synthesis of products 298f, 299f, 305f and 305f’ 
 
 From 1,5-bisallene 266f (72 mg, 0.24 mmol), PtCl2(MeCN)2 (4 mg, 0.01 mmol), silver 
hexafluoroantimonate (8 mg, 0.02 mmol), dry MeOH (270 µl, 6.59 mmol), 2.4 mL of dry 
THF. Obtained after column chromatography using Hex/EtOAc (8:1) then (6:1) then (2:1) as 
eluent: 298f, 3 mg, 0.01 mmol (2%): yellow oil; 299f:305f’ (1.5:1) as inseparable mixture, 36 
mg, 0.11 mmol (31%): yellow oil; and 305f 22 mg, 0.07 mmol (17%): yellow oil. 
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1-(4-Chloro-benzenesulfonyl)-4-methoxymethyl-3-vinyl-1,2,3,6-tetrahydro-pyridine 
(305f) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.74 – 7.70 (m, 2H; HAr-11 or HAr-12), 7.53 – 7.48 (m, 
2H; HAr-11 or HAr-12), 5.83 – 5.73 (m, 1H; H-6), 5.68 (m, 1H; H-4), 5.17 – 5.15 (m, 1H; H-
7), 5.16 – 5.12 (m, 1H; H-7), 3.86 (d, J = 12.1 Hz, 1H; H-8), 3.85 – 3.81 (m, 1H; H-5), 3.68 
(d, J = 12.1 Hz, 1H; H-8), 3.44 (dd, J = 11.3, 3.4 Hz, 1H; H-1), 3.41 – 3.35 (m, 1H; H-5), 3.26 
(s, 3H; H-9), 2.96 – 2.92 (m, 1H; H-2), 2.90 (dd, J = 11.3, 4.1 Hz, 1H; H-1). 13C NMR (126 
MHz, CDCl3, 25 oC) δ = 139.5 (Cq), 136.7 (CH; C-6), 135.4 (Cq), 135.0 (Cq), 129.5 (2 x CHAr; 
C-11 or C-12), 129.2 (2 x CHAr; C-11 or C-12), 119.8 (CH; C-4), 117.5 (CH2; C-7), 73.5 (CH2; 
C-8), 58.2 (CH3; C-9), 47.8 (CH2; C-1), 44.8 (CH2; C-5), 40.4 (CH; C-2). IR (Film, cm-1): ν̃ = 
3086 (C-HAlkene), 2922 (C-HAlkane), 2850 (C-HAlkane), 2828 (C-HAlkane), 1714 (C=C), 1585 
(C=CAr), 1476 (C-HAlkane), 1349 (S=O), 1200 (C-O), 1165 (S=O), 1091 (C-N), 962, 828. 
HRMS (FTMS + p NSI ((DCM) / MeOH + NH4OAc)): Calc. for C15H19O3NS35Cl [M+H]+: 
328.0769. Found: 328.0769. Calc. For C15H19O3NS37Cl [M+H]+: 330.0738. Found: 330.0736. 
4-Chloro-N-(3-methoxymethyl-4-methylene-hexa-2,5-dienyl)-benzenesulfonamide 
(298f) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.79 – 7.76 (m, 2H; HAr-11 or HAr-12), 7.49 – 7.46 (m, 
2H; HAr-11 or HAr-12), 6.32 (dd, J = 17.4, 10.4 Hz, 1H; H-5), 5.63 (tt, J = 7.0, 1.5 Hz, 1H; H-
2), 5.20 (s, 1H; H-9), 5.08 (d, J = 10.4 Hz, 1H; H-6), 5.03 (d, J = 17.4 Hz, 1H; H-6), 4.90 (s, 
1H; H-9), 4.35 (bt, J = 5.8 Hz, 1H; NH), 3.83 (s, 2H; H-7), 3.54 – 3.50 (m, 2H; H-1), 3.31 (s, 
3H; H-8). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 143.6 (Cq), 140.4 (Cq), 139.3 (Cq), 138.7 
(Cq), 137.2 (CH; C-5), 129.5 (2 x CHAr; C-11 or C-12), 128.7 (2 x CHAr; C-11 or C-12), 122.8 
(CH; C-2), 119.0 (CH2; C-9), 116.4 (CH2; C-6), 75.1 (CH2; C-7), 58.5 (CH3; C-8), 41.6 (CH2; 
C-1). IR (Film, cm-1): ν̃ = 3286 (N-H), 3097 (C-HAlkene), 2925 (C-HAlkane), 2859 (C-HAlkane), 
2826 (C-HAlkane), 1717 (C=C), 1586, 1476 (C-HAlkane), 1395 (S=O), 1337 (C-O), 1163 (S=O), 
1093 (C-N), 1013 (C-O). HRMS (FTMS + p NSI ((DCM) / MeOH + NH4OAc)): Calc. for 
C15H2235ClO3N2S [M+NH4]+: 345.1034. Found: 345.1040. Calc. for C15H2237ClO3N2S 
[M+NH4]+: 347.1003. Found: 345.1003. 
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1-(4-Chloro-benzenesulfonyl)-4-methoxymethyl-5-methyl-2,7-dihydro-1H-azepine 
(299f) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.76 – 7.73 (m, 2H; HAr-11 or HAr-12), 7.51 – 7.47 (m, 
2H; HAr-11 or HAr-12), 5.86 (t, J = 7.0 Hz, 1H; H-2), 5.75 (tq, J = 7.1, 1.4 Hz, 1H; H-5), 3.92 
(s, 2H; H-7), 3.60 (d, J = 7.0 Hz, 2H; H-1), 3.58 (d, J = 7.1 Hz, 2H; H-6), 3.20 (s, 3H; H-8), 
1.80 (s, 3H; H-9). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 145.7 (Cq; C-4), 142.9 (Cq; C-3), 
139.2 (Cq; C-10 or C-13), 137.8 (Cq; C-10 or C-13), 129.5 (2 x CHAr; C-11 or C-12), 129.0 (2 
x CHAr; C-11 or C-12), 123.9 (CH; C-2), 123.8 (CH; C-5), 73.5 (CH2; C-7), 58.1 (CH3; C-8), 
43.8 (CH2; C-6), 43.6 (CH2; C-1), 19.8 (CH3; C-9). 
1-(4-Chloro-benzenesulfonyl)-3-ethylidene-4-methoxymethyl-1,2,3,6-tetrahydro-
pyridine (305f’) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.73 – 7.70 (m, 2H; HAr-11 or HAr-12), 7.47 – 7.43 (m, 
2H; HAr-11 or HAr-12), 5.67 – 5.60 (m, 2H; H-6 and H-4), 3.95 (s, 2H; H-1), 3.90 (s, 2H; H-
8), 3.87 – 3.83 (m, 2H; H-5), 3.23 (s, 3H; H-9), 1.75 (d, J = 7.2 Hz, 3H; H-7). 13C NMR (126 
MHz, CDCl3, 25 oC) δ = 139.4 (Cq; C-10 or C-13), 136.0 (Cq; C-10 or C-13), 133.4 (Cq; C-2 
or C-3), 129.3 (2 x CHAr; C-11 or C-12), 129.2 (2 x CHAr; C-11 or C-12), 128.2 (Cq; C-2 or C-
3), 121.6 (CH; C-6 or C-4), 121.0 (CH; C-6 or C-4), 72.5 (CH2; C-8), 58.1 (CH3; C-9), 45.2 
(CH2; C-5), 43.9 (CH2; C-1), 13.4 (CH3; C-9). 
299f and 305f’ as inseparable mixture. IR (Film, cm-1): ν̃ = 3095 (C-HAlkene), 3067 (C-HAr), 
2925 (C-HAlkane), 2854 (C-HAlkane), 1733 (C=C), 1586, 1477 (C-HAlkane), 1349 (S=O), 1299 (C-
O), 1165 (S=O), 1091 (C-N), 1013 (C-O), 829, 757. HRMS (FTMS + p NSI ((DCM) / MeOH 
+ NH4OAc)): Calc. for C15H2235ClO3N2S [M+H]+: 328.0729. Found: 328.0774. Calc. for 
C15H2237ClO3N2S [M+H]+: 330.0738. Found: 330.0742. 
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Synthesis of products 298g, 299g, 305g and 305g’ (traces) 
 From 1,5-bisallene 266g (195 mg, 0.59 mmol), PtCl2(MeCN)2 (10 mg, 0.03 mmol), 
silver hexafluoroantimonate (20 mg, 0.02 mmol), dry MeOH (652 µl, 16.11 mmol) and 5.9 
mL of dry THF. Obtained after column chromatography using PET / EtOAc (14:1) then (10:1) 
then (8:1) then (4:1) as eluent: 298g, 1 mg, 0.003 mmol (1%): yellow oil; 298g and traces of 
305g’ as inseparable mixture, 13 mg, 0.04 mmol (6%): yellow oil; and 305g, 12 mg, 0.03 
mmol (6%): colourless oil.  
N-(3-Methoxymethyl-4-methylene-hexa-2,5-dienyl)-4-trifluoromethyl-
benzenesulfonamide (298g) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.97 (d, J = 8.3 Hz, 2H; HAr-11), 7.78 (d, J = 8.3 Hz, 
2H; HAr-12), 6.31 (dd, J = 17.4, 10.5 Hz, 1H; H-5), 5.62 (tt, J = 7.0, 1.4 Hz, 1H; H-2), 5.19 (d, 
J = 0.7 Hz, 1H; H-9), 5.07 (d, J = 10.5 Hz, 1H; H-6), 5.03 (d, J = 17.4 Hz, 1H; H-6), 4.90 (s, 
1H; H-9), 4.41 (bt, J = 5.8 Hz, 1H; NH), 3.82 (d, J = 1.4 Hz, 2H; H-7), 3.58 – 3.53 (m, 2H; H-
1), 3.30 (s, 3H; H-8). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 143.6 (Cq; C-10), 140.7 (Cq; C-
3 or C-4), 137.2 (CH; C-5), 134.5 (q, JC-F = 32.9 Hz; Cq; C-13), 127.8 (2 x CHAr; C-11), 127.2 
(q, JC-F = 231.7 Hz; CF3), 126.3 (q, JC-F = 3.8 Hz; 2 x CHAr; C-12), 122.5 (CH; C-2), 119.0 
(CH2; C-9), 116.4 (CH2; C-6), 75.0 (CH2; C-7), 58.5 (CH3; C-8), 41.7 (CH2; C-1). 19F NMR 
(471 MHz, CDCl3, 25 oC) δ = - 63.11. IR (Film, cm-1): ν̃  = 3282 (N-H), 3097 (C-HAlkene), 2960 
(C-HAlkane), 2924 (C-HAlkane), 2853 (C-HAlkane), 1713 (C=C), 1456 (C-HAlkane), 1404, 1322 
(S=O), 1167 (S=O), 1132 (C-F), 1062 (C-O), 917, 843. HRMS (FTMS + p NSI ((DCM) / 
MeOH + NH4OAc)): Calc. for C16H19F3O3NS [M+H]+: 362.1032 Found: 362.1036.  
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4-Methoxymethyl-5-methyl-1-(4-trifluoromethyl-benzenesulfonyl)-2,7-dihydro-1H-
azepine (299g) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.94 (d, J = 8.2 Hz, 2H; HAr-11), 7.79 (d, J = 8.2 Hz, 
2H; HAr-12), 5.86 (t, J = 7.0 Hz, 1H; H-2), 5.76 (tq, J = 7.1, 1.4 Hz, 1H; H-5), 3.91 (s, 2H; H-
7), 3.64 (d, J = 7.0 Hz, 2H; H-1), 3.60 (d, J = 7.1 Hz, 2H; H-6), 3.17 (s, 3H; H-8), 1.79 (s, 3H; 
H-9). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 145.7 (Cq), 143.0 (Cq), 128.1 (2 x CHAr; C-11), 
127.2 (q, JC-F = 262.3 Hz; CF3), 126.2 (q, JC-F = 3.6 Hz; 2 x CHAr-C-12), 123.8 (CH; C-5), 
123.6 (CH; C-2), 73.4 (CH2; C-7), 58.1 (CH3; C-8), 43.9 (CH2; C-6), 43.7 (CH2; C-1), 19.8 
(CH3; C-9). (Cq; C-13) could not be identified. 19F NMR (471 MHz, CDCl3, 25 oC) δ = - 63.07. 
IR (Film, cm-1): ν̃ = 3118, 3052 (C-HAlkene), 2924 (C-HAlkane), 2852 (C-HAlkane), 2826 (C-
HAlkane), 1738 (C=C), 1456 (C-HAlkane), 1323 (S=O), 1167 (S=O), 1110 (C-O), 1062 (C-N), 
1015, 845. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for C16H19F3O3NS 
[M+H]+: 362.1032 Found: 362.1036.  
 Compound 305g’ was identify as inseparable mixture with compound 299g, however, 
due to the low concentration was impossible to fully characterize the product. 
4-Methoxymethyl-1-(4-trifluoromethyl-benzenesulfonyl)-3-vinyl-1,2,3,6-tetrahydro-
pyridine (305g) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.92 (d, J = 8.2 Hz, 2H; HAr-11), 7.80 (d, J = 8.2 Hz, 
2H; HAr-12), 5.82 – 5.72 (m, 1H; H-6), 5.70 – 5.66 (m, 1H; H-4), 5.18 – 5.16 (m, 1H; H-7), 
5.14 – 5.11 (m, 1H; H-7), 3.91 – 3.87 (m, 1H; H-5), 3.88 – 3.83 (m, 1H; H-8), 3.68 (d, J = 
12.3 Hz, 1H; H-8), 3.51 – 3.45 (m, 1H; H-1), 3.45 – 3.38 (m, 1H; H-5), 3.26 (s, 3H; H-9), 2.98 
– 2.94 (m, 1H; H-2), 2.94 – 2.91 (m, 1H; H-1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 136.6 
(CH; C-6), 135.5 (Cq; C-10), 132.9 (Cq; C-3), 128.2 (2 x CHAr; C-11), 126.4 (q, JC-F = 3.7 Hz; 
2 x CHAr; C-12), 119.6 (CH; C-4), 117.7 (CH2; C-7), 73.5 (CH2; C-8), 58.2 (CH3; C-9), 47.8 
(CH2; C-1), 44.8 (CH2; C-5), 40.3 (CH; C-2). (Cq; C-13), (Cq; CF3) could not be identified. 19F 
NMR (471 MHz, CDCl3, 25 oC) δ = - 63.11. IR (Film, cm-1): ν̃  = 3095 (C-HAlkene), 2963 (C-
HAlkane), 2923 (C-HAlkane), 2852 (C-HAlkane), 1607 (C=C), 1457, 1322 (S=O), 1302 (C-O), 1170 
226 
 
(S=O), 1133 (C-F), 961. HRMS (FTMS + p NSI ((DCM) / MeOH + NH4OAc)): Calc. for 
C16H19F3NO3S [M+H]+: 362.1032 Found: 362.1035.  
Synthesis of 4-methoxymethyl-3-(2-methyl-propenyl)-1-(toluene-4-sulfonyl)-1,2,3,6-
tetrahydro-pyridine (305l) 
 
 From 1,5-bisallene 207 (66 mg, 0.22 mmol), PtCl2(MeCN)2 (4 mg, 0.01 mmol), silver 
hexafluoroantimonate (8 mg, 0.02 mmol), dry MeOH (240 µl, 5.95 mmol) and  2.2 mL of dry 
THF. Obtained after column chromatography using Hex / EtOAc (4:1) as eluent: 305l, 11 mg, 
0.03 mmol (16%): colourless oil. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.66 (d, J = 8.2 Hz, 
2H; HAr-13), 7.31 (d, J = 8.2 Hz, 2H; HAr-14), 5.62 – 5.59 (m, 1H; H-4), 5.07 – 5.02 (m, 1H; 
H-6), 3.79 – 3.75 (m, 1H; H-10), 3.75 – 3.70 (m, 1H; H-5), 3.60 (d, J = 12.6 Hz, 1H; H-10), 
3.46 – 3.39 (m, 1H; H-5), 3.24 (s, 3H; H-11), 3.20 – 3.17 (m, 1H; H-1), 3.16 – 3.13 (m, 1H; 
H-2), 2.98 – 2.93 (m, 1H; H-1), 2.42 (s, 3H; H-16), 1.71 (d, J = 1.1 Hz, 3H; H-8), 1.68 (d, J = 
1.1 Hz, 3H; H-9). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 143.6 (Cq; C-15), 136.9 (Cq; C-12), 
134.3 (Cq; C-3), 129.7 (2 x CHAr; C-14), 127.9 (2 x CHAr; C-13), 123.5 (CH; C-6), 119.2 (CH; 
C-4), 73.7 (CH2; C-10), 58.1 (CH3; C-11), 48.3 (CH2; C-1), 44.8 (CH2; C-5), 35.1 (CH; C-2), 
26.0 (CH3; C-9), 21.7 (CH3; C-16), 18.3 (CH3; C-8). IR (Film, cm-1): ν̃ = 3034 (C-HAlkene), 
2958 (C-HAlkane), 2922 (C-HAlkane), 2853 (C-HAlkane), 1733 (C=C), 1600 (C=CAr), 1454 (C-
HAlkane), 1346 (S=O), 1160 (S=O), 1100 (C-O), 1098 (C-N), 961, 819. HRMS (FTMS + p NSI 
((DCM)/MeOH + NH4OAc)): Calc. for C18H26O3NS [M+H]+: 336.1628 Found: 336.1629. 
Synthesis of products 305i, 298i and 299i (traces) 
 
 From 1,5-bisallene 266i (104 mg, 0.52 mmol), PtCl2(MeCN)2 (9 mg, 0.03 mmol), 
silver hexafluoroantimonate (18 mg, 0.05 mmol), dry MeOH (574 µl, 14.18 mmol) and  5.2 
mL of dry THF. Obtained as inseparable mixture after column chromatography using PET / 
EtOAc (7:1) then (4:1) as eluent: 305i:298i (2.9:1), 38 mg, 0.16 mmol (32%): colourless oil. 
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Compound 299i was identified by 1H NMR in the reaction crude, however, due to the low 
concentration of product, it was difficult identify the signals accurately. 
1-Methanesulfonyl-4-methoxymethyl-3-vinyl-1,2,3,6-tetrahydro-pyridine (305i) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.83 – 5.74 (m, 1H; H-4), 5.78 – 5.74 (m, 1H; H-6), 
5.18 – 5.12 (m, 2H; H-7), 3.95 – 3.90 (m, 1H; H-5), 3.92 – 3.87 (m, 1H; H-8), 3.73 (d, J = 
12.0 Hz, 1H; H-8), 3.69 – 3.63 (m, 1H; H-5), 3.48 (dd, J = 11.9, 3.7 Hz, 1H; H-1), 3.30 (s, 3H; 
H-9), 3.17 (dd, J = 11.9, 4.1 Hz, 1H; H-1), 3.00 – 2.96 (m, 1H; H-2), 2.80 (s, 3H; H-10). 13C 
NMR (126 MHz, CDCl3, 25 oC) δ = 136.7 (CH; C-6), 135.6 (Cq; C-3), 120.2 (CH; C-4), 117.5 
(CH2; C-7), 73.6 (CH2; C-8), 58.3 (CH3; C-9), 47.4 (CH2; C-1), 44.7 (CH2; C-5), 40.4 (CH; C-
2), 35.5 (CH3; C-10).  
N-(3-Methoxymethyl-4-methylene-hexa-2,5-dienyl)-methanesulfonamide (298i) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 6.40 (dd, J = 17.3, 10.5 Hz, 1H; H-5), 5.79 – 5.74 (m, 
1H; H-2), 5.30 (d, J = 0.8 Hz, 1H; H-9), 5.18 – 5.13 (m, 1H; H-6), 5.14 – 5.08 (m, 1H; H-6), 
5.00 (s, 1H; H-9), 4.32 – 4.29 (m, 1H; NH), 3.89 (d, J = 1.3 Hz, 2H; H-7), 3.69 – 3.65 (m, 2H; 
H-1), 3.35 (s, 3H; H-8), 2.92 (s, 3H; H-10). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 143.8 (Cq; 
C-3 or C-4), 140.1 (Cq; C-3 or C-4), 137.2 (CH; C-5), 123.5 (CH; C-2) 119.0 (CH2; C-9), 
116.5 (CH2; C-6), 75.1 (CH2; C-7), 58.5 (CH3; C-8), 41.7 (CH2; C-1), 40.7 (CH3; C-10). 
305i and 298i as inseparable mixture. IR (Film, cm-1): ν̃ = 3480 (N-H), 3081 (C-HAlkene), 2980 
(C-HAlkane), 2929 (C-HAlkane), 2854 (C-HAlkane), 1638 (C=C), 1337 (S=O), 1151 (S=O), 1095 
(C-O), 967, 778. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for C18H26O3NS 
[M+H]+: 336.1628 Found: 336.1629. 
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Synthesis of products 314 and 318 using EtOH as nucleophile. 
 
 From 1,5-bisallene 204a (50 mg, 0.18 mmol), PtCl2(MeCN)2 (3 mg, 0.01 mmol), 
silver hexafluoroantimonate (6 mg, 0.02 mmol), dry EtOH (288 µl, 4.94 mmol) and 1.8 mL of 
dry THF. Obtained after column chromatography using PET / EtOAc (4:1) as eluent: 314, 14 
mg, 0.04 mmol (23%): colourless oil; and 318, 12 mg, 0.04 mmol (20%): colourless oil. 
4-Ethoxymethyl-1-(toluene-4-sulfonyl)-3-vinyl-1,2,3,6-tetrahydro-pyridine (314) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.66 (d, J = 8.2 Hz, 2H; HAr-12), 7.31 (d, J = 8.2 Hz, 
2H; HAr-13), 5.80 (ddd, J = 17.1, 10.1, 8.5 Hz, 1H; H-6), 5.68 – 5.65 (m, 1H; H-4), 3.87 (dd, 
J = 12.3, 2.0 Hz, 1H; H-8), 3.84 – 3.79 (m, 1H; H-5), 3.75 (dd, J = 12.3, 0.8 Hz, 1H; H-8), 
3.45 – 3.40 (m, 2H; H-9), 3.45 – 3.35 (m, 1H; H-1), 3.37 – 3.32 (m, 1H; H-5), 2.96 – 2.92 (m, 
1H; H-2), 2.87 (dd, J = 11.4, 4.1 Hz, 1H; H-1), 2.43 (s, 3H; H-15), 1.16 (t, J = 7.0 Hz, 3H; H-
10). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 143.7 (Cq), 137.1 (CH; C-6), 135.6 (Cq), 133.3 
(Cq), 129.8 (2 x CHAr; C-13), 127.9 (2 x CHAr; C-12), 119.7 (CH; C-4), 117.2 (CH2; C-7), 71.5 
(CH2; C-8), 65.9 (CH2; C-9), 47.8 (CH2; C-1), 44.9 (CH2; C-5), 40.6 (CH; C-2), 21.7 (CH3; C-
15), 15.3 (CH3; C-10). IR (Film, cm-1): ν̃ = 3090 (C-HAlkene), 3066 (C-HAr), 3039 (C-HAr), 2966 
(C-HAlkane), 2919 (C-HAlkane), 2850 (C-HAlkane), 1648 (C=C), 1598, 1456 (C-HAlkane), 1331 
(S=O), 1161 (S=O), 1094 (C-N), 1042 (C-O), 908, 814. HRMS (FTMS + p NSI 
((DCM)/MeOH + NH4OAc)): Calc. for C18H26O3NS [M+H]+: 322.1471. Found: 322.1472. 
N-(3-Ethoxymethyl-4-methylene-hexa-2,5-dienyl)-4-methyl-benzenesulfonamide (318) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.72 (d, J = 8.2 Hz, 2H; HAr-12), 7.29 (d, J = 8.2 Hz, 
2H; HAr-13), 6.30 (dd, J = 17.3, 10.5 Hz, 1H; H-5), 5.62 (tt, J = 7.0, 1.5 Hz, 1H; H-2), 5.17 (d, 
J = 0.8 Hz, 1H; H-10), 5.08 – 5.04 (m, 1H; H-6), 5.03 (d, J = 17.3 Hz, 1H; H-6), 4.88 (s, 1H; 
H-10), 4.28 (bt, J = 5.9 Hz, 1H; NH), 3.86 (d, J = 1.5 Hz, 2H; H-7), 3.52 – 3.47 (m, 2H; H-1), 
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3.44 (q, J = 7.0 Hz, 2H; H-8), 2.43 (s, 3H; H-15), 1.17 (t, J = 7.0 Hz, 3H; H-9). 13C NMR (126 
MHz, CDCl3, 25 oC) δ = 143.8 (Cq), 143.5 (Cq), 140.4 (Cq), 137.2 (CH; C-5), 137.2 (Cq), 129.8 
(2 x CHAr; C-13), 127.3 (2 x CHAr; C-12), 122.7 (CH; C-2), 118.8 (CH2; C-10), 116.3 (CH2; 
C-6), 73.0 (CH2; C-7), 66.1 (CH2; C-8), 41.6 (CH2; C-1), 21.7 (CH3; C-15), 15.2 (CH3 C-9). 
IR (Film, cm-1): ν̃ = 3286 (N-H), 3094 (C-HAlkene), 3028 (C-HAr), 2977 (C-HAlkane), 2925 (C-
HAlkane), 2857 (C-HAlkane), 1720 (C=C), 1598, 1442 (C-HAlkane), 1352 (S=O), 1336, 1161 (S=O), 
1094 (C-O), 1051, 912, 815. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for 
C18H26O3NS [M + H]+: 322.1471. Found: 322.1474. 
Synthesis of products 317 and 313 using 1-propanol as nucleophile 
 
 From 1,5-bisallene 204a (53 mg, 0.19 mmol), PtCl2(MeCN)2 (3 mg, 0.01 mmol), 
silver hexafluoroantimonate (7 mg, 0.02 mmol), 1-Propanol (393 µl, 5.27 mmol) and 1.9 mL 
of dry THF. Obtained after column chromatography using PET / EtOAc (7:1) as eluent: 317, 
13 mg, 0.04 mmol (20%): colourless oil; and 313, 15 mg, 0.05 mmol (24%): colourless oil. 
4-Propoxymethyl-1-(toluene-4-sulfonyl)-3-vinyl-1,2,3,6-tetrahydro-pyridine (317) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.66 (d, J = 8.2 Hz, 2H; HAr-13), 7.31 (d, J = 8.2 Hz, 
2H; HAr-14), 5.80 (ddd, J = 17.1, 10.1, 8.5 Hz, 1H; H-6), 5.69 – 5.64 (m, 1H; H-4), 5.18 – 5.10 
(m, 2H; H-7), 3.87 (d, J = 12.3 Hz, 1H; H-8), 3.84 – 3.78 (m, 1H; H-5), 3.74 (d, J = 12.3 Hz, 
1H; H-8), 3.42 (dd, J = 11.4, 3.6 Hz, 1H; H-1), 3.38 – 3.34 (m, 1H; H-5), 3.33 – 3.23 (m, 2H; 
H-9), 2.97 – 2.93 (m, 1H; H-2), 2.87 (dd, J = 11.4, 4.1 Hz, 1H; H-1), 2.43 (s, 3H; H-16), 1.55 
(sex, J = 7.3 Hz, 1H; H-10), 0.89 (t, J = 7.3 Hz, 3H; H-11). 13C NMR (126 MHz, CDCl3, 25 
oC) δ = 143.7 (Cq), 137.1 (CH; C-6), 135.7 (Cq), 133.3 (Cq), 129.8 (2 x CHAr; C-14), 127.9 (2 
x CHAr; C-13), 119.6 (CH; C-4), 117.2 (CH2; C-7), 72.3 (CH2; C-9), 71.7 (CH2; C-8), 47.8 
(CH2; C-1), 44.9 (CH2; C-5), 40.6 (CH; C-2), 23.0 (CH2; C-10), 21.7 (CH3; C-16), 10.8 (CH3; 
C-11). IR (Film, cm-1): ν̃ = 3083 (C-HAlkene), 3069 (C-HAlkene), 3035 (C-HAr), 2961 (C-HAlkane), 
2924 (C-HAlkane), 2852 (C-HAlkane), 1637 (C=C), 1597, 1457 (C-HAlkane), 1347 (S=O), 1163 
(S=O), 1120 (C-O), 1093 (C-N), 955, 815. HRMS (FTMS + p NSI ((DCM)/MeOH + 
NH4OAc)): Calc. for C14H17O5N2S [M-H+O]+: 350.1421. Found: 350.1425. 
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4-Methyl-N-(4-methylene-3-propoxymethyl-hexa-2,5-dienyl)-benzenesulfonamide (313) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.72 (d, J = 8.2 Hz, 2H; HAr-13), 7.29 (d, J = 8.2 Hz, 
2H; HAr-14), 6.30 (dd, J = 17.3, 10.5 Hz, 1H; H-5), 5.62 (tt, J = 7.0, 1.5 Hz, 1H; H-2), 5.17 (d, 
J = 0.8 Hz, 1H; H-11), 5.07 (d, J = 10.5 Hz, 1H; H-6), 5.04 (d, J = 17.3 Hz, 1H; H-6), 4.88 (s, 
1H; H-11), 4.26 (bt, J = 5.9 Hz, 1H; NH), 3.86 (d, J = 1.5 Hz, 2H; H-7), 3.53 – 3.47 (m, 2H; 
H-1), 3.34 (t, J = 6.9 Hz, 2H; H-8), 2.43 (s, 3H; H-16), 1.61 – 1.52 (m, 2H; H-9), 0.90 (t, J = 
7.2 Hz, 3H; H-10). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 143.8 (Cq), 143.5 (Cq), 140.5 (Cq), 
137.3 (CH; C-5), 137.2 (Cq), 129.8 (2 x CHAr; C-14), 127.3 (2 x CHAr; C-13), 122.6 (CH; C-
2), 118.8 (CH2; C-11), 116.3 (CH2; C-6), 73.2 (CH2; C-7 or C-8), 72.5 (CH2; C-7 or C-8), 41.6 
(CH2; C-1), 23.0 (CH3; C-16), 21.7 (CH2; C-9), 10.8 (CH3; C-10). IR (Film, cm-1): ν̃ = 3291 
(N-H), 3090 (C-HAlkene), 3066 (C-HAlkene), 3039 (C-HAr), 2966 (C-HAlkane), 2929 (C-HAlkane), 
2850 (C-HAlkane), 1648 (C=C), 1598, 1456 (C-HAlkane), 1331 (S=O), 1161 (S=O), 1094 (C-N), 
1042 (C-O), 908, 814. HRMS (FTMS + p APCI (OIL)): Calc. for C18H26O3NS [M+H]+: 
336.1628. Found: 336.1624. 
General procedures for platinum-catalysed hydroxycyclisation of 1,5-bisallenes 
Procedure 1 
 To a microwave vial were added PtCl2(MeCN)2 (0.05 Eq.) and AgSbF6 (0.1 Eq.). Then 
the vial was closed with a stopper and flushed with N2 during 3 min. A small amount of dry 
THF was added and the solution was stirred at room temperature for a few min to preform the 
cationic complex. The corresponding 1,5-bisallene (1.0 Eq., 0.091 M – absolute concentration) 
dissolved in dry THF was added, then distilled H2O (THF:H2O, 18:1). The vial was sealed and 
placed in a pre-heated oil bath at 70 oC or under microwave irradiation until completed 
conversion, following the reaction by TLC. The crude was filtered through a pad of celite / 
MgSO4 anhydrous (1:2), washed with dichloromethane and concentrated under vacuum. The 
mixture was purified by column chromatography using (Sigma-Aldrich Silica gel) and PET, 
Hex / Et2O, EtOAc as eluents.    
Procedure 2 
 To a microwave vial were added PtCl2(MeCN)2 (0.05 Eq.) and AgSbF6 (0.12 Eq.). 
Then the vial was closed with a stopper and flushed with N2 during 3 min. A small amount of 
dry THF was added and the solution was stirred at room temperature for a few min to preform 
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the cationic complex. The corresponding 1,5-bisallene (1.0 Eq., 0.09 M – absolute 
concentration) dissolved in dry THF was added, then distilled H2O (THF:H2O, 1:3) was added. 
The vial was sealed under N2 and placed in a pre-heated oil bath at 70 oC or under microwave 
irradiation until completed conversion, following the reaction by TLC. The crude was filtered 
through a pad of celite / MgSO4 anhydrous (1:2), washed with acetonitrile and concentrated 
under vacuum. The mixture was purified by column chromatography using (Sigma-Aldrich 
Silica gel) and PET, Hex / Et2O, EtOAc as eluents. 
Synthesis of products 315a, 316a and 319a 
Procedure 1 
 From 1,5-bisallene 204a (116 mg, 0.42 mmol), PtCl2(MeCN)2 (7 mg, 0.02 mmol), 
silver hexafluoroantimonate (14 mg, 0.04 mmol), distilled water (234 µl, 10.95 mmol) and 4.0 
mL of dry THF. Obtained as inseparable mixture after column chromatography using Hex / 
EtOAc (10:1) then (3:1) as eluent: 315a:316a:319a (1:1.4:2), 50 mg, 0.17 mmol (41%): yellow 
oil. 
Procedure 2 
 From 1,5-bisallene 204a (100 mg, 0.36 mmol), PtCl2(MeCN)2 (6 mg, 0.02 mmol), 
silver hexafluoroantimonate (15 mg, 0.04 mmol), distilled water (3.0 mL, 0.17 mmol) and 1.0 
mL of dry THF. Obtained as inseparable mixture after column chromatography using PET / 
EtOAc (5:1) then (1:1) as eluent: 316a:319a (1:9.8), 46 mg, 0.16 mmol (43%): yellow oil. 
N-(3-Hydroxymethyl-4-methylene-hexa-2,5-dienyl)-4-methyl-benzenesulfonamide 
(315a) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.71 (d, J = 8.2 Hz, 2H; HAr-10), 7.33 – 7.29 (m, 2H; 
HAr-11), 6.31 (dd, J = 17.4, 10.5 Hz, 1H; H-5), 5.64 (tt, J = 6.8, 1.3 Hz, 1H; H-2), 5.19 (s, 1H; 
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H-8), 5.08 (d, J = 10.5 Hz, 1H; H-6), 5.03 (d, J = 17.4 Hz, 2H; H-6), 4.91 (s, 1H; H-8), 4.45 
(bt, J = 6.1 Hz, 1H; NH), 4.04 (s, 2H; H-7), 3.49 (d, J = 6.8 Hz, 1H; H-1), 3.48 (d, J = 6.1 Hz, 
1H; H-1), 2.42 (s, 3H; H-13). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 143.6 (Cq), 143.5 (Cq), 
142.7 (Cq), 137.1 (CH; C-5), 137.1 (Cq), 129.8 (2 x CHAr; C-11), 127.3 (2 x CHAr; C-10), 122.4 
(CH; C-2), 65.8 (CH2; C-7), 41.6 (CH2; C-1), 21.7 (CH3; C-13). 
[5-Methyl-1-(toluene-4-sulfonyl)-2,7-dihydro-1H-azepin-4-yl]-methanol (316a) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.68 (d, J = 8.2 Hz, 2H; HAr-11), 7.30 (d, J = 8.2 Hz, 
2H; HAr-10), 5.88 (t, J = 7.0 Hz, 1H; H-2), 5.73 (tq, J = 7.0, 1.2 Hz, 1H; H-5), 4.13 (s, 2H; H-
7), 3.58 (d, J = 7.0 Hz, 2H; H-1), 3.57 (d, J = 7.0 Hz, 2H; H-6), 2.42 (s, 3H; H-13), 1.79 (s, 
3H; H-8). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 147.6 (Cq), 143.4 (Cq), 142.0 (Cq), 136.2 
(Cq), 129.8 (2 x CHAr; C-11), 127.6 (2 x CHAr; C-10), 124.5 (CH; C-5), 122.5 (CH; C-2), 63.8 
(CH2; C-7), 43.8 (CH2; C-6), 43.5 (CH2; C-1), 21.7 (CH3; C-13), 19.8 (CH3; C-8).  
[5-methylene-1-(toluene-4-sulfonyl)-2,5,6,7-tetrahydro-1H-azepin-4-yl]-methanol (319a) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.63 (d, J = 8.2 Hz, 2H; HAr-10), 7.25 (d, J = 8.2 Hz, 
2H; HAr-11), 5.80 (t, J = 5.3 Hz, 1H; H-2), 5.00 (s, 1H; H-8), 4.95 (s, 1H; H-8), 4.11 (s, 2H; 
H-7), 3.95 (d, J = 5.3 Hz, 2H; H-1), 3.44 (t, J = 6.4 Hz, 2H; H-6), 2.49 (t, J = 6.4 Hz, 2H; H-
5), 2.40 (s, 3H; H-13). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 143.3 (Cq), 142.8 (Cq), 142.6 
(Cq), 136.3 (Cq), 129.5 (2 x CHAr; C-11), 127.5 (2 x CHAr; C-10), 124.8 (CH; C-2), 115.1 (CH2; 
C-8), 65.3 (CH2; C-7), 48.8 (CH2; C-6), 45.0 (CH2; C-1), 36.3 (CH2; C-5), 21.6 (CH3; C-13). 
M.P. = 79 – 81 oC. 
315a, 316a and 319a as inseparable mixture. IR (Film, cm-1): ν̃ = 3521 (O-H), 3296 (N-H), 
3087 (C-HAlkene), 3063 (C-HAlkene), 3035 (C-HAr), 2925 (C-HAlkane), 2857 (C-HAlkane), 1725 
(C=C), 1598, 1455 (C-HAlkane), 1333 (S=O), 1159 (S=O), 1094 (C-N), 1070 (C-O), 904, 816. 
HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for C15H20O3NS [M+H]+: 
294.1158. Found: 294.1154. 
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Synthesis of products 316a-d4 and 319a-d4  
 
Procedure 2 
 From 1,5-bisallene 204a-d4 (150 mg, 0.54 mmol), PtCl2(MeCN)2 (9 mg, 0.03 mmol), 
silver hexafluoroantimonate (22 mg, 0.06 mmol), distilled water (4.5 mL, 0.25 mmol) and 1.5 
mL of dry THF. Obtained as inseparable mixture after column chromatography using PET / 
EtOAc (2:1) as eluent: 316a-d4:319a-d4 (1:10), 63 mg, 0.21 mmol (40%): white solid. 
[5-Methyl-1-(toluene-4-sulfonyl)-2,7-dihydro-1H-azepin-4-yl]-methanol-d4 (316a-d4) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.61 (d, J = 8.2 Hz, 2H; HAr-12), 7.23 (d, J = 8.2 Hz, 
2H; HAr-13), 5.81 (t, J = 7.0 Hz, 1H; H-2), 5.66 (t, J = 7.0 Hz, 1H; H-5), 4.07 (s, 2H; H-7, 5 
% H), 3.51 (d, J = 7.0 Hz, 2H; H-1), 3.51 (d, J = 7.0 Hz, 2H; H-6), 2.36 (s, 3H; H-15), 1.70 
(m, 1H; H-10). The deuterium incorporation in C-9, could not be accurately determine due to 
overlapping with other signals. 13C NMR (126 MHz, CDCl3, 25 oC) δ = 147.5 (Cq), 143.4 (Cq), 
142.7 (Cq), 136.1 (Cq), 129.8 (2 x CHAr; C-13), 127.5 (2 x CHAr; C-12), 124.4 (CH; C-5), 122.5 
(CH; C-2), 43.8 (CH2; C-6), 43.5 (CH2; C-1), 21.6 (CH3; C-15). C-8 and C-9 could not be 
assigned due to the high deuterium incorporation. 2H NMR (77 MHz, CDCl3, 25 oC) δ = 4.11 
(bs, 22H; 2H-7), 1.81 (bs, 12H; 2H-10), 1.79 (bs, 12H; 2H-10).  
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[5-methylene-1-(toluene-4-sulfonyl)-2,5,6,7-tetrahydro-1H-azepin-4-yl]-methanol-d4 
(319a-d4) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.57 (d, J = 8.2 Hz, 2H; HAr-12), 7.19 (d, J = 8.2 Hz, 
2H; HAr-13), 5.73 (t, J = 5.3 Hz, 1H; H-2), 4.92 (s, 1H; H-10, 5 % H), 4.87 (s, 1H; H-10, 5 % 
H), 4.05 (s, 2H; H-7, < 5 % H), 3.88 (d, J = 5.3 Hz, 2H; H-1), 3.37 (t, J = 6.4 Hz, 2H; H-6), 
2.42 (t, J = 6.4 Hz, 2H; H-5), 2.34 (s, 3H; H-15). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 
143.3 (Cq), 142.6 (Cq), 142.5 (Cq), 136.2 (Cq), 129.5 (2 x CHAr; C-13), 127.5 (2 x CHAr; C-12), 
48.8 (CH2; C-6), 45.0 (CH2; C-1), 36.2 (CH2; C-5), 21.6 (CH3; C-15). C-8 and C-9 could not 
be assigned due to the high deuterium incorporation. 2H NMR (77 MHz, CDCl3, 25 oC) δ = 
5.06 (bs, 12H; 2H-10), 5.01 (bs, 12H; 2H-10), 4.11 (bs, 22H; 2H-7).  
316a-d4 and 319a-d4 as inseparable mixture. IR (Film, cm-1): ν̃ = 3514 (O-H), 2954 (C-HAlkane), 
2853 (C-HAlkane), 1644 (C=C), 1454 (C-HAlkane), 1332 (S=O), 1157 (S=O), 1096 (C-N), 1062 
(C-O), 907. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for C15H16D4O3NS 
[M+H]+: 298.1409. Found: 298.1409. M.P. = 106 – 108 oC. 
Synthesis of products 316c and 319c  
Procedure 1 
 
 From 1,5-bisallene 266c (103 mg, 0.34 mmol), PtCl2(MeCN)2 (6 mg, 0.02 mmol), 
silver hexafluoroantimonate (12 mg, 0.03 mmol), distilled water (187 µl, 10.38 mmol) and 3.4 
mL of dry THF. Obtained as inseparable mixture after column chromatography using PET / 
EtOAc (80:1) then (50:1) then (10:1) then (2:1) as eluent: 316c:319c (1:1), 55 mg, 0.18 mmol 
(54%): yellow solid.  
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Procedure 2 
 
 From 1,5-bisallene 266c (204 mg, 0.67 mmol), PtCl2(MeCN)2 (12 mg, 0.03 mmol), 
silver hexafluoroantimonate (28 mg, 0.08 mmol), distilled water (5.5 mL, 0.30 mmol) and 1.8 
mL of dry THF. Obtained after column chromatography using PET / EtOAc (2:1) as eluent: 
328c, 6 mg, 0.02 mmol (3%): yellow solid; and 315c:319c (1:5.9) as inseparable mixture, 75 
mg, 0.23 mmol (35%): yellow solid. 
[5-Methyl-1-(4-nitro-benzenesulfonyl)-2,7-dihydro-1H-azepin-4-yl]-methanol (316c) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 8.37 (d, J = 8.8 Hz, 2H; HAr-11), 7.99 (d, J = 8.8 Hz, 
2H; HAr-10), 5.93 (t, J = 7.1 Hz, 1H; H-2), 5.77 (tq, J = 7.2, 1.3 Hz, 1H; H-5), 4.18 (s, 2H; H-
7), 3.65 (d, J = 7.1 Hz, 2H; H-1), 3.63 (d, J = 7.2 Hz, 2H; H-6), 1.82 (s, 3H; H-8). 13C NMR 
(126 MHz, CDCl3, 25 oC) δ = 150.2 (Cq; C-12), 148.2 (Cq; C-3), 145.3 (Cq; C-9), 142.8 (Cq; 
C-4), 128.6 (2 x CHAr; C-10), 124.5 (2 x CHAr; C-11), 123.8 (CH; C-5), 121.6 (CH; C-2), 63.6 
(CH2; C-7), 43.8 (CH2; C-6), 43.6 (CH2; C-1), 19.9 (CH3; C-8). 
[5-methylene-1-(4-nitro-benzenesulfonyl)-2,5,6,7-tetrahydro-1H-azepin-4-yl]-methanol 
(319c) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 8.29 (d, J = 9.0 Hz, 2H; HAr-11), 7.95 (d, J = 9.0 Hz, 
2H; HAr-10), 5.84 (t, J = 4.3 Hz, 1H; H-2), 4.99 (s, 1H; H-8), 4.86 (s, 1H; H-8), 4.14 – 4.10 
(m, 2H; H-1), 4.09 (s, 2H; H-7), 3.53 (t, J = 6.4 Hz, 2H; H-6), 2.53 (t, J = 6.4 Hz, 2H; H-5), 
1.56 (bs, 1H; OH). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 150.0 (Cq; C-12), 145.5 (Cq; C-9), 
142.8 (Cq; C-4), 142.4 (Cq; C-3), 128.7 (2 x CHAr; C-10), 124.2 (2 x CHAr; C-11), 124.1 (CH; 
C-2), 115.6 (CH2; C-8), 64.8 (CH2; C-7), 49.0 (CH2; C-6), 45.0 (CH2; C-1), 36.3 (CH2; C-5). 
315c and 319c as inseparable mixture. IR (Film, cm-1): ν̃ = 3543 (O-H), 3104 (C-HAlkene), 3031 
(C-HAlkene), 2926 (C-HAlkane), 2863 (C-HAlkane), 1606 (C=C), 1531 (N-O), 1351 (S=O), 1309, 
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1161 (S=O), 1094 (C-N), 1061 (C-O), 910. HRMS (FTMS + p APCI (Solid)): Calc. for 
C14H17O5N2S [M+H]+: 325.0853. Found: 325.0854. M.P. = 141 – 143 oC. 
6,7-Dimethylene-3-(4-nitro-benzenesulfonyl)-3-aza-bicyclo[3.2.0]heptan (328c) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 8.35 (d, J = 8.8 Hz, 2H; HAr-7), 7.99 (d, J = 8.8 Hz, 
2H; HAr-6), 5.18 (s, 2H; H-4), 4.80 (s, 2H; H-4), 3.70 (d, J = 10.2 Hz, 2H; H-1), 3.40 – 3.35 
(m, 2H; H-2), 2.95 (dd, J = 10.2, 6.1 Hz, 2H; H-1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 
150.3 (Cq; C-8), 148.8 (2 x Cq; C-3), 142.4 (Cq; C-5), 129.1 (2 x CHAr; C-6), 124.2 (2 x CHAr; 
C-7), 106.2 (2 x CH2; C-4), 53.6 (2 x CH2; C-1), 44.9 (2 x CH; C-2). IR (Film, cm-1): ν̃ = 3110 
(C-HAlkene), 2969 (C-HAlkane), 2923 (C-HAlkane), 2853 (C-HAlkane), 1527 (N-O), 1347 (S=O), 
1168 (S=O), 1089 (C-N), 1015 (C-O), 897. HRMS (FTMS + p APCI (Solid)): Calc. for 
C14H15O4N2S [M+H]+: 307.0747. Found: 307.0749. M.P. = 156 – 158 oC. 
Synthesis of 2-[3-(2-Methyl-propenyl)-1-(toluene-4-sulfonyl)-1,2,3,6-tetrahydro-pyridin-
4-yl]-propan-2-ol (324p) 
Procedure 1 
 
 From 1,5-bisallene 293 (22 mg, 0.07 mmol), PtCl2(MeCN)2 (1 mg, 0.003 mmol), 
silver hexafluoroantimonate (2 mg, 0.01 mmol), distilled water (37 µl, 2.02 mmol) and 694 µl 
of dry THF. Obtained after column chromatography using Hex / EtOAc (10:1) then (6:1) then 
(2:1) as eluent: 324p, 4 mg, 0.01 mmol (16%): colourless oil. 1H NMR (500 MHz, CDCl3, 25 
oC) δ = 7.65 (d, J = 8.1 Hz, 2H; HAr-14), 7.31 (d, J = 8.1 Hz, 2H; HAr-15), 5.66 (dd, J = 3.5, 
3.0 Hz, 1H; H-4), 5.23 – 5.18 (m, 1H; H-6), 3.92 (dd, J = 16.2, 3.5 Hz, 1H; H-5), 3.42 (dd, J 
= 10.8, 3.0 Hz, 1H; H-1), 3.32 – 3.30 (m, 1H; H-5), 3.30 – 3.26 (m, 1H; H-2), 2.68 (dd, J = 
10.8, 3.6 Hz, 1H; H-1), 2.42 (s, 3H; H-17), 1.71 (d, J = 1.3 Hz, 3H; H-8 or H-9), 1.70 (d, J = 
1.3 Hz, 3H; H-8 or H-9), 1.27 (s, 3H; H-10 or H-11), 1.24 (s, 3H; H-10 or H-11). 13C NMR 
(126 MHz, CDCl3, 25 oC) δ = 146.1 (Cq), 143.6 (Cq), 133.3 (Cq), 133.3 (Cq), 129.7 (2 x CHAr; 
C-15), 127.9 (2 x CHAr; C-14), 126.8 (CH; C-6), 115.9 (CH; C-4), 73.1 (Cq; C-12), 49.8 (CH2; 
C-1), 44.9 (CH2; C-5), 34.8 (CH; C-2), 30.1 (CH3; C-10 or C-11), 29.9 (CH3; C-10 or C-11), 
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26.0 (CH3; C-8 or C-9), 21.7 (CH3; C-17), 18.2 (CH3; C-8 or C-9). IR (Film, cm-1): ν̃ = 3522 
(O-H), 3054 (C-HAlkene), 2970 (C-HAlkane), 2923 (C-HAlkane), 2853 (C-HAlkane), 1721 (C=C), 
1600, 1456 (C-HAlkane), 1340 (S=O), 1163 (S=O), 1092 (C-N), 1060 (C-O), 960. HRMS 
(FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for C19H27O3NSNa [M+Na]+: 372.1604. 
Found: 372.1602. 
Synthesis of products 324o and 326o 
Procedure 1 
 From 1,5-bisallene 207 (103 mg, 0.34 mmol), PtCl2(MeCN)2 (6 mg, 0.02 mmol), 
silver hexafluoroantimonate (12 mg, 0.03 mmol), distilled water (188 µl, 10.44 mmol) and 3.4 
mL of dry THF. Obtained after column chromatography using Hex / EtOAc (15:1) then (10:1) 
then (6:1) then (2:1) as eluent: 324o, 31 mg, 0.10 mmol (28%): yellow oil; and 326o, 26 mg, 
0.08 mmol (24%): yellow oil. 
[3-(2-Methyl-propenyl)-1-(toluene-4-sulfonyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-
methanol (324o) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.66 (d, J = 8.2 Hz, 2H; HAr-12), 7.32 (d, J = 8.2 Hz, 
2H; HAr-13), 5.65 – 5.61 (m, 1H; H-4), 5.05 – 5.00 (m, 1H; H-6), 3.95 (s, 2H; H-10), 3.70 – 
3.63 (m, 1H; H-5), 3.54 – 3.48 (m, 1H; H-5), 3.22 – 3.19 (m, 1H; H-2), 3.08 – 3.03 (m, 1H; 
H-1), 3.06 – 3.01 (m, 1H; H-1), 2.43 (s, 3H; H-15), 1.71 (d, J = 1.3 Hz, 3H; H-8 or H-9), 1.70 
(d, J = 1.3 Hz, 3H; H-8 or H-9). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 143.7 (Cq), 139.4 
(Cq), 134.8 (Cq), 133.3 (Cq), 129.8 (2 x CHAr; C-13), 127.9 (2 x CHAr; C-12), 123.5 (CH; C-
6), 117.7 (CH; C-4), 64.5 (CH2; C-10), 48.3 (CH2; C-1), 44.8 (CH2; C-5), 35.4 (CH; C-2), 26.0 
(CH3; C-8 or C-9), 21.7 (CH3; C-15), 18.4 (CH3; C-8 or C-9). IR (Film, cm-1): ν̃ = 3480 (O-
H), 3063 (C-HAlkene), 2977 (C-HAlkane), 2926 (C-HAlkane), 2881 (C-HAlkane), 1714 (C=C), 1598, 
1456 (C-HAlkane), 1338 (S=O), 1163 (S=O), 1092 (C-N), 1071 (C-O), 816. HRMS (FTMS + p 
NSI ((DCM)/MeOH + NH4OAc)): Calc. for C17H24O3NS [M+H]+: 322.1471. Found: 
322.1469. 
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N-(3-Isopropenyl-4-methylene-hexa-2,5-dienyl)-4-methyl-benzenesulfonamide (326o) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.73 (d, J = 8.2 Hz, 2H; HAr-12), 7.31 (d, J = 8.2 Hz, 
2H; HAr-13), 6.34 (dd, J = 17.3, 10.3 Hz, 1H; H-5), 5.58 (t, J = 7.1 Hz, 1H; H-2), 5.27 (d, J = 
1.1 Hz, 1H; H-10), 5.03 (d, J = 10.3 Hz, 1H; H-6), 4.96 (s, 2H; H-9), 4.92 (d, J = 17.3 Hz, 1H; 
H-6), 4.85 (s, 1H; H-10), 4.25 (bt, J = 6.0 Hz, 1H; NH), 3.57 – 3.53 (m, 2H; H-1), 2.43 (s, 3H; 
H-15), 1.81 (s, 3H; H-8). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 144.5 (Cq), 143.9 (Cq), 143.6 
(Cq), 141.3 (Cq), 138.0 (CH; C-5), 137.3 (Cq), 129.8 (2 x CHAr; C-13), 127.3 (2 x CHAr; C-12), 
122.6 (CH; C-2), 119.3 (CH2; C-10), 116.8 (CH2; C-9), 116.6 (CH2, C-6), 42.5 (CH2; C-1), 
21.7 (CH3; C-15), 20.1 (CH3; C-8). IR (Film, cm-1): ν̃ = 3093 (C-HAlkene), 3069 (C-HAlkene), 
3042 (C-HAlkene), 2926 (C-HAlkane), 2860 (C-HAlkane), 1718 (C=C), 1598, 1451 (C-HAlkane), 1333 
(S=O), 1160 (S=O), 1093 (C-N), 816. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): 
Calc. for C17H22O2NS [M+H]+: 304.1366. Found: 304.1368. 
Synthesis of products 315d, 316d and 319d 
 
Procedure 1 
 From 1,5-bisallene 266d (106 mg, 0.41 mmol), PtCl2(MeCN)2 (7 mg, 0.02 mmol), 
silver hexafluoroantimonate (14 mg, 0.04 mmol), distilled water (225 µl, 10.53 mmol) and 4.3 
mL of dry THF. Obtained as inseparable mixture after column chromatography using Hex / 
EtOAc (20:1) then (5:1) then (1:1) as eluent: 315f:316f:319f (2:1:3.8), 60 mg, 0.21 mmol 
(53%): colourless oil.  
Procedure 2 
 
 From 1,5-bisallene 266d (154 mg, 0.59 mmol), PtCl2(MeCN)2 (10 mg, 0.03 mmol), 
silver hexafluoroantimonate (24 mg, 0.07 mmol), distilled water (4.9 mL, 0.27 mmol) and 1.6 
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mL of dry THF. Obtained as inseparable mixture after column chromatography using PET / 
EtOAc (5:1) then (1:1) as eluent: 316d:319d (1:7.8), 86 mg, 0.31 mmol (52%): colourless oil.  
N-(3-Hydroxymethyl-4-methylene-hexa-2,5-dienyl)-benzenesulfonamide (315d) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.87 – 7.73 (m, 2H; HAr-10), 7.58 – 7.54 (m, 1H; HAr-
12), 7.51 – 7.44 (m, 2H; HAr-11), 6.28 (dd, J = 17.3, 10.5 Hz, 1H; H-5), 5.63 (t, J = 7.0 Hz, 
1H; H-2), 5.17 (s, 1H; H-8), 5.07 – 5.02 (m, 1H; H-6), 5.01 – 4.98 (m, 1H; H-6), 4.89 (s, 1H; 
H-8), 4.72 (bt, J = 5.7 Hz, 1H; NH), 4.02 (s, 2H; H-7), 3.53 – 3.40 (m, 2H; H-1). 13C NMR 
(126 MHz, CDCl3, 25 oC) δ = 142.7 (Cq; C-9), 140.0 (Cq; C-3 or C-4), 139.0 (Cq; C-3 or C-4), 
137.1 (CH; C-5), 132.8 (CHAr; C-12), 129.2 (2 x CHAr; C-11), 127.2 (2 x CHAr; C-10), 122.1 (CH; 
C-2), 119.0 (CH2; C-8), 116.6 (CH2; C-6), 65.7 (CH2; C-7), 41.6 (CH2; C-1).  
(1-Benzenesulfonyl-5-methylene-2,5,6,7-tetrahydro-1H-azepin-4-yl)-methanol (316d) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.82 – 7.79 (m, 2H; HAr-10), 7.60 – 7.49 (m, 1H; HAr-
12), 7.48 – 7.46 (m, 2H; HAr-11), 5.87 (t, J = 7.0 Hz, 1H; H-2), 5.71 (tq, J = 7.0, 1.4 Hz, 1H; 
H-5), 4.13 (s, 2H; H-7), 3.59 (d, J = 7.0 Hz, 2H; H-1), 3.58 (d, J = 7.0 Hz, 2H; H-6), 1.78 (s, 
3H; H-8). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 147.7 (Cq; C-3 or C-4), 142.1 (Cq; C-3 or 
C-4), 139.1 (Cq; C-9), 132.7 (CHAr; C-12), 129.2 (2 x CHAr; C-11), 127.5 (2 x CHAr; C-10), 
124.3 (CH; C-5), 122.3 (CH; C-2), 63.7 (CH2; C-7), 43.9 (CH2; C-6), 43.6 (CH2; C-1), 19.8 
(CH3; C-8).  
(1-Benzenesulfonyl-5-methyl-2,7-dihydro-1H-azepin-4-yl)-methanol (319d) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.78 – 7.73 (m, 2H; HAr-10), 7.59 – 7.56 (m, 1H; HAr-
12), 7.49 – 7.43 (m, 2H; HAr-11), 5.80 (tt, J = 5.0, 0.9 Hz, 1H; H-2), 4.99 (s, 1H; H-8), 4.91 (s, 
1H; H-8), 4.08 (d, J = 0.9 Hz, 2H; H-7), 3.99 (d, J = 5.0 Hz, 2H; H-1), 3.47 (t, J = 6.4 Hz, 2H; 
H-6), 2.49 (t, J = 6.4 Hz, 2H; H-5). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 142.7 (Cq; C-3 or 
C-4), 142.6 (Cq; C-3 or C-4), 139.3 (Cq; C-9), 132.5 (CHAr; C-12), 128.9 (2 x CHAr; C-11), 
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127.5 (2 x CHAr; C-10), 124.6 (CH; C-2), 115.2 (CH2; C-8), 65.1 (CH2; C-7), 48.8 (CH2; C-6), 
45.0 (CH2; C-1), 36.3 (CH2; C-5). 
315d, 316d and 319d as inseparable mixture. IR (Film, cm-1): ν̃ = 3518 (O-H), 3064 (C-
HAlkene), 2924 (C-HAlkane), 2864 (C-HAlkane), 1606 (C=C), 1447 (C-HAlkane), 1329 (S=O), 1159 
(S=O), 1095 (C-N), 1061 (C-O), 903. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): 
Calc. for C14H18O3NS [M+H]+: 280.1002. Found: 280.1003.  
Synthesis of products 315f, 316f and 319f 
Procedure 1 
 From 1,5-bisallene 266f (109 mg, 0.37 mmol), PtCl2(MeCN)2 (6 mg, 0.02 mmol), 
silver hexafluoroantimonate (13 mg, 0.04 mmol), distilled water (204 µl, 11.33 mmol) and 3.7 
mL of dry THF. Obtained as inseparable mixture after column chromatography using Hex / 
EtOAc (10:1) then (4:1) then (1:1) as eluent: 315f:316f:319f (1:4.7:6.9), 40 mg, 0.13 mmol 
(35%): yellow oil.  
Procedure 2 
 
 From 1,5-bisallene 266f (161 mg, 0.59 mmol), PtCl2(MeCN)2 (10 mg, 0.03 mmol), 
silver hexafluoroantimonate (23 mg, 0.07 mmol), distilled H2O (4.5 mL, 0.25 mmol) and 1.5 
mL of dry THF. Obtained as inseparable mixture after column chromatography using PET / 
EtOAc (2:1) then (1:1) as eluent: 316f:319f (1:7.6), 77 mg, 0.25 mmol (46%): yellow oil. 
4-Chloro-N-(3-hydroxymethyl-4-methylene-hexa-2,5-dienyl)-benzenesulfonamide (315f) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.77 (d, J = 8.7 Hz, 2H; HAr-10), 7.48 (d, J = 8.7 Hz, 
2H; HAr-11), 6.33 (dd, J = 17.3, 10.5 Hz, 1H; H-5), 5.66 (tt, J = 6.9, 1.4 Hz, 1H; H-2), 5.22 (s, 
1H; H-8), 5.09 (d, J = 10.5 Hz, 1H; H-6), 5.04 (d, J = 17.3 Hz, 1H; H-6), 5.01(overlap) (s, 1H; H-
8), 4.06 (s, 2H; H-7), 3.53 – 3.49 (m, 2H; H-1). Signal H-8, overlaps with a signal from 319f. 
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13C NMR (126 MHz, CDCl3, 25 oC) δ = 143.4 (Cq), 143.0 (Cq), 139.3 (Cq), 138.5 (Cq), 129.5 
(2 x CHAr; C-11), 128.7 (2 x CHAr; C-10), 121.9 (CH; C-2), 119.1 (CH2; C-8), 116.6 (CH2; C-
6), 65.7 (CH2; C-7), 41.6 (CH2; C-1).  
 [1-(4-Chloro-benzenesulfonyl)-5-methyl-2,7-dihydro-1H-azepin-4-yl]-methanol (316f)  
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.74 (d, J = 8.7 Hz, 2H; HAr-10), 7.49 (d, J = 8.7 Hz, 
2H; HAr-11), 5.91 (t, J = 7.2 Hz, 1H; H-2), 5.75 (tq, J = 7.3, 1.4 Hz, 1H; H-5), 4.16 (s, 2H; H-
7), 3.60 (d, J = 7.2 Hz, 2H; H-1), 3.58 (d, J = 7.3 Hz, 2H; H-6), 1.81 (bs, 3H; H-8). 13C NMR 
(126 MHz, CDCl3, 25 oC) δ = 147.9 (Cq), 142.4 (Cq), 139.2 (Cq), 129.5 (2 x CHAr; C-11), 128.9 
(2 x CHAr; C-10), 124.2 (CH; C-5), 122.1 (CH; C-2), 63.8 (CH2; C-7), 43.8 (CH2; C-6), 43.6 
(CH2; C-1), 19.8 (CH3; C-8). IR (Film, cm-1): ν̃ = 3494 (O-H), 3097 (C-HAlkene), 2923 (C-
HAlkane), 2860 (C-HAlkane), 1727 (C=C), 1586, 1336 (S=O), 1162 (S=O), 1093 (C-N), 1064 (C-
O), 913, 828. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for C14H1735ClO3NS 
[M+H]+: 314.0612. Found: 314.0616. Calc. for C14H1737ClO3NS [M+H]+: 316.0581. Found: 
316.0585.  
[1-(4-chloro-benzenesulfonyl)-5-methylene-2,5,6,7-tetrahydro-1H-azepin-4-yl]-
methanol  (319f) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.69 (d, J = 8.7 Hz, 2H; HAr-10), 7.43 (d, J = 8.7 Hz, 
2H; HAr-11), 5.81 (tt, J = 5.2, 1.0 Hz, 1H; H-2), 5.00 (s, 1H; H-8), 4.91 (s, 1H; H-8), 4.11 (d, 
J = 1.0 Hz, 2H; H-7), 4.01 (d, J = 5.2 Hz, 2H; H-1), 3.46 (t, J = 6.4 Hz, 2H; H-6), 2.50 (t, J = 
6.4 Hz, 2H; H-5). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 142.7 (Cq), 142.6 (Cq), 139.0 (Cq), 
138.0 (Cq), 129.2 (2 x CHAr; C-11), 129.0 (2 x CHAr; C-10), 124.4 (CH; C-2), 115.3 (CH2; C-
8), 65.0 (CH2; C-7), 48.8 (CH2; C-6), 45.0 (CH2; C-1), 36.3 (CH2; C-5).  
315f:316f:319f as inseparable mixture. IR (Film, cm-1): ν̃ = 3498 (O-H), 3350 (N-H), 3090 (C-
HAlkene), 2924 (C-HAlkane), 2854 (C-HAlkane), 1648 (C=C), 1585, 1335 (S=O), 1161 (S=O), 1093 
(C-N), 1052 (C-O), 903, 828. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for 
C14H1735ClO3NS [M+H]+: 314.0612. Found: 314.0616. Calc. for C14H1737ClO3NS [M+H]+: 
316.0581. Found: 316.0585. 
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Synthesis of products 316g and 319g 
Procedure 1 
 
 From 1,5-bisallene 266g (99 mg, 0.30 mmol), PtCl2(MeCN)2 (5 mg, 0.015 mmol), 
silver hexafluoroantimonate (10 mg, 0.03 mmol), distilled water (167 µl, 9.25 mmol) and 3.0 
mL of dry THF. Obtained as inseparable mixture after column chromatography using Hex / 
EtOAc (10:1) then (5:1) then (2:1) as eluent: 316g:319g (1:2.6), 35 mg, 0.10 mmol (34%): 
yellow solid.  
Procedure 2 
 From 1,5-bisallene 266g (149 mg, 0.45 mmol), PtCl2(MeCN)2 (8 mg, 0.02 mmol), 
silver hexafluoroantimonate (19 mg, 0.05 mmol), distilled water (3.8 mL, 0.21 mmol) and 1.3 
mL of dry THF. Obtained after column chromatography using PET / EtOAc (1:1) as eluent: 
316g:319g (1:8.5), 81 mg, 0.23 mmol (52%): yellow solid. 
[5-Methyl-1-(4-trifluoromethyl-benzenesulfonyl)-2,7-dihydro-1H-azepin-4-yl]-methanol 
(316g) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.94 (d, J = 8.2 Hz, 2H; HAr-10), 7.79 (d, J = 8.2 Hz, 
2H; HAr-11), 5.92 (t, J = 7.0 Hz, 1H; H-2), 5.76 (tq, J = 7.1, 1.5 Hz, 1H; H-5), 4.18 (s, 2H; H-
7), 3.64 (d, J = 7.0 Hz, 2H; H-1), 3.62 (d, J = 7.1 Hz, 2H; H-6), 1.82 (s, 3H; H-8). 13C NMR 
(126 MHz, CDCl3, 25 oC) δ = 147.9 (Cq), 143.0 (Cq), 142.5 (Cq), 128.0 (2 x CHAr; C-10), 127.3 
(q, JC-F = 238.0 Hz, Cq; CF3), 126.4 (q, JC-F = 3.7 Hz, 2 x CHAr; C-11), 124.1 (CH; C-5), 122.0 
(CH; C-2), 63.8 (CH2; C-7), 43.8 (CH2; C-1), 43.6 (CH2; C-6), 19.9 (CH3; C-8). Cq-12 could 
not be identified. 19F NMR (471 MHz, CDCl3, 25 oC) δ = - 63.00. IR (Film, cm-1): ν̃ = 3522 
(O-H), 3104 (C-HAlkene), 3059 (C-HAlkene), 2924 (C-HAlkane), 2860 (C-HAlkane), 1727 (C=C), 
1323 (S=O), 1165 (S=O), 1132 (C-F), 1058 (C-O), 920, 844. HRMS (FTMS + p NSI 
((DCM)/MeOH + NH4OAc)): Calc. for C15H17O3NSF3 [M+H]+: 348.0876. Found: 348.0876. 
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[5-Methylene-1-(4-trifluoromethyl-benzenesulfonyl)-2,5,6,7-tetrahydro-1H-azepin-4-
yl]-methanol (319g) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.87 (d, J = 8.2 Hz, 2H; HAr-10), 7.70 (d, J = 8.2 Hz, 
2H; HAr-11), 5.80 (t, J = 4.6 Hz, 1H; H-2), 4.94 (s, 1H; H-8), 4.82 (s, 1H; H-8), 4.05(Overlap) (s, 
2H; H-7), 4.04(overlap) (d, 2H; H-1), 3.48 (t, J = 6.4 Hz, 2H; H-6), 2.49 (t, J = 6.4 Hz, 2H; H-5). 
J coupling from the doublet at 4.04 ppm could not be obtained as it is overlapping with H-7. 
13C NMR (126 MHz, CDCl3, 25 oC) δ = 143.0 (Cq), 142.7 (Cq), 142.4 (Cq), 134.1 (q, JC-F = 
33.0 Hz, Cq; C-12), 128.0 (2 x CHAr; C-10), 126.0 (q, JC-F = 3.7 Hz, 2 x CHAr; C-11), 124.1 
(CH; C-2), 123.4 (q, JC-F = 272.9 Hz, Cq; CF3), 115.3 (CH2; C-8), 64.7 (CH2; C-7), 48.8 (CH2; 
C-6), 45.0 (CH2; C-1), 36.3 (CH2; C-5). 19F NMR (471 MHz, CDCl3, 25 oC) δ = - 63.07. IR 
(Film, cm-1): ν̃ = 3522 (O-H), 3107 (C-HAlkene), 3063 (C-HAlkene), 2926 (C-HAlkane), 2860 (C-
HAlkane), 1720 (C=C), 1404, 1324 (S=O), 1165 (S=O), 1133 (C-F), 1063 (C-O), 905, 844. 
HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for C15H20O3N2SF3 [M+NH4]+: 
365.1141. Found: 365.1146. M.P. of 316g and 319g as inseparable mixture = 104 – 106 oC. 
Synthesis of products 315i, 316i amd 319i 
Procedure 1 
 From 1,5-bisallene 266i (180 mg, 0.91 mmol), PtCl2(MeCN)2 (16 mg, 0.04 mmol), 
silver hexafluoroantimonate (31 mg, 0.09 mmol), distilled water (504 µl, 27.90 mmol) and 9.1 
mL of dry THF. Obtained as inseparable mixture after column chromatography using EtOAc 
/ DCM (1:1) as eluent: 315i:316i:319i (3:1:3), 101 mg, 0.47 mmol (52%): yellow-orange oil.  
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Procedure 2 
 From 1,5-bisallene 266i (151 mg, 0.76 mmol), PtCl2(MeCN)2 (13 mg, 0.04 mmol), 
silver hexafluoroantimonate (31 mg, 0.07 mmol), distilled water (6.3 mL, 0.35 mmol) and 2.1 
mL of dry THF. Obtained after column chromatography using PET / EtOAc (1:1) as eluent: 
315i:316i:319i (2.1:1:8.5), 51 mg, 0.24 mmol (31%): yellow-orange oil. 
N-(3-hydroxymethyl-4-methylene-hexa-2,5-dienyl)-methanesulfonamide (315i) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 6.41 (dd, J = 17.4, 10.6 Hz, 1H; H-5), 5.78 (t, J = 6.8 
Hz, 1H; H-2), 5.31 (s, 1H; H-8), 5.17 (d, J = 10.6 Hz, 1H; H-6), 5.13 (d, J = 17.4 Hz, 1H; H-
6), 5.04 (s, 1H; H-8), 4.15 – 4.12 (m, 2H; H-7), 3.68 (d, J = 6.8 Hz, 2H; H-1), 2.94 (s, 3H; H-
9). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 142.8 (Cq; C-4), 142.8 (Cq; C-3), 137.2 (CH; C-
5), 122.3 (CH; C-2), 119.1 (CH2; C-8), 116.7 (CH2; C-6), 65.7 (CH2; C-7), 41.7 (CH2; C-1), 
40.6 (CH3; C-9). 
(1-Methanesulfonyl-5-methyl-2,7-dihydro-1H-azepin-4-yl)-methanol (316i) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 6.13 (t, J = 7.0 Hz, 1H; H-2), 5.98 (tq, J = 7.0, 1.5 Hz, 
1H; H-5), 4.27 (s, 2H; H-7), 3.63 (d, J = 7.0 Hz, 2H; H-1), 3.60 (d, J = 7.0 Hz, 2H; H-6), 2.81 
(s, 3H; H-9), 1.93 (s, 3H; H-8). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 148.1 (Cq; C-3), 142.6 
(Cq; C-4), 124.5 (CH; C-5), 122.5 (CH; C-2), 63.8 (CH2; C-7), 43.6 (CH2; C-6), 43.4 (CH2; C-
1), 37.2 (CH3; C-9), 20.0 (CH3; C-8).  
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(1-methanesulfonyl-5-methylene-2,5,6,7-tetrahydro-1H-azepin-4-yl)-methanol (319i) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.92 (t, J = 5.2 Hz, 1H; H-2), 5.17 (s, 2H; H-8), 4.26 
– 4.24 (m, 2H; H-7), 4.05 (d, J = 5.2 Hz, 2H; H-1), 3.54 (t, J = 6.5 Hz, 2H; H-6), 2.79 (s, 3H; 
H-9), 2.61 (t, J = 6.5 Hz, 2H; H-5). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 143.7 (Cq; C-3), 
143.3 (Cq; C-4), 125.3 (CH; C-2), 115.5 (CH2; C-8), 65.1 (CH2; C-7), 48.7 (CH2; C-6), 44.5 
(CH2; C-1), 38.5 (CH3; C-9), 36.7 (CH2; C-5).  
315i:316i:319i as inseparable mixture. IR (Film, cm-1): ν̃ = 3512 (O-H), 3293 (N-H), 3088 (C-
HAlkene), 3011 (C-HAlkene), 2929 (C-HAlkane), 2870 (C-HAlkane), 1709 (C=C), 1585, 1411 (C-
HAlkane), 1319 (S=O), 1147 (S=O), 1061 (C-O), 964. HRMS (FTMS + p NSI ((DCM)/MeOH 
+ NH4OAc)): Calc. for C9H16O3NS [M+H]+: 218.0845. Found: 218.0844. Calc. for 
C9H19O3N2S [M+NH4]+: 235.1111 Found: 235.1111. 
Synthesis of products 316b, 319b, 324b and 325b 
Procedure 1 
 From 1,5-bisallene 204b (153 mg, 0.65 mmol), PtCl2(MeCN)2 (11 mg, 0.03 mmol), 
silver hexafluoroantimonate (22 mg, 0.06 mmol), distilled water (359 µl, 19.91 mmol) and 6.5 
mL of dry THF. Obtained after column chromatography using PET / EtOAc (10:1) then (7:1) 
then (2:1) as eluent: 316b, 15 mg, 0.06 mmol (9%): colourless oil; and 324b:325b (1:1.3) as 
inseparable mixture, 18 mg, 0.07 mmol (11%): colourless oil. 
Procedure 2 
 From 1,5-bisallene 204b (162 mg, 0.78 mmol), PtCl2(MeCN)2 (13 mg, 0.04 mmol), 
silver hexafluoroantimonate (32 mg, 0.09 mmol), distilled water (6.4 mL, 0.35 mmol) and 2.1 
mL of dry THF. Obtained as inseparable mixture after column chromatography using PET / 
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EtOAc (10:1) then (1:1) as eluent: 316b:319b:324b (3.1:1:9.3), 11 mg, 0.04 mmol (6%): 
colourless oil. 
4-Hydroxymethyl-5-methyl-cyclohepta-3,5-diene-1,1-dicarboxylic acid dimethyl ester 
(316b) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 6.16 (t, J = 6.8 Hz, 1H; H-2), 6.03 (tq, J = 6.8, 1.4 Hz, 
1H; H-5), 4.19 (s, 2H; H-7), 3.72 (s, 6H; H-11), 2.42 (d, J = 6.8 Hz, 2H; H-1), 2.40 (d, J = 6.8 
Hz, 2H; H-6), 1.85 (s, 3H; H-8). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 172.1 (2 x Cq; C-10), 
144.7 (Cq; C-3), 138.6 (Cq; C-4), 127.8 (CH; C-2 or C-5), 126.8 (CH; C-2 or C-5), 71.7 (CH2; 
C-7), 64.7 (Cq; C-9), 52.8 (2 x CH3; C-11), 32.1 (CH2; C-1 or C-6), 31.9 (CH; C-1 or C-6), 
20.2 (CH3; C-8). IR (Film, cm-1): ν̃ = 3480 (O-H), 2958 (C-HAlkane), 2931 (C-HAlkane), 1732 
(C=O), 1442, 1270 (C-O), 1250, 1085 (C-OOH). HRMS (FTMS + p NSI ((DCM)/MeOH + 
NH4OAc)): Calc. for C13H19O5 [M+H]+: 255.1227. Found: 255.1229. Calc. for C13H22O5N 
[M+NH4]+: 272.1492 Found: 272.1495. 
4-Hydroxymethyl-5-vinyl-cyclohex-3-ene-1,1-dicarboxylic acid dimethyl ester (324b) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.72 – 5.68 (m, 1H; H-4), 5.58 – 5.48 (m, 1H; H-6), 
5.10 (ddd, J = 17.1, 1.5, 0.8 Hz, 1H; H-7), 5.04 (dd, J = 10.0, 1.5 Hz, 1H; H-7), 3.97 – 3.88 
(m, 2H; H-8), 3.65 (s, 6H; H-11), 2.96 – 2.87 (m, 1H; H-2), 2.71 – 2.66 (m, 1H; H-5), 2.47 – 
2.40 (m, 1H; H-5), 2.37 (ddd, J = 13.5, 6.1, 2.0 Hz, 1H; H-1), 1.84 (dd, J = 13.5, 9.3 Hz, 1H; 
H-1). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 172.3 (2 x Cq; C-10), 139.8 (CH; C-6), 138.1 
(Cq; C-3), 122.6 (CH; C-4), 117.1 (CH2; C-7), 65.2 (CH2; C-8), 54.0 (Cq; C-9), 52.8 (2 x CH3; 
C-11), 39.4 (CH; C-2), 34.5 (CH2; C-1), 30.5 (CH2; C-5).  
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5-Ethylidene-4-hydroxymethyl-cyclohex-3-ene-1,1-dicarboxylic acid dimethyl ester 
(325b) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.71 – 5.68 (m, 1H; H-4), 5.66 (q, J = 7.0 Hz, 1H; H-
6), 4.18 (d, J = 1.0 Hz, 2H; H-8), 3.64 (s, 6H; H-11), 2.80 (s, 2H; H-1), 2.66 (d, J = 3.8 Hz, 
2H; H-5), 1.70 (d, J = 7.0 Hz, 3H; H-7). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 171.5 (2 x 
Cq; C-10), 138.1 (Cq; C-3), 121.3 (CH; C-6), 120.9 (CH; C-4), 63.8 (CH2; C-8), 52.9 (2 x CH3; 
C-11), 31.3 (CH2; C-5), 30.9 (CH2; C-1), 13.3 (CH3; C-7). Cq-3 and Cq-9 could not be 
identified.  
324b and 325b as inseparable mixture. IR (Film, cm-1): ν̃ = 3488 (O-H), 2960 (C-HAlkane), 2925 
(C-HAlkane), 2853 (C-HAlkane), 1730 (C=O), 1439, 1274 (C-O), 1271, 1200, 1086 (C-OOH). 
HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for C13H22O5N [M+NH4]+: 
272.1494 Found: 272.1495. 
4-Hydroxymethyl-5-methylene-cyclohept-3-ene-1,1-dicarboxylic acid dimethyl ester 
(319b) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 5.80 (t, J = 6.7 Hz, 1H; H-2), 5.07 (s, 1H; H-8), 5.02 
(s, 1H; H-8), 4.19 (s, 2H; H-7), 3.71 (s, 6H; H-11), 2.75 (d, J = 6.7 Hz, 2H; H-1), 2.51 – 2.48 
(m, 2H; H-6), 2.28 – 2.24 (m, 2H; H-5). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 172.2 (2 x 
Cq; C-10), 145.9 (Cq; C-3), 142.6 (Cq; C-4), 123.9 (CH; C-2), 113.5 (CH2; C-8), 66.2 (CH2; C-
7), 56.9 (Cq; C-9), 52.8 (2 x CH3; C-11), 32.8 (CH2; C-1), 32.5(CH2; C-6), 31.1 (CH2; C-5). 
IR (Film, cm-1): ν̃ = 3463 (O-H), 2960 (C-HAlkane), 2928 (C-HAlkane), 1730 (C=O), 1270 (C-O), 
1262, 1085 (C-OOH). HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for C13H19O5 
[M+H]+: 255.1228. Found: 255.1229. Calc. for C13H22O5N [M+NH4]+: 272.1494 Found: 
272.1495. 
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Synthesis of product 320a  
 
Procedure 1 
 To a microwave vial was added PtCl2(MeCN)2 (2 mg, 0.004 mmol, 0.05 Eq.). Then 
the vial was closed with a stopper and flushed with N2 during 3 min. A small amount of dry 
THF was added and the solution was stirred at room temperature for a few min. The 1,5-
bisallene 204a  (23 mg, 0.08 mmol, 1.0 Eq., 0.091 M – absolute concentration) dissolved in 
dry THF was added, then distilled water (THF:H2O, 18:1). Then the vial was sealed and placed 
in a pre-heated oil bath at 70 oC until completed conversion, following the reaction by TLC. 
The crude was filtered through a pad of celite / MgSO4 anhydrous (1:2), washed with 
dichloromethane and concentrated under vacuum. Obtained after column chromatography 
using PET / EtOAc (7:1) as eluent: 320a, 24 mg, 0.08 mmol (91%): yellow oil. 1H NMR (500 
MHz, CDCl3, 25 oC) δ = 9.77 (t, J = 0.8 Hz, 2H; H-5), 7.68 – 7.63 (m, 2H; HAr-7), 7.32 – 7.27 
(m, 2H; HAr-8), 3.14 – 3.09 (m, 4H; H-1), 2.54 (td, J = 7.0, 0.8 Hz, 4H; H-3), 2.42 (s, 3H; H-
10), 1.84 (p, J = 7.0 Hz, 4H; H-2). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 201.3 (2 x Cq; C-
4), 143.6 (Cq; C-9), 136.4 (Cq; C-6), 129.9 (2 x CHAr; C-8), 127.2 (2 x CHAr; C-7), 48.1 (2 x 
CH2; C-1), 40.8 (2 x CH2; C-3), 21.6 (CH3; C-10), 21.4 (2 x CH2; C-2). IR (Film, cm-1): ν̃ = 
3433, 2922 (C-HAlkane), 2851(C-HAlkane), 2729 (C-HAldehyde), 1717 (C=O), 1650 (C=C), 1454 
(C-HAlkane), 1334 (S=O), 1157 (S=O), 1089 (C-N). HRMS (FTMS + p NSI ((DCM)/MeOH + 
NH4OAc)): Calc. for C15H22O4NS [M+H]+: 312.1264. Found: 312.1268.  
Synthesis of product 315l 
Procedure 1 (under Mw irradiation) 
 From 1,5-bisallene 280a (140 mg, 0.40 mmol), PtCl2(MeCN)2 (7 mg, 0.02 mmol), 
silver hexafluoroantimonate (14 mg, 0.04 mmol), distilled water (222 µl, 12.30 mmol) and 4.0 
mL of dry THF. Obtained after column chromatography using PET / EtOAc (4:1) as eluent: 
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315l, 11 mg, 0.03 mmol (8%): yellow oil. 1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.73 (d, J = 
8.2 Hz, 2H; HAr-14), 7.33 – 7.26 (m, 5H; HAr), 7.17 – 7.13 (m, 2H; HAr), 5.65 (t, J = 6.8 Hz, 
1H; H-2), 5.17 (s, 1H; H-6 or H-8), 5.14 (s, 1H; H-6 or H-8), 5.09 (s, 1H; H-6 or H-8), 5.02 
(s, 1H; H-6 or H-8), 4.54 (bt, J = 5.9 Hz, 1H; NH), 4.12 (s, 2H; H-7), 3.64 (t, J = 6.8 Hz, 2H; 
H-1), 2.41 (s, 3H; H-17). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 148.6 (Cq), 144.7 (Cq), 144.5 
(Cq), 140.3 (Cq), 136.9 (Cq), 129.8 (CHAr), 128.6 (2 x CHAr), 128.2 (CHAr), 127.3 (2 x CHAr; 
C-14), 122.5 (CH; C-2), 119.7 (CH2; C-8 or C-6), 116.8 (CH2; C-8 or C-6), 65.9 (CH2; C-7), 
41.8 (CH2; C-1), 21.7 (CH3; C-17). IR (Film, cm-1): ν̃ = 3523 (O-H), 3280 (N-H), 3087 (C-
HAlkene), 3057 (C-HAlkene), 2929 (C-HAlkane), 2854 (C-HAlkane), 1690 (C=C), 1493, 1327 (S=O), 
1160 (S=O), 1093 (C-N), 1051 (C-O), 910. HRMS (FTMS + p NSI ((DCM)/MeOH + 
NH4OAc)): Calc. for C21H24O3NS [M+H]+: 370.1471 Found: 370.1473. 
Synthesis of products 315m, 315m’, 316m and 319m 
 
Procedure 1 
 From 1,5-bisallene 283 (132 mg, 0.46 mmol), PtCl2(MeCN)2 (8 mg, 0.02 mmol), 
silver hexafluoroantimonate (16 mg, 0.05 mmol), distilled water (253 µl, 14.03 mmol) and 4.6 
mL of dry THF. Obtained after column chromatography using PET / EtOAc (7:1) then (5:1) 
then (2:1) as eluent: 315m:315m’, (1.2:1) as inseparable mixture, 31 mg, 0.10 mmol (22%): 
yellow oil; and 316m:319m (1:1.4) as inseparable mixture, 30 mg, 0.10 mmol (21%): yellow 
oil. 
N-(3-Hydroxymethyl-1-methyl-4-methylene-hexa-2,5-dienyl)-4-methyl-
benzenesulfonamide (315m) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.74 – 7.71 (m, 2H; HAr-11), 7.31 – 7.28 (m, 2H; HAr-
12), 6.26 (dd, J = 17.4, 10.5 Hz, 1H; H-5), 5.51 – 5.47 (m, 1H; H-2), 5.13 (d, J = 1.0 Hz, 1H; 
H-8), 5.03 (d, J = 10.5 Hz, 1H; H-6), 5.00 (d, J = 17.4 Hz, 1H; H-6), 4.81 (s, 1H; H-8), 4.44 
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(bt, J = 5.9 Hz, 1H; NH), 4.02 (d, J = 1.2 Hz, 2H; H-7), 3.95 – 3.87 (m, 1H; H-1), 2.43 (s, 3H; 
H-14), 1.15 (d, J = 6.6 Hz, 3H; H-9). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 143.8 (Cq), 143.4 
(Cq), 139.8 (Cq), 138.0 (Cq), 136.9 (CH; C-5), 129.6 (2 x CHAr; C-12), 128.7 (CH; C-2), 127.3 
(2 x CHAr; C-11), 119.0 (CH2; C-8), 116.8 (CH2; C-6), 65.9 (CH2; C-7), 48.7 (CH; C-1), 22.9 
(CH3; C-9), 21.7 (CH3; C-14).  
N-(3-hydroxymethyl-4-methylene-hepta-2,5-dienyl)-4-methyl-benzenesulfonamide 
(315m’) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.71 – 7.68 (m, 2H; HAr-11), 7.28 – 7.25 (m, 2H; HAr-
12), 6.01 (dq, J = 15.6, 1.6 Hz, 1H; H-5), 5.59 (tt, J = 6.9, 1.5 Hz, 1H; H-2), 5.53 (q, J = 6.9 
Hz, 1H; H-6), 5.04 (s, 1H; H-8), 4.73 (s, 1H; H-8), 4.54 (t, J = 5.8 Hz, 1H; NH), 3.99 – 3.96 
(m, 2H; H-7), 3.52 – 3.48 (m, 2H; H-1), 2.42 (s, 3H; H-14), 1.71 (dd, J = 6.9, 1.6 Hz, 3H; H-
9). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 143.6 (Cq), 143.4 (Cq), 143.3 (Cq), 137.2 (Cq), 
131.7 (CH; C-5), 129.8 (2 x CHAr; C-12), 128.7 (CH; C-6), 127.4 (2 x CHAr; C-11), 121.9 
(CH; C-2), 116.0 (CH; C-8), 65.8 (CH2; C-7), 41.6 (CH2; C-1), 21.6 (CH3; C-14), 18.2 (CH3; 
C-9). 
315m and 315m’ as inseparable mixture. IR (Film, cm-1): ν̃ = 3567 (O-H), 3334 (N-H), 2921 
(C-HAlkane), 2851 (C-HAlkane), 1740 (C=C), 1648 (N-H(Bend)), 1538, 1459, 1370 (S=O), 1164 
(S=O), 1051 (C-O) . HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for 
C16H22O3NS [M+H]+: 308.1316. Found: 308.1318. 
[2,5-Dimethyl-1-(toluene-4-sulfonyl)-2,7-dihydro-1H-azepin-4-yl]-methanol (316m) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.67 – 7.62 (m, 2H; HAr-11), 7.26 – 7.21 (m, 2H; HAr-
12), 5.82 (d, J = 6.1 Hz, 1H; H-2), 5.83 – 5.79 (m, 1H; H-5), 4.50 – 4.42 (m, 1H; H-1), 4.04 
(s, 2H; H-7), 3.74 (dd, J = 14.5, 6.5 Hz, 1H; H-6), 3.68 (dd, J = 14.5, 6.7 Hz, 1H; H-6), 2.40 
(s, 3H; H-14), 1.70 (s, 3H; H-8), 1.32 (d, J = 6.9 Hz, 3H; H-9). 13C NMR (126 MHz, CDCl3, 
25 oC) δ = 140.3 (Cq; C-3), 138.2 (Cq; C-4), 137.7 (CqAr), 131.4 (CH; C-2), 129.6 (2 x CHAr; 
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C-12), 127.5 (2 x CHAr; C-11), 127.3 (CH; C-5), 66.0 (CH2; C-7), 53.0 (CH; C-1), 42.7 (CH2; 
C-6), 23.1 (CH3; C-9), 21.6 (CH3; C-14), 20.5 (CH3; C-8).  
[2-methyl-5-methylene-1-(toluene-4-sulfonyl)-2,5,6,7-tetrahydro-1H-azepin-4-yl]-
methanol (319m) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.67 – 7.63 (m, 2H; HAr-11), 7.26 – 7.21 (m, 2H; HAr-
12), 5.63 (d, J = 5.8 Hz, 1H; H-2), 4.96 (s, 1H; H-8), 4.88 (s, 1H; H-8), 4.84 – 4.77 (m, 1H; 
H-1), 4.12 (d, J = 13.5 Hz, 1H; H-7), 4.08 (d, J = 13.5 Hz, 1H; H-7), 3.90 – 3.82 (m, 1H; H-
6), 3.31 (dt, J = 13.6, 5.7 Hz, 1H; H-6), 2.51 – 2.44 (m, 2H; H-5), 2.40 (s, 3H; H-14), 1.21 (d, 
J = 7.1 Hz, 3H; H-9). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 143.1 (Cq; C-13), 142.6 (Cq; C-
3), 140.0 (Cq; C-4), 138.0 (Cq; C-10), 129.5 (2 x CHAr; C-12), 129.1 (CH; C-2), 127.4 (2 x 
CHAr; C-11), 115.2 (CH2; C-8), 66.2 (CH2; C-7), 52.4 (CH; C-1), 43.1 (CH2; C-6), 37.8 (CH2; 
C-5), 21.6 (CH3; C-14), 18.3 (CH3; C-9). 
316m and 319m as inseparable mixture. IR (Film, cm-1): ν̃ = 3517 (O-H), 2973 (C-HAlkane), 
2921 (C-HAlkane), 2852 (C-HAlkane), 1597 (C=C), 1451 (C-HAlkane), 1329 (S=O), 1155 (S=O), 
1095 (C-N), 1051 (C-O), 976, 815. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): 
Calc. for C16H25O3N2S [M+NH4]+: 325.1580. Found: 325.1582. Calc. for C16H22O3NS 
[M+H]+: 308.1315. Found: 308.1317. 
Synthesis of products 315e and 319e 
Procedure 2 
 From 1,5-bisallene 266e (160 mg, 0.55 mmol), PtCl2(MeCN)2 (9 mg, 0.03 mmol), 
silver hexafluoroantimonate (23 mg, 0.07 mmol), distilled water (4.5 mL, 0.25 mmol) and 1.5 
mL of dry THF. Obtained as inseparable mixture after column chromatography using PET / 
EtOAc (1:1) as eluent: 315e:319e (1:10), 71 mg, 0.23 mmol (42%): yellow oil. 
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[1-(4-Methoxy-benzenesulfonyl)-5-methyl-2,7-dihydro-1H-azepin-4-yl]-methanol (315e) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.74 – 7.70 (m, 2H; HAr-10), 6.99 – 6.95 (m, 2H; HAr-
11), 5.88 (t, J = 7.0 Hz, 1H; H-2), 5.73 (tq, J = 7.0, 1.4 Hz, 1H; H-5), 4.13 (s, 2H; H-7), 3.86 
(s, 3H; H-13), 3.56 (d, J = 7.0 Hz, 2H; H-1), 3.55 (d, J = 7.0 Hz, 2H; H-6), 1.79 (s, 3H; H-8). 
13C NMR (126 MHz, CDCl3, 25 oC) δ = 162.9 (Cq; C-12), 147.7 (Cq; C-3), 142.1 (Cq; C-4), 
130.7 (Cq; C-9), 129.6 (2 x CHAr; C-10), 124.5 (CH; C-5), 122.5 (CH; C-2), 114.4 (2 x CHAr; 
C-11), 63.7 (CH2; C-7), 55.8 (CH3; C-13), 43.8 (CH2; C-6), 43.5 (CH2; C-1), 19.8 (CH3; C-8).  
[1-(4-methoxy-benzenesulfonyl)-5-methylene-2,5,6,7-tetrahydro-1H-azepin-4-yl]-
methanol (319e) 
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.70 – 7.66 (m, 2H; HAr-10), 6.94 – 6.90 (m, 2H; HAr-
11), 5.80 (t, J = 5.0 Hz, 1H; H-2), 4.99 (s, 1H; H-8), 4.94 (s, 1H; H-8), 4.11 (s, 2H; H-7), 3.94 
(d, J = 5.0 Hz, 2H; H-1), 3.84 (s, 3H; H-13), 3.42 (t, J = 6.4 Hz, 2H; H-6), 2.48 (t, J = 6.4 Hz, 
2H; H-5).  13C NMR (126 MHz, CDCl3, 25 oC) δ = 162.9 (Cq; C-12), 142.8 (Cq; C-3 or C-4), 
142.6 (Cq; C-3 or C-4), 130.9 (Cq; C-9), 129.6 (2 x CHAr; C-10), 124.6 (CH; C-2), 115.0 (CH2; 
C-8), 114.1 (2 x CHAr; C-11), 65.2 (CH2; C-7), 55.7 (CH3; C-13), 48.7 (CH2; C-6), 45.0 (CH2; 
C-1), 36.3 (CH2; C-5). 
316e and 319e as inseparable mixture. IR (Film, cm-1): ν̃ = 3520 (O-H), 3096 (C-HAlkene), 3076 
(C-HAlkene), 2927 (C-HAlkane), 2845 (C-HAlkane), 1596 (C=C), 1498, 1332 (S=O), 1260 (C-O), 
1154 (S=O), 1096 (C-N), 1063 (C-O), 899. HRMS (FTMS + p NSI ((DCM)/MeOH + 
NH4OAc)): Calc. for C15H20O4NS [M+H]+: 310.1108. Found: 310.1112.  
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Synthesis of 315q and 319q (traces)  
 
Procedure 2 
 From 1,5-bisallene 259 (188 mg, 1.54 mmol), PtCl2(MeCN)2 (27 mg, 0.08 mmol), 
silver hexafluoroantimonate (63 mg, 0.18 mmol), distilled water (12.7 mL, 0.70 mmol) and 
4.2 mL of dry THF. Obtained after column chromatography using DCM / Et2O (1:1) as eluent: 
315q, 29 mg, 0.21 mmol (13%): yellow oil; and traces of 319q.  
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 6.43 (dd, J = 17.4, 10.5 Hz, 1H; H-5), 5.91 (t, J = 6.7 
Hz, 1H; H-2), 5.30 (s, 1H; H-8), 5.16 (d, J = 17.4 Hz, 1H; H-6), 5.15 (d, J = 10.5 Hz, 1H; H-
6), 5.03 (s, 1H; H-8), 4.14 (s, 2H; H-7), 4.08 (d, J = 6.7 Hz, 2H; H-1). 13C NMR (126 MHz, 
CDCl3, 25 oC) δ = 144.0 (Cq; C-4), 141.0 (Cq; C-3), 137.5 (CH; C-5), 126.7 (CH; C-2), 118.9 
(CH2; C-8), 116.6 (CH2; C-6), 66.2 (CH2; C-7), 60.1 (CH2; C-1). IR (Film, cm-1): ν̃ = 3349 (O-
H), 3087 (C-HAlkene), 2925 (C-HAlkane), 2856 (C-HAlkane), 1738 (C=C), 1585 (N-H(Bend)), 1432, 
1364, 1231, 1086 (C-OOH), 993, 907. HRMS (FTMS + p APCI (DCM)): Calc. for C8H13O2 
[M+H]+: 141.0910. Found: 141.0906. 
 Product 319q could not be fully characterised by 1H and 13C NMR due to the low 
concentration of the product in the crude of reaction. 
Synthesis of 4-methoxymethyl-5-methyl-1-(toluene-4-sulfonyl)-2,7-dihydro-1H-azepine 
(299a) 
 
 To a flame-dried Schlenk tube, were added PtCl2(MeCN)2 (6 mg, 0.02 mmol, 0.05 
Eq.) and silver hexafluoroantimonate (12 mg, 0.04 mmol, 0.1 Eq.) under N2 flow. Then, dry 
MeOH (2.0 mL) was added and the solution was stirred at room temperature for a few min to 
preform the cationic complex. 1,5-Bisallene 204a (98 mg, 0.36 mmol, 1.0 Eq., 0.07 M – 
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absolute concentration) dissolved in dry MeOH (3.0 mL) was added under N2 and the Schlenk 
tube was placed in a pre-heated oil bath at 70 oC until completed conversion, following the 
reaction by TLC. The crude was filtered through celite, washed with dichloromethane and 
concentrated under vacuum. The mixture was purified by column chromatography using 
(Sigma-Aldrich Silica gel) and Hex / EtOAc (10:1) and (4:1) as eluent: 299a, 14 mg, 0.05 
mmol (13%): yellow oil; 305a, 12 mg, 0.04 mmol, (11%): yellow oil; and 298a, 28 mg, 0.09 
mmol, (25%): yellow oil.  
299a 1H NMR (300 MHz, CDCl3, 25 oC) δ = 7.69 (d, J = 8.2 Hz, 2H; HAr-11), 7.30 (d, J = 8.2 
Hz, 2H; HAr-12), 5.84 (t, J = 7.1 Hz, 1H; H-2), 5.74 (tq, J = 7.2, 1.2 Hz, 1H; H-5), 3.91 (s, 2H; 
H-7), 3.59 (d, J = 7.1 Hz, 2H; H-1), 3.56 (d, J = 7.2 Hz, 2H; H-6), 3.15 (s, 3H; H-8), 2.43 (s, 
3H; H-14), 1.78 (s, 3H; H-9). 13C NMR (75 MHz, CDCl3, 25 oC) δ = 144.2 (Cq), 142.2 (Cq), 
141.4 (Cq), 135.0 (Cq), 128.7 (2 x CHAr; C-12), 126.5 (2 x CHAr; C-11), 123.2 (CH; C-5), 123.1 
(CH; C-2), 72.3 (CH2; C-7), 56.8 (CH3; C-8), 42.7 (CH2; C-6), 42.4 (CH2; C-1), 20.5 (CH3; C-
14), 18.6 (CH3; C-9). IR (Film, cm-1): ν̃ = 3098 (C-HAlkene), 3082 (C-HAlkene), 2925 (C-HAlkane), 
2855 (C-HAlkane), 1727 (C=C), 1598, 1450, 1310 (S=O), 1240 (C-O), 1161 (S=O), 1094 (C-
N), 1002 (C-O), 911. HRMS (ESI-HRMS) Calc. for C16H22O3NS [M+H]+: 308.1320 Found: 
308.1323. 
Synthesis of N-(3-methoxymethyl-4-methylene-hexa-2,5-dienyl)-benzenesulfonamide 
(298d) 
 
 To a microwave vial were added PtCl2(MeCN)2 (5 mg, 0.01 mmol, 0.05 Eq.) and 
AgSbF6 (9 mg, 0.03 mmol, 0.1 Eq.). Then the vial was closed with a stopper and flushed with 
N2 during 3 min. A small amount of dry THF was added and the solution was stirred at room 
temperature for a few min to preform the cationic complex. 1,5-Bisallene 266d (72 mg, 0.27 
mmol, 1.0 Eq., 0.09 M – absolute concentration) dissolved in dry THF was added, then dry 
MeOH (THF:MeOH 9:1). The vial was sealed under N2 and placed in a pre-heated oil bath at 
70 oC until completed conversion, following the reaction by TLC. The crude was filtered 
through celite, washed with dichloromethane and concentrated under vacuum. The mixture 
was purified by column chromatography using (Sigma-Aldrich Silica gel) and Hex / EtOAc 
(8:1) as eluent: 298d, 34 mg, 0.12 mmol, (43%): yellow oil; and 305d, 15 mg, 0.05 mmol, 
(19%): yellow oil.  
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1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.87 – 7.82 (m, 2H; HAr-11), 7.60 – 7.55 (m, 1H; HAr-
13), 7.54 – 7.48 (m, 2H; HAr-12), 6.30 (dd, J = 17.5, 10.5 Hz, 1H; H-5), 5.63 (tt, J = 7.0, 1.4 
Hz, 1H; H-2), 5.17 (s, 1H; H-9), 5.06 (d, J = 10.5 Hz, 1H; H-6), 5.03 (d, J = 17.5 Hz, 1H; H-
6), 4.89 (s, 1H; H-9), 4.34 (bt, J = 5.7 Hz, 1H; NH), 3.82 (s, 2H; H-7), 3.55 – 3.48 (m, 2H; H-
1), 3.30 (s, 3H; H-8). 13C NMR (126 MHz, CDCl3, 25 oC) δ = 143.7 (Cq), 140.2 (Cq), 140.1 
(Cq), 137.2 (CH; C-5), 132.8 (CHAr; C-13), 129.2 (2 x CHAr; C-12), 127.3 (2 x CHAr; C-11), 
123.2 (CH; C-2), 118.9 (CH2; C-9), 116.4 (CH2; C-6), 75.2 (CH2; C-7), 58.4 (CH3; C-8), 41.6 
(CH2; C-1). IR (Film, cm-1): ν̃ = 3269 (N-H), 3100 (C-HAlkene), 2922 (C-HAlkane), 2852 (C-
HAlkane), 1739 (C=C), 1583 (N-H(Bend)), 1446, 1308 (S=O), 1240 (C-O), 1152 (S=O), 1090 (C-
N), 1038 (C-O), 986. HRMS (FTMS + p NSI ((DCM)/MeOH + NH4OAc)): Calc. for 
C15H23O3N2S [M+NH4]+: 311.1424. Found: 311.1425. 
N,N-Bis-(4,4-dimethoxy-butyl)-4-methyl-benzenesulfonamide (300)  
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.66 (d, J = 8.2 Hz, 2H; HAr-8), 7.27 (d, J = 8.2 Hz, 
2H; HAr-7), 4.32 (t, J = 5.0 Hz, 2H; H-4), 3.28 (s, 12H; H-5), 3.10 (t, J = 7.0 Hz, 4H; H-1), 
2.40 (s, 3H; H-10), 1.61 – 1.52 (m, 8H; H-3 and H-2). IR (Film, cm-1): ν̃ = 2926 (C-HAlkane), 
2870 (C-HAlkane), 1719, 1682, 1335 (S=O), 1158 (S=O), 1091 (C-N), 1015 (C-O), 815. HRMS 
(+ESI): Calc. for C19H33O6NSNa [M+Na]+: 426.1921. Found: 426.1924. M.P. = 115 – 117 oC. 
1-(Toluene-4-sulfonyl)-2,5-dihydro-1H-pyrrole (314)[272]  
 
1H NMR (500 MHz, CDCl3, 25 oC) δ = 7.74 – 7.70 (m, 2H; HAr-4), 7.32 (d, J = 8.2 Hz, 2H; 
HAr-5), 5.65 (s, 2H; H-2), 4.12 (s, 4H; H-1), 2.43 (s, 3H; H-7). 13C NMR (126 MHz, CDCl3, 
25 oC) δ = 143.6 (Cq; C-6), 134.5 (Cq; C-3), 129.9 (2 x CHAr; C-3), 127.6 (2 x CH; C-2), 125.6 
(2 x CHAr; C-4), 55.0 (2 x CH2; C-1), 21.7 (CH3; C-7). 
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Appendix A 
X-ray Data  
 The crystallographic data for the structures presented in the text are given in this 
experimental section. All the crystallographic analyses were performed by Dr. J. Christensen 
at NCS, UK National Crystallography Service.  
Compound 319a-d4 
Crystal data and structure refinement for compound 319a-d4. 
 
Empirical formula   C15H15D4NO3S  
Formula weight   297.40  
Temperature   100(2) K  
Wavelength   0.71073 Å  
Crystal system   Triclinic  
Space group   P1   
Unit cell dimensions  a = 7.7739(5) Å  = 81.084(4)° 
  b = 8.1108(5) Å  = 77.029(4)° 
  c = 11.6326(5) Å   = 84.725(5)° 
Volume  704.87(7) Å3  
Z  2  
Density (calculated)  1.401 Mg / m3  
Absorption coefficient  0.236 mm1  
F(000)  312  
Crystal  Chip; colourless  
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Crystal size  0.09  0.07  0.03 mm3  
 range for data collection  2.546  29.975°  
Index ranges  10  h  10, 11  k  11, 
15  l  15 
 
Reflections collected  12909  
Independent reflections  3710 [Rint = 0.0582]  
Completeness to  = 25.242°  100.0 %   
Absorption correction  Semiempirical from 
equivalents 
 
Max. and min. transmission  1.00000 and 0.71189  
Refinement method  Full-matrix least-squares on 
F2 
 
Data / restraints / parameters  3710 / 0 / 232  
Goodness-of-fit on F2  1.044  
Final R indices [F2 > 2(F2)]  R1 = 0.0448, wR2 = 0.0994  
R indices (all data)  R1 = 0.0661, wR2 = 0.1086  
Extinction coefficient  n/a  
Largest diff. peak and hole  0.329 and 0.388 e Å3  
 
Compound 319c 
Crystal data and structure refinement for compound 319c. 
 
Empirical formula   C14H16N2O5S  
Formula weight   324.35  
Temperature   100(2) K  
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Wavelength   0.71073 Å  
Crystal system   Triclinic  
Space group   P1   
Unit cell dimensions  a = 7.4327(3) Å  = 84.381(3)° 
  b = 7.9704(3) Å  = 77.298(3)° 
  c = 12.1638(5) Å   = 87.637(3)° 
Volume  699.45(5) Å3  
Z  2  
Density (calculated)  1.540 Mg / m3  
Absorption coefficient  0.259 mm1  
F(000)  340  
Crystal  Block; colourless  
Crystal size  0.17  0.08  0.06 mm3  
 range for data collection  2.568  29.509°  
Index ranges  9  h  10, 10  k  10, 14 
 l  16 
 
Reflections collected  9013  
Independent reflections  3478 [Rint = 0.0422]  
Completeness to  = 25.242°  99.8 %   
Absorption correction  Semiempirical from 
equivalents 
 
Max. and min. transmission  1.00000 and 0.71296  
Refinement method  Full-matrix least-squares on 
F2 
 
Data / restraints / parameters  3478 / 0 / 203  
Goodness-of-fit on F2  1.042  
Final R indices [F2 > 2(F2)]  R1 = 0.0379, wR2 = 0.0986  
R indices (all data)  R1 = 0.0468, wR2 = 0.1034  
Extinction coefficient  n/a  
Largest diff. peak and hole  0.386 and 0.412 e Å3  
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Apendix B 
Gold-catalysed hydroazidation reaction of allenes monitored by IR  
 
IR carried out after 30 min. 
 
IR carried out after 1 h 45 min. 
 
IR carried out after 6 h. 
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 IR carried out after 9 h 30 min. 
Stoichiometric NMR Experiments 
Experiment A 
Results obtained in stoichiometric experiment A 
4000 5003500 3000 2500 2000 1500 1000
89
21
25
30
35
40
45
50
55
60
65
70
75
80
85
cm-1
%
T
1175.24cm-11215.35cm-1
2929.21cm-1
1783.84cm-1
2855.35cm-1
2101.14cm-1
1666.84cm-1
1032.21cm-1
1450.46cm-1 940.68cm-1
3454.84cm-1
1589.74cm-1
970.52cm-1
1599.77cm-1
1487.38cm-1
Addition 
Time 
(min) 
31P NMR 
(ppm) 
1H NMR integral (1H) 
96b 124a 125a 127 128 126 
(PhO)3PAuCl 0 110 - - - - - - 
AgOTf 0 - - - - - - - 
- 30 104 - - - - - - 
TMSN3 75 - - - - - - - 
- 105 106 - - - - - - 
109b 145 - - - - - - - 
- 205 104 5.27 0.3 1 0.00 0.39 0.00 
TFA 285 - - - - - - - 
- 305 103 3.09 0.64 1 0.3 0.5 0.00 
- 425 103 2.14 0.90 1 0.56 0.5 0.00 
H2O 485 - - - - - - - 
- 545 103 1.96 1.10 1 0.86 0.56 0.4 
- 1405 - 0.8 1.84 1 1.16 0.80 0.65 
Addition 
Time 
(min) 
% Conversion 
96b 124a 125a 127 128 126 
(PhO)3PAuCl - - - - - - - 
AgOTf - - - - - - - 
- - - - - - - - 
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Experiment B 
Results obtained in stoichiometric experiment B 
TMSN3 - - - - - - - 
- - - - - - - - 
109b 0 100 0.00 0.00 0.00 0.00 0.00 
- 60 75.72 4.31 14.37 0.00 5.60 0.00 
TFA - - - - - - - 
- 160 55.88 11.57 18.08 5.42 9.04 0.00 
- 280 39.96 16.90 18.67 10.46 9.34 4.67 
H2O        
- 400 33.25 18.74 16.96 14.67 9.58 6.79 
- 1260 12.78 29.47 15.97 18.53 12.86 10.38 
Addition 
Time 
(min) 
31P NMR 
(ppm) 
1H NMR integral (1H) 
96b 124a 125a 127 128 126 
(PhO)3PAuCl 0 110 - - - - - - 
AgOTf 0 - - - - - - - 
- 30 104 - - - - - - 
109b 75 - - - - - - - 
- 105 105 - - - - - - 
TMSN3 145 - - - - - - - 
- 205 106 4.97 0.45 1 0.3 0.36 0.00 
TFA 285 - - - - - - - 
- 305 103 4.71 0.62 1 0.56 0.63 0.00 
- 425 103 3.09 0.78 1 0.66 0.60 0.15 
- 545 103 3.37 1.19 1 0.89 0.6 0.25 
- 1405 - 1.23 1.52 1 1.18 0.55 0.5 
Addition 
Time 
(min) 
% Conversion 
96b 124a 125a 127 128 126 
(PhO)3PAuCl - - - - - - - 
AgOTf - - - - - - - 
- - - - - - - - 
109b - - - - - - - 
- - - - - - - - 
TMSN3 0 100 0.00 0.00 0.00 0.00 0.00 
- 60 70.20 6.36 14.12 4.24 5.08 0.00 
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Experiment C 
Results obtained in stoichiometric experiment C 
TFA - - - - - - - 
- 160 62.55 8.30 13.28 7.44 8.43 0.00 
- 280 49.09 12.39 15.89 10.56 9.61 2.46 
- 400 46.10 16.35 13.68 12.24 8.21 3.42 
- 1260 20.55 25.48 16.71 19.72 9.19 8.35 
Addition 
Time 
(min) 
31P NMR 
(ppm) 
1H NMR integral (1H) 
96b 124a 125a 127 128 126 
(PhO)3PAuCl 0 110 - - - - - - 
AgOTf 0 - - - - - - - 
- 30 104 - - - - - - 
TFA 75 - - - - - - - 
- 105 99 - - - - - - 
TMSN3 145 - - - - - - - 
- 205 97.69 - - - - - - 
109b 285 - - - - - - - 
- 305 98.16 5.68 0.36 1 0.54 0.28 0.00 
- 425 98.56 2.3 0.70 1 1.01 0.25 0.15 
- 545 97.96 2.03 0.98 1 1.22 0.3 0.28 
- 1405 - 0.94 1.53 1 1.68 0.25 0.67 
Addition 
Time 
(min) 
% Conversion 
96b 124a 125a 127 128 126 
(PhO)3PAuCl - - - - - - - 
AgOTf - - - - - - - 
- - - - - - - - 
TFA - - - - - - - 
- - - - - - - - 
TMSN3 - - - - - - - 
- - - - - - - - 
109b 0 100 0.00 0.00 0.00 0.00 0.00 
- 20 72.17 4.64 12.71 6.86 3.62 0.00 
- 140 42.40 13.00 18.43 18.62 4.70 2.86 
- 260 34.91 16.85 17.20 20.98 5.16 4.90 
- 1120 15.56 25.19 16.46 27.65 4.12 11.03 
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Time 
(h) 
1H NMR integral (1H) / Conversion (%) 
96b 124a 125a 127 128 126 
0 1 100 0 0 1 0 0 0 0 0 0 0 
1 0.78 24.2 0.65 20.2 1 30.9 0.3 9.26 0.5 15.4 0 0.00 
3 0 0.00 3.12 53.4 1 17.1 0.24 4.10 1.46 24.9 0.03 0.51 
5 0 0.00 4.03 57.4 1 14.2 0.23 3.27 1.75 24.9 0.01 0.14 
7 0 0.00 4.21 56.7 1 13.5 0.3 4.04 1.91 25.7 0.01 0.13 
9 0 0.00 4.38 54.8 1 13.1 0.33 4.13 2.17 27.1 0.11 1.38 
11 0 0.00 4.23 54.3 1 12.5 0.33 4.24 2.12 27.2 0.11 1.41 
22 0 0.00 4.22 57.0 1 12.8 0.35 4.73 1.71 23.1 0.12 1.62 
Table 15. Further information about the integrals related to the different products. 
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